country,term,count
AX,ARTHRALGIA,1
AL,HYPOTENSION,2
AL,ANAPHYLACTIC REACTION,1
AL,ANGIOEDEMA,1
AL,CHEST DISCOMFORT,1
AL,CILIARY HYPERAEMIA,1
AL,COUGH,1
AL,DRUG HYPERSENSITIVITY,1
AL,DYSPNOEA,1
AL,ERYTHEMA,1
AL,PAIN IN EXTREMITY,1
AL,PYREXIA,1
AL,RHINORRHOEA,1
AL,TACHYCARDIA,1
DZ,ABORTION SPONTANEOUS,1
DZ,ARTHRALGIA,1
DZ,ASTHENIA,1
DZ,DERMATITIS BULLOUS,1
DZ,DRUG ERUPTION,1
DZ,GAIT DISTURBANCE,1
DZ,OEDEMA PERIPHERAL,1
DZ,PARALYSIS,1
DZ,SWELLING FACE,1
AR,FALL,3
AR,DRUG INEFFECTIVE,2
AR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
AR,MONONEUROPATHY,2
AR,ACCIDENT,1
AR,ACUTE KIDNEY INJURY,1
AR,ANAEMIA,1
AR,ARTHRALGIA,1
AR,ARTHRITIS,1
AR,BLOOD PRESSURE INCREASED,1
AR,CHRONIC GASTRITIS,1
AR,DECREASED IMMUNE RESPONSIVENESS,1
AR,DUODENAL ULCER,1
AR,ENTEROCOLITIS,1
AR,FATIGUE,1
AR,FEAR,1
AR,FEELING ABNORMAL,1
AR,FIBROMYALGIA,1
AR,FUNGAL INFECTION,1
AR,GASTROINTESTINAL HAEMORRHAGE,1
AR,GENERAL PHYSICAL HEALTH DETERIORATION,1
AR,HAEMATOCRIT DECREASED,1
AR,HEADACHE,1
AR,HIATUS HERNIA,1
AR,HYPOTHERMIA,1
AR,JOINT INJURY,1
AR,KIDNEY INFECTION,1
AR,LABORATORY TEST ABNORMAL,1
AR,LIMB DEFORMITY,1
AR,MOLLUSCUM CONTAGIOSUM,1
AR,NAUSEA,1
AR,NERVE INJURY,1
AR,OESOPHAGITIS,1
AR,OROPHARYNGEAL PAIN,1
AR,OSTEOARTHRITIS,1
AR,PAIN,1
AR,PANCYTOPENIA,1
AR,PERIPHERAL SWELLING,1
AR,PLATELET COUNT DECREASED,1
AR,PNEUMONIA,1
AR,PNEUMONIA PSEUDOMONAL,1
AR,PRODUCT USE IN UNAPPROVED INDICATION,1
AR,PSYCHOMOTOR HYPERACTIVITY,1
AR,RED BLOOD CELL COUNT DECREASED,1
AR,RENAL FAILURE,1
AR,RHEUMATOID ARTHRITIS,1
AR,SALIVARY HYPERSECRETION,1
AR,SEPTIC SHOCK,1
AR,SPINAL DISORDER,1
AR,THROMBOCYTOPENIA,1
AR,TONSILLAR INFLAMMATION,1
AR,TYPE 2 DIABETES MELLITUS,1
AR,URINARY TRACT INFECTION,1
AR,URTICARIA,1
AR,VARICELLA,1
AR,VOMITING,1
AR,WHITE BLOOD CELL COUNT DECREASED,1
AR,WRIST FRACTURE,1
AU,PAIN,39
AU,PYREXIA,38
AU,FALL,36
AU,DYSPNOEA,33
AU,FATIGUE,33
AU,NAUSEA,32
AU,DIARRHOEA,28
AU,MALAISE,28
AU,ARTHRALGIA,24
AU,DIZZINESS,24
AU,LOWER RESPIRATORY TRACT INFECTION,23
AU,BACK PAIN,22
AU,CHEST PAIN,22
AU,PAIN IN EXTREMITY,22
AU,HEADACHE,21
AU,OVERDOSE,19
AU,NEUTROPENIA,18
AU,ANAEMIA,17
AU,CONSTIPATION,17
AU,DECREASED APPETITE,17
AU,DRUG INEFFECTIVE,17
AU,INSOMNIA,17
AU,RASH,16
AU,VOMITING,16
AU,ABDOMINAL PAIN,15
AU,DRUG-INDUCED LIVER INJURY,15
AU,FEBRILE NEUTROPENIA,15
AU,GAIT DISTURBANCE,15
AU,HYPOTENSION,15
AU,PRURITUS,15
AU,TOXICITY TO VARIOUS AGENTS,15
AU,URINARY TRACT INFECTION,15
AU,ATRIAL FIBRILLATION,14
AU,CONFUSIONAL STATE,14
AU,FEELING ABNORMAL,14
AU,SYNCOPE,14
AU,CEREBROVASCULAR ACCIDENT,13
AU,DEHYDRATION,13
AU,LETHARGY,13
AU,OEDEMA PERIPHERAL,13
AU,HYPERTENSION,12
AU,PNEUMONIA,12
AU,CHILLS,11
AU,OSTEOARTHRITIS,11
AU,WEIGHT DECREASED,11
AU,DEPRESSION,10
AU,SCHIZOPHRENIA,10
AU,TACHYCARDIA,10
AU,URINARY RETENTION,10
AU,ACUTE MYOCARDIAL INFARCTION,9
AU,ANXIETY,9
AU,ASTHENIA,9
AU,BLOOD PRESSURE INCREASED,9
AU,GASTROOESOPHAGEAL REFLUX DISEASE,9
AU,HYPONATRAEMIA,9
AU,MUSCLE SPASMS,9
AU,NECK PAIN,9
AU,PERICARDITIS,9
AU,PULMONARY EMBOLISM,9
AU,SUICIDAL IDEATION,9
AU,TREMOR,9
AU,URINARY INCONTINENCE,9
AU,VITAMIN D DECREASED,9
AU,ABNORMAL BEHAVIOUR,8
AU,ACUTE KIDNEY INJURY,8
AU,ALOPECIA,8
AU,ASTHMA,8
AU,CONDITION AGGRAVATED,8
AU,COUGH,8
AU,DRUG DOSE OMISSION,8
AU,FLUSHING,8
AU,HAEMOGLOBIN DECREASED,8
AU,MALIGNANT NEOPLASM PROGRESSION,8
AU,MOUTH ULCERATION,8
AU,MYALGIA,8
AU,PALPITATIONS,8
AU,PARAESTHESIA,8
AU,PLEURAL EFFUSION,8
AU,RENAL IMPAIRMENT,8
AU,SEPSIS,8
AU,THROMBOCYTOPENIA,8
AU,VISION BLURRED,8
AU,ANTIPSYCHOTIC DRUG LEVEL DECREASED,7
AU,ARTHROPATHY,7
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,7
AU,C-REACTIVE PROTEIN DECREASED,7
AU,DEATH,7
AU,DEMENTIA,7
AU,FEMUR FRACTURE,7
AU,GASTROINTESTINAL DISORDER,7
AU,INFLUENZA LIKE ILLNESS,7
AU,LIVER FUNCTION TEST ABNORMAL,7
AU,LYMPHADENOPATHY MEDIASTINAL,7
AU,MUSCULAR WEAKNESS,7
AU,MUSCULOSKELETAL PAIN,7
AU,MYOCARDITIS,7
AU,OSTEOPOROSIS,7
AU,RESPIRATORY FAILURE,7
AU,SPLENOMEGALY,7
AU,ABDOMINAL DISCOMFORT,6
AU,ACUTE MYELOID LEUKAEMIA,6
AU,BALANCE DISORDER,6
AU,BLOOD ALKALINE PHOSPHATASE INCREASED,6
AU,CATARACT,6
AU,DELIRIUM,6
AU,DYSPHAGIA,6
AU,EPISTAXIS,6
AU,ERYTHEMA,6
AU,HEART RATE INCREASED,6
AU,IMPAIRED HEALING,6
AU,INFLUENZA,6
AU,JOINT SWELLING,6
AU,LOSS OF CONSCIOUSNESS,6
AU,MEMORY IMPAIRMENT,6
AU,NASOPHARYNGITIS,6
AU,OROPHARYNGEAL PAIN,6
AU,PANIC ATTACK,6
AU,PERIPHERAL SWELLING,6
AU,PNEUMONITIS,6
AU,PULMONARY OEDEMA,6
AU,RENAL FAILURE ACUTE,6
AU,RHEUMATOID ARTHRITIS,6
AU,RIB FRACTURE,6
AU,SEROTONIN SYNDROME,6
AU,TRANSIENT ISCHAEMIC ATTACK,6
AU,ACTIVITIES OF DAILY LIVING IMPAIRED,5
AU,AGITATION,5
AU,AMNESIA,5
AU,ANAPHYLACTIC REACTION,5
AU,ATELECTASIS,5
AU,BASAL CELL CARCINOMA,5
AU,BLOOD CHOLESTEROL INCREASED,5
AU,BLOOD GLUCOSE INCREASED,5
AU,BONE PAIN,5
AU,BREAST CANCER,5
AU,CARDIAC DISORDER,5
AU,CHEST DISCOMFORT,5
AU,CIRCULATORY COLLAPSE,5
AU,COLITIS,5
AU,COMA,5
AU,CONTUSION,5
AU,CORONARY ARTERY DISEASE,5
AU,CROHN^S DISEASE,5
AU,DEEP VEIN THROMBOSIS,5
AU,DRUG HYPERSENSITIVITY,5
AU,DYSARTHRIA,5
AU,EMOTIONAL DISTRESS,5
AU,GAMMA-GLUTAMYLTRANSFERASE INCREASED,5
AU,GENERAL PHYSICAL HEALTH DETERIORATION,5
AU,HAEMORRHAGE,5
AU,HALLUCINATION,5
AU,HIP FRACTURE,5
AU,HYPERHIDROSIS,5
AU,HYPERKALAEMIA,5
AU,HYPERSENSITIVITY,5
AU,HYPOAESTHESIA,5
AU,HYPOGLYCAEMIA,5
AU,INCONTINENCE,5
AU,INFUSION RELATED REACTION,5
AU,MIGRAINE,5
AU,MITRAL VALVE INCOMPETENCE,5
AU,MUSCULOSKELETAL CHEST PAIN,5
AU,MYOCARDIAL INFARCTION,5
AU,POST PROCEDURAL COMPLICATION,5
AU,PRODUCTIVE COUGH,5
AU,RECTAL HAEMORRHAGE,5
AU,SQUAMOUS CELL CARCINOMA,5
AU,SWELLING FACE,5
AU,TREATMENT NONCOMPLIANCE,5
AU,UNEVALUABLE EVENT,5
AU,VISUAL IMPAIRMENT,5
AU,ABDOMINAL DISTENSION,4
AU,AGGRESSION,4
AU,ALANINE AMINOTRANSFERASE INCREASED,4
AU,ANGIOEDEMA,4
AU,BLOOD CREATININE INCREASED,4
AU,BURNING SENSATION,4
AU,CARDIAC ARREST,4
AU,CARDIAC FAILURE,4
AU,COGNITIVE DISORDER,4
AU,DISORIENTATION,4
AU,DIVERTICULITIS,4
AU,DRUG DISPENSING ERROR,4
AU,DRY EYE,4
AU,DRY MOUTH,4
AU,ELECTROCARDIOGRAM QT PROLONGED,4
AU,EMPHYSEMA,4
AU,EYE PAIN,4
AU,FEELING COLD,4
AU,GLOMERULAR FILTRATION RATE DECREASED,4
AU,HAEMATURIA,4
AU,HEART RATE IRREGULAR,4
AU,HEPATIC FAILURE,4
AU,HEPATITIS ACUTE,4
AU,HIATUS HERNIA,4
AU,HYPOPHAGIA,4
AU,INTENTIONAL OVERDOSE,4
AU,INTERVERTEBRAL DISC DEGENERATION,4
AU,LIVER FUNCTION TEST INCREASED,4
AU,MALIGNANT MELANOMA,4
AU,MOBILITY DECREASED,4
AU,MYELODYSPLASTIC SYNDROME,4
AU,NEURALGIA,4
AU,NEUROLEPTIC MALIGNANT SYNDROME,4
AU,PAIN IN JAW,4
AU,RED BLOOD CELL COUNT DECREASED,4
AU,RENAL FAILURE,4
AU,RESPIRATORY DEPRESSION,4
AU,RESPIRATORY TRACT INFECTION,4
AU,RHABDOMYOLYSIS,4
AU,SEIZURE,4
AU,SLEEP APNOEA SYNDROME,4
AU,SOMNOLENCE,4
AU,SPINAL FRACTURE,4
AU,TRICUSPID VALVE INCOMPETENCE,4
AU,VIRAL INFECTION,4
AU,VULVOVAGINAL CANDIDIASIS,4
AU,WEIGHT INCREASED,4
AU,WHITE BLOOD CELL COUNT DECREASED,4
AU,ABDOMINAL PAIN UPPER,3
AU,ACIDOSIS,3
AU,ACUTE CORONARY SYNDROME,3
AU,APHASIA,3
AU,ARRHYTHMIA,3
AU,ASPIRATION,3
AU,BLOOD PARATHYROID HORMONE INCREASED,3
AU,BLOOD TRIGLYCERIDES INCREASED,3
AU,BLOOD UREA INCREASED,3
AU,BRONCHITIS,3
AU,CARDIAC FAILURE CONGESTIVE,3
AU,CELLULITIS,3
AU,CHOLANGITIS,3
AU,CHOLELITHIASIS,3
AU,CHROMATURIA,3
AU,CHRONIC SINUSITIS,3
AU,COMA SCALE ABNORMAL,3
AU,COMPLETED SUICIDE,3
AU,CONGESTIVE CARDIOMYOPATHY,3
AU,CONVULSION,3
AU,DEPRESSED LEVEL OF CONSCIOUSNESS,3
AU,DEVICE RELATED INFECTION,3
AU,DIPLOPIA,3
AU,DISEASE RECURRENCE,3
AU,DRUG DEPENDENCE,3
AU,DRUG EFFECT INCOMPLETE,3
AU,DRUG LEVEL INCREASED,3
AU,DRY SKIN,3
AU,DYSGEUSIA,3
AU,ECZEMA,3
AU,EXTRAPYRAMIDAL DISORDER,3
AU,FOOT FRACTURE,3
AU,GASTRITIS,3
AU,HEMIPARESIS,3
AU,HYPERCHOLESTEROLAEMIA,3
AU,HYPOKALAEMIA,3
AU,HYPOTHYROIDISM,3
AU,HYPOXIA,3
AU,INFECTION,3
AU,INTENTIONAL SELF-INJURY,3
AU,INTERVERTEBRAL DISC PROTRUSION,3
AU,IRRITABILITY,3
AU,JOINT INJURY,3
AU,KNEE ARTHROPLASTY,3
AU,LIMB DISCOMFORT,3
AU,LIP SWELLING,3
AU,LYMPHOCYTE COUNT DECREASED,3
AU,MENTAL DISORDER,3
AU,METABOLIC ACIDOSIS,3
AU,MULTI-ORGAN FAILURE,3
AU,OEDEMA,3
AU,ORAL HERPES,3
AU,PALLOR,3
AU,PANCREATITIS,3
AU,PANCYTOPENIA,3
AU,PHOTOPHOBIA,3
AU,PLATELET COUNT DECREASED,3
AU,POISONING DELIBERATE,3
AU,PYODERMA GANGRENOSUM,3
AU,RASH ERYTHEMATOUS,3
AU,RASH MACULAR,3
AU,RASH PRURITIC,3
AU,RED BLOOD CELL SEDIMENTATION RATE INCREASED,3
AU,RED CELL DISTRIBUTION WIDTH INCREASED,3
AU,RESTLESSNESS,3
AU,SECOND PRIMARY MALIGNANCY,3
AU,SKIN CANCER,3
AU,SKIN LESION,3
AU,SKIN ULCER,3
AU,SPINAL CORD COMPRESSION,3
AU,SPINAL OSTEOARTHRITIS,3
AU,SQUAMOUS CELL CARCINOMA OF SKIN,3
AU,STEVENS-JOHNSON SYNDROME,3
AU,STRESS,3
AU,SUBDURAL HAEMATOMA,3
AU,SUICIDE ATTEMPT,3
AU,TROPONIN INCREASED,3
AU,VESTIBULAR NEURONITIS,3
AU,VITAMIN D DEFICIENCY,3
AU,ABASIA,2
AU,ABDOMINAL HERNIA,2
AU,ABSCESS LIMB,2
AU,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,2
AU,ACCIDENTAL OVERDOSE,2
AU,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,2
AU,ACUTE HEPATIC FAILURE,2
AU,ADDISON^S DISEASE,2
AU,ADVERSE EVENT,2
AU,ANGINA PECTORIS,2
AU,ANISOCYTOSIS,2
AU,AORTIC VALVE INCOMPETENCE,2
AU,APPENDICECTOMY,2
AU,ARTHRITIS,2
AU,ARTHRITIS INFECTIVE,2
AU,ASCITES,2
AU,ASPARTATE AMINOTRANSFERASE INCREASED,2
AU,BACTERAEMIA,2
AU,BLADDER DISORDER,2
AU,BLEPHARITIS,2
AU,BLISTER,2
AU,BLOOD CALCIUM DECREASED,2
AU,BLOOD CALCIUM INCREASED,2
AU,BLOOD CREATININE ABNORMAL,2
AU,BLOOD LACTATE DEHYDROGENASE INCREASED,2
AU,BLOOD POTASSIUM ABNORMAL,2
AU,BLOOD POTASSIUM INCREASED,2
AU,BLOOD PRESSURE ABNORMAL,2
AU,BLOOD PRESSURE DECREASED,2
AU,BLOOD PRESSURE SYSTOLIC INCREASED,2
AU,BLOOD SODIUM DECREASED,2
AU,BLOOD TEST ABNORMAL,2
AU,BOWEN^S DISEASE,2
AU,BRAIN NEOPLASM,2
AU,C-REACTIVE PROTEIN INCREASED,2
AU,CANDIDA INFECTION,2
AU,CARDIO-RESPIRATORY ARREST,2
AU,CARDIOMEGALY,2
AU,CEREBRAL HAEMORRHAGE,2
AU,CHOLANGIOCARCINOMA,2
AU,CHOLECYSTITIS,2
AU,CLAVICLE FRACTURE,2
AU,CORONARY ARTERY OCCLUSION,2
AU,CORONARY ARTERY STENOSIS,2
AU,CYANOSIS,2
AU,CYTOMEGALOVIRUS INFECTION,2
AU,DEAFNESS,2
AU,DELUSION,2
AU,DEPRESSED MOOD,2
AU,DERMAL CYST,2
AU,DIABETES MELLITUS,2
AU,DISCOMFORT,2
AU,DISSEMINATED INTRAVASCULAR COAGULATION,2
AU,DISTURBANCE IN ATTENTION,2
AU,DRUG EFFECT DECREASED,2
AU,DRUG PRESCRIBING ERROR,2
AU,DRUG WITHDRAWAL SYNDROME,2
AU,DYSURIA,2
AU,EJECTION FRACTION DECREASED,2
AU,EXOSTOSIS,2
AU,EXTRA DOSE ADMINISTERED,2
AU,FAECES DISCOLOURED,2
AU,FAT TISSUE INCREASED,2
AU,FEELING HOT,2
AU,FEMORAL NECK FRACTURE,2
AU,FLUID OVERLOAD,2
AU,FLUID RETENTION,2
AU,FOOD INTOLERANCE,2
AU,FOOT OPERATION,2
AU,FRACTURE,2
AU,GASTRIC ULCER,2
AU,GLAUCOMA,2
AU,GROIN PAIN,2
AU,HAEMATOCRIT DECREASED,2
AU,HAEMATOMA,2
AU,HAEMOGLOBIN ABNORMAL,2
AU,HAEMORRHAGE INTRACRANIAL,2
AU,HEPATIC CYST,2
AU,HEPATIC FUNCTION ABNORMAL,2
AU,HEPATIC STEATOSIS,2
AU,HEPATITIS,2
AU,HEPATITIS C,2
AU,HEPATOTOXICITY,2
AU,HERNIA,2
AU,HERPES ZOSTER,2
AU,HOT FLUSH,2
AU,HUMERUS FRACTURE,2
AU,HYPERCALCAEMIA,2
AU,HYPERLIPIDAEMIA,2
AU,HYPOAESTHESIA ORAL,2
AU,HYPOTHERMIA,2
AU,HYPOVOLAEMIA,2
AU,IMMUNE SYSTEM DISORDER,2
AU,INCORRECT DOSE ADMINISTERED,2
AU,INCORRECT DRUG ADMINISTRATION DURATION,2
AU,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,2
AU,INGROWING NAIL,2
AU,INTENTIONAL PRODUCT USE ISSUE,2
AU,INTERNATIONAL NORMALISED RATIO INCREASED,2
AU,INTERSTITIAL LUNG DISEASE,2
AU,IRON DEFICIENCY,2
AU,IRON DEFICIENCY ANAEMIA,2
AU,JOINT DISLOCATION,2
AU,JOINT STIFFNESS,2
AU,KIDNEY INFECTION,2
AU,LACERATION,2
AU,LEFT ATRIAL DILATATION,2
AU,LEFT VENTRICULAR DYSFUNCTION,2
AU,LICHEN PLANUS,2
AU,LICHENOID KERATOSIS,2
AU,LIVER DISORDER,2
AU,LIVER INJURY,2
AU,LOCAL SWELLING,2
AU,LOCALISED INFECTION,2
AU,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
AU,LUNG DISORDER,2
AU,LYMPHADENOPATHY,2
AU,METASTASES TO CENTRAL NERVOUS SYSTEM,2
AU,METASTASES TO LIVER,2
AU,METASTASES TO LYMPH NODES,2
AU,MOOD ALTERED,2
AU,MUCOSAL INFLAMMATION,2
AU,MULTIPLE FRACTURES,2
AU,MULTIPLE SCLEROSIS RELAPSE,2
AU,MUSCLE RUPTURE,2
AU,MUSCULOSKELETAL STIFFNESS,2
AU,MYOPATHY,2
AU,MYOSITIS,2
AU,NERVE INJURY,2
AU,NERVOUS SYSTEM DISORDER,2
AU,NIGHT SWEATS,2
AU,NO THERAPEUTIC RESPONSE,2
AU,NOCTURIA,2
AU,OBESITY,2
AU,OBSTRUCTIVE AIRWAYS DISORDER,2
AU,OCULAR HYPERAEMIA,2
AU,ORAL CANDIDIASIS,2
AU,OSTEITIS DEFORMANS,2
AU,OSTEONECROSIS OF JAW,2
AU,OXYGEN SATURATION DECREASED,2
AU,PALMOPLANTAR KERATODERMA,2
AU,PANCREATITIS NECROTISING,2
AU,PARANOIA,2
AU,PELVIC PAIN,2
AU,PNEUMONIA ASPIRATION,2
AU,PNEUMONIA PSEUDOMONAL,2
AU,PNEUMOTHORAX,2
AU,POLLAKIURIA,2
AU,POLYARTHRITIS,2
AU,POST-TRAUMATIC STRESS DISORDER,2
AU,PRODUCT QUALITY ISSUE,2
AU,PRODUCT USE ISSUE,2
AU,PROTEINURIA,2
AU,PSORIASIS,2
AU,PSORIATIC ARTHROPATHY,2
AU,PULMONARY HYPERTENSION,2
AU,RENAL CYST,2
AU,RENAL DISORDER,2
AU,RENAL FUNCTION TEST ABNORMAL,2
AU,RENAL TUBULAR ACIDOSIS,2
AU,RESPIRATORY ARREST,2
AU,RESPIRATORY DISTRESS,2
AU,RESTLESS LEGS SYNDROME,2
AU,RETINOPATHY,2
AU,SCIATICA,2
AU,SKIN DISCOLOURATION,2
AU,SKIN INJURY,2
AU,SLEEP DISORDER,2
AU,SPEECH DISORDER,2
AU,SPINAL PAIN,2
AU,SPUTUM DISCOLOURED,2
AU,SURGERY,2
AU,SYSTEMIC LUPUS ERYTHEMATOSUS,2
AU,TEMPERATURE INTOLERANCE,2
AU,TENDERNESS,2
AU,TENDON RUPTURE,2
AU,TENDONITIS,2
AU,THORACIC VERTEBRAL FRACTURE,2
AU,TOOTHACHE,2
AU,TUBULOINTERSTITIAL NEPHRITIS,2
AU,TYPE 2 DIABETES MELLITUS,2
AU,UPPER GASTROINTESTINAL HAEMORRHAGE,2
AU,UPPER RESPIRATORY TRACT INFECTION,2
AU,URTICARIA,2
AU,UVEITIS,2
AU,VAGINAL HAEMORRHAGE,2
AU,VASCULITIS,2
AU,VENTRICULAR EXTRASYSTOLES,2
AU,VERTIGO,2
AU,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
AU,WHITE BLOOD CELL COUNT INCREASED,2
AU,WOUND SECRETION,2
AU,WRIST FRACTURE,2
AU,WRONG DRUG ADMINISTERED,2
AU,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
AU,ABDOMINAL HERNIA REPAIR,1
AU,ABDOMINAL PAIN LOWER,1
AU,ABDOMINAL TENDERNESS,1
AU,ABDOMINAL WALL HAEMATOMA,1
AU,ABNORMAL LOSS OF WEIGHT,1
AU,ABORTION SPONTANEOUS,1
AU,ACCIDENTAL EXPOSURE TO PRODUCT,1
AU,ACNE,1
AU,ACQUIRED DIAPHRAGMATIC EVENTRATION,1
AU,ACUTE LEUKAEMIA,1
AU,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,1
AU,ADRENAL NEOPLASM,1
AU,ALBUMIN URINE PRESENT,1
AU,ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
AU,ALVEOLAR OSTEITIS,1
AU,ALVEOLITIS,1
AU,ANAESTHETIC COMPLICATION PULMONARY,1
AU,ANAL FISTULA,1
AU,ANASTOMOTIC LEAK,1
AU,ANGER,1
AU,ANGINA UNSTABLE,1
AU,ANGIOMYOLIPOMA,1
AU,ANHEDONIA,1
AU,ANIMAL BITE,1
AU,ANION GAP INCREASED,1
AU,ANKLE ARTHROPLASTY,1
AU,ANKLE FRACTURE,1
AU,ANKYLOSING SPONDYLITIS,1
AU,ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC,1
AU,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
AU,AORTIC DILATATION,1
AU,AORTIC DISSECTION,1
AU,AORTIC STENOSIS,1
AU,AORTIC VALVE SCLEROSIS,1
AU,APATHY,1
AU,APPENDICITIS,1
AU,APPETITE DISORDER,1
AU,APPLICATION SITE HYPERSENSITIVITY,1
AU,APPLICATION SITE REACTION,1
AU,ARRHYTHMIA SUPRAVENTRICULAR,1
AU,ARTHRITIS REACTIVE,1
AU,ATAXIA,1
AU,ATRIAL FLUTTER,1
AU,ATYPICAL FEMUR FRACTURE,1
AU,AUTOIMMUNE NEPHRITIS,1
AU,AUTOIMMUNE THYROIDITIS,1
AU,AVULSION FRACTURE,1
AU,BACK DISORDER,1
AU,BACK INJURY,1
AU,BACTERIAL INFECTION,1
AU,BALANOPOSTHITIS,1
AU,BAND SENSATION,1
AU,BEZOAR,1
AU,BILE DUCT OBSTRUCTION,1
AU,BILE DUCT STONE,1
AU,BILIARY SEPSIS,1
AU,BILIRUBIN CONJUGATED INCREASED,1
AU,BIOPSY UTERUS,1
AU,BLADDER CYST,1
AU,BLADDER DIVERTICULUM,1
AU,BLADDER DYSFUNCTION,1
AU,BLADDER OUTLET OBSTRUCTION,1
AU,BLAST CELLS PRESENT,1
AU,BLINDNESS UNILATERAL,1
AU,BLOOD ALBUMIN DECREASED,1
AU,BLOOD IRON DECREASED,1
AU,BLOOD LACTIC ACID INCREASED,1
AU,BLOOD MAGNESIUM DECREASED,1
AU,BLOOD PHOSPHORUS INCREASED,1
AU,BLOOD POTASSIUM DECREASED,1
AU,BLOOD PRESSURE DIASTOLIC DECREASED,1
AU,BLOOD PROLACTIN INCREASED,1
AU,BLOOD THYROID STIMULATING HORMONE DECREASED,1
AU,BLOOD URIC ACID INCREASED,1
AU,BLUNTED AFFECT,1
AU,BODY HEIGHT DECREASED,1
AU,BODY MASS INDEX INCREASED,1
AU,BODY TEMPERATURE DECREASED,1
AU,BODY TEMPERATURE INCREASED,1
AU,BONE DENSITY DECREASED,1
AU,BONE LOSS,1
AU,BONE MARROW DISORDER,1
AU,BONE MARROW FAILURE,1
AU,BRAIN DEATH,1
AU,BRAIN STEM INFARCTION,1
AU,BREAST CANCER FEMALE,1
AU,BREAST CANCER METASTATIC,1
AU,BREAST DISORDER FEMALE,1
AU,BREAST ENLARGEMENT,1
AU,BREAST HAEMORRHAGE,1
AU,BREAST HYPERPLASIA,1
AU,BREAST PAIN,1
AU,BREAST SWELLING,1
AU,BREAST TENDERNESS,1
AU,BRONCHIAL DISORDER,1
AU,BRONCHIECTASIS,1
AU,BRONCHITIS CHRONIC,1
AU,BRUXISM,1
AU,BURSA DISORDER,1
AU,BURSITIS,1
AU,C-REACTIVE PROTEIN ABNORMAL,1
AU,CACHEXIA,1
AU,CALCIPHYLAXIS,1
AU,CARBOHYDRATE ANTIGEN 15-3 INCREASED,1
AU,CARCINOEMBRYONIC ANTIGEN INCREASED,1
AU,CARCINOID CRISIS,1
AU,CARDIAC FLUTTER,1
AU,CARDIAC INFECTION,1
AU,CARDIAC MURMUR,1
AU,CARDIAC PACEMAKER INSERTION,1
AU,CARDIOVASCULAR DISORDER,1
AU,CAROTID ARTERIOSCLEROSIS,1
AU,CATARACT OPERATION,1
AU,CENTRAL NERVOUS SYSTEM INFECTION,1
AU,CENTRAL NERVOUS SYSTEM LESION,1
AU,CERVICAL DISCHARGE,1
AU,CERVICAL SPINAL STENOSIS,1
AU,CHEMICAL BURNS OF EYE,1
AU,CHOLESTASIS,1
AU,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
AU,CLOSTRIDIUM DIFFICILE INFECTION,1
AU,COAGULOPATHY,1
AU,COELIAC DISEASE,1
AU,COGWHEEL RIGIDITY,1
AU,COLECTOMY,1
AU,COLITIS MICROSCOPIC,1
AU,COLON CANCER,1
AU,COLONIC ABSCESS,1
AU,COMPULSIVE SHOPPING,1
AU,CONCOMITANT DISEASE AGGRAVATED,1
AU,CONGENITAL TRICUSPID VALVE STENOSIS,1
AU,CONJUNCTIVAL HAEMORRHAGE,1
AU,CONJUNCTIVITIS,1
AU,CORONARY ARTERY BYPASS,1
AU,CREATININE RENAL CLEARANCE ABNORMAL,1
AU,CREATININE RENAL CLEARANCE DECREASED,1
AU,CULTURE URINE POSITIVE,1
AU,CYST,1
AU,CYSTIC FIBROSIS LUNG,1
AU,CYSTITIS HAEMORRHAGIC,1
AU,CYTOKINE RELEASE SYNDROME,1
AU,CYTOMEGALOVIRUS CHORIORETINITIS,1
AU,CYTOMEGALOVIRUS TEST POSITIVE,1
AU,CYTOPENIA,1
AU,DECREASED ACTIVITY,1
AU,DECUBITUS ULCER,1
AU,DERMATITIS ACNEIFORM,1
AU,DERMATITIS ALLERGIC,1
AU,DERMATITIS BULLOUS,1
AU,DERMATOMYOSITIS,1
AU,DIABETES MELLITUS INADEQUATE CONTROL,1
AU,DIABETIC COMA,1
AU,DIABETIC ULCER,1
AU,DIAPHRAGMATIC HERNIA,1
AU,DIAPHRAGMATIC PARALYSIS,1
AU,DIASTOLIC DYSFUNCTION,1
AU,DILATATION ATRIAL,1
AU,DILATATION VENTRICULAR,1
AU,DIVERTICULUM,1
AU,DRUG EFFECT DELAYED,1
AU,DRUG ERUPTION,1
AU,DRUG INTOLERANCE,1
AU,DRUG USE DISORDER,1
AU,DUODENAL ULCER,1
AU,DUPUYTREN^S CONTRACTURE,1
AU,DYSKINESIA,1
AU,DYSPHONIA,1
AU,DYSPLASTIC NAEVUS,1
AU,DYSPNOEA EXERTIONAL,1
AU,DYSSTASIA,1
AU,DYSTONIA,1
AU,EAR SWELLING,1
AU,ECCHYMOSIS,1
AU,EGFR GENE MUTATION,1
AU,ELECTROCARDIOGRAM ABNORMAL,1
AU,ELECTROCARDIOGRAM AMBULATORY ABNORMAL,1
AU,ELECTROCARDIOGRAM CHANGE,1
AU,ELECTROCARDIOGRAM Q WAVE ABNORMAL,1
AU,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,1
AU,ELECTROCARDIOGRAM ST-T CHANGE,1
AU,ELECTROLYTE IMBALANCE,1
AU,ELEVATED MOOD,1
AU,EMBOLISM,1
AU,EMOTIONAL DISORDER,1
AU,ENDOMETRIAL HYPERPLASIA,1
AU,ENDOTRACHEAL INTUBATION COMPLICATION,1
AU,ENTEROCOCCAL SEPSIS,1
AU,ENTEROCOLITIS,1
AU,EOSINOPHIL COUNT INCREASED,1
AU,EOSINOPHILIA,1
AU,EPILEPSY,1
AU,ERUCTATION,1
AU,ESCHERICHIA BACTERAEMIA,1
AU,EXOSTOSIS OF JAW,1
AU,EXPOSURE DURING PREGNANCY,1
AU,EXTRAOCULAR MUSCLE PARESIS,1
AU,EYE DISORDER,1
AU,EYE IRRITATION,1
AU,EYE MOVEMENT DISORDER,1
AU,EYE PRURITUS,1
AU,EYE ULCER,1
AU,EYELID OEDEMA,1
AU,EYELID PTOSIS,1
AU,FACIAL PAIN,1
AU,FAECES PALE,1
AU,FEEDING DISORDER,1
AU,FEELING DRUNK,1
AU,FIBRIN D DIMER INCREASED,1
AU,FLANK PAIN,1
AU,FLUID INTAKE REDUCED,1
AU,FOETAL EXPOSURE DURING PREGNANCY,1
AU,FOLLICULITIS,1
AU,FOOD POISONING,1
AU,FORAMEN MAGNUM STENOSIS,1
AU,FOREIGN BODY SENSATION IN EYES,1
AU,FRACTURE DISPLACEMENT,1
AU,FULL BLOOD COUNT DECREASED,1
AU,FUNGAL INFECTION,1
AU,FUNGATING WOUND,1
AU,FURUNCLE,1
AU,GANGRENE,1
AU,GASTRIC CANCER,1
AU,GASTRIC DISORDER,1
AU,GASTRIC ULCER HAEMORRHAGE,1
AU,GASTROENTERITIS,1
AU,GASTROENTERITIS VIRAL,1
AU,GASTROINTESTINAL MOTILITY DISORDER,1
AU,GASTROINTESTINAL PERFORATION,1
AU,GASTROINTESTINAL SOUNDS ABNORMAL,1
AU,GINGIVAL PAIN,1
AU,GLOBULINS DECREASED,1
AU,GLOMERULONEPHRITIS,1
AU,GLOMERULONEPHRITIS ACUTE,1
AU,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
AU,GRAND MAL CONVULSION,1
AU,GRIP STRENGTH DECREASED,1
AU,GYNAECOMASTIA,1
AU,HAEMATEMESIS,1
AU,HAEMATOCHEZIA,1
AU,HAEMOLYSIS,1
AU,HAEMOLYTIC ANAEMIA,1
AU,HAEMOPHILIA,1
AU,HAEMOPTYSIS,1
AU,HAEMORRHAGIC STROKE,1
AU,HAEMORRHOIDS,1
AU,HALLUCINATION_ VISUAL,1
AU,HEAD INJURY,1
AU,HEART RATE DECREASED,1
AU,HELICOBACTER INFECTION,1
AU,HEPATIC CANCER,1
AU,HEPATIC ENZYME INCREASED,1
AU,HEPATIC VEIN THROMBOSIS,1
AU,HEPATITIS B,1
AU,HEPATITIS C ANTIBODY POSITIVE,1
AU,HEPATOSPLENOMEGALY,1
AU,HICCUPS,1
AU,HILAR LYMPHADENOPATHY,1
AU,HODGKIN^S DISEASE,1
AU,HODGKIN^S DISEASE STAGE IV,1
AU,HORMONE LEVEL ABNORMAL,1
AU,HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR DECREASED,1
AU,HYDRONEPHROSIS,1
AU,HYPERGLYCAEMIA,1
AU,HYPERPHAGIA,1
AU,HYPERTENSIVE CRISIS,1
AU,HYPERTHYROIDISM,1
AU,HYPERTONIA,1
AU,HYPOACUSIS,1
AU,HYPOALBUMINAEMIA,1
AU,HYPOCALCAEMIA,1
AU,HYPOKINESIA,1
AU,HYPOPHYSITIS,1
AU,HYPOPITUITARISM,1
AU,HYPOPLASTIC RIGHT HEART SYNDROME,1
AU,IMMUNODEFICIENCY,1
AU,IMMUNOSUPPRESSION,1
AU,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
AU,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
AU,INCARCERATED HERNIA,1
AU,INCORRECT DRUG ADMINISTRATION RATE,1
AU,INCORRECT PRODUCT STORAGE,1
AU,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
AU,INCREASED UPPER AIRWAY SECRETION,1
AU,INFECTION SUSCEPTIBILITY INCREASED,1
AU,INFLAMMATORY MARKER INCREASED,1
AU,INGUINAL HERNIA,1
AU,INJECTION SITE DISCOMFORT,1
AU,INJECTION SITE INFLAMMATION,1
AU,INJECTION SITE PAIN,1
AU,INJECTION SITE SWELLING,1
AU,INJECTION SITE URTICARIA,1
AU,INTENTIONAL DOSE OMISSION,1
AU,INTENTIONAL PRODUCT MISUSE,1
AU,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
AU,INTERVERTEBRAL DISC COMPRESSION,1
AU,INTESTINAL OBSTRUCTION,1
AU,INTRAOCULAR PRESSURE INCREASED,1
AU,INVASIVE DUCTAL BREAST CARCINOMA,1
AU,ISCHAEMIC HEPATITIS,1
AU,ISCHAEMIC STROKE,1
AU,JAUNDICE,1
AU,JAUNDICE CHOLESTATIC,1
AU,JOINT EFFUSION,1
AU,JOINT FLUID DRAINAGE,1
AU,JUGULAR VEIN THROMBOSIS,1
AU,KLEBSIELLA INFECTION,1
AU,KNEE OPERATION,1
AU,LACRIMATION INCREASED,1
AU,LACTIC ACIDOSIS,1
AU,LARGE INTESTINE POLYP,1
AU,LEFT ATRIAL ENLARGEMENT,1
AU,LEFT VENTRICULAR FAILURE,1
AU,LEFT VENTRICULAR HYPERTROPHY,1
AU,LESION EXCISION,1
AU,LEUKAEMIA,1
AU,LIGAMENT RUPTURE,1
AU,LIGAMENT SPRAIN,1
AU,LIP AND/OR ORAL CAVITY CANCER,1
AU,LIP SQUAMOUS CELL CARCINOMA,1
AU,LIVING IN RESIDENTIAL INSTITUTION,1
AU,LOBAR PNEUMONIA,1
AU,LOW DENSITY LIPOPROTEIN INCREASED,1
AU,LUMBAR VERTEBRAL FRACTURE,1
AU,LUNG ABSCESS,1
AU,LUNG CANCER METASTATIC,1
AU,LUNG INFECTION,1
AU,LUNG NEOPLASM MALIGNANT,1
AU,LYMPHANGITIS,1
AU,LYMPHOCYTIC HYPOPHYSITIS,1
AU,LYMPHOPROLIFERATIVE DISORDER,1
AU,MACROCYTOSIS,1
AU,MAGNESIUM DEFICIENCY,1
AU,MALIGNANT BOWEL OBSTRUCTION,1
AU,MALIGNANT MELANOMA IN SITU,1
AU,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,1
AU,MALNUTRITION,1
AU,MANIA,1
AU,MEAN CELL HAEMOGLOBIN DECREASED,1
AU,MEAN CELL HAEMOGLOBIN INCREASED,1
AU,MEAN CELL VOLUME INCREASED,1
AU,MEDICAL DEVICE PAIN,1
AU,MEDICATION RESIDUE PRESENT,1
AU,MELANOCYTIC NAEVUS,1
AU,MELANOSIS COLI,1
AU,MENIERE^S DISEASE,1
AU,MENINGIOMA,1
AU,MERALGIA PARAESTHETICA,1
AU,MESENTERIC VEIN THROMBOSIS,1
AU,METASTASES TO BONE,1
AU,METASTASES TO GASTROINTESTINAL TRACT,1
AU,METASTASES TO PERITONEUM,1
AU,METASTASES TO SPINE,1
AU,METASTATIC NEOPLASM,1
AU,METASTATIC RENAL CELL CARCINOMA,1
AU,METASTATIC SQUAMOUS CELL CARCINOMA,1
AU,MICROANGIOPATHIC HAEMOLYTIC ANAEMIA,1
AU,MITRAL VALVE DISEASE,1
AU,MITRAL VALVE STENOSIS,1
AU,MONOCYTE COUNT DECREASED,1
AU,MONOCYTE COUNT INCREASED,1
AU,MONOPLEGIA,1
AU,MOUTH SWELLING,1
AU,MOVEMENT DISORDER,1
AU,MULTIPLE GATED ACQUISITION SCAN ABNORMAL,1
AU,MULTIPLE SCLEROSIS,1
AU,MUSCLE ATROPHY,1
AU,MUSCLE CONTRACTIONS INVOLUNTARY,1
AU,MUSCLE FATIGUE,1
AU,MUSCLE TIGHTNESS,1
AU,MYASTHENIA GRAVIS,1
AU,MYOCARDIAL ISCHAEMIA,1
AU,NASAL CONGESTION,1
AU,NECK MASS,1
AU,NECROSIS,1
AU,NEEDLE ISSUE,1
AU,NEOPLASM MALIGNANT,1
AU,NEOPLASM PROGRESSION,1
AU,NEOPLASM PROSTATE,1
AU,NEPHRITIS,1
AU,NEPHRITIS AUTOIMMUNE,1
AU,NEUROENDOCRINE CARCINOMA,1
AU,NEUROLOGICAL DECOMPENSATION,1
AU,NEUROPATHY PERIPHERAL,1
AU,NEUTROPENIC INFECTION,1
AU,NEUTROPENIC SEPSIS,1
AU,NEUTROPHIL COUNT INCREASED,1
AU,NEUTROPHILIA,1
AU,NIGHTMARE,1
AU,NODULE,1
AU,NON-CARDIOGENIC PULMONARY OEDEMA,1
AU,NONINFECTIVE SIALOADENITIS,1
AU,NORMOCYTIC ANAEMIA,1
AU,NYSTAGMUS,1
AU,OEDEMA MUCOSAL,1
AU,OESOPHAGEAL RUPTURE,1
AU,OLIGURIA,1
AU,ONYCHOMYCOSIS,1
AU,OPHTHALMIC HERPES ZOSTER,1
AU,OPTIC NEURITIS,1
AU,OPTIC NEUROPATHY,1
AU,ORAL DISORDER,1
AU,ORAL INFECTION,1
AU,ORAL PAIN,1
AU,ORTHOSTATIC HYPOTENSION,1
AU,OSTEOMYELITIS,1
AU,OSTEONECROSIS,1
AU,OSTEOPOROTIC FRACTURE,1
AU,OVARIAN CYST,1
AU,OVERWEIGHT,1
AU,PANCREATIC CARCINOMA STAGE II,1
AU,PANNICULITIS,1
AU,PAPILLOEDEMA,1
AU,PARAESTHESIA ORAL,1
AU,PARAPLEGIA,1
AU,PAROTITIS,1
AU,PATHOLOGICAL FRACTURE,1
AU,PENILE BLISTER,1
AU,PERIARTICULAR DISORDER,1
AU,PERICARDIAL EFFUSION,1
AU,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
AU,PERIPHERAL ARTERY STENOSIS,1
AU,PERIPHERAL MOTOR NEUROPATHY,1
AU,PERIPHERAL SENSORY NEUROPATHY,1
AU,PERSONALITY DISORDER,1
AU,PETECHIAE,1
AU,PHARYNGEAL OEDEMA,1
AU,PHOTOELECTRIC CONJUNCTIVITIS,1
AU,PHOTOPSIA,1
AU,PHOTOSENSITIVITY REACTION,1
AU,PLANTAR FASCIITIS,1
AU,PLASMA CELL MYELOMA,1
AU,PLATELET COUNT INCREASED,1
AU,PLEURITIC PAIN,1
AU,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
AU,PNEUMONIA CYTOMEGALOVIRAL,1
AU,PNEUMONIA PNEUMOCOCCAL,1
AU,POLYCHROMASIA,1
AU,POLYMYALGIA RHEUMATICA,1
AU,POLYP,1
AU,POLYSUBSTANCE DEPENDENCE,1
AU,PORTAL VEIN DILATATION,1
AU,POST PROCEDURAL INFECTION,1
AU,POST-TRAUMATIC NECK SYNDROME,1
AU,POSTMENOPAUSAL HAEMORRHAGE,1
AU,POSTOPERATIVE WOUND INFECTION,1
AU,PRECANCEROUS SKIN LESION,1
AU,PRESBYOPIA,1
AU,PRODUCT USE IN UNAPPROVED INDICATION,1
AU,PROSTATE CANCER,1
AU,PROSTATE CANCER METASTATIC,1
AU,PROTEIN TOTAL DECREASED,1
AU,PROTEIN TOTAL INCREASED,1
AU,PSYCHIATRIC SYMPTOM,1
AU,PSYCHOTIC BEHAVIOUR,1
AU,PSYCHOTIC DISORDER,1
AU,PTERYGIUM,1
AU,PULMONARY FIBROSIS,1
AU,PULMONARY INFARCTION,1
AU,PULMONARY MASS,1
AU,PULMONARY THROMBOSIS,1
AU,PULSE ABSENT,1
AU,PURPURA,1
AU,PYELONEPHRITIS,1
AU,PYLORIC STENOSIS,1
AU,RASH PAPULAR,1
AU,RECTAL PERFORATION,1
AU,RECTOSIGMOID CANCER,1
AU,RECURRENT CANCER,1
AU,RED BLOOD CELL MORPHOLOGY ABNORMAL,1
AU,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,1
AU,REMOVAL OF INTERNAL FIXATION,1
AU,RENAL CANCER,1
AU,RENAL CELL CARCINOMA,1
AU,RENAL PAIN,1
AU,RESPIRATION ABNORMAL,1
AU,RESPIRATORY RATE INCREASED,1
AU,RESPIRATORY TRACT CONGESTION,1
AU,RESPIRATORY TRACT INFECTION BACTERIAL,1
AU,RESPIRATORY TRACT INFECTION VIRAL,1
AU,RETCHING,1
AU,RETINAL EXUDATES,1
AU,RHINITIS,1
AU,RHINORRHOEA,1
AU,RIGHT ATRIAL ENLARGEMENT,1
AU,RIGHT VENTRICULAR FAILURE,1
AU,ROTATOR CUFF SYNDROME,1
AU,SALIVARY GLAND CANCER,1
AU,SALMONELLA SEPSIS,1
AU,SCOLIOSIS,1
AU,SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS,1
AU,SEDATION,1
AU,SENSORY DISTURBANCE,1
AU,SENSORY LOSS,1
AU,SERRATIA INFECTION,1
AU,SERUM FERRITIN DECREASED,1
AU,SILENT MYOCARDIAL INFARCTION,1
AU,SINUS BRADYCARDIA,1
AU,SINUS DISORDER,1
AU,SINUS OPERATION,1
AU,SKIN ABRASION,1
AU,SKIN BURNING SENSATION,1
AU,SKIN DISORDER,1
AU,SKIN INFECTION,1
AU,SKIN NEOPLASM EXCISION,1
AU,SKIN ULCER HAEMORRHAGE,1
AT,ANAEMIA,1
AT,ANGIOPATHY,1
AT,AORTIC ARTERIOSCLEROSIS,1
AT,APHASIA,1
AT,ASCITES,1
AT,ATELECTASIS,1
AT,CANDIDURIA,1
AT,CHEST DISCOMFORT,1
AT,DIARRHOEA,1
AT,DIASTOLIC DYSFUNCTION,1
AT,DILATATION VENTRICULAR,1
AT,DYSARTHRIA,1
AT,DYSPNOEA,1
AT,ERYSIPELAS,1
AT,FALL,1
AT,FATIGUE,1
AT,FEMUR FRACTURE,1
AT,HAEMOGLOBIN DECREASED,1
AT,HEADACHE,1
AT,HEPATOMEGALY,1
AT,INTESTINAL ISCHAEMIA,1
AT,LI-FRAUMENI SYNDROME,1
AT,MEDULLOBLASTOMA RECURRENT,1
AT,MUSCULAR WEAKNESS,1
AT,NEPHROPATHY,1
AT,OEDEMA PERIPHERAL,1
AT,PNEUMONIA KLEBSIELLA,1
AT,PNEUMONITIS,1
AT,PYREXIA,1
AT,RENAL CYST,1
AT,RENAL FAILURE,1
AT,RENAL FAILURE ACUTE,1
AT,SEPSIS,1
AT,SKIN ULCER,1
AT,SPLENOMEGALY,1
AT,SYSTOLIC DYSFUNCTION,1
AT,UPPER GASTROINTESTINAL HAEMORRHAGE,1
AT,VARICES OESOPHAGEAL,1
AT,VOMITING,1
BB,HAEMATEMESIS,1
BB,UPPER GASTROINTESTINAL HAEMORRHAGE,1
BE,METABOLIC ACIDOSIS,6
BE,TOXICITY TO VARIOUS AGENTS,5
BE,ACUTE HEPATIC FAILURE,4
BE,FATIGUE,3
BE,GENERAL PHYSICAL HEALTH DETERIORATION,3
BE,LUNG INFECTION,3
BE,PRURITUS,3
BE,ASTHENIA,2
BE,COMA,2
BE,CONSTIPATION,2
BE,DECREASED APPETITE,2
BE,ENCEPHALOPATHY,2
BE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
BE,HAEMATURIA,2
BE,HYPERTENSION,2
BE,HYPERTHERMIA,2
BE,LOSS OF CONSCIOUSNESS,2
BE,MALAISE,2
BE,MYOCLONUS,2
BE,PAIN,2
BE,PROSTATE CANCER,2
BE,PULMONARY EMBOLISM,2
BE,PYROGLUTAMATE INCREASED,2
BE,RENAL IMPAIRMENT,2
BE,RESPIRATORY DISORDER,2
BE,RESPIRATORY FAILURE,2
BE,RHABDOMYOLYSIS,2
BE,STATUS EPILEPTICUS,2
BE,ABDOMINAL DISTENSION,1
BE,ABDOMINAL PAIN,1
BE,ACCIDENTAL OVERDOSE,1
BE,ACIDOSIS,1
BE,ACUTE RESPIRATORY DISTRESS SYNDROME,1
BE,ALANINE AMINOTRANSFERASE INCREASED,1
BE,ANAEMIA,1
BE,ANAPHYLACTIC SHOCK,1
BE,ASPARTATE AMINOTRANSFERASE INCREASED,1
BE,BACK DISORDER,1
BE,BACK PAIN,1
BE,BURNING SENSATION,1
BE,CACHEXIA,1
BE,CARDIOGENIC SHOCK,1
BE,CENTRAL NERVOUS SYSTEM LESION,1
BE,CHILLS,1
BE,CHOLECYSTITIS,1
BE,COAGULOPATHY,1
BE,COLITIS ISCHAEMIC,1
BE,CYTOTOXIC OEDEMA,1
BE,DELUSION,1
BE,DEPRESSION,1
BE,DIARRHOEA,1
BE,DISTURBANCE IN ATTENTION,1
BE,DIVERTICULITIS,1
BE,DIZZINESS,1
BE,DRUG LEVEL INCREASED,1
BE,DRUG-INDUCED LIVER INJURY,1
BE,DUODENAL PERFORATION,1
BE,DYSKINESIA,1
BE,DYSPNOEA,1
BE,ECCHYMOSIS,1
BE,ERYTHEMA,1
BE,FRACTURE,1
BE,HAEMORRHAGE,1
BE,HEADACHE,1
BE,HEMIPARESIS,1
BE,HEPATIC PAIN,1
BE,HEPATITIS TOXIC,1
BE,HIP FRACTURE,1
BE,HYPERCHOLESTEROLAEMIA,1
BE,IMMUNODEFICIENCY,1
BE,INCORRECT DOSE ADMINISTERED,1
BE,INTENTIONAL OVERDOSE,1
BE,INTERNATIONAL NORMALISED RATIO INCREASED,1
BE,INTERVERTEBRAL DISC PROTRUSION,1
BE,JAUNDICE,1
BE,LIPASE INCREASED,1
BE,LIVER FUNCTION TEST ABNORMAL,1
BE,LIVER TRANSPLANT,1
BE,LIVIDITY,1
BE,MENINGITIS ASEPTIC,1
BE,MENTAL IMPAIRMENT,1
BE,MENTAL STATUS CHANGES,1
BE,MOBILITY DECREASED,1
BE,MULTIPLE SCLEROSIS RELAPSE,1
BE,NAUSEA,1
BE,OEDEMA PERIPHERAL,1
BE,ORGANISING PNEUMONIA,1
BE,PARAPARESIS,1
BE,PSORIASIS,1
BE,PSYCHOGENIC SEIZURE,1
BE,PYREXIA,1
BE,RECTAL HAEMORRHAGE,1
BE,RESPIRATORY DISTRESS,1
BE,SEROTONIN SYNDROME,1
BE,SHOCK,1
BE,SKIN BURNING SENSATION,1
BE,SKIN LESION,1
BE,SKIN NECROSIS,1
BE,SKIN ULCER,1
BE,THROMBOCYTOPENIA,1
BE,THROMBOTIC MICROANGIOPATHY,1
BE,TRANSPLANT FAILURE,1
BE,URINARY TRACT INFECTION,1
BE,VERTIGO,1
BE,VIITH NERVE PARALYSIS,1
BE,VISUAL IMPAIRMENT,1
BE,VOMITING,1
BE,WEIGHT DECREASED,1
BR,PAIN,71
BR,HEADACHE,52
BR,MALAISE,45
BR,ARTHRALGIA,44
BR,DRUG INEFFECTIVE,36
BR,DYSPNOEA,34
BR,NAUSEA,34
BR,GAIT DISTURBANCE,32
BR,FATIGUE,31
BR,WEIGHT DECREASED,31
BR,URINARY TRACT INFECTION,30
BR,PAIN IN EXTREMITY,29
BR,PYREXIA,29
BR,DIZZINESS,26
BR,HYPERSENSITIVITY,24
BR,ASTHENIA,23
BR,DRUG-INDUCED LIVER INJURY,23
BR,FALL,23
BR,DIARRHOEA,22
BR,INSOMNIA,22
BR,PNEUMONIA,22
BR,INFLUENZA,21
BR,HYPERTENSION,20
BR,IMMUNODEFICIENCY,20
BR,ANAEMIA,19
BR,BACK PAIN,18
BR,NASOPHARYNGITIS,17
BR,LIVER INJURY,16
BR,RHEUMATOID ARTHRITIS,16
BR,ABDOMINAL PAIN,15
BR,DRUG HYPERSENSITIVITY,15
BR,MUSCULAR WEAKNESS,15
BR,PRODUCT USE ISSUE,15
BR,SOMNOLENCE,15
BR,VOMITING,15
BR,MULTIPLE SCLEROSIS RELAPSE,14
BR,PERIPHERAL SWELLING,14
BR,PRURITUS,14
BR,TACHYCARDIA,14
BR,DECREASED APPETITE,13
BR,WEIGHT INCREASED,13
BR,ANAPHYLACTIC REACTION,12
BR,ARTHROPATHY,12
BR,BLOOD CHOLESTEROL INCREASED,12
BR,BLOOD PRESSURE INCREASED,12
BR,CHEST PAIN,12
BR,COUGH,12
BR,DEPRESSION,12
BR,INFLUENZA LIKE ILLNESS,12
BR,MUSCLE SPASMS,12
BR,SWELLING,12
BR,DIABETES MELLITUS,11
BR,MYALGIA,11
BR,TREMOR,11
BR,ABDOMINAL DISTENSION,10
BR,ABDOMINAL PAIN UPPER,10
BR,BEDRIDDEN,10
BR,DRUG DOSE OMISSION,10
BR,HYPOAESTHESIA,10
BR,INFUSION RELATED REACTION,10
BR,JOINT SWELLING,10
BR,LIVER DISORDER,10
BR,NERVOUSNESS,10
BR,ALOPECIA,9
BR,BURNING SENSATION,9
BR,CHILLS,9
BR,ERYTHEMA,9
BR,INJECTION SITE PAIN,9
BR,ABASIA,8
BR,ADVERSE EVENT,8
BR,ANXIETY,8
BR,BLOOD PRESSURE DECREASED,8
BR,CATARACT,8
BR,DEATH,8
BR,DRUG ADMINISTRATION ERROR,8
BR,INCORRECT DOSE ADMINISTERED,8
BR,INJECTION SITE ERYTHEMA,8
BR,MEMORY IMPAIRMENT,8
BR,STRESS,8
BR,CEREBROVASCULAR ACCIDENT,7
BR,CHOLELITHIASIS,7
BR,CONSTIPATION,7
BR,CRYING,7
BR,DENGUE FEVER,7
BR,EYE PAIN,7
BR,HEART RATE INCREASED,7
BR,HYPERHIDROSIS,7
BR,LABYRINTHITIS,7
BR,MEDICATION ERROR,7
BR,PARAESTHESIA,7
BR,SINUSITIS,7
BR,SPEECH DISORDER,7
BR,URTICARIA,7
BR,AMNESIA,6
BR,ARTHRITIS,6
BR,DEPRESSED MOOD,6
BR,DYSPHONIA,6
BR,DYSURIA,6
BR,EATING DISORDER,6
BR,FEMUR FRACTURE,6
BR,GASTROOESOPHAGEAL REFLUX DISEASE,6
BR,HAEMATOMA,6
BR,HEPATITIS,6
BR,LIMB INJURY,6
BR,LOCAL SWELLING,6
BR,MUSCULOSKELETAL STIFFNESS,6
BR,NEPHROLITHIASIS,6
BR,OSTEOARTHRITIS,6
BR,RASH,6
BR,SPINAL PAIN,6
BR,VISUAL IMPAIRMENT,6
BR,ACCIDENTAL OVERDOSE,5
BR,ARRHYTHMIA,5
BR,ASTHMA,5
BR,BALANCE DISORDER,5
BR,BLOOD PRESSURE ABNORMAL,5
BR,BRONCHITIS,5
BR,CARDIAC DISORDER,5
BR,CONFUSIONAL STATE,5
BR,DECREASED IMMUNE RESPONSIVENESS,5
BR,DYSPHAGIA,5
BR,DYSSTASIA,5
BR,FEELING ABNORMAL,5
BR,FORMICATION,5
BR,HAEMORRHAGE,5
BR,HEPATIC STEATOSIS,5
BR,HYPOTENSION,5
BR,ILL-DEFINED DISORDER,5
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,5
BR,JOINT DISLOCATION,5
BR,JOINT STIFFNESS,5
BR,LUNG DISORDER,5
BR,MUSCULOSKELETAL PAIN,5
BR,OVERDOSE,5
BR,PALPITATIONS,5
BR,PLATELET COUNT DECREASED,5
BR,SKIN DISCOLOURATION,5
BR,SPINAL DISORDER,5
BR,SYNCOPE,5
BR,THERAPEUTIC RESPONSE DECREASED,5
BR,UPPER LIMB FRACTURE,5
BR,VERTIGO,5
BR,VISION BLURRED,5
BR,ALANINE AMINOTRANSFERASE INCREASED,4
BR,ANAPHYLACTIC SHOCK,4
BR,ASPARTATE AMINOTRANSFERASE INCREASED,4
BR,BACTERIAL INFECTION,4
BR,BLOOD CHOLESTEROL ABNORMAL,4
BR,BLOOD PRESSURE FLUCTUATION,4
BR,BODY HEIGHT DECREASED,4
BR,BONE PAIN,4
BR,CARDIO-RESPIRATORY ARREST,4
BR,CENTRAL NERVOUS SYSTEM LESION,4
BR,CONDITION AGGRAVATED,4
BR,CONVULSION,4
BR,CYANOSIS,4
BR,FEEDING DISORDER,4
BR,FEELING COLD,4
BR,FEELING HOT,4
BR,FLATULENCE,4
BR,FOOT DEFORMITY,4
BR,GASTROENTERITIS,4
BR,GLUCOSE TOLERANCE IMPAIRED,4
BR,HEPATIC FAILURE,4
BR,HEPATITIS C,4
BR,HYPOKINESIA,4
BR,HYPOTHERMIA,4
BR,INTENTIONAL PRODUCT MISUSE,4
BR,IRRITABILITY,4
BR,JOINT RANGE OF MOTION DECREASED,4
BR,LARYNGEAL OEDEMA,4
BR,LIMB DEFORMITY,4
BR,LIMB DISCOMFORT,4
BR,LOWER LIMB FRACTURE,4
BR,LUNG INFECTION,4
BR,MYOCARDIAL INFARCTION,4
BR,NODULE,4
BR,OROPHARYNGEAL PAIN,4
BR,OXYGEN SATURATION DECREASED,4
BR,RENAL FAILURE,4
BR,SEPTIC SHOCK,4
BR,STOMATITIS,4
BR,SWELLING FACE,4
BR,THYROID DISORDER,4
BR,URINARY INCONTINENCE,4
BR,VARICOSE VEIN,4
BR,VIRAL INFECTION,4
BR,WHITE BLOOD CELL COUNT DECREASED,4
BR,ABDOMINAL DISCOMFORT,3
BR,ABDOMINAL HERNIA,3
BR,ACUTE HAEMORRHAGIC OEDEMA OF INFANCY,3
BR,ADVERSE DRUG REACTION,3
BR,ANGINA PECTORIS,3
BR,ANKYLOSING SPONDYLITIS,3
BR,BONE LOSS,3
BR,CHEST DISCOMFORT,3
BR,COORDINATION ABNORMAL,3
BR,CYST,3
BR,CYSTITIS,3
BR,DEVICE RELATED INFECTION,3
BR,DRUG DEPENDENCE,3
BR,DRY MOUTH,3
BR,DYSGEUSIA,3
BR,DYSPEPSIA,3
BR,EAR PAIN,3
BR,EMOTIONAL DISORDER,3
BR,ERYSIPELAS,3
BR,EXPOSURE DURING PREGNANCY,3
BR,EYE DISORDER,3
BR,EYE SWELLING,3
BR,FEAR,3
BR,FLUID INTAKE REDUCED,3
BR,FOETAL EXPOSURE DURING PREGNANCY,3
BR,GENERAL PHYSICAL HEALTH DETERIORATION,3
BR,HAEMOGLOBIN DECREASED,3
BR,HAEMORRHOIDS,3
BR,HEPATIC ENZYME INCREASED,3
BR,HERPES VIRUS INFECTION,3
BR,HERPES ZOSTER,3
BR,HORMONE LEVEL ABNORMAL,3
BR,IMPAIRED HEALING,3
BR,INFARCTION,3
BR,INFECTION,3
BR,INFLAMMATION,3
BR,JOINT EFFUSION,3
BR,LOSS OF CONSCIOUSNESS,3
BR,MASS,3
BR,MIGRAINE,3
BR,MOBILITY DECREASED,3
BR,MOOD ALTERED,3
BR,MOVEMENT DISORDER,3
BR,MUSCLE RIGIDITY,3
BR,NASAL CONGESTION,3
BR,NECK PAIN,3
BR,NEUROGENIC BLADDER,3
BR,OEDEMA PERIPHERAL,3
BR,OSTEONECROSIS,3
BR,OSTEOPOROSIS,3
BR,PALLOR,3
BR,PETECHIAE,3
BR,PHARYNGITIS,3
BR,PRODUCT QUALITY ISSUE,3
BR,PSORIASIS,3
BR,PULMONARY FIBROSIS,3
BR,RED BLOOD CELL COUNT DECREASED,3
BR,RESPIRATORY DISORDER,3
BR,RESPIRATORY FAILURE,3
BR,SEIZURE,3
BR,SENSORY DISTURBANCE,3
BR,SKIN DISORDER,3
BR,SKIN EXFOLIATION,3
BR,SKIN INJURY,3
BR,SKIN PLAQUE,3
BR,SNEEZING,3
BR,TACHYPNOEA,3
BR,THROAT IRRITATION,3
BR,THROAT TIGHTNESS,3
BR,THROMBOSIS,3
BR,URINARY RETENTION,3
BR,UTERINE DISORDER,3
BR,WOUND,3
BR,ABSCESS,2
BR,ACNE,2
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,2
BR,ACUTE KIDNEY INJURY,2
BR,AGITATION,2
BR,ANGIOEDEMA,2
BR,ARTICULAR CALCIFICATION,2
BR,ASTHMATIC CRISIS,2
BR,ATELECTASIS,2
BR,BLOOD ALKALINE PHOSPHATASE INCREASED,2
BR,BLOOD LACTATE DEHYDROGENASE INCREASED,2
BR,BONE DISORDER,2
BR,BONE EROSION,2
BR,BRADYCARDIA,2
BR,BREAST CANCER,2
BR,BREAST MASS,2
BR,BRONCHOSPASM,2
BR,BURSITIS,2
BR,CARDIAC ARREST,2
BR,CARTILAGE INJURY,2
BR,CELLULITIS,2
BR,CHONDROPATHY,2
BR,CHROMATURIA,2
BR,COGNITIVE DISORDER,2
BR,COMA,2
BR,DEMENTIA ALZHEIMER^S TYPE,2
BR,DERMATITIS,2
BR,DERMATITIS ALLERGIC,2
BR,DEVICE DISLOCATION,2
BR,DIPLOPIA,2
BR,DISCOMFORT,2
BR,DISEASE PROGRESSION,2
BR,DISORIENTATION,2
BR,DIVERTICULITIS,2
BR,DRUG EFFECT DECREASED,2
BR,DRUG EFFECT INCOMPLETE,2
BR,DRUG PRESCRIBING ERROR,2
BR,DRY EYE,2
BR,DYSARTHRIA,2
BR,EAR INFECTION,2
BR,EYE IRRITATION,2
BR,FEELING OF BODY TEMPERATURE CHANGE,2
BR,FIBROMYALGIA,2
BR,FISTULA,2
BR,FLUSHING,2
BR,FOOT FRACTURE,2
BR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,2
BR,GASTRIC DISORDER,2
BR,GASTRITIS,2
BR,GENERAL SYMPTOM,2
BR,HEART RATE DECREASED,2
BR,HELICOBACTER INFECTION,2
BR,HEPATIC PAIN,2
BR,HEPATITIS TOXIC,2
BR,HOSPITALISATION,2
BR,HYPERAEMIA,2
BR,HYPERAESTHESIA,2
BR,HYPERGLYCAEMIA,2
BR,HYPERTHERMIA,2
BR,HYPOGLYCAEMIA,2
BR,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
BR,INJECTION SITE SWELLING,2
BR,INJURY,2
BR,INTERVERTEBRAL DISC PROTRUSION,2
BR,INTESTINAL HAEMORRHAGE,2
BR,KIDNEY INFECTION,2
BR,KNEE ARTHROPLASTY,2
BR,LOCALISED INFECTION,2
BR,LOWER EXTREMITY MASS,2
BR,LYMPHADENITIS,2
BR,LYMPHADENOPATHY,2
BR,MENOPAUSE,2
BR,MENTAL DISORDER,2
BR,METAMORPHOPSIA,2
BR,MOUTH INJURY,2
BR,MULTIPLE SCLEROSIS,2
BR,MUSCLE ATROPHY,2
BR,MUSCLE SPASTICITY,2
BR,MUSCLE TWITCHING,2
BR,MUSCULOSKELETAL DISORDER,2
BR,NAIL DISORDER,2
BR,NECROSIS,2
BR,NEUTROPENIA,2
BR,NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL,2
BR,OBESITY,2
BR,OCULAR HYPERAEMIA,2
BR,OCULAR ICTERUS,2
BR,ORAL CANDIDIASIS,2
BR,PANCREATIC CARCINOMA,2
BR,PELVIC DEFORMITY,2
BR,PELVIC PAIN,2
BR,PLEURAL EFFUSION,2
BR,POISONING,2
BR,POST PROCEDURAL COMPLICATION,2
BR,PRODUCT DROPPER ISSUE,2
BR,PULMONARY EMBOLISM,2
BR,PYELONEPHRITIS,2
BR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
BR,RENAL DISORDER,2
BR,RENAL PAIN,2
BR,RHINITIS,2
BR,RHINORRHOEA,2
BR,SCIATICA,2
BR,SELF-MEDICATION,2
BR,SENSATION OF FOREIGN BODY,2
BR,SEPSIS,2
BR,SLEEP DISORDER,2
BR,SLUGGISHNESS,2
BR,SPINAL FRACTURE,2
BR,STEVENS-JOHNSON SYNDROME,2
BR,SUICIDAL IDEATION,2
BR,TENDONITIS,2
BR,THERAPEUTIC RESPONSE UNEXPECTED,2
BR,THROMBOCYTOPENIA,2
BR,TOOTH DISORDER,2
BR,TOOTH INFECTION,2
BR,TROPONIN INCREASED,2
BR,UNEVALUABLE EVENT,2
BR,VIRAL SINUSITIS,2
BR,VITAMIN D DECREASED,2
BR,VITAMIN D DEFICIENCY,2
BR,WHEEZING,2
BR,WHITE BLOOD CELL COUNT INCREASED,2
BR,YELLOW SKIN,2
BR,ABNORMAL BEHAVIOUR,1
BR,ABNORMAL FAECES,1
BR,ABNORMAL WITHDRAWAL BLEEDING,1
BR,ABORTION SPONTANEOUS,1
BR,ABSCESS JAW,1
BR,ABSCESS LIMB,1
BR,ACCIDENT,1
BR,ACCIDENTAL EXPOSURE TO PRODUCT,1
BR,ACIDOSIS,1
BR,ACUTE CORONARY SYNDROME,1
BR,ACUTE RESPIRATORY FAILURE,1
BR,AGEUSIA,1
BR,AGGRESSION,1
BR,ALANINE AMINOTRANSFERASE ABNORMAL,1
BR,ALLERGIC BRONCHITIS,1
BR,ANAL FISSURE,1
BR,ANAL FISTULA,1
BR,ANAL HAEMORRHAGE,1
BR,ANGIOPATHY,1
BR,ANTI FACTOR XA ACTIVITY DECREASED,1
BR,ANURIA,1
BR,APHAGIA,1
BR,APHASIA,1
BR,APHONIA,1
BR,APHTHOUS STOMATITIS,1
BR,APPETITE DISORDER,1
BR,APPLICATION SITE ERYTHEMA,1
BR,APPLICATION SITE PRURITUS,1
BR,APPLICATION SITE REACTION,1
BR,APPLICATION SITE SWELLING,1
BR,ARTERIAL OCCLUSIVE DISEASE,1
BR,ARTHRITIS BACTERIAL,1
BR,ARTHRITIS INFECTIVE,1
BR,ASPIRATION BRONCHIAL,1
BR,AUTOIMMUNE THYROIDITIS,1
BR,BACK DISORDER,1
BR,BASAL CELL CARCINOMA,1
BR,BENIGN NEOPLASM,1
BR,BLADDER DISORDER,1
BR,BLADDER PAIN,1
BR,BLOOD BILIRUBIN ABNORMAL,1
BR,BLOOD CALCIUM DECREASED,1
BR,BLOOD CALCIUM INCREASED,1
BR,BLOOD COUNT ABNORMAL,1
BR,BLOOD CREATININE INCREASED,1
BR,BLOOD DISORDER,1
BR,BLOOD GLUCOSE ABNORMAL,1
BR,BLOOD GLUCOSE DECREASED,1
BR,BLOOD GLUCOSE INCREASED,1
BR,BLOOD SODIUM ABNORMAL,1
BR,BLOOD TEST ABNORMAL,1
BR,BLOOD THYROID STIMULATING HORMONE ABNORMAL,1
BR,BLOOD TRIGLYCERIDES ABNORMAL,1
BR,BLOOD TRIGLYCERIDES INCREASED,1
BR,BLOOD URIC ACID INCREASED,1
BR,BLOOD URINE PRESENT,1
BR,BODY TEMPERATURE INCREASED,1
BR,BONE LESION,1
BR,BONE MARROW OEDEMA,1
BR,BONE NEOPLASM,1
BR,BRAIN DEATH,1
BR,BRAIN INJURY,1
BR,BREAST ENLARGEMENT,1
BR,BREATH ODOUR,1
BR,BRONCHITIS CHRONIC,1
BR,BULIMIA NERVOSA,1
BR,BURNING SENSATION MUCOSAL,1
BR,BURNS THIRD DEGREE,1
BR,C-REACTIVE PROTEIN INCREASED,1
BR,CANDIDA INFECTION,1
BR,CARDIAC MURMUR,1
BR,CARPAL TUNNEL SYNDROME,1
BR,CATARRH,1
BR,CATHETER PLACEMENT,1
BR,CATHETER SITE INFECTION,1
BR,CELLULITIS GANGRENOUS,1
BR,CEREBELLAR TUMOUR,1
BR,CEREBRAL THROMBOSIS,1
BR,CERVIX OEDEMA,1
BR,CHEST X-RAY ABNORMAL,1
BR,CHIKUNGUNYA VIRUS INFECTION,1
BR,CHOKING,1
BR,CHOKING SENSATION,1
BR,CHONDROPLASTY,1
BR,CHRONIC GASTRITIS,1
BR,CHRONIC KIDNEY DISEASE,1
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
BR,COCCYDYNIA,1
BR,COLD SWEAT,1
BR,COLON CANCER,1
BR,COLON NEOPLASM,1
BR,COMPLICATION ASSOCIATED WITH DEVICE,1
BR,COMPLICATION OF PREGNANCY,1
BR,COMPULSIONS,1
BR,CONGENITAL INTESTINAL MALFORMATION,1
BR,CONJUNCTIVITIS,1
BR,CONNECTIVE TISSUE DISORDER,1
BR,CONTRAINDICATION TO MEDICAL TREATMENT,1
BR,CONTUSION,1
BR,CORNEAL THICKENING,1
BR,CORONARY ARTERY DISEASE,1
BR,CORONARY ARTERY INSUFFICIENCY,1
BR,CORONARY ARTERY OCCLUSION,1
BR,CROHN^S DISEASE,1
BR,CYTOMEGALOVIRUS HEPATITIS,1
BR,DECUBITUS ULCER,1
BR,DEEP VEIN THROMBOSIS,1
BR,DEFORMITY,1
BR,DEHYDRATION,1
BR,DEPENDENT PERSONALITY DISORDER,1
BR,DEVICE BREAKAGE,1
BR,DEVICE MALFUNCTION,1
BR,DEVICE MATERIAL ISSUE,1
BR,DIABETIC NEUROPATHY,1
BR,DISTURBANCE IN SOCIAL BEHAVIOUR,1
BR,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
BR,DRUG EFFECT DELAYED,1
BR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
BR,DRUG INTOLERANCE,1
BR,DRUG TOLERANCE,1
BR,DRY THROAT,1
BR,DYSCHEZIA,1
BR,DYSENTERY,1
BR,EAR DISORDER,1
BR,EAR PRURITUS,1
BR,ELECTROLYTE IMBALANCE,1
BR,EMPHYSEMA,1
BR,ENCEPHALOPATHY,1
BR,ENDOCARDITIS,1
BR,ENDOMETRIOSIS,1
BR,ENTERITIS INFECTIOUS,1
BR,EPILEPSY,1
BR,EPISTAXIS,1
BR,ERUCTATION,1
BR,ESCHERICHIA URINARY TRACT INFECTION,1
BR,ESSENTIAL TREMOR,1
BR,EXERCISE TOLERANCE DECREASED,1
BR,EXOSTOSIS,1
BR,EXPOSURE VIA FATHER,1
BR,EXTRA DOSE ADMINISTERED,1
BR,EYE ALLERGY,1
BR,EYE HAEMORRHAGE,1
BR,EYE MOVEMENT DISORDER,1
BR,EYE PRURITUS,1
BR,EYELID OEDEMA,1
BR,FACE INJURY,1
BR,FACE OEDEMA,1
BR,FACIAL BONES FRACTURE,1
BR,FACIAL PAIN,1
BR,FEAR OF DISEASE,1
BR,FEELING JITTERY,1
BR,FEELING OF DESPAIR,1
BR,FEMALE GENITAL TRACT FISTULA,1
BR,FEMORAL NECK FRACTURE,1
BR,FINGER DEFORMITY,1
BR,FLUID RETENTION,1
BR,FOOD CRAVING,1
BR,FRACTURE,1
BR,FRACTURE NONUNION,1
BR,FRACTURE PAIN,1
BR,FRACTURED COCCYX,1
BR,FREQUENT BOWEL MOVEMENTS,1
BR,FUNCTIONAL GASTROINTESTINAL DISORDER,1
BR,FUNGAL INFECTION,1
BR,FURUNCLE,1
BR,GAIT INABILITY,1
BR,GASTRIC HAEMORRHAGE,1
BR,GASTROINTESTINAL DISORDER,1
BR,GASTROINTESTINAL INFECTION,1
BR,GASTROINTESTINAL INFLAMMATION,1
BR,GASTROINTESTINAL POLYP HAEMORRHAGE,1
BR,GASTROINTESTINAL TOXICITY,1
BR,GESTATIONAL DIABETES,1
BR,GLAUCOMA,1
BR,GROIN PAIN,1
BR,GUILLAIN-BARRE SYNDROME,1
BR,H1N1 INFLUENZA,1
BR,HAEMATEMESIS,1
BR,HAEMATOCHEZIA,1
BR,HAEMATOCRIT DECREASED,1
BR,HAEMATURIA,1
BR,HAEMOLYSIS,1
BR,HAIR DISORDER,1
BR,HALLUCINATION,1
BR,HALLUCINATION_ VISUAL,1
BR,HAND DEFORMITY,1
BR,HEARING IMPAIRED,1
BR,HEART RATE IRREGULAR,1
BR,HEMIPARESIS,1
BR,HEPATIC CIRRHOSIS,1
BR,HEPATIC ENCEPHALOPATHY,1
BR,HEPATIC ENZYME ABNORMAL,1
BR,HEPATIC FIBROSIS,1
BR,HEPATIC NECROSIS,1
BR,HEPATIC NEOPLASM,1
BR,HEPATITIS B,1
BR,HEPATITIS FULMINANT,1
BR,HEPATOMEGALY,1
BR,HEPATOTOXICITY,1
BR,HERNIA,1
BR,HIATUS HERNIA,1
BR,HIP ARTHROPLASTY,1
BR,HORDEOLUM,1
BR,HUMERUS FRACTURE,1
BR,HUNGER,1
BR,HYPERCALCAEMIA,1
BR,HYPERPHAGIA,1
BR,HYPERPYREXIA,1
BR,HYPERSENSITIVITY VASCULITIS,1
BR,HYPERSOMNIA,1
BR,HYPERTENSIVE CRISIS,1
BR,HYPERTHYROIDISM,1
BR,HYPERVITAMINOSIS D,1
BR,HYPOCALCAEMIA,1
BR,HYPOKALAEMIA,1
BR,HYPOPHAGIA,1
BR,HYPOTHYROIDISM,1
BR,HYPOVITAMINOSIS,1
BR,HYPOVOLAEMIA,1
BR,HYSTERECTOMY,1
BR,IMMOBILE,1
BR,IMMUNE SYSTEM DISORDER,1
BR,IMPLANT SITE PAIN,1
BR,INCORRECT DRUG ADMINISTRATION RATE,1
BR,INCORRECT PRODUCT STORAGE,1
BR,INJECTION SITE ATROPHY,1
BR,INJECTION SITE BRUISING,1
BR,INJECTION SITE DISCOMFORT,1
BR,INJECTION SITE HAEMATOMA,1
BR,INJECTION SITE HAEMORRHAGE,1
BR,INJECTION SITE INDURATION,1
BR,INJECTION SITE MASS,1
BR,INJECTION SITE PRURITUS,1
BR,INJURY CORNEAL,1
BR,INSTILLATION SITE FOREIGN BODY SENSATION,1
BR,INTERSTITIAL LUNG DISEASE,1
BR,INTESTINAL DILATATION,1
BR,INTESTINAL PERFORATION,1
BR,INTESTINAL POLYP,1
BR,IRON DEFICIENCY,1
BR,IRREGULAR SLEEP PHASE,1
BR,ISCHAEMIC STROKE,1
BR,JAUNDICE,1
BR,JOINT INJURY,1
BR,JOINT LOCK,1
BR,JOINT PROSTHESIS USER,1
BR,KERATITIS,1
BR,KIDNEY MALFORMATION,1
BR,LARYNGEAL STENOSIS,1
BR,LEFT VENTRICULAR HYPERTROPHY,1
BR,LETHARGY,1
BR,LEUKOPENIA,1
BR,LIGAMENT SPRAIN,1
BR,LIMB ASYMMETRY,1
BR,LIMB OPERATION,1
BR,LIP OEDEMA,1
BR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
BR,LOWER GASTROINTESTINAL HAEMORRHAGE,1
BR,LYMPHOCYTE COUNT DECREASED,1
BR,LYMPHOCYTE COUNT INCREASED,1
BR,LYMPHOMA,1
BR,MACULAR HOLE,1
BR,MALABSORPTION FROM INJECTION SITE,1
BR,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,1
BR,MALNUTRITION,1
BR,MASTICATION DISORDER,1
BR,MATERNAL EXPOSURE BEFORE PREGNANCY,1
BR,MATERNAL EXPOSURE DURING PREGNANCY,1
BR,MEDICAL DEVICE COMPLICATION,1
BR,MEDICAL DEVICE IMPLANTATION,1
BR,MENINGIOMA BENIGN,1
BR,MENISCUS INJURY,1
BR,MENORRHAGIA,1
BR,MENSTRUAL DISORDER,1
BR,MENSTRUATION IRREGULAR,1
BR,METRORRHAGIA,1
BR,MITRAL VALVE DISEASE,1
BR,MONOPLEGIA,1
BR,MOUTH SWELLING,1
BR,MUCOSAL DRYNESS,1
BR,MUCOSAL INFLAMMATION,1
BR,MULTI-ORGAN FAILURE,1
BR,MULTIPLE FRACTURES,1
BR,MUSCLE CONTRACTURE,1
BR,MUSCLE TIGHTNESS,1
BR,MUSCULOSKELETAL CHEST PAIN,1
BR,MYOSITIS,1
BR,NAIL DISCOLOURATION,1
BR,NAIL INFECTION,1
BR,NASAL DISCOMFORT,1
BR,NASAL PRURITUS,1
BR,NASAL SEPTUM DEVIATION,1
BR,NEEDLE ISSUE,1
BR,NEOPLASM MALIGNANT,1
BR,NEPHRITIS,1
BR,NEPHROPATHY,1
BR,NERVOUS SYSTEM DISORDER,1
BR,NEUROLOGICAL DECOMPENSATION,1
BR,NEUROMYELITIS OPTICA,1
BR,NEUROMYELITIS OPTICA SPECTRUM DISORDER,1
BR,NEUROPATHY PERIPHERAL,1
BR,NIGHTMARE,1
BR,NO ADVERSE EVENT,1
BR,NO THERAPEUTIC RESPONSE,1
BR,NONSPECIFIC REACTION,1
BR,NOSOCOMIAL INFECTION,1
BR,OCULAR VASCULAR DISORDER,1
BR,OESOPHAGEAL DISORDER,1
BR,ONYCHOCLASIS,1
BR,ONYCHOMADESIS,1
BR,OPEN FRACTURE,1
BR,OPTIC ISCHAEMIC NEUROPATHY,1
BR,OPTIC NERVE DISORDER,1
BR,OPTIC NEURITIS,1
BR,ORAL DISCOMFORT,1
BR,ORAL DISORDER,1
BR,ORAL PRURITUS,1
BR,ORAL SURGERY,1
BR,ORTHOPAEDIC PROCEDURE,1
BR,OSTEOMYELITIS,1
BR,OVARIAN CANCER,1
BR,OVARIAN CYST,1
BR,OVARIAN DISORDER,1
BR,OVERWEIGHT,1
BR,PAIN IN JAW,1
BR,PAINFUL RESPIRATION,1
BR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
BR,PANCREATIC DISORDER,1
BR,PANCREATIC MASS,1
BR,PANIC DISORDER,1
BR,PANIC REACTION,1
BR,PARAESTHESIA ORAL,1
BR,PARESIS,1
BR,PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA,1
BR,PATHOGEN RESISTANCE,1
BR,PELVIC FRACTURE,1
BR,PERICARDIAL EFFUSION,1
BR,PERIODONTITIS,1
BR,PERIPHERAL COLDNESS,1
BR,PERITONSILLAR ABSCESS,1
BR,PERTUSSIS,1
BR,PHARYNGEAL OEDEMA,1
BR,PHOTOSENSITIVITY REACTION,1
BR,PLEURAL DISORDER,1
BR,PNEUMONITIS,1
BR,POLLAKIURIA,1
BR,POOR PERIPHERAL CIRCULATION,1
BR,PORTAL HYPERTENSION,1
BR,PORTAL VEIN THROMBOSIS,1
BR,POST PROCEDURAL INFLAMMATION,1
BR,POSTOPERATIVE WOUND INFECTION,1
BR,POSTURE ABNORMAL,1
BR,PREMATURE BABY,1
BR,PREMATURE SEPARATION OF PLACENTA,1
BR,PRESBYACUSIS,1
BR,PROCEDURAL HYPERTENSION,1
BR,PROCTALGIA,1
BR,PRODUCT PACKAGING ISSUE,1
BR,PRODUCT PHYSICAL ISSUE,1
BR,PRODUCT STORAGE ERROR,1
BR,PRODUCT SUBSTITUTION ISSUE,1
BR,PRODUCTIVE COUGH,1
BR,PROGRESSIVE MULTIPLE SCLEROSIS,1
BR,PROSTATE CANCER,1
BR,PROTEIN TOTAL DECREASED,1
BR,PROTEIN URINE PRESENT,1
BR,PROTEINURIA,1
BR,PRURITUS GENERALISED,1
BR,PSEUDOMONAS INFECTION,1
BR,PSORIATIC ARTHROPATHY,1
BR,PSYCHIATRIC SYMPTOM,1
BR,PSYCHOLOGICAL TRAUMA,1
BR,PTERYGIUM,1
BR,PULMONARY MASS,1
BR,PULMONARY OEDEMA,1
BR,PURULENT DISCHARGE,1
BR,PUSTULAR PSORIASIS,1
BR,RASH ERYTHEMATOUS,1
BR,RASH MACULAR,1
BR,RECTAL DISCHARGE,1
BR,RENAL CANCER,1
BR,RENAL CYST,1
BR,RENAL FAILURE ACUTE,1
BR,RENAL INJURY,1
BR,RESPIRATORY ARREST,1
BR,RESPIRATORY RATE INCREASED,1
BR,RESPIRATORY TRACT CONGESTION,1
BR,RESPIRATORY TRACT INFECTION,1
BR,RESTLESSNESS,1
BR,RETCHING,1
BR,RETICULOCYTE COUNT ABNORMAL,1
BR,RETICULOCYTE COUNT INCREASED,1
BR,RETINAL HAEMORRHAGE,1
BR,RETINAL TEAR,1
BR,RHEUMATIC DISORDER,1
BR,RHEUMATOID NODULE,1
BR,RHINOPLASTY,1
BR,SALIVARY GLAND ENLARGEMENT,1
BR,SCAR,1
BR,SCREAMING,1
BR,SECRETION DISCHARGE,1
BR,SEDATION,1
BR,SELF ESTEEM DECREASED,1
BR,SEROTONIN SYNDROME,1
BR,SHARED PSYCHOTIC DISORDER,1
BR,SKELETAL INJURY,1
BR,SKIN CANCER,1
BR,SKIN FISSURES,1
BR,SKIN HAEMORRHAGE,1
BR,SKIN HYPERTROPHY,1
BR,SKIN INFECTION,1
BR,SKIN IRRITATION,1
BR,SKIN MASS,1
BR,SKIN ODOUR ABNORMAL,1
BR,SKIN WARM,1
BR,SPINAL COLUMN INJURY,1
BR,SPINAL COMPRESSION FRACTURE,1
BR,SPINAL DEFORMITY,1
BR,SPLEEN DISORDER,1
BR,SPUTUM PURULENT,1
BR,SUFFOCATION FEELING,1
BR,SUICIDE ATTEMPT,1
BR,SUPPRESSED LACTATION,1
BR,SURGERY,1
BR,SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT,1
BR,SWOLLEN TONGUE,1
BR,SYRINGE ISSUE,1
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
BR,SYSTOLIC HYPERTENSION,1
BR,TENDON DISORDER,1
BR,TENDON INJURY,1
BR,TENDON RUPTURE,1
BR,TENSION,1
BR,THERAPY CESSATION,1
BR,THROMBOSIS MESENTERIC VESSEL,1
BR,THYROID CANCER,1
BR,THYROID HORMONES INCREASED,1
BR,THYROID NEOPLASM,1
BR,TIBIA FRACTURE,1
BR,TINNITUS,1
BR,TONGUE INJURY,1
BR,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
BR,TONSILLITIS,1
BR,TOOTH FRACTURE,1
BR,TOOTH INJURY,1
BR,TOOTH LOSS,1
BR,TOXICITY TO VARIOUS AGENTS,1
BR,TRACHEAL OEDEMA,1
BR,TRACHEAL OPERATION,1
BR,TRANSAMINASES INCREASED,1
BR,TUBERCULIN TEST POSITIVE,1
BR,TUBERCULOSIS,1
BR,TYPE 1 DIABETES MELLITUS,1
BR,ULCER,1
BR,ULCER HAEMORRHAGE,1
BR,UNDERWEIGHT,1
BR,UNINTENDED PREGNANCY,1
BR,URETHRAL PAIN,1
BR,URETHRAL STENOSIS,1
BR,URINARY TRACT DISORDER,1
BR,URINE ANALYSIS ABNORMAL,1
BR,UTERINE CYST,1
BR,UTERINE LEIOMYOMA,1
BR,UTERINE PROLAPSE,1
BR,UVEITIS,1
BR,VARICELLA,1
BR,VASCULAR PAIN,1
BR,VASCULAR RUPTURE,1
BR,VASCULITIS,1
BR,VIRAL LOAD INCREASED,1
BR,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
BR,VIROLOGIC FAILURE,1
BR,VISUAL ACUITY REDUCED,1
BR,VOCAL CORD DISORDER,1
BR,VULVOVAGINAL BURNING SENSATION,1
BR,VULVOVAGINAL INJURY,1
BR,VULVOVAGINAL PAIN,1
BR,WEIGHT BEARING DIFFICULTY,1
BR,WEIGHT DECREASE NEONATAL,1
BR,WITHDRAWAL SYNDROME,1
BR,WOUND DEHISCENCE,1
BR,WOUND INFECTION,1
BR,WRIST DEFORMITY,1
BR,WRIST FRACTURE,1
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
BG,ABDOMINAL DISTENSION,1
BG,ASCITES,1
BG,CHROMATURIA,1
BG,CITROBACTER INFECTION,1
BG,DYSPNOEA,1
BG,FATIGUE,1
BG,HAEMOGLOBIN DECREASED,1
BG,HAEMOSIDEROSIS,1
BG,HYPERBILIRUBINAEMIA,1
BG,PERIPHERAL SWELLING,1
BG,PYREXIA,1
BG,SWELLING,1
CM,BODY TEMPERATURE INCREASED,1
CM,CHILLS,1
CM,EYE MOVEMENT DISORDER,1
CM,RESPIRATORY ARREST,1
CM,SEIZURE,1
CA,FATIGUE,1045
CA,DRUG INEFFECTIVE,1032
CA,ARTHRALGIA,854
CA,PAIN,837
CA,INFUSION RELATED REACTION,785
CA,NAUSEA,739
CA,HEADACHE,692
CA,RHEUMATOID ARTHRITIS,645
CA,BLOOD PRESSURE INCREASED,610
CA,DIARRHOEA,608
CA,DYSPNOEA,592
CA,WEIGHT DECREASED,504
CA,PAIN IN EXTREMITY,499
CA,MALAISE,487
CA,NASOPHARYNGITIS,460
CA,PNEUMONIA,455
CA,COUGH,451
CA,VOMITING,451
CA,ASTHENIA,432
CA,FALL,431
CA,PYREXIA,428
CA,DIZZINESS,425
CA,JOINT SWELLING,417
CA,WEIGHT INCREASED,394
CA,HYPOTENSION,369
CA,ABDOMINAL PAIN,366
CA,BACK PAIN,361
CA,PERIPHERAL SWELLING,346
CA,HAEMOGLOBIN DECREASED,326
CA,HYPERTENSION,312
CA,RASH,303
CA,HEART RATE INCREASED,299
CA,OXYGEN SATURATION DECREASED,296
CA,DEATH,294
CA,INSOMNIA,264
CA,URINARY TRACT INFECTION,262
CA,PRURITUS,257
CA,GAIT DISTURBANCE,244
CA,INFECTION,241
CA,OVERDOSE,228
CA,INFLUENZA,226
CA,OROPHARYNGEAL PAIN,225
CA,ARTHRITIS,208
CA,DECREASED APPETITE,208
CA,CHILLS,207
CA,CHEST PAIN,205
CA,MUSCULOSKELETAL STIFFNESS,204
CA,SINUSITIS,204
CA,ABDOMINAL PAIN UPPER,203
CA,BLOOD PRESSURE FLUCTUATION,202
CA,ANXIETY,201
CA,DRUG INTOLERANCE,197
CA,HEART RATE DECREASED,197
CA,CONDITION AGGRAVATED,195
CA,ERYTHEMA,194
CA,CONSTIPATION,186
CA,SOMNOLENCE,183
CA,HYPOAESTHESIA,175
CA,ARTHROPATHY,173
CA,CHEST DISCOMFORT,172
CA,MUSCULOSKELETAL PAIN,169
CA,HERPES ZOSTER,168
CA,MYALGIA,163
CA,OSTEOARTHRITIS,163
CA,PRODUCT USE ISSUE,161
CA,URTICARIA,161
CA,WHITE BLOOD CELL COUNT DECREASED,160
CA,DEPRESSION,159
CA,FLUSHING,158
CA,HYPERHIDROSIS,156
CA,SWELLING,156
CA,DRUG HYPERSENSITIVITY,154
CA,BRONCHITIS,152
CA,CONTUSION,150
CA,LOWER RESPIRATORY TRACT INFECTION,146
CA,GENERAL PHYSICAL HEALTH DETERIORATION,145
CA,TOXICITY TO VARIOUS AGENTS,142
CA,ABDOMINAL DISCOMFORT,139
CA,DEHYDRATION,139
CA,ANAEMIA,138
CA,PLATELET COUNT DECREASED,138
CA,PRODUCTIVE COUGH,138
CA,MUSCULAR WEAKNESS,137
CA,MUSCLE SPASMS,131
CA,CONFUSIONAL STATE,130
CA,DRUG EFFECT DECREASED,130
CA,PALPITATIONS,129
CA,HYPERSENSITIVITY,128
CA,PARAESTHESIA,127
CA,SEPSIS,123
CA,HEPATIC ENZYME INCREASED,122
CA,STRESS,120
CA,BLOOD PRESSURE SYSTOLIC INCREASED,119
CA,MOBILITY DECREASED,119
CA,THROAT IRRITATION,118
CA,TREMOR,118
CA,OEDEMA PERIPHERAL,117
CA,BLOOD PRESSURE DECREASED,116
CA,CROHN^S DISEASE,115
CA,SYNOVITIS,113
CA,BALANCE DISORDER,111
CA,INFLAMMATION,111
CA,MIGRAINE,110
CA,CATARACT,109
CA,HAEMATOCHEZIA,109
CA,MYOCARDIAL INFARCTION,109
CA,FIBROMYALGIA,107
CA,TACHYCARDIA,106
CA,DISEASE PROGRESSION,105
CA,CELLULITIS,104
CA,DYSPHAGIA,104
CA,BLOOD CREATININE INCREASED,103
CA,FEBRILE NEUTROPENIA,102
CA,FEELING ABNORMAL,102
CA,HEPATIC FAILURE,101
CA,BLOOD CHOLESTEROL INCREASED,100
CA,HOT FLUSH,97
CA,NEPHROLITHIASIS,97
CA,ALOPECIA,96
CA,DYSPEPSIA,95
CA,RHINORRHOEA,95
CA,NASAL CONGESTION,94
CA,CYSTITIS,92
CA,PLEURAL EFFUSION,92
CA,BODY TEMPERATURE DECREASED,91
CA,ATRIAL FIBRILLATION,90
CA,DIABETES MELLITUS,89
CA,ABDOMINAL DISTENSION,88
CA,BODY TEMPERATURE INCREASED,88
CA,DRY MOUTH,88
CA,LYMPHOCYTE COUNT DECREASED,88
CA,RENAL FAILURE,87
CA,FEELING HOT,85
CA,ILL-DEFINED DISORDER,85
CA,LUNG INFECTION,85
CA,PULMONARY OEDEMA,85
CA,WOUND,85
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,83
CA,EPISTAXIS,83
CA,SYNCOPE,83
CA,GASTROINTESTINAL DISORDER,82
CA,LOSS OF CONSCIOUSNESS,82
CA,CEREBROVASCULAR ACCIDENT,81
CA,NECK PAIN,81
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,79
CA,LOCALISED INFECTION,79
CA,NEUTROPENIA,78
CA,EXPOSURE DURING PREGNANCY,77
CA,HAEMORRHAGE,76
CA,OSTEOPOROSIS,76
CA,VISUAL IMPAIRMENT,76
CA,TREATMENT FAILURE,75
CA,ACUTE KIDNEY INJURY,74
CA,ALANINE AMINOTRANSFERASE INCREASED,74
CA,ASTHMA,74
CA,BLOOD GLUCOSE INCREASED,74
CA,BLOOD PRESSURE DIASTOLIC DECREASED,74
CA,LUNG DISORDER,74
CA,NEUTROPHIL COUNT DECREASED,74
CA,SUICIDE ATTEMPT,74
CA,RENAL IMPAIRMENT,72
CA,PALLOR,71
CA,VISION BLURRED,71
CA,WHITE BLOOD CELL COUNT INCREASED,71
CA,BONE PAIN,70
CA,RED BLOOD CELL COUNT DECREASED,70
CA,INFLUENZA LIKE ILLNESS,69
CA,INTENTIONAL OVERDOSE,69
CA,EYE DISORDER,68
CA,LIVER FUNCTION TEST ABNORMAL,68
CA,ORAL HERPES,68
CA,SLEEP DISORDER,68
CA,LEUKOPENIA,67
CA,DEPRESSED MOOD,65
CA,LOCAL SWELLING,65
CA,CARDIAC DISORDER,64
CA,GASTROOESOPHAGEAL REFLUX DISEASE,64
CA,HEART RATE IRREGULAR,64
CA,LIMB INJURY,64
CA,NEUROPATHY PERIPHERAL,64
CA,RESPIRATORY RATE INCREASED,64
CA,SKIN ULCER,64
CA,THERAPEUTIC RESPONSE DECREASED,63
CA,BURNING SENSATION,62
CA,CLOSTRIDIUM DIFFICILE INFECTION,62
CA,INJECTION SITE PAIN,62
CA,DRUG EFFECT INCOMPLETE,61
CA,EAR PAIN,61
CA,MALIGNANT NEOPLASM PROGRESSION,61
CA,URINARY INCONTINENCE,61
CA,ACUTE HEPATIC FAILURE,60
CA,DRY EYE,60
CA,IMPAIRED HEALING,60
CA,THROMBOSIS,60
CA,HAEMATOCRIT DECREASED,59
CA,HIP FRACTURE,59
CA,ASPARTATE AMINOTRANSFERASE INCREASED,58
CA,BLOOD URINE PRESENT,58
CA,COGNITIVE DISORDER,58
CA,DYSPNOEA EXERTIONAL,58
CA,EAR INFECTION,58
CA,PULMONARY EMBOLISM,58
CA,AMNESIA,57
CA,DYSPHONIA,57
CA,TOOTH DISORDER,57
CA,JOINT STIFFNESS,56
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,56
CA,SWELLING FACE,56
CA,THROAT TIGHTNESS,56
CA,ACNE,55
CA,BLISTER,55
CA,DRUG DOSE OMISSION,55
CA,WHEEZING,55
CA,CARDIAC FAILURE CONGESTIVE,54
CA,RECTAL HAEMORRHAGE,54
CA,COLITIS ULCERATIVE,53
CA,SEIZURE,53
CA,FREQUENT BOWEL MOVEMENTS,52
CA,SKIN LESION,52
CA,BRAIN OEDEMA,51
CA,NEOPLASM MALIGNANT,51
CA,OEDEMA,51
CA,UPPER RESPIRATORY TRACT INFECTION,51
CA,URINE ABNORMALITY,51
CA,EYE PAIN,50
CA,INTERNATIONAL NORMALISED RATIO INCREASED,50
CA,INTESTINAL OBSTRUCTION,50
CA,LACERATION,50
CA,NIGHT SWEATS,50
CA,RASH ERYTHEMATOUS,50
CA,RIB FRACTURE,50
CA,STOMATITIS,50
CA,DIVERTICULITIS,49
CA,GASTROINTESTINAL HAEMORRHAGE,49
CA,MASS,49
CA,MEMORY IMPAIRMENT,49
CA,AGITATION,48
CA,ARTERIOSCLEROSIS CORONARY ARTERY,48
CA,BLOOD LACTATE DEHYDROGENASE INCREASED,48
CA,BREAST CANCER,48
CA,SCIATICA,48
CA,SLEEP APNOEA SYNDROME,48
CA,BLOOD PRESSURE DIASTOLIC INCREASED,47
CA,BURSITIS,47
CA,FUNGAL INFECTION,47
CA,JAUNDICE,47
CA,VIRAL INFECTION,47
CA,CHOLELITHIASIS,46
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,46
CA,DRY SKIN,46
CA,LETHARGY,46
CA,RENAL PAIN,46
CA,SKIN DISCOLOURATION,46
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,46
CA,POOR VENOUS ACCESS,45
CA,PSORIASIS,45
CA,RED CELL DISTRIBUTION WIDTH INCREASED,45
CA,C-REACTIVE PROTEIN INCREASED,44
CA,SUICIDAL IDEATION,44
CA,SURGERY,44
CA,BLOOD BILIRUBIN INCREASED,43
CA,CYST,43
CA,DISCOMFORT,43
CA,HOSPITALISATION,43
CA,PAIN IN JAW,43
CA,ASPHYXIA,42
CA,CARDIAC ARREST,42
CA,KIDNEY INFECTION,42
CA,LACRIMATION INCREASED,42
CA,LIMB DISCOMFORT,42
CA,NEURALGIA,42
CA,PANCREATITIS,42
CA,RENAL DISORDER,42
CA,SKIN EXFOLIATION,42
CA,TOOTHACHE,42
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,41
CA,FOOT DEFORMITY,41
CA,LIVER INJURY,41
CA,PRURITUS GENERALISED,41
CA,ENCEPHALOPATHY,40
CA,FOOT FRACTURE,40
CA,INCORRECT DOSE ADMINISTERED,40
CA,POLLAKIURIA,40
CA,PULMONARY CONGESTION,40
CA,RESPIRATORY FAILURE,40
CA,SEPTIC SHOCK,40
CA,SINUS CONGESTION,40
CA,COLITIS,39
CA,FLUID RETENTION,39
CA,MUSCULOSKELETAL DISCOMFORT,39
CA,C-REACTIVE PROTEIN ABNORMAL,38
CA,CARDIAC FAILURE,38
CA,GASTRIC DISORDER,38
CA,HEPATITIS,38
CA,RASH PRURITIC,38
CA,THROMBOCYTOPENIA,38
CA,BRADYCARDIA,37
CA,DELIRIUM,37
CA,EYE SWELLING,37
CA,FLATULENCE,37
CA,HAND DEFORMITY,37
CA,HEPATOTOXICITY,37
CA,NEUTROPHIL COUNT INCREASED,37
CA,ORTHOSTATIC HYPOTENSION,37
CA,OSTEOPENIA,37
CA,RESPIRATORY DISORDER,37
CA,ULCER,37
CA,ADVERSE EVENT,36
CA,BLOOD POTASSIUM DECREASED,36
CA,DEEP VEIN THROMBOSIS,36
CA,INTESTINAL RESECTION,36
CA,JOINT RANGE OF MOTION DECREASED,36
CA,LYMPHADENOPATHY,36
CA,ROAD TRAFFIC ACCIDENT,36
CA,SKIN DISORDER,36
CA,DYSGEUSIA,35
CA,GLAUCOMA,35
CA,HAEMATOMA,35
CA,HAEMOPTYSIS,35
CA,KNEE ARTHROPLASTY,35
CA,RASH GENERALISED,35
CA,TOOTH INFECTION,35
CA,VERTIGO,35
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,34
CA,BLOOD PRESSURE ABNORMAL,34
CA,DYSURIA,34
CA,MOUTH ULCERATION,34
CA,MOVEMENT DISORDER,34
CA,MUSCULOSKELETAL CHEST PAIN,34
CA,POST PROCEDURAL INFECTION,34
CA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,34
CA,RESPIRATORY TRACT CONGESTION,34
CA,ROTATOR CUFF SYNDROME,34
CA,SOFT TISSUE DISORDER,34
CA,SPUTUM DISCOLOURED,34
CA,BLOOD MAGNESIUM DECREASED,33
CA,HALLUCINATION,33
CA,NERVOUSNESS,33
CA,SPINAL FRACTURE,33
CA,TYPE 2 DIABETES MELLITUS,33
CA,VASCULITIS,33
CA,WOUND INFECTION,33
CA,COAGULOPATHY,32
CA,COMA,32
CA,FEMUR FRACTURE,32
CA,INJECTION SITE EXTRAVASATION,32
CA,LIVER DISORDER,32
CA,MULTIPLE SCLEROSIS,32
CA,TINNITUS,32
CA,UPPER LIMB FRACTURE,32
CA,ABSCESS,31
CA,ADVERSE DRUG REACTION,31
CA,APHONIA,31
CA,DEAFNESS NEUROSENSORY,31
CA,DISORIENTATION,31
CA,EYE INFECTION,31
CA,GRANULOMATOSIS WITH POLYANGIITIS,31
CA,MUSCULOSKELETAL DISORDER,31
CA,SPEECH DISORDER,31
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,31
CA,TOOTH ABSCESS,31
CA,ANAPHYLACTIC REACTION,30
CA,BACTERIAL INFECTION,30
CA,GASTRIC ULCER,30
CA,HERNIA,30
CA,HYPOPHAGIA,30
CA,INJECTION SITE REACTION,30
CA,JOINT INJURY,30
CA,MONOCYTE COUNT INCREASED,30
CA,PANCYTOPENIA,30
CA,PEMPHIGUS,30
CA,UNRESPONSIVE TO STIMULI,30
CA,ACCIDENTAL OVERDOSE,29
CA,ANGINA PECTORIS,29
CA,BLOOD TEST ABNORMAL,29
CA,CHROMATURIA,29
CA,ECZEMA,29
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,29
CA,HAEMATEMESIS,29
CA,HAEMORRHOIDS,29
CA,HEPATIC CIRRHOSIS,29
CA,LUNG NEOPLASM MALIGNANT,29
CA,OCULAR HYPERAEMIA,29
CA,OSTEOMYELITIS,29
CA,PNEUMONIA ASPIRATION,29
CA,POST PROCEDURAL COMPLICATION,29
CA,SCOLIOSIS,28
CA,SNEEZING,28
CA,ACUTE MYOCARDIAL INFARCTION,27
CA,APHTHOUS ULCER,27
CA,BLOOD IRON DECREASED,27
CA,FEELING COLD,27
CA,FOETAL EXPOSURE DURING PREGNANCY,27
CA,GOUT,27
CA,HEPATIC STEATOSIS,27
CA,HYPOKINESIA,27
CA,HYPOXIA,27
CA,METABOLIC ACIDOSIS,27
CA,MUSCLE STRAIN,27
CA,NODULE,27
CA,PRESBYACUSIS,27
CA,PRODUCT USE IN UNAPPROVED INDICATION,27
CA,PULMONARY FIBROSIS,27
CA,PULMONARY MASS,27
CA,RASH MACULAR,27
CA,RESPIRATORY DISTRESS,27
CA,TENDONITIS,27
CA,ABASIA,26
CA,BLOOD CREATINE PHOSPHOKINASE INCREASED,26
CA,CARPAL TUNNEL SYNDROME,26
CA,DRUG ADMINISTRATION ERROR,26
CA,EPIGASTRIC DISCOMFORT,26
CA,GALLBLADDER DISORDER,26
CA,GASTROENTERITIS VIRAL,26
CA,HAEMOLYSIS,26
CA,HYPOTHYROIDISM,26
CA,INTERVERTEBRAL DISC PROTRUSION,26
CA,MATERNAL EXPOSURE DURING PREGNANCY,26
CA,NEOPLASM,26
CA,ORAL PAIN,26
CA,PHOTOPHOBIA,26
CA,RENAL FAILURE ACUTE,26
CA,TRANSIENT ISCHAEMIC ATTACK,26
CA,UNEVALUABLE EVENT,26
CA,ANKLE FRACTURE,25
CA,ARRHYTHMIA,25
CA,DENTAL CARIES,25
CA,DIABETES MELLITUS INADEQUATE CONTROL,25
CA,FINGER DEFORMITY,25
CA,FISTULA,25
CA,GASTROENTERITIS,25
CA,HYPERAESTHESIA,25
CA,LOWER LIMB FRACTURE,25
CA,SKIN INFECTION,25
CA,STAPHYLOCOCCAL INFECTION,25
CA,VISUAL ACUITY REDUCED,25
CA,ADRENAL INSUFFICIENCY,24
CA,BASAL CELL CARCINOMA,24
CA,BONE DISORDER,24
CA,DRY THROAT,24
CA,EMPHYSEMA,24
CA,EXOSTOSIS,24
CA,IRRITABLE BOWEL SYNDROME,24
CA,LARYNGITIS,24
CA,LIGAMENT SPRAIN,24
CA,PLEURAL FIBROSIS,24
CA,ANAPHYLACTIC SHOCK,23
CA,DEFORMITY,23
CA,DEMENTIA,23
CA,DRUG-INDUCED LIVER INJURY,23
CA,GLOMERULAR FILTRATION RATE DECREASED,23
CA,HYPOKALAEMIA,23
CA,JOINT EFFUSION,23
CA,MULTI-ORGAN FAILURE,23
CA,MULTIPLE SCLEROSIS RELAPSE,23
CA,PELVIC FRACTURE,23
CA,PHARYNGITIS,23
CA,RESTLESSNESS,23
CA,STEVENS-JOHNSON SYNDROME,23
CA,THYROID DISORDER,23
CA,WEIGHT FLUCTUATION,23
CA,ABDOMINAL PAIN LOWER,22
CA,BLOOD CREATININE DECREASED,22
CA,BLOOD DISORDER,22
CA,BONE EROSION,22
CA,CEREBRAL HAEMORRHAGE,22
CA,CRYING,22
CA,CYANOSIS,22
CA,DEVICE RELATED INFECTION,22
CA,DRUG DEPENDENCE,22
CA,ENCEPHALITIS,22
CA,EYE HAEMORRHAGE,22
CA,HEAD INJURY,22
CA,HYPOAESTHESIA ORAL,22
CA,IMPAIRED WORK ABILITY,22
CA,IRRITABILITY,22
CA,PERIPHERAL COLDNESS,22
CA,PSORIATIC ARTHROPATHY,22
CA,PSYCHOTIC DISORDER,22
CA,SEDATION,22
CA,SKIN FISSURES,22
CA,TOOTH EXTRACTION,22
CA,WHITE BLOOD CELLS URINE POSITIVE,22
CA,WRIST FRACTURE,22
CA,ARTHRITIS INFECTIVE,21
CA,ATELECTASIS,21
CA,CHOKING,21
CA,DYSKINESIA,21
CA,EMOTIONAL DISTRESS,21
CA,HEPATIC ENCEPHALOPATHY,21
CA,LIVER FUNCTION TEST INCREASED,21
CA,MEDICATION ERROR,21
CA,MUSCLE SPASTICITY,21
CA,ORAL CANDIDIASIS,21
CA,PAIN OF SKIN,21
CA,PLASMA CELL MYELOMA,21
CA,SKIN CANCER,21
CA,TENDERNESS,21
CA,URINARY RETENTION,21
CA,ACUTE RESPIRATORY DISTRESS SYNDROME,20
CA,APHASIA,20
CA,COMPLETED SUICIDE,20
CA,CONTRAINDICATED PRODUCT ADMINISTERED,20
CA,COORDINATION ABNORMAL,20
CA,DIPLOPIA,20
CA,DISTURBANCE IN ATTENTION,20
CA,EAR PRURITUS,20
CA,GASTRITIS,20
CA,JOINT DISLOCATION,20
CA,LIP SWELLING,20
CA,LYMPHOMA,20
CA,POOR QUALITY SLEEP,20
CA,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,20
CA,RESTLESS LEGS SYNDROME,20
CA,RHABDOMYOLYSIS,20
CA,SCAR,20
CA,SPLENOMEGALY,20
CA,UNDERDOSE,20
CA,ASCITES,19
CA,BLOOD POTASSIUM INCREASED,19
CA,BREAST PAIN,19
CA,DYSARTHRIA,19
CA,DYSSTASIA,19
CA,EAR DISCOMFORT,19
CA,EATING DISORDER,19
CA,FACE OEDEMA,19
CA,FAECES DISCOLOURED,19
CA,HAEMATURIA,19
CA,HAEMOGLOBIN INCREASED,19
CA,HEPATIC ENZYME ABNORMAL,19
CA,HEPATIC NECROSIS,19
CA,HYPONATRAEMIA,19
CA,INJECTION SITE ERYTHEMA,19
CA,INJURY,19
CA,INTERSTITIAL LUNG DISEASE,19
CA,LACTIC ACIDOSIS,19
CA,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,19
CA,METASTASES TO LIVER,19
CA,MIDDLE INSOMNIA,19
CA,MULTIPLE ORGAN DYSFUNCTION SYNDROME,19
CA,NERVE INJURY,19
CA,NERVOUS SYSTEM DISORDER,19
CA,PARALYSIS,19
CA,PHOTOSENSITIVITY REACTION,19
CA,POLYP,19
CA,RESPIRATORY DEPRESSION,19
CA,RESPIRATORY TRACT INFECTION,19
CA,SHOCK,19
CA,SKIN IRRITATION,19
CA,SPINAL DISORDER,19
CA,TOOTH FRACTURE,19
CA,ANGER,18
CA,BLADDER DISORDER,18
CA,BLOOD CALCIUM DECREASED,18
CA,BONE DENSITY DECREASED,18
CA,CONVULSION,18
CA,GAIT INABILITY,18
CA,IMMUNODEFICIENCY,18
CA,INJECTION SITE SWELLING,18
CA,MENTAL DISORDER,18
CA,OVARIAN CYST,18
CA,PHARYNGEAL OEDEMA,18
CA,PROCEDURAL PAIN,18
CA,SCAB,18
CA,SINUS DISORDER,18
CA,SMALL INTESTINAL OBSTRUCTION,18
CA,ABORTION SPONTANEOUS,17
CA,AGGRESSION,17
CA,BLOOD PRESSURE DIASTOLIC ABNORMAL,17
CA,BREAST MASS,17
CA,CORONARY ARTERY OCCLUSION,17
CA,DEMYELINATION,17
CA,DIARRHOEA HAEMORRHAGIC,17
CA,DRUG WITHDRAWAL SYNDROME,17
CA,EOSINOPHIL COUNT INCREASED,17
CA,EYE PRURITUS,17
CA,FEELING OF BODY TEMPERATURE CHANGE,17
CA,HEAD DISCOMFORT,17
CA,HYPOGLYCAEMIA,17
CA,INJECTION SITE HAEMORRHAGE,17
CA,INTENTIONAL PRODUCT MISUSE,17
CA,INTERVERTEBRAL DISCITIS,17
CA,MEAN CELL HAEMOGLOBIN INCREASED,17
CA,PERICARDIAL EFFUSION,17
CA,PNEUMONIA VIRAL,17
CA,PNEUMONITIS,17
CA,PRESYNCOPE,17
CA,RALES,17
CA,RESPIRATORY RATE DECREASED,17
CA,SPINAL COLUMN STENOSIS,17
CA,SPINAL PAIN,17
CA,TEMPERATURE INTOLERANCE,17
CA,URINE ANALYSIS ABNORMAL,17
CA,BACK DISORDER,16
CA,BLOOD ALBUMIN DECREASED,16
CA,CONCUSSION,16
CA,ECCHYMOSIS,16
CA,EYE IRRITATION,16
CA,EYE OPERATION,16
CA,GASTROINTESTINAL INFECTION,16
CA,HEMIPARESIS,16
CA,HYPERGLYCAEMIA,16
CA,IMMUNE SYSTEM DISORDER,16
CA,MEAN CELL VOLUME INCREASED,16
CA,MUSCLE ATROPHY,16
CA,MYOCARDITIS,16
CA,PANIC ATTACK,16
CA,PHARYNGITIS STREPTOCOCCAL,16
CA,POST-TRAUMATIC STRESS DISORDER,16
CA,PROTEINURIA,16
CA,SWOLLEN TONGUE,16
CA,SYNOVIAL CYST,16
CA,UPPER-AIRWAY COUGH SYNDROME,16
CA,UROSEPSIS,16
CA,VAGINAL HAEMORRHAGE,16
CA,BACK INJURY,15
CA,BLOOD SODIUM DECREASED,15
CA,BRAIN INJURY,15
CA,BREATH SOUNDS ABNORMAL,15
CA,BRONCHIECTASIS,15
CA,CAESAREAN SECTION,15
CA,CANDIDA INFECTION,15
CA,ELECTRIC SHOCK,15
CA,EMOTIONAL DISORDER,15
CA,GENERALISED OEDEMA,15
CA,GLOSSODYNIA,15
CA,HAND FRACTURE,15
CA,HIATUS HERNIA,15
CA,HYPERSOMNIA,15
CA,HYPOACUSIS,15
CA,INCREASED APPETITE,15
CA,INTERVERTEBRAL DISC DEGENERATION,15
CA,INTESTINAL PERFORATION,15
CA,KNEE OPERATION,15
CA,LYMPHOCYTE PERCENTAGE DECREASED,15
CA,OBESITY,15
CA,PERICARDITIS,15
CA,PLATELET COUNT INCREASED,15
CA,PLEURAL THICKENING,15
CA,PRODUCT QUALITY ISSUE,15
CA,PULMONARY HYPERTENSION,15
CA,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,15
CA,RESPIRATORY ARREST,15
CA,SENSORY LOSS,15
CA,SPINAL COMPRESSION FRACTURE,15
CA,THERAPY NON-RESPONDER,15
CA,TRANSFUSION,15
CA,UPPER GASTROINTESTINAL HAEMORRHAGE,15
CA,ADVERSE REACTION,14
CA,ANKLE DEFORMITY,14
CA,ARTHROPOD BITE,14
CA,BACTERIAL TEST,14
CA,BLOOD COUNT ABNORMAL,14
CA,BLOOD GLUCOSE ABNORMAL,14
CA,BLOOD GLUCOSE DECREASED,14
CA,BLOOD PRESSURE SYSTOLIC ABNORMAL,14
CA,COLD SWEAT,14
CA,GASTROINTESTINAL INFLAMMATION,14
CA,GASTROINTESTINAL PAIN,14
CA,GINGIVAL BLEEDING,14
CA,HEPATIC CANCER,14
CA,HEPATIC PAIN,14
CA,HYPERCHOLESTEROLAEMIA,14
CA,INJECTION SITE BRUISING,14
CA,LIPASE INCREASED,14
CA,MALIGNANT MELANOMA,14
CA,MELANOCYTIC NAEVUS,14
CA,MOOD ALTERED,14
CA,NIGHTMARE,14
CA,PNEUMOTHORAX,14
CA,PREMATURE DELIVERY,14
CA,PROSTATE CANCER METASTATIC,14
CA,PROTEIN URINE PRESENT,14
CA,SKIN ABRASION,14
CA,SQUAMOUS CELL CARCINOMA,14
CA,TENDON RUPTURE,14
CA,THERMAL BURN,14
CA,VITAMIN D DEFICIENCY,14
CA,WRIST DEFORMITY,14
CA,ABNORMAL BEHAVIOUR,13
CA,ACCIDENT,13
CA,ANGIOEDEMA,13
CA,CHOLECYSTITIS,13
CA,COLON CANCER,13
CA,CONJUNCTIVITIS,13
CA,CREATININE RENAL CLEARANCE DECREASED,13
CA,DIABETIC KETOACIDOSIS,13
CA,DISABILITY,13
CA,EXPOSURE DURING BREAST FEEDING,13
CA,EYE INFLAMMATION,13
CA,FEEDING DISORDER,13
CA,GINGIVITIS,13
CA,GROIN PAIN,13
CA,HAEMOGLOBIN ABNORMAL,13
CA,HIP ARTHROPLASTY,13
CA,INTENTIONAL PRODUCT USE ISSUE,13
CA,INTESTINAL STENOSIS,13
CA,LIGAMENT RUPTURE,13
CA,NERVE COMPRESSION,13
CA,POSTOPERATIVE WOUND INFECTION,13
CA,SEASONAL ALLERGY,13
CA,SHOULDER ARTHROPLASTY,13
CA,SINUS TACHYCARDIA,13
CA,TACHYPNOEA,13
CA,URINE KETONE BODY PRESENT,13
CA,URINE ODOUR ABNORMAL,13
CA,URINE OUTPUT DECREASED,13
CA,VAGINAL INFECTION,13
CA,VEIN DISORDER,13
CA,WALKING AID USER,13
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,13
CA,ANKYLOSING SPONDYLITIS,12
CA,ARTERIOSCLEROSIS,12
CA,BLADDER CANCER,12
CA,BLOOD PRESSURE SYSTOLIC DECREASED,12
CA,CHRONIC KIDNEY DISEASE,12
CA,DEAFNESS,12
CA,DISEASE RECURRENCE,12
CA,DRUG LEVEL INCREASED,12
CA,ELECTROCARDIOGRAM QT PROLONGED,12
CA,ERUCTATION,12
CA,HYPERKERATOSIS,12
CA,HYSTERECTOMY,12
CA,INCREASED TENDENCY TO BRUISE,12
CA,INFUSION SITE EXTRAVASATION,12
CA,INTERNAL HAEMORRHAGE,12
CA,LIP DRY,12
CA,LYMPHOEDEMA,12
CA,MENSTRUATION IRREGULAR,12
CA,MYOCARDIAL ISCHAEMIA,12
CA,NAIL DISORDER,12
CA,NEUTROPHIL PERCENTAGE INCREASED,12
CA,NO THERAPEUTIC RESPONSE,12
CA,OPTIC NEURITIS,12
CA,OSTEONECROSIS OF JAW,12
CA,PNEUMOCYSTIS JIROVECII PNEUMONIA,12
CA,PREMATURE BABY,12
CA,PROSTATE CANCER,12
CA,PULMONARY FUNCTION TEST DECREASED,12
CA,RASH PAPULAR,12
CA,RHINITIS,12
CA,SCRATCH,12
CA,SENSITIVITY TO WEATHER CHANGE,12
CA,SINUS HEADACHE,12
CA,SJOGREN^S SYNDROME,12
CA,SKIN ATROPHY,12
CA,SUBSTANCE ABUSE,12
CA,WHEELCHAIR USER,12
CA,WOUND COMPLICATION,12
CA,AORTIC ANEURYSM,11
CA,ARTERIAL OCCLUSIVE DISEASE,11
CA,ASPIRATION,11
CA,ATRIOVENTRICULAR BLOCK COMPLETE,11
CA,BACTERAEMIA,11
CA,BLOOD THYROID STIMULATING HORMONE DECREASED,11
CA,BRONCHOSPASM,11
CA,DEVICE ISSUE,11
CA,EYE OEDEMA,11
CA,FACIAL PARALYSIS,11
CA,FEAR,11
CA,FULL BLOOD COUNT DECREASED,11
CA,FUNGAL SKIN INFECTION,11
CA,HIP SURGERY,11
CA,HYPOMAGNESAEMIA,11
CA,INCISION SITE INFECTION,11
CA,JOINT CREPITATION,11
CA,JOINT LOCK,11
CA,LUNG INFILTRATION,11
CA,MENORRHAGIA,11
CA,MENTAL STATUS CHANGES,11
CA,MYELODYSPLASTIC SYNDROME,11
CA,OBSTRUCTION,11
CA,OBSTRUCTIVE AIRWAYS DISORDER,11
CA,OSTEOSCLEROSIS,11
CA,PHLEBITIS,11
CA,POST PROCEDURAL HAEMORRHAGE,11
CA,QUALITY OF LIFE DECREASED,11
CA,RASH MACULO-PAPULAR,11
CA,RENAL CYST,11
CA,SECRETION DISCHARGE,11
CA,SEROTONIN SYNDROME,11
CA,SKIN BURNING SENSATION,11
CA,SPINAL OSTEOARTHRITIS,11
CA,SUBDURAL HAEMATOMA,11
CA,TOXIC EPIDERMAL NECROLYSIS,11
CA,TREATMENT NONCOMPLIANCE,11
CA,UTERINE LEIOMYOMA,11
CA,ALCOHOL ABUSE,10
CA,ANAL INCONTINENCE,10
CA,ARTERIOVENOUS FISTULA OCCLUSION,10
CA,ATAXIA,10
CA,BACTERIAL TEST POSITIVE,10
CA,BLINDNESS,10
CA,BLOOD MAGNESIUM INCREASED,10
CA,BONE CYST,10
CA,CARDIO-RESPIRATORY ARREST,10
CA,CARDIOMEGALY,10
CA,CARDIOVASCULAR DISORDER,10
CA,COLITIS ISCHAEMIC,10
CA,DECREASED ACTIVITY,10
CA,DECUBITUS ULCER,10
CA,DYSLIPIDAEMIA,10
CA,FOOD ALLERGY,10
CA,FRACTURE,10
CA,HAEMOGLOBINURIA,10
CA,HAEMORRHAGE URINARY TRACT,10
CA,HEPATIC CYST,10
CA,HYPERKALAEMIA,10
CA,IMPAIRED SELF-CARE,10
CA,INCORRECT DRUG ADMINISTRATION DURATION,10
CA,INFUSION SITE PAIN,10
CA,INJECTION SITE MASS,10
CA,MELAENA,10
CA,MENTAL IMPAIRMENT,10
CA,METASTASES TO LUNG,10
CA,METASTASIS,10
CA,MICTURITION URGENCY,10
CA,MUSCLE TWITCHING,10
CA,NASAL DISCHARGE DISCOLOURATION,10
CA,NEEDLE ISSUE,10
CA,NEOPLASM PROGRESSION,10
CA,PLANTAR FASCIITIS,10
CA,PROTEIN TOTAL DECREASED,10
CA,PYELONEPHRITIS,10
CA,RECURRENT CANCER,10
CA,RED BLOOD CELL COUNT INCREASED,10
CA,RETINAL DETACHMENT,10
CA,RHEUMATOID NODULE,10
CA,SCLERODERMA,10
CA,SERUM FERRITIN INCREASED,10
CA,SKIN REACTION,10
CA,SUBCUTANEOUS ABSCESS,10
CA,TUMOUR LYSIS SYNDROME,10
CA,UMBILICAL HERNIA,10
CA,UVEITIS,10
CA,VITREOUS FLOATERS,10
CA,ABDOMINAL HERNIA,9
CA,ACIDOSIS,9
CA,ADENOCARCINOMA OF COLON,9
CA,ANAL FISTULA,9
CA,AORTIC BRUIT,9
CA,APPENDICITIS,9
CA,ARTHRITIS BACTERIAL,9
CA,ATRIAL FLUTTER,9
CA,AUTONOMIC NERVOUS SYSTEM IMBALANCE,9
CA,BEDRIDDEN,9
CA,BLINDNESS UNILATERAL,9
CA,BLOOD UREA INCREASED,9
CA,CARDIOMYOPATHY,9
CA,CHANGE OF BOWEL HABIT,9
CA,ELBOW OPERATION,9
CA,ESCHERICHIA URINARY TRACT INFECTION,9
CA,FACIAL PAIN,9
CA,FAECES SOFT,9
CA,FRUSTRATION TOLERANCE DECREASED,9
CA,FURUNCLE,9
CA,GENERALISED ERYTHEMA,9
CA,HEPATIC FUNCTION ABNORMAL,9
CA,HERPES SIMPLEX,9
CA,HERPES VIRUS INFECTION,9
CA,HYDRONEPHROSIS,9
CA,HYPERBILIRUBINAEMIA,9
CA,HYPOTHERMIA,9
CA,INCONTINENCE,9
CA,INCORRECT DRUG ADMINISTRATION RATE,9
CA,INCREASED UPPER AIRWAY SECRETION,9
CA,INFUSION SITE ERYTHEMA,9
CA,INTERVERTEBRAL DISC DISORDER,9
CA,JOINT INSTABILITY,9
CA,LABORATORY TEST ABNORMAL,9
CA,LOWER RESPIRATORY TRACT CONGESTION,9
CA,MACULAR DEGENERATION,9
CA,MEAN PLATELET VOLUME DECREASED,9
CA,MONOCYTE PERCENTAGE INCREASED,9
CA,MUCOUS STOOLS,9
CA,OCULAR ICTERUS,9
CA,PARKINSON^S DISEASE,9
CA,PELVIC PAIN,9
CA,PERIPHERAL VENOUS DISEASE,9
CA,PERITONITIS,9
CA,POLYMYALGIA RHEUMATICA,9
CA,PROCTALGIA,9
CA,PULMONARY HAEMORRHAGE,9
CA,RED BLOOD CELLS URINE POSITIVE,9
CA,RETCHING,9
CA,SCHIZOPHRENIA,9
CA,THERAPEUTIC RESPONSE SHORTENED,9
CA,URINARY SEDIMENT PRESENT,9
CA,URINE LEUKOCYTE ESTERASE POSITIVE,9
CA,VITAMIN D DECREASED,9
CA,VITAMIN K DEFICIENCY,9
CA,VULVOVAGINAL MYCOTIC INFECTION,9
CA,WOUND SECRETION,9
CA,YELLOW SKIN,9
CA,ABDOMINAL TENDERNESS,8
CA,ACUTE FEBRILE NEUTROPHILIC DERMATOSIS,8
CA,ALANINE AMINOTRANSFERASE ABNORMAL,8
CA,BILIRUBIN CONJUGATED INCREASED,8
CA,BLADDER TRANSITIONAL CELL CARCINOMA,8
CA,BLOOD TRIGLYCERIDES INCREASED,8
CA,BLUE TOE SYNDROME,8
CA,BONE MARROW FAILURE,8
CA,BRAIN NEOPLASM,8
CA,CARTILAGE INJURY,8
CA,CHOKING SENSATION,8
CA,CHRONIC SINUSITIS,8
CA,COMPRESSION FRACTURE,8
CA,CORONARY ARTERY DISEASE,8
CA,CREPITATIONS,8
CA,CULTURE URINE POSITIVE,8
CA,DERMATITIS CONTACT,8
CA,DEVICE BREAKAGE,8
CA,DEVICE OCCLUSION,8
CA,DIVERTICULUM,8
CA,DRUG ABUSE,8
CA,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,8
CA,DYSMENORRHOEA,8
CA,ELECTROLYTE IMBALANCE,8
CA,EYELID DISORDER,8
CA,EYELID PTOSIS,8
CA,FOOT OPERATION,8
CA,FORCED EXPIRATORY VOLUME DECREASED,8
CA,GASTRIC HAEMORRHAGE,8
CA,GENERALISED TONIC-CLONIC SEIZURE,8
CA,GINGIVAL DISORDER,8
CA,HELICOBACTER INFECTION,8
CA,HUNGER,8
CA,HYPERCALCAEMIA,8
CA,HYPOPNOEA,8
CA,ILEOSTOMY,8
CA,INCORRECT ROUTE OF DRUG ADMINISTRATION,8
CA,INFECTED SKIN ULCER,8
CA,INJECTION SITE PRURITUS,8
CA,LEUKAEMIA,8
CA,LEUKOCYTOSIS,8
CA,LIMB OPERATION,8
CA,LUNG CONSOLIDATION,8
CA,LUNG NEOPLASM,8
CA,MALNUTRITION,8
CA,MEAN CELL HAEMOGLOBIN DECREASED,8
CA,MENINGITIS,8
CA,MENOPAUSE,8
CA,METASTASES TO CENTRAL NERVOUS SYSTEM,8
CA,MONOCYTE COUNT DECREASED,8
CA,MOOD SWINGS,8
CA,MOUTH HAEMORRHAGE,8
CA,MUSCLE RUPTURE,8
CA,MYOCLONUS,8
CA,OESOPHAGITIS,8
CA,ORAL FUNGAL INFECTION,8
CA,OROPHARYNGEAL DISCOMFORT,8
CA,PARAESTHESIA ORAL,8
CA,PETECHIAE,8
CA,PROCEDURAL COMPLICATION,8
CA,PYODERMA GANGRENOSUM,8
CA,RENAL CANCER,8
CA,SINUS BRADYCARDIA,8
CA,SKIN PLAQUE,8
CA,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,8
CA,SMEAR CERVIX ABNORMAL,8
CA,SOCIAL AVOIDANT BEHAVIOUR,8
CA,TENDON DISORDER,8
CA,THERAPEUTIC RESPONSE UNEXPECTED,8
CA,TRISMUS,8
CA,TROPONIN INCREASED,8
CA,VASODILATATION,8
CA,VEIN COLLAPSE,8
CA,VISUAL FIELD DEFECT,8
CA,ABSCESS LIMB,7
CA,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,7
CA,ANAL ABSCESS,7
CA,APNOEA,7
CA,AUTOIMMUNE DISORDER,7
CA,BLOOD CALCIUM INCREASED,7
CA,BLOOD CREATINE INCREASED,7
CA,BLOOD GLUCOSE FLUCTUATION,7
CA,BLOOD IRON INCREASED,7
CA,BOWEL MOVEMENT IRREGULARITY,7
CA,BREAST CANCER METASTATIC,7
CA,CARDIAC FLUTTER,7
CA,CHOLANGITIS,7
CA,CHOLECYSTECTOMY,7
CA,CHONDROPATHY,7
CA,COLITIS MICROSCOPIC,7
CA,COMPLICATION ASSOCIATED WITH DEVICE,7
CA,CRYSTAL URINE PRESENT,7
CA,CUSHING^S SYNDROME,7
CA,DEVICE DISLOCATION,7
CA,DEVICE LEAKAGE,7
CA,DRUG LEVEL DECREASED,7
CA,DRUG PRESCRIBING ERROR,7
CA,DUODENITIS,7
CA,ERYTHEMA MULTIFORME,7
CA,ESCHERICHIA INFECTION,7
CA,EYE DISCHARGE,7
CA,EYELID OEDEMA,7
CA,FLANK PAIN,7
CA,FUNCTIONAL GASTROINTESTINAL DISORDER,7
CL,DIZZINESS,5
CL,HEADACHE,4
CL,NAUSEA,4
CL,VOMITING,4
CL,ARTHRALGIA,3
CL,DECREASED APPETITE,3
CL,DIARRHOEA,3
CL,DRUG INEFFECTIVE,3
CL,PAIN,3
CL,PNEUMONIA,3
CL,PULMONARY HYPERTENSION,3
CL,AMNESIA,2
CL,ARRHYTHMIA,2
CL,CHEST PAIN,2
CL,DEATH,2
CL,DISEASE PROGRESSION,2
CL,DYSPHAGIA,2
CL,GLAUCOMA,2
CL,HEARING IMPAIRED,2
CL,HEART RATE DECREASED,2
CL,HYPERTENSION,2
CL,HYPOAESTHESIA,2
CL,LUNG DISORDER,2
CL,MENSTRUATION IRREGULAR,2
CL,MULTIPLE SCLEROSIS RELAPSE,2
CL,RASH,2
CL,SKIN DISCOLOURATION,2
CL,TACHYCARDIA,2
CL,VISUAL ACUITY REDUCED,2
CL,ABASIA,1
CL,ABDOMINAL DISCOMFORT,1
CL,ABDOMINAL DISTENSION,1
CL,ABDOMINAL PAIN,1
CL,AFFECTIVE DISORDER,1
CL,ALLERGIC BRONCHITIS,1
CL,AMENORRHOEA,1
CL,ANXIETY,1
CL,APPENDICITIS,1
CL,ARTHRITIS,1
CL,ARTHROPATHY,1
CL,ASTHENIA,1
CL,BACK DISORDER,1
CL,BEDRIDDEN,1
CL,BLOOD PRESSURE INCREASED,1
CL,BONE DISORDER,1
CL,BREAST PAIN,1
CL,CARDIAC DISORDER,1
CL,CARDIO-RESPIRATORY ARREST,1
CL,CARPAL TUNNEL SYNDROME,1
CL,CATARACT,1
CL,CHOKING SENSATION,1
CL,CHOLESTASIS,1
CL,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
CL,CONSTIPATION,1
CL,DEAFNESS,1
CL,DEMENTIA ALZHEIMER^S TYPE,1
CL,DEPRESSED MOOD,1
CL,DEPRESSION,1
CL,DERMATITIS ALLERGIC,1
CL,DIABETES MELLITUS,1
CL,DIABETIC COMA,1
CL,DIPLOPIA,1
CL,DRY SKIN,1
CL,DYSPNOEA,1
CL,EAR PAIN,1
CL,ECHOCARDIOGRAM ABNORMAL,1
CL,EPILEPSY,1
CL,EPISTAXIS,1
CL,FALL,1
CL,FATIGUE,1
CL,FEELING ABNORMAL,1
CL,FEELING OF DESPAIR,1
CL,GAIT DISTURBANCE,1
CL,GASTROENTERITIS VIRAL,1
CL,GENERALISED TONIC-CLONIC SEIZURE,1
CL,GINGIVAL PAIN,1
CL,HEPATIC STEATOSIS,1
CL,HEPATOTOXICITY,1
CL,HERPES ZOSTER DISSEMINATED,1
CL,HYPERHIDROSIS,1
CL,HYPERTENSIVE CRISIS,1
CL,HYPERTHYROIDISM,1
CL,HYPOACUSIS,1
CL,HYPOTENSION,1
CL,ILL-DEFINED DISORDER,1
CL,IMMUNE SYSTEM DISORDER,1
CL,IMPAIRED GASTRIC EMPTYING,1
CL,INCORRECT DOSAGE ADMINISTERED,1
CL,INCORRECT DOSE ADMINISTERED,1
CL,INTERVERTEBRAL DISC DISORDER,1
CL,INTESTINAL OBSTRUCTION,1
CL,LACRIMAL DISORDER,1
CL,LARYNGITIS,1
CL,LOCALISED OEDEMA,1
CL,LOSS OF CONSCIOUSNESS,1
CL,MALAISE,1
CL,MEMORY IMPAIRMENT,1
CL,MENINGITIS,1
CL,MENOMETRORRHAGIA,1
CL,METASTASES TO CENTRAL NERVOUS SYSTEM,1
CL,METASTASES TO LIVER,1
CL,MITRAL VALVE DISEASE,1
CL,NASOPHARYNGITIS,1
CL,NECK PAIN,1
CL,NEOPLASM PROGRESSION,1
CL,NEUTROPENIC SEPSIS,1
CL,NODULE,1
CL,NONINFECTIVE ENCEPHALITIS,1
CL,NYSTAGMUS,1
CL,OEDEMA PERIPHERAL,1
CL,OESOPHAGEAL OBSTRUCTION,1
CL,OPTIC NEURITIS,1
CL,PAIN IN EXTREMITY,1
CL,PARKINSON^S DISEASE,1
CL,PHARYNGITIS,1
CL,PHOTOPHOBIA,1
CL,POST PROCEDURAL COMPLICATION,1
CL,PULMONARY THROMBOSIS,1
CL,PYREXIA,1
CL,RESPIRATORY DISTRESS,1
CL,SKIN DISORDER,1
CL,SPINAL DISORDER,1
CL,STAPHYLOCOCCAL INFECTION,1
CL,SWELLING,1
CL,SYNCOPE,1
CL,SYSTEMIC LUPUS ERYTHEMATOSUS,1
CL,THIRST,1
CL,THROAT IRRITATION,1
CL,THYROID CANCER,1
CL,TONGUE DISORDER,1
CL,UPPER GASTROINTESTINAL HAEMORRHAGE,1
CL,UPPER RESPIRATORY TRACT INFECTION,1
CL,URINARY TRACT INFECTION,1
CL,URINARY TRACT INFLAMMATION,1
CL,UTERINE LEIOMYOMA,1
CL,VASCULAR CAUTERISATION,1
CL,VERTIGO,1
CL,WEIGHT DECREASED,1
CL,WHITE BLOOD CELL COUNT DECREASED,1
CL,WOUND,1
CN,RASH,38
CN,LEUKOPENIA,20
CN,PRURITUS,18
CN,HEPATIC FUNCTION ABNORMAL,14
CN,DRUG ERUPTION,12
CN,PYREXIA,11
CN,DRUG-INDUCED LIVER INJURY,10
CN,HEPATIC ENZYME INCREASED,10
CN,VOMITING,9
CN,DIARRHOEA,8
CN,DRUG INEFFECTIVE,8
CN,LIVER FUNCTION TEST ABNORMAL,8
CN,ACUTE HEPATIC FAILURE,7
CN,NAUSEA,7
CN,PRODUCT USE ISSUE,7
CN,TOXIC EPIDERMAL NECROLYSIS,7
CN,TOXICITY TO VARIOUS AGENTS,7
CN,URTICARIA,7
CN,WHITE BLOOD CELL COUNT DECREASED,7
CN,ASPARTATE AMINOTRANSFERASE INCREASED,6
CN,ACUTE KIDNEY INJURY,5
CN,ALANINE AMINOTRANSFERASE INCREASED,5
CN,COMA,5
CN,COUGH,5
CN,DEATH,5
CN,ERYTHEMA MULTIFORME,5
CN,GRANULOCYTOPENIA,5
CN,HEPATITIS,5
CN,OVERDOSE,5
CN,ABDOMINAL PAIN,4
CN,DECREASED APPETITE,4
CN,HEART RATE INCREASED,4
CN,RASH GENERALISED,4
CN,RASH PRURITIC,4
CN,STEVENS-JOHNSON SYNDROME,4
CN,CHEST DISCOMFORT,3
CN,CONVULSION,3
CN,DRUG ADMINISTRATION ERROR,3
CN,ENCEPHALOPATHY,3
CN,ERYTHEMA,3
CN,EYELID OEDEMA,3
CN,HEPATOCELLULAR INJURY,3
CN,HYPERHIDROSIS,3
CN,INCORRECT DOSE ADMINISTERED,3
CN,JAUNDICE,3
CN,LIVER INJURY,3
CN,MALAISE,3
CN,NEUTROPENIA,3
CN,PLATELET COUNT DECREASED,3
CN,PRODUCT QUALITY ISSUE,3
CN,PRODUCT USE IN UNAPPROVED INDICATION,3
CN,RASH ERYTHEMATOUS,3
CN,TUBULOINTERSTITIAL NEPHRITIS,3
CN,AGRANULOCYTOSIS,2
CN,ANAPHYLACTOID REACTION,2
CN,AZOTAEMIA,2
CN,BODY TEMPERATURE FLUCTUATION,2
CN,CHILLS,2
CN,CRYING,2
CN,DERMATITIS,2
CN,DERMATITIS ALLERGIC,2
CN,DIZZINESS,2
CN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
CN,DYSPHORIA,2
CN,DYSPNOEA,2
CN,EXPOSURE DURING PREGNANCY,2
CN,EXTRA DOSE ADMINISTERED,2
CN,FACE OEDEMA,2
CN,FLUSHING,2
CN,FOETAL EXPOSURE DURING PREGNANCY,2
CN,GASTROINTESTINAL HAEMORRHAGE,2
CN,HAEMATURIA,2
CN,HEADACHE,2
CN,HYPERSENSITIVITY,2
CN,HYPOTONIA,2
CN,INTERSTITIAL LUNG DISEASE,2
CN,INTRAVENTRICULAR HAEMORRHAGE,2
CN,LYMPHOCYTE COUNT INCREASED,2
CN,MACULE,2
CN,MOUTH ULCERATION,2
CN,OCCULT BLOOD POSITIVE,2
CN,OLIGURIA,2
CN,PAIN,2
CN,PERIORBITAL OEDEMA,2
CN,PNEUMONIA,2
CN,PREMATURE BABY,2
CN,PREMATURE LABOUR,2
CN,PRURITUS GENERALISED,2
CN,RASH MACULO-PAPULAR,2
CN,RASH PAPULAR,2
CN,RENAL IMPAIRMENT,2
CN,RESPIRATORY ARREST,2
CN,RESPIRATORY FAILURE,2
CN,RESPIRATORY RATE INCREASED,2
CN,SELF-MEDICATION,2
CN,SKIN EXFOLIATION,2
CN,SYNCOPE,2
CN,TRANSAMINASES INCREASED,2
CN,UPPER GASTROINTESTINAL HAEMORRHAGE,2
CN,URINARY RETENTION,2
CN,WHITE BLOOD CELL COUNT ABNORMAL,2
CN,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
CN,YELLOW SKIN,2
CN,ABDOMINAL DISCOMFORT,1
CN,ABDOMINAL DISTENSION,1
CN,ACCIDENTAL OVERDOSE,1
CN,ACIDOSIS,1
CN,ACUTE RESPIRATORY DISTRESS SYNDROME,1
CN,ACUTE TONSILLITIS,1
CN,ALTERED STATE OF CONSCIOUSNESS,1
CN,ANXIETY,1
CN,ARRHYTHMIA,1
CN,BLISTER,1
CN,BLOOD CHLORIDE DECREASED,1
CN,BLOOD PRESSURE DECREASED,1
CN,BLOOD SODIUM DECREASED,1
CN,BODY TEMPERATURE ABNORMAL,1
CN,BODY TEMPERATURE INCREASED,1
CN,BONE MARROW DISORDER,1
CN,BONE MARROW FAILURE,1
CN,BRAIN OEDEMA,1
CN,BRONCHITIS,1
CN,BRONCHOPNEUMONIA,1
CN,BRONCHOPULMONARY DYSPLASIA,1
CN,CARDIAC ARREST,1
CN,CARDIAC FAILURE CONGESTIVE,1
CN,CEREBROVASCULAR ACCIDENT,1
CN,CHROMATURIA,1
CN,COAGULOPATHY,1
CN,COLON CANCER,1
CN,CONDITION AGGRAVATED,1
CN,CONFUSIONAL STATE,1
CN,CONGESTIVE CARDIOMYOPATHY,1
CN,CONTINUOUS HAEMODIAFILTRATION,1
CN,CYANOSIS,1
CN,DELUSION,1
CN,DISSEMINATED INTRAVASCULAR COAGULATION,1
CN,DRUG HYPERSENSITIVITY,1
CN,DRUG LEVEL INCREASED,1
CN,DRUG PRESCRIBING ERROR,1
CN,DRUG-DISEASE INTERACTION,1
CN,DUODENAL ULCER,1
CN,DYSPEPSIA,1
CN,ELECTROLYTE IMBALANCE,1
CN,EPIDERMAL NECROSIS,1
CN,EYELIDS PRURITUS,1
CN,FATIGUE,1
CN,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
CN,GASTRIC HAEMORRHAGE,1
CN,GASTRIC LAVAGE ABNORMAL,1
CN,GASTROINTESTINAL DISORDER,1
CN,HAEMATEMESIS,1
CN,HAEMATOCHEZIA,1
CN,HAEMOGLOBIN DECREASED,1
CN,HAEMOLYTIC ANAEMIA,1
CN,HAEMORRHAGE INTRACRANIAL,1
CN,HALLUCINATION,1
CN,HALLUCINATION_ AUDITORY,1
CN,HALLUCINATION_ VISUAL,1
CN,HEPATIC CIRRHOSIS,1
CN,HEPATIC CONGESTION,1
CN,HEPATIC ENCEPHALOPATHY,1
CN,HEPATIC ENZYME ABNORMAL,1
CN,HEPATITIS ACUTE,1
CN,HEPATOSPLENOMEGALY,1
CN,HEPATOTOXICITY,1
CN,HICCUPS,1
CN,HYPERAESTHESIA,1
CN,HYPERBILIRUBINAEMIA,1
CN,HYPERPYREXIA,1
CN,HYPERTENSION,1
CN,HYPOKALAEMIA,1
CN,HYPOPROTEINAEMIA,1
CN,HYPOREFLEXIA,1
CN,HYPOTENSION,1
CN,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CN,INTENTIONAL OVERDOSE,1
CN,INTENTIONAL PRODUCT USE ISSUE,1
CN,INTRACRANIAL PRESSURE INCREASED,1
CN,JAUNDICE CHOLESTATIC,1
CN,LETHARGY,1
CN,LEUKOCYTOSIS,1
CN,LIVER DISORDER,1
CN,MEASLES,1
CN,METABOLIC ENCEPHALOPATHY,1
CN,MILIARIA,1
CN,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
CN,MYALGIA,1
CN,MYOCARDIAL NECROSIS MARKER INCREASED,1
CN,MYOCARDITIS,1
CN,NAIL BED BLEEDING,1
CN,NASOPHARYNGITIS,1
CN,NECROTISING COLITIS,1
CN,NECROTISING ENTEROCOLITIS NEONATAL,1
CN,NEONATAL ANURIA,1
CN,NEPHRITIC SYNDROME,1
CN,NEPHROPATHY TOXIC,1
CN,NEUTROPHIL COUNT DECREASED,1
CN,OEDEMA,1
CN,ONYCHOCLASIS,1
CN,ORAL PAIN,1
CN,PALLOR,1
CN,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
CN,PANCREATITIS ACUTE,1
CN,PARONYCHIA,1
CN,PERSECUTORY DELUSION,1
CN,PHARYNGEAL DISORDER,1
CN,PIGMENTATION DISORDER,1
CN,PRESCRIBED UNDERDOSE,1
CN,PROTEIN URINE PRESENT,1
CN,PULMONARY OEDEMA,1
CN,PURPURA FULMINANS,1
CN,RASH SCARLATINIFORM,1
CN,RASH VESICULAR,1
CN,REGURGITATION,1
CN,RENAL DISORDER,1
CN,RENAL FAILURE,1
CN,RESPIRATORY DISORDER,1
CN,RESTLESSNESS,1
CN,SCARLET FEVER,1
CN,SECRETION DISCHARGE,1
CN,SEPSIS,1
CN,SEPTIC SHOCK,1
CN,SKIN DISCOLOURATION,1
CN,SMALL INTESTINAL OBSTRUCTION,1
CN,SOMNOLENCE,1
CN,STROKE IN EVOLUTION,1
CN,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,1
CN,SUFFOCATION FEELING,1
CN,SUICIDE ATTEMPT,1
CN,SUPERIOR VENA CAVA SYNDROME,1
CN,SYSTEMIC LUPUS ERYTHEMATOSUS,1
CN,THROMBOCYTOPENIA,1
CN,URINARY INCONTINENCE,1
CN,VARICELLA,1
CN,VIRAL INFECTION,1
CN,XANTHOCHROMIA,1
CO,HEADACHE,116
CO,ARTHRALGIA,81
CO,PYREXIA,78
CO,MALAISE,76
CO,PAIN IN EXTREMITY,74
CO,DIZZINESS,68
CO,PAIN,59
CO,DIARRHOEA,55
CO,VOMITING,50
CO,ABDOMINAL PAIN,49
CO,FALL,47
CO,COUGH,45
CO,INFLUENZA,44
CO,ASTHENIA,43
CO,NAUSEA,42
CO,CHEST PAIN,40
CO,DEATH,40
CO,DYSPNOEA,40
CO,PLATELET COUNT DECREASED,39
CO,DRUG INEFFECTIVE,36
CO,GAIT DISTURBANCE,36
CO,WEIGHT DECREASED,36
CO,HYPERTENSION,35
CO,URINARY TRACT INFECTION,35
CO,ABDOMINAL PAIN UPPER,33
CO,BACK PAIN,33
CO,CARDIO-RESPIRATORY ARREST,33
CO,FATIGUE,33
CO,INFLAMMATION,33
CO,DECREASED APPETITE,32
CO,GENERAL PHYSICAL HEALTH DETERIORATION,32
CO,ACUTE MYOCARDIAL INFARCTION,29
CO,SYNCOPE,28
CO,FEELING ABNORMAL,25
CO,HAEMOGLOBIN DECREASED,25
CO,ASPHYXIA,23
CO,DEPRESSED MOOD,23
CO,GASTRITIS,23
CO,PRURITUS,23
CO,ANAEMIA,21
CO,BONE PAIN,21
CO,HYPOTENSION,21
CO,INSOMNIA,19
CO,SEPSIS,19
CO,CHILLS,18
CO,DRY SKIN,17
CO,MALIGNANT NEOPLASM PROGRESSION,17
CO,PERIPHERAL SWELLING,17
CO,PNEUMONIA,17
CO,DEPRESSION,15
CO,DISCOMFORT,15
CO,EATING DISORDER,15
CO,HYPERHIDROSIS,15
CO,HYPOAESTHESIA,15
CO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,15
CO,LOSS OF CONSCIOUSNESS,15
CO,OROPHARYNGEAL PAIN,15
CO,ABDOMINAL DISCOMFORT,14
CO,JOINT SWELLING,14
CO,MUSCLE SPASMS,14
CO,CARDIAC FAILURE,13
CO,MOUTH HAEMORRHAGE,13
CO,OEDEMA PERIPHERAL,13
CO,PARAESTHESIA,13
CO,RASH,13
CO,BLOOD GLUCOSE INCREASED,12
CO,BLOOD PRESSURE INCREASED,12
CO,FEELING OF DESPAIR,12
CO,MYALGIA,12
CO,PALLOR,12
CO,PULMONARY OEDEMA,12
CO,RESPIRATORY DISTRESS,12
CO,SEIZURE,12
CO,SOMNOLENCE,12
CO,STOMATITIS,12
CO,ABDOMINAL DISTENSION,11
CO,CHOLELITHIASIS,11
CO,DIABETES MELLITUS,11
CO,MOBILITY DECREASED,11
CO,MYOCARDIAL INFARCTION,11
CO,NEPHROLITHIASIS,11
CO,OSTEOARTHRITIS,11
CO,PLEURAL EFFUSION,11
CO,RASH GENERALISED,11
CO,SKIN DISCOLOURATION,11
CO,TACHYCARDIA,11
CO,VISION BLURRED,11
CO,ARTHROPATHY,10
CO,BLISTER,10
CO,CONTUSION,10
CO,DRUG DOSE OMISSION,10
CO,EYE PAIN,10
CO,HAEMORRHAGE,10
CO,MEMORY IMPAIRMENT,10
CO,VERTIGO,10
CO,ABASIA,9
CO,ANXIETY,9
CO,ARTHRITIS,9
CO,CEREBROVASCULAR ACCIDENT,9
CO,DISORIENTATION,9
CO,ERYTHEMA,9
CO,FOOT DEFORMITY,9
CO,HYPERSENSITIVITY,9
CO,JOINT DISLOCATION,9
CO,MUSCULOSKELETAL PAIN,9
CO,PRODUCT USE ISSUE,9
CO,TREMOR,9
CO,ALOPECIA,8
CO,BLINDNESS,8
CO,CATARACT,8
CO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,8
CO,CONDITION AGGRAVATED,8
CO,CONSTIPATION,8
CO,DIABETIC FOOT,8
CO,EPISTAXIS,8
CO,HAEMATEMESIS,8
CO,HIP FRACTURE,8
CO,INTESTINAL OBSTRUCTION,8
CO,LIMB INJURY,8
CO,MASS,8
CO,MUSCULAR WEAKNESS,8
CO,RECTAL HAEMORRHAGE,8
CO,RESPIRATORY ARREST,8
CO,SPLENOMEGALY,8
CO,THROMBOSIS,8
CO,BLOOD GLUCOSE DECREASED,7
CO,CARDIAC DISORDER,7
CO,CHOKING,7
CO,CORONARY ARTERY DISEASE,7
CO,DRUG INTOLERANCE,7
CO,DYSSTASIA,7
CO,DYSURIA,7
CO,FLUID RETENTION,7
CO,GAIT INABILITY,7
CO,GASTROINTESTINAL HAEMORRHAGE,7
CO,GASTROINTESTINAL INFECTION,7
CO,HAEMATOMA,7
CO,HEPATITIS,7
CO,INFARCTION,7
CO,KIDNEY INFECTION,7
CO,LIMB DISCOMFORT,7
CO,LUNG DISORDER,7
CO,MUSCULOSKELETAL STIFFNESS,7
CO,NASAL CONGESTION,7
CO,NECK PAIN,7
CO,ORAL MUCOSAL BLISTERING,7
CO,PETECHIAE,7
CO,PRURITUS GENERALISED,7
CO,PSYCHIATRIC SYMPTOM,7
CO,SWELLING FACE,7
CO,THROMBOCYTOPENIA,7
CO,URINARY INCONTINENCE,7
CO,VIRAL INFECTION,7
CO,WEIGHT INCREASED,7
CO,APHONIA,6
CO,ARRHYTHMIA,6
CO,BRAIN NEOPLASM,6
CO,BRONCHITIS,6
CO,BURNING SENSATION,6
CO,CONJUNCTIVITIS,6
CO,CYANOSIS,6
CO,DECREASED IMMUNE RESPONSIVENESS,6
CO,DEHYDRATION,6
CO,GASTRIC ULCER,6
CO,GINGIVAL BLEEDING,6
CO,HAEMATURIA,6
CO,HERPES ZOSTER,6
CO,HIATUS HERNIA,6
CO,HYPERGLYCAEMIA,6
CO,HYPOKINESIA,6
CO,JOINT STIFFNESS,6
CO,LOCAL SWELLING,6
CO,METASTASES TO LUNG,6
CO,NERVOUS SYSTEM DISORDER,6
CO,OXYGEN SATURATION DECREASED,6
CO,PERITONITIS,6
CO,PRODUCT QUALITY ISSUE,6
CO,SPEECH DISORDER,6
CO,SPINAL PAIN,6
CO,STRESS,6
CO,TOOTHACHE,6
CO,TUBERCULOSIS,6
CO,URTICARIA,6
CO,VAGINAL HAEMORRHAGE,6
CO,VISUAL IMPAIRMENT,6
CO,APNOEA,5
CO,BREAST CANCER,5
CO,CARDIAC ARREST,5
CO,CHEST DISCOMFORT,5
CO,CHRONIC GASTRITIS,5
CO,DECUBITUS ULCER,5
CO,DIABETIC COMA,5
CO,DIARRHOEA HAEMORRHAGIC,5
CO,DISEASE COMPLICATION,5
CO,DYSARTHRIA,5
CO,DYSPHAGIA,5
CO,DYSPHONIA,5
CO,FEELING HOT,5
CO,GASTROENTERITIS,5
CO,HAEMORRHOIDS,5
CO,HYPOGLYCAEMIA,5
CO,INFECTION,5
CO,INJECTION SITE ERYTHEMA,5
CO,INJECTION SITE SWELLING,5
CO,JOINT INJURY,5
CO,MOOD ALTERED,5
CO,MOUTH ULCERATION,5
CO,MOVEMENT DISORDER,5
CO,MUSCULOSKELETAL CHEST PAIN,5
CO,NODULE,5
CO,PAIN IN JAW,5
CO,PERIPHERAL COLDNESS,5
CO,PHARYNGITIS,5
CO,PLATELET COUNT INCREASED,5
CO,POSTOPERATIVE WOUND INFECTION,5
CO,PRODUCTIVE COUGH,5
CO,PULMONARY MASS,5
CO,RENAL PAIN,5
CO,RESPIRATORY FAILURE,5
CO,ROAD TRAFFIC ACCIDENT,5
CO,SINUSITIS,5
CO,SKIN ULCER,5
CO,SWELLING,5
CO,TERMINAL STATE,5
CO,THYROID DISORDER,5
CO,TINNITUS,5
CO,TONSILLITIS,5
CO,TRANSAMINASES INCREASED,5
CO,TUBERCULIN TEST POSITIVE,5
CO,WALKING DISABILITY,5
CO,WHITE BLOOD CELL COUNT INCREASED,5
CO,ABDOMINAL SEPSIS,4
CO,ACNE,4
CO,AGITATION,4
CO,AMNESIA,4
CO,ANAL HAEMORRHAGE,4
CO,APPENDICITIS,4
CO,ASCITES,4
CO,ASTHMATIC CRISIS,4
CO,BLOOD IRON INCREASED,4
CO,BLOOD PRESSURE DECREASED,4
CO,BRADYCARDIA,4
CO,BREAST PAIN,4
CO,CARDIOVASCULAR DISORDER,4
CO,CELLULITIS,4
CO,CEREBRAL HAEMORRHAGE,4
CO,CHRONIC MYELOID LEUKAEMIA,4
CO,EXPOSURE DURING PREGNANCY,4
CO,EYE INFECTION,4
CO,FEMUR FRACTURE,4
CO,GASTRIC DISORDER,4
CO,GASTROINTESTINAL DISORDER,4
CO,GASTROINTESTINAL INFLAMMATION,4
CO,GROIN PAIN,4
CO,HEAD INJURY,4
CO,HEPATIC PAIN,4
CO,HYPERSOMNIA,4
CO,INCORRECT DOSE ADMINISTERED,4
CO,INFLUENZA LIKE ILLNESS,4
CO,LARYNGITIS,4
CO,LOCALISED INFECTION,4
CO,METASTASES TO BONE,4
CO,METASTASES TO LIVER,4
CO,MULTIPLE SCLEROSIS RELAPSE,4
CO,NEOPLASM PROGRESSION,4
CO,NONINFECTIVE GINGIVITIS,4
CO,ORAL DISORDER,4
CO,OSTEOMYELITIS,4
CO,OSTEOPOROSIS,4
CO,OVARIAN CYST,4
CO,PELVIC PAIN,4
CO,PERITONITIS BACTERIAL,4
CO,PURULENT DISCHARGE,4
CO,RHEUMATOID ARTHRITIS,4
CO,RHINITIS,4
CO,SECOND PRIMARY MALIGNANCY,4
CO,SLEEP DISORDER,4
CO,SPLENITIS,4
CO,TREATMENT NONCOMPLIANCE,4
CO,UPPER LIMB FRACTURE,4
CO,UTERINE LEIOMYOMA,4
CO,WHITE BLOOD CELL COUNT DECREASED,4
CO,WOUND,4
CO,ANAL INCONTINENCE,3
CO,ANORECTAL DISCOMFORT,3
CO,APATHY,3
CO,BACTERIAL INFECTION,3
CO,BENIGN PROSTATIC HYPERPLASIA,3
CO,BLINDNESS UNILATERAL,3
CO,BLOOD CHOLESTEROL INCREASED,3
CO,BLOOD IRON DECREASED,3
CO,BLOOD URIC ACID INCREASED,3
CO,BRAIN DEATH,3
CO,CARDIAC FAILURE CONGESTIVE,3
CO,CARDIOMEGALY,3
CO,CEREBRAL INFARCTION,3
CO,COLD SWEAT,3
CO,CONCOMITANT DISEASE AGGRAVATED,3
CO,CORONARY ARTERY OCCLUSION,3
CO,CYSTITIS,3
CO,DEPENDENT PERSONALITY DISORDER,3
CO,DERMATITIS ALLERGIC,3
CO,DIABETIC COMPLICATION,3
CO,DIABETIC NEUROPATHY,3
CO,DIPLOPIA,3
CO,DRUG HYPERSENSITIVITY,3
CO,DYSPEPSIA,3
CO,EAR PAIN,3
CO,EYE DISORDER,3
CO,EYE IRRITATION,3
CO,EYE PRURITUS,3
CO,FACIAL PAIN,3
CO,FEEDING DISORDER,3
CO,FEELING COLD,3
CO,FISTULA,3
CO,FLATULENCE,3
CO,FREQUENT BOWEL MOVEMENTS,3
CO,GALLBLADDER DISORDER,3
CO,GASTROOESOPHAGEAL REFLUX DISEASE,3
CO,GENERALISED OEDEMA,3
CO,HAEMATOCHEZIA,3
CO,HAEMOPTYSIS,3
CO,HAND DEFORMITY,3
CO,HORMONE LEVEL ABNORMAL,3
CO,HUMERUS FRACTURE,3
CO,HYPOACUSIS,3
CO,HYPOTONIA,3
CO,IMMUNE SYSTEM DISORDER,3
CO,IMMUNODEFICIENCY,3
CO,IMMUNOSUPPRESSION,3
CO,INGUINAL HERNIA,3
CO,INJECTION SITE BRUISING,3
CO,INTERVERTEBRAL DISC PROTRUSION,3
CO,ISCHAEMIA,3
CO,ISCHAEMIC CARDIOMYOPATHY,3
CO,JOINT EFFUSION,3
CO,LEUKOPENIA,3
CO,LIVER DISORDER,3
CO,LOWER LIMB FRACTURE,3
CO,LYMPHADENOPATHY,3
CO,MALLORY-WEISS SYNDROME,3
CO,MALNUTRITION,3
CO,MENORRHAGIA,3
CO,MOUTH INJURY,3
CO,MUSCULOSKELETAL DISCOMFORT,3
CO,NASOPHARYNGITIS,3
CO,NERVOUSNESS,3
CO,NEURALGIA,3
CO,NEUTROPENIA,3
CO,NIGHT SWEATS,3
CO,ONYCHOMADESIS,3
CO,PARANEOPLASTIC SYNDROME,3
CO,PELVIC FRACTURE,3
CO,PHARYNGEAL DISORDER,3
CO,PNEUMONITIS,3
CO,POST PROCEDURAL INFECTION,3
CO,PROSTATITIS,3
CO,PSORIASIS,3
CO,PTERYGIUM,3
CO,PULMONARY FIBROSIS,3
CO,PULMONARY HYPERTENSION,3
CO,PULMONARY THROMBOSIS,3
CO,RASH MACULAR,3
CO,RENAL FAILURE,3
CO,RHINORRHOEA,3
CO,SKIN EXFOLIATION,3
CO,SKIN HAEMORRHAGE,3
CO,SKIN PAPILLOMA,3
CO,SOFT TISSUE DISORDER,3
CO,SOFT TISSUE INFECTION,3
CO,SPINAL FRACTURE,3
CO,SPINAL OSTEOARTHRITIS,3
CO,SPLEEN DISORDER,3
CO,STAPHYLOCOCCAL SEPSIS,3
CO,THIRST,3
CO,TIBIA FRACTURE,3
CO,TOOTH FRACTURE,3
CO,ULCERATIVE KERATITIS,3
CO,VARICOSE VEIN,3
CO,VULVOVAGINAL INFLAMMATION,3
CO,ABDOMINAL INFECTION,2
CO,ACCIDENT,2
CO,ACTIVITIES OF DAILY LIVING IMPAIRED,2
CO,ACUTE RESPIRATORY FAILURE,2
CO,ALTERED STATE OF CONSCIOUSNESS,2
CO,AMENORRHOEA,2
CO,ANGER,2
CO,ANGINA PECTORIS,2
CO,APHASIA,2
CO,APLASTIC ANAEMIA,2
CO,ARTHRITIS BACTERIAL,2
CO,ASTHMA,2
CO,ATAXIA,2
CO,BACK INJURY,2
CO,BACTERAEMIA,2
CO,BALANCE DISORDER,2
CO,BASAL CELL CARCINOMA,2
CO,BLOOD CALCIUM DECREASED,2
CO,BLOOD CHOLESTEROL ABNORMAL,2
CO,BLOOD CREATININE INCREASED,2
CO,BLOOD GLUCOSE ABNORMAL,2
CO,BLOOD GROWTH HORMONE INCREASED,2
CO,BLOOD URINE PRESENT,2
CO,BRONCHOPNEUMONIA,2
CO,CARDIOGENIC SHOCK,2
CO,CARPAL TUNNEL SYNDROME,2
CO,CATHETERISATION CARDIAC,2
CO,CENTRAL NERVOUS SYSTEM LESION,2
CO,CHOKING SENSATION,2
CO,CHOLECYSTITIS,2
CO,COAGULOPATHY,2
CO,COCCYDYNIA,2
CO,COMA,2
CO,CONVULSION,2
CO,COORDINATION ABNORMAL,2
CO,CRANIOCEREBRAL INJURY,2
CO,CYST,2
CO,DEAFNESS UNILATERAL,2
CO,DELIRIUM,2
CO,DEPRESSIVE SYMPTOM,2
CO,DERMATITIS,2
CO,DEVICE DISLOCATION,2
CO,DEVICE MATERIAL ISSUE,2
CO,DEVICE RELATED INFECTION,2
CO,DIABETES MELLITUS INADEQUATE CONTROL,2
CO,DISEASE RECURRENCE,2
CO,DISLOCATION OF VERTEBRA,2
CO,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,2
CO,DRUG PRESCRIBING ERROR,2
CO,DRUG RESISTANCE,2
CO,DYSGEUSIA,2
CO,EAR HAEMORRHAGE,2
CO,ELECTROLYTE IMBALANCE,2
CO,ENDOCARDITIS,2
CO,ENDOCARDITIS BACTERIAL,2
CO,ENDOMETRIOSIS,2
CO,EPILEPSY,2
CO,EYE INFLAMMATION,2
CO,EYELID OEDEMA,2
CO,FACE INJURY,2
CO,FEBRILE CONVULSION,2
CO,FOETAL CARDIAC DISORDER,2
CO,FOETAL EXPOSURE TIMING UNSPECIFIED,2
CO,FOOD INTOLERANCE,2
CO,FOOT FRACTURE,2
CO,GASTROINTESTINAL PAIN,2
CO,GINGIVAL PAIN,2
CO,GLUCOSE TOLERANCE IMPAIRED,2
CO,HALLUCINATION,2
CO,HAND FRACTURE,2
CO,HEAD DISCOMFORT,2
CO,HEART RATE INCREASED,2
CO,HEPATIC CIRRHOSIS,2
CO,HEPATIC FAILURE,2
CO,HEPATIC INFECTION,2
CO,HEPATIC STEATOSIS,2
CO,HERPES VIRUS INFECTION,2
CO,HYDRONEPHROSIS,2
CO,HYPERKERATOSIS,2
CO,HYPERPHAGIA,2
CO,HYPERTENSIVE CRISIS,2
CO,ILL-DEFINED DISORDER,2
CO,INCREASED UPPER AIRWAY SECRETION,2
CO,INFUSION RELATED REACTION,2
CO,INGROWING NAIL,2
CO,INJECTION SITE HAEMORRHAGE,2
CO,INJECTION SITE PAIN,2
CO,INJECTION SITE PRURITUS,2
CO,INTENTIONAL DRUG MISUSE,2
CO,INTENTIONAL PRODUCT MISUSE,2
CO,INTESTINAL ISCHAEMIA,2
CO,JAUNDICE,2
CO,JOINT DESTRUCTION,2
CO,JOINT RANGE OF MOTION DECREASED,2
CO,LABORATORY TEST ABNORMAL,2
CO,LETHARGY,2
CO,LIVER FUNCTION TEST ABNORMAL,2
CO,LIVER INJURY,2
CO,LOWER GASTROINTESTINAL HAEMORRHAGE,2
CO,LUNG INFECTION,2
CO,LYMPHOPENIA,2
CO,MAJOR DEPRESSION,2
CO,MELAENA,2
CO,MENINGOENCEPHALITIS HERPETIC,2
CO,MENOPAUSE,2
CO,MENTAL DISORDER,2
CO,METASTASES TO KIDNEY,2
CO,MULTI-ORGAN FAILURE,2
CO,MULTIMORBIDITY,2
CO,MULTIPLE FRACTURES,2
CO,MUSCLE SPASTICITY,2
CO,MUSCULOSKELETAL DISORDER,2
CO,MYELOFIBROSIS,2
CO,MYOCARDIAL ISCHAEMIA,2
CO,NASAL POLYPS,2
CO,NEOPLASM,2
CO,NEPHRITIS,2
CO,NEUROLOGICAL DECOMPENSATION,2
CO,NIPPLE DISORDER,2
CO,NO ADVERSE EVENT,2
CO,OCULAR DISCOMFORT,2
CO,OCULAR HYPERAEMIA,2
CO,OEDEMA,2
CO,OLIGURIA,2
CO,OPTIC NERVE DISORDER,2
CO,ORAL DISCOMFORT,2
CO,ORAL PAIN,2
CO,OSTEOPENIA,2
CO,PAIN OF SKIN,2
CO,PALPITATIONS,2
CO,PARALYSIS,2
CO,PEAU D^ORANGE,2
CO,PERIPHERAL VASCULAR DISORDER,2
CO,PNEUMONIA BACTERIAL,2
CO,POLYURIA,2
CO,POST PROCEDURAL COMPLICATION,2
CO,PSORIATIC ARTHROPATHY,2
CO,PULMONARY CONGESTION,2
CO,PULMONARY EMBOLISM,2
CO,PULMONARY HAEMORRHAGE,2
CO,RENAL SURGERY,2
CO,RENAL TRANSPLANT,2
CO,RETINAL DETACHMENT,2
CO,SCRATCH,2
CO,SENSE OF OPPRESSION,2
CO,SENSORY LOSS,2
CO,SEPTIC SHOCK,2
CO,SHOCK,2
CO,SINUS BRADYCARDIA,2
CO,SKELETAL INJURY,2
CO,SKIN CANCER,2
CO,SKIN PLAQUE,2
CO,SPINAL COLUMN INJURY,2
CO,SUBCUTANEOUS ABSCESS,2
CO,SWOLLEN TONGUE,2
CO,SYNOVITIS,2
CO,TENDON DISORDER,2
CO,THERAPY NON-RESPONDER,2
CO,THERMAL BURN,2
CO,THROMBOPHLEBITIS,2
CO,THYROID CANCER,2
CO,TONSILLAR INFLAMMATION,2
CO,TOOTH DISORDER,2
CO,TOOTH LOSS,2
CO,TRAUMATIC LUNG INJURY,2
CO,TRIGGER FINGER,2
CO,TUMOUR RUPTURE,2
CO,UMBILICAL HERNIA,2
CO,UNDERWEIGHT,2
CO,UPPER GASTROINTESTINAL HAEMORRHAGE,2
CO,URETHRAL OBSTRUCTION,2
CO,UROSEPSIS,2
CO,UTERINE DISORDER,2
CO,VARICOSE ULCERATION,2
CO,VENOUS OCCLUSION,2
CO,VENOUS VALVE RUPTURED,2
CO,VISUAL ACUITY REDUCED,2
CO,WHEELCHAIR USER,2
CO,WHEEZING,2
CO,WOUND COMPLICATION,2
CO,WOUND INFECTION,2
CO,WOUND SECRETION,2
CO,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
CO,YELLOW SKIN,2
CO,ABDOMINAL COMPARTMENT SYNDROME,1
CO,ABDOMINAL MASS,1
CO,ABDOMINAL PAIN LOWER,1
CO,ABDOMINAL WALL ABSCESS,1
CO,ABNORMAL BEHAVIOUR,1
CO,ABORTION SPONTANEOUS,1
CO,ABSCESS,1
CO,ABSCESS LIMB,1
CO,ACETABULUM FRACTURE,1
CO,ACUTE CORONARY SYNDROME,1
CO,ACUTE LYMPHOCYTIC LEUKAEMIA,1
CO,ADMINISTRATION SITE PAIN,1
CO,ADVERSE EVENT,1
CO,AGGRESSION,1
CO,AGNOSIA,1
CO,ALANINE AMINOTRANSFERASE ABNORMAL,1
CO,AMOEBIASIS,1
CO,AMYLASE INCREASED,1
CO,ANAL ABSCESS,1
CO,ANAL FISTULA,1
CO,ANAL PRURITUS,1
CO,ANEURYSM,1
CO,ANGINA UNSTABLE,1
CO,ANGIOPLASTY,1
CO,ANGLE CLOSURE GLAUCOMA,1
CO,ANTIBIOTIC LEVEL BELOW THERAPEUTIC,1
CO,ANTIBODY TEST POSITIVE,1
CO,AORTIC ANEURYSM,1
CO,AORTIC ARTERIOSCLEROSIS,1
CO,AORTIC DILATATION,1
CO,AORTIC RUPTURE,1
CO,AORTIC VALVE DISEASE,1
CO,AORTIC VALVE INCOMPETENCE,1
CO,APHAGIA,1
CO,APPENDICITIS PERFORATED,1
CO,APPLICATION SITE DRYNESS,1
CO,APPLICATION SITE RASH,1
CO,ARTERIAL THROMBOSIS,1
CO,ARTERIOSCLEROSIS,1
CO,ARTERIOVENOUS FISTULA SITE INFECTION,1
CO,ARTHROPOD BITE,1
CO,ARTHROPOD STING,1
CO,ASOCIAL BEHAVIOUR,1
CO,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
CO,ATELECTASIS,1
CO,ATONIC SEIZURES,1
CO,ATROPHY,1
CO,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
CO,AUTOIMMUNE HEPATITIS,1
CO,AXILLARY MASS,1
CO,BENIGN BONE NEOPLASM,1
CO,BENIGN BREAST NEOPLASM,1
CO,BILE DUCT STONE,1
CO,BIOPSY,1
CO,BIOPSY PHARYNX,1
CO,BLADDER MASS,1
CO,BLISTER INFECTED,1
CO,BLOOD BILIRUBIN ABNORMAL,1
CO,BLOOD BILIRUBIN INCREASED,1
CO,BLOOD CALCIUM INCREASED,1
CO,BLOOD CHROMOGRANIN A INCREASED,1
CO,BLOOD CORTISOL INCREASED,1
CO,BLOOD COUNT ABNORMAL,1
CO,BLOOD DISORDER,1
CO,BLOOD GLUCOSE FLUCTUATION,1
CO,BLOOD LACTATE DEHYDROGENASE ABNORMAL,1
CO,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CO,BLOOD OESTROGEN ABNORMAL,1
CO,BLOOD PHOSPHORUS DECREASED,1
CO,BLOOD POTASSIUM DECREASED,1
CO,BLOOD PRESSURE ABNORMAL,1
CO,BLOOD PRESSURE FLUCTUATION,1
CO,BLOOD PRESSURE SYSTOLIC INCREASED,1
CO,BLOOD PROLACTIN ABNORMAL,1
CO,BLOOD SODIUM DECREASED,1
CO,BLOOD TEST ABNORMAL,1
CO,BLOOD THYROID STIMULATING HORMONE INCREASED,1
CO,BLOOD TRIGLYCERIDES INCREASED,1
CO,BLOOD UREA DECREASED,1
CO,BLOOD URINE,1
CO,BODY HEIGHT DECREASED,1
CO,BODY TEMPERATURE INCREASED,1
CO,BONE CANCER,1
CO,BONE DECALCIFICATION,1
CO,BONE DEFORMITY,1
CO,BONE DISORDER,1
CO,BONE GIANT CELL TUMOUR,1
CO,BONE LOSS,1
CO,BONE MARROW FAILURE,1
CO,BONE NEOPLASM,1
CO,BOREDOM,1
CO,BRAIN INJURY,1
CO,BRAIN OEDEMA,1
CO,BREAST CANCER RECURRENT,1
CO,BREAST INDURATION,1
CO,BREAST INFLAMMATION,1
CO,BREATH ODOUR,1
CO,BUNION,1
CO,BURNING SENSATION MUCOSAL,1
CO,C-REACTIVE PROTEIN ABNORMAL,1
CO,CACHEXIA,1
CO,CAESAREAN SECTION,1
CO,CALCINOSIS,1
CO,CALCULUS URETHRAL,1
CO,CARDIAC DISCOMFORT,1
CO,CARDIAC MURMUR,1
CO,CARDIAC PACEMAKER INSERTION,1
CO,CARDIAC VALVE DISEASE,1
CO,CARDIOPULMONARY FAILURE,1
CO,CARTILAGE INJURY,1
CO,CATARACT OPERATION,1
CO,CATHETER SITE INFECTION,1
CO,CATHETER SITE PAIN,1
CO,CD8 LYMPHOCYTES ABNORMAL,1
CO,CELLULITIS ORBITAL,1
CO,CENTRAL PAIN SYNDROME,1
CO,CEREBRAL DISORDER,1
CO,CEREBRAL HAEMATOMA,1
CO,CEREBRAL ISCHAEMIA,1
CO,CEREBRAL THROMBOSIS,1
CO,CERVICAL MYELOPATHY,1
CO,CERVICAL RIB,1
CO,CERVICAL SPINAL STENOSIS,1
CO,CERVIX CARCINOMA,1
CO,CHEMOTHERAPY,1
CO,CHIKUNGUNYA VIRUS INFECTION,1
CO,CHOLECYSTITIS ACUTE,1
CO,CHOLESTASIS,1
CO,CHONDROPATHY,1
CO,CHRONIC MYELOID LEUKAEMIA RECURRENT,1
CO,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,1
CO,CLOSTRIDIUM DIFFICILE INFECTION,1
CO,COLITIS,1
CO,COLITIS ULCERATIVE,1
CO,COLON CANCER,1
CO,COLPOSCOPY,1
CO,COMPLICATIONS OF TRANSPLANTED KIDNEY,1
CO,CONCOMITANT DISEASE PROGRESSION,1
CO,CONFUSIONAL STATE,1
CO,CONGENITAL ANOMALY IN OFFSPRING,1
CO,CONJUNCTIVAL HAEMORRHAGE,1
CO,CONJUNCTIVAL ULCER,1
CO,CONTRAINDICATED PRODUCT ADMINISTERED,1
CO,CORONARY ARTERY STENOSIS,1
CO,COUNTERFEIT PRODUCT ADMINISTERED,1
CO,CRYING,1
CO,CYSTITIS BACTERIAL,1
CO,CYTOPENIA,1
CO,DEAFNESS,1
CO,DEEP VEIN THROMBOSIS,1
CO,DEMENTIA,1
CO,DENGUE FEVER,1
CO,DENTAL CARIES,1
CO,DERMATOMYOSITIS,1
CO,DEVICE BREAKAGE,1
CO,DEVICE RELATED SEPSIS,1
CO,DIALYSIS,1
CO,DIET REFUSAL,1
CO,DIPLEGIA,1
CO,DIVERTICULITIS,1
CO,DIVERTICULUM,1
CO,DIVERTICULUM INTESTINAL,1
CO,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
CO,DIZZINESS POSTURAL,1
CO,DROWNING,1
CO,DRUG ADMINISTRATION ERROR,1
CO,DRUG DISPENSING ERROR,1
CO,DRY EYE,1
CO,DRY MOUTH,1
CO,DRY THROAT,1
CO,DYSPNOEA AT REST,1
CO,DYSPNOEA EXERTIONAL,1
CO,EAR DISCOMFORT,1
CO,EAR INFECTION,1
CO,EAR NEOPLASM MALIGNANT,1
CO,ENCEPHALITIS AUTOIMMUNE,1
CO,ENCEPHALITIS VIRAL,1
CO,ENTEROBACTER SEPSIS,1
CO,EOSINOPHIL COUNT ABNORMAL,1
CO,EOSINOPHILIA,1
CO,ERUCTATION,1
CO,ERYTHROPENIA,1
CO,ESCHERICHIA URINARY TRACT INFECTION,1
CO,EXPOSURE DURING BREAST FEEDING,1
CO,EXPOSURE TO TOXIC AGENT,1
CO,EXTREMITY NECROSIS,1
CO,EYE BURNS,1
CO,EYE DEGENERATIVE DISORDER,1
CO,EYE DISCHARGE,1
CO,EYE INJURY,1
CO,EYELID DISORDER,1
CO,FACIAL BONES FRACTURE,1
CO,FACTOR XI DEFICIENCY,1
CO,FEAR,1
CO,FEAR OF EATING,1
CO,FEBRILE NEUTROPENIA,1
CO,FEELING DRUNK,1
CO,FIBROADENOMA OF BREAST,1
CO,FIBROMYALGIA,1
CO,FIBULA FRACTURE,1
CO,FLAVIVIRUS INFECTION,1
CO,FLUID OVERLOAD,1
CO,FOOD POISONING,1
CO,FOREIGN BODY SENSATION IN EYES,1
CO,FUNGAL INFECTION,1
CO,FUNGAL PERITONITIS,1
CO,FUNGAL SKIN INFECTION,1
CO,FURUNCLE,1
CO,GALLBLADDER PAIN,1
CO,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
CO,GASTRIC ULCER PERFORATION,1
CO,GASTRITIS BACTERIAL,1
CO,GASTRITIS FUNGAL,1
CO,GASTROINTESTINAL PERFORATION,1
CO,GASTROINTESTINAL ULCER,1
CO,GENERAL PHYSICAL CONDITION ABNORMAL,1
CO,GENERALISED ERYTHEMA,1
CO,GINGIVAL ABSCESS,1
CO,GINGIVAL INFLAMMATION,1
CO,GLAUCOMA,1
CO,GLYCOSYLATED HAEMOGLOBIN DECREASED,1
CO,GOITRE,1
CO,GOUT,1
CO,GRANULOMA,1
CO,GRANULOMATOUS LIVER DISEASE,1
CO,GRIP STRENGTH DECREASED,1
CO,GROIN ABSCESS,1
CO,HAEMATOCRIT ABNORMAL,1
CO,HAEMATOCRIT DECREASED,1
CO,HAEMATOTOXICITY,1
CO,HAEMOGLOBIN INCREASED,1
CO,HAEMOLYSIS,1
CO,HAEMORRHAGIC DISORDER,1
CO,HAEMORRHAGIC EROSIVE GASTRITIS,1
CO,HALLUCINATIONS_ MIXED,1
CO,HEAD TITUBATION,1
CO,HELICOBACTER INFECTION,1
CO,HEMIPARESIS,1
CO,HEMIPLEGIA,1
CO,HEPATIC CANCER,1
CO,HEPATIC ENZYME INCREASED,1
CO,HEPATIC INFECTION BACTERIAL,1
CO,HEPATIC NEOPLASM,1
CO,HEPATITIS A,1
CO,HEPATITIS B,1
CO,HEPATOMEGALY,1
CO,HEPATOTOXICITY,1
CO,HERNIA PAIN,1
CO,HERNIA REPAIR,1
CO,HIGH DENSITY LIPOPROTEIN DECREASED,1
CO,HISTOPLASMOSIS,1
CO,HOMICIDAL IDEATION,1
CO,HORDEOLUM,1
CO,HOT FLUSH,1
CO,HYDROCEPHALUS,1
CO,HYPERCALCAEMIA,1
CO,HYPOAESTHESIA ORAL,1
CO,HYPOALBUMINAEMIA,1
CO,HYPOCALCAEMIA,1
CO,HYPOMAGNESAEMIA,1
CO,HYPOPERFUSION,1
CO,HYPOPHAGIA,1
CO,HYPOPITUITARISM,1
CO,HYPOTHYROIDISM,1
CO,HYPOVOLAEMIC SHOCK,1
CO,IMMOBILE,1
CO,IMPAIRED HEALING,1
CO,IMPAIRED SELF-CARE,1
CO,INCOHERENT,1
CO,INCORRECT DRUG ADMINISTRATION RATE,1
CO,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
CO,INFECTED SKIN ULCER,1
CO,INFLAMMATORY PAIN,1
CO,INFREQUENT BOWEL MOVEMENTS,1
CO,INJECTION SITE HAEMATOMA,1
CO,INJECTION SITE HYPERSENSITIVITY,1
CO,INJECTION SITE OEDEMA,1
CO,INJECTION SITE URTICARIA,1
CO,INJECTION SITE WARMTH,1
CO,INTENTIONAL PRODUCT USE ISSUE,1
CO,INTERNAL HAEMORRHAGE,1
CO,INTERNATIONAL NORMALISED RATIO INCREASED,1
CO,INTESTINAL ANGINA,1
CO,INTESTINAL DILATATION,1
CO,INTESTINAL MASS,1
CO,INTESTINAL PERFORATION,1
CO,INTRA-ABDOMINAL FLUID COLLECTION,1
CO,INTRA-ABDOMINAL HAEMORRHAGE,1
CO,INTRACRANIAL ANEURYSM,1
CO,INTRACRANIAL HAEMATOMA,1
CO,IRIDOCYCLITIS,1
CO,IRON DEFICIENCY,1
CO,IRON OVERLOAD,1
CO,IRRITABILITY,1
CO,ISCHAEMIC STROKE,1
CO,JAUNDICE NEONATAL,1
CO,JAW DISORDER,1
CO,JOINT ANKYLOSIS,1
CO,JOINT INSTABILITY,1
CO,KLEBSIELLA SEPSIS,1
CO,KNEE DEFORMITY,1
CO,KNEE OPERATION,1
CO,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
CO,LACERATION,1
CO,LACK OF SPONTANEOUS SPEECH,1
CO,LACRIMATION DECREASED,1
CO,LACRIMATION INCREASED,1
CO,LACUNAR INFARCTION,1
CO,LAGOPHTHALMOS,1
CO,LARGE INTESTINAL ULCER,1
CO,LATENT TUBERCULOSIS,1
CO,LIGAMENT DISORDER,1
CO,LIMB CRUSHING INJURY,1
CO,LIMB DEFORMITY,1
CO,LIP BLISTER,1
CO,LIP DRY,1
CO,LIP SWELLING,1
CO,LIPASE INCREASED,1
CO,LIPOMA,1
CO,LIVER ABSCESS,1
CO,LOCALISED OEDEMA,1
CO,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,1
CO,LUMBAR SPINAL STENOSIS,1
CO,LUNG INFILTRATION,1
CO,LUNG NEOPLASM MALIGNANT,1
CO,LUPUS-LIKE SYNDROME,1
CO,LYMPHOCYTE COUNT ABNORMAL,1
CO,LYMPHOCYTE PERCENTAGE DECREASED,1
CO,LYMPHOMA,1
CO,MACULAR DEGENERATION,1
CO,MALIGNANT NEOPLASM OF EYE,1
CO,MALIGNANT NEOPLASM OF LACRIMAL GLAND,1
CO,MALIGNANT NEOPLASM OF THORAX,1
CO,MASTECTOMY,1
CO,MATERNAL EXPOSURE DURING PREGNANCY,1
CO,MEDICAL DEVICE COMPLICATION,1
CO,MEDICAL DEVICE DISCOMFORT,1
CO,MEDICAL INDUCTION OF COMA,1
CO,MENINGITIS,1
CO,MENINGITIS BACTERIAL,1
CO,MENISCUS INJURY,1
CO,METASTASES TO CENTRAL NERVOUS SYSTEM,1
CO,METASTASES TO HEART,1
CO,METASTASES TO SPINE,1
CO,METASTATIC NEOPLASM,1
CO,METRORRHAGIA,1
CO,MICTURITION DISORDER,1
CO,MIGRAINE,1
CO,MILIARIA,1
CO,MITRAL VALVE INCOMPETENCE,1
CO,MITRAL VALVE REPLACEMENT,1
CO,MONOPLEGIA,1
CO,MUCOSAL DISCOLOURATION,1
CO,MUCOSAL INFLAMMATION,1
CO,MULTI-ORGAN DISORDER,1
CO,MULTIPLE SCLEROSIS,1
CO,MUSCLE DISORDER,1
CO,MUSCLE RIGIDITY,1
CO,MUSCLE SWELLING,1
CO,MYOCLONIC EPILEPSY AND RAGGED-RED FIBRES,1
CO,MYOSITIS,1
CO,NAIL AVULSION,1
CO,NAIL INJURY,1
CO,NASAL CYST,1
CO,NASAL DISORDER,1
CO,NASAL SEPTUM DEVIATION,1
CO,NASAL TURBINATE HYPERTROPHY,1
CO,NECK MASS,1
CO,NEOPLASM RECURRENCE,1
CO,NERVE COMPRESSION,1
CO,NERVE INJURY,1
CO,NEUROPATHY PERIPHERAL,1
CO,NEUROTOXICITY,1
CO,NEUTROPHIL COUNT INCREASED,1
CO,NIPPLE INFLAMMATION,1
CO,NIPPLE PAIN,1
CO,NONINFECTIOUS PERITONITIS,1
CO,NOSOCOMIAL INFECTION,1
CO,NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL,1
CO,OBESITY,1
CO,OBSTRUCTIVE AIRWAYS DISORDER,1
CO,ODYNOPHAGIA,1
CO,ONCOLOGIC COMPLICATION,1
CO,ONYCHOCLASIS,1
CO,ONYCHOMYCOSIS,1
CO,OPTIC NERVE COMPRESSION,1
CO,OPTIC NEURITIS,1
CO,ORAL FUNGAL INFECTION,1
CO,ORAL INFECTION,1
CO,ORAL MUCOSAL EXFOLIATION,1
CO,OROPHARYNGEAL DISCOMFORT,1
CO,OSTEOCHONDRITIS,1
CO,OSTEOMYELITIS CHRONIC,1
CO,OSTEONECROSIS OF JAW,1
CO,OSTEOSCLEROSIS,1
CO,OTORRHOEA,1
CO,OTOSCLEROSIS,1
CO,OVARIAN DISORDER,1
CO,OVARIAN GERM CELL TERATOMA,1
CO,OXYGEN CONSUMPTION DECREASED,1
CO,PANCREATITIS,1
CO,PANCREATITIS ACUTE,1
CO,PAPILLARY THYROID CANCER,1
CO,PARAESTHESIA ORAL,1
CO,PARATHYROID CYST,1
CO,PARATHYROID DISORDER,1
CO,PARKINSON^S DISEASE,1
CO,PAROSMIA,1
CO,PATIENT-DEVICE INCOMPATIBILITY,1
CO,PENILE ULCERATION,1
CO,PERICARDITIS,1
CO,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
CO,PERIPHERAL ARTERY THROMBOSIS,1
CO,PERIPHERAL ISCHAEMIA,1
CO,PERIPHERAL VENOUS DISEASE,1
CO,PERITONEAL DIALYSIS COMPLICATION,1
CO,PHARYNGEAL OEDEMA,1
CO,PHLEBITIS,1
CO,PHOTOPSIA,1
CO,PITUITARY TUMOUR,1
CO,PITUITARY-DEPENDENT CUSHING^S SYNDROME,1
CO,PLATELET COUNT ABNORMAL,1
CO,PLATELET DISORDER,1
CO,PNEUMONITIS CHEMICAL,1
CO,POISONING,1
CO,POLLAKIURIA,1
CO,POLYCYTHAEMIA VERA,1
CO,POLYDIPSIA,1
CO,POLYMERASE CHAIN REACTION POSITIVE,1
CO,POLYMYALGIA RHEUMATICA,1
CO,POLYP,1
CO,POOR PERIPHERAL CIRCULATION,1
CO,POOR QUALITY SLEEP,1
CO,POST PROCEDURAL SEPSIS,1
CR,DIZZINESS,4
CR,DYSPNOEA,3
CR,DYSARTHRIA,2
CR,MALAISE,2
CR,PERIPHERAL SWELLING,2
CR,URTICARIA,2
CR,VOMITING,2
CR,ABDOMINAL ADHESIONS,1
CR,ABDOMINAL PAIN,1
CR,ACUTE PULMONARY OEDEMA,1
CR,ALTERED STATE OF CONSCIOUSNESS,1
CR,ANXIETY,1
CR,ARTHRITIS,1
CR,BLOOD TEST ABNORMAL,1
CR,BONE PAIN,1
CR,CHEST PAIN,1
CR,DEPRESSED MOOD,1
CR,DERMATITIS ALLERGIC,1
CR,DRUG HYPERSENSITIVITY,1
CR,DRUG INTOLERANCE,1
CR,DRY MOUTH,1
CR,DYSPHAGIA,1
CR,ERYTHEMA,1
CR,FATIGUE,1
CR,FIBROSIS,1
CR,FOOD INTERACTION,1
CR,GASTRIC CANCER,1
CR,GASTRIC DISORDER,1
CR,GASTROINTESTINAL PAIN,1
CR,HEADACHE,1
CR,INSOMNIA,1
CR,INTESTINAL OBSTRUCTION,1
CR,INTRADUCTAL PROLIFERATIVE BREAST LESION,1
CR,JAUNDICE,1
CR,LEUKAEMIA,1
CR,LIMB DISCOMFORT,1
CR,MUSCLE DISORDER,1
CR,MYELOFIBROSIS,1
CR,NAUSEA,1
CR,NERVE COMPRESSION,1
CR,OSTEOARTHRITIS,1
CR,OVERDOSE,1
CR,PALPITATIONS,1
CR,PNEUMONIA,1
CR,POST PROCEDURAL COMPLICATION,1
CR,POSTOPERATIVE ADHESION,1
CR,POSTOPERATIVE WOUND COMPLICATION,1
CR,PRURITUS,1
CR,RADICULAR PAIN,1
CR,RASH,1
CR,RHEUMATOID ARTHRITIS,1
CR,SECOND PRIMARY MALIGNANCY,1
CR,SKIN ULCER,1
CR,SOMNOLENCE,1
CR,SWELLING FACE,1
CR,SYNCOPE,1
CR,TACHYCARDIA,1
HR,TUBULOINTERSTITIAL NEPHRITIS,1
CZ,SEROTONIN SYNDROME,5
CZ,CIRCULATORY COLLAPSE,3
CZ,DRUG INEFFECTIVE,3
CZ,METABOLIC ACIDOSIS,3
CZ,PNEUMONIA FUNGAL,3
CZ,SINUS TACHYCARDIA,3
CZ,AGITATION,2
CZ,ARTHRALGIA,2
CZ,DELIRIUM,2
CZ,DYSPNOEA,2
CZ,HYPERHIDROSIS,2
CZ,HYPERTENSION,2
CZ,LEUKOCYTOSIS,2
CZ,MUSCLE SPASMS,2
CZ,MYDRIASIS,2
CZ,MYOCLONUS,2
CZ,MYOGLOBIN BLOOD INCREASED,2
CZ,OLIGURIA,2
CZ,PYREXIA,2
CZ,RESTLESSNESS,2
CZ,TACHYCARDIA,2
CZ,TREMOR,2
CZ,DEPRESSED LEVEL OF CONSCIOUSNESS,1
CZ,DISSEMINATED INTRAVASCULAR COAGULATION,1
CZ,DRUG-INDUCED LIVER INJURY,1
CZ,MEDICATION ERROR,1
CZ,MICROCYTIC ANAEMIA,1
CZ,OSTEONECROSIS,1
CZ,PERITONEAL HAEMORRHAGE,1
CZ,PLEURAL EFFUSION,1
CZ,PRODUCT QUALITY ISSUE,1
CZ,RHABDOMYOLYSIS,1
CZ,SELF-MEDICATION,1
CZ,SHOCK HAEMORRHAGIC,1
CZ,THROMBOCYTOPENIA,1
CZ,TOXICITY TO VARIOUS AGENTS,1
DK,DIZZINESS,7
DK,HYPOTENSION,7
DK,SEDATION,7
DK,DIPLOPIA,5
DK,NAUSEA,4
DK,CONFUSIONAL STATE,3
DK,FATIGUE,3
DK,TOXIC EPIDERMAL NECROLYSIS,3
DK,BALANCE DISORDER,2
DK,DEPRESSED LEVEL OF CONSCIOUSNESS,2
DK,MEMORY IMPAIRMENT,2
DK,PULMONARY EMBOLISM,2
DK,VISUAL IMPAIRMENT,2
DK,ABSCESS,1
DK,ADENOCARCINOMA GASTRIC,1
DK,ADRENAL INSUFFICIENCY,1
DK,ALLERGIC OEDEMA,1
DK,ANAEMIA,1
DK,ARTHRALGIA,1
DK,ASTHENIA,1
DK,BACTERIAL INFECTION,1
DK,BEZOAR,1
DK,BODY TEMPERATURE INCREASED,1
DK,BONE MARROW FAILURE,1
DK,BRONCHITIS,1
DK,CARDIAC FAILURE,1
DK,CARDIOVASCULAR DISORDER,1
DK,COLITIS,1
DK,CONSCIOUSNESS FLUCTUATING,1
DK,CONSTIPATION,1
DK,COUGH,1
DK,DEATH,1
DK,DIARRHOEA,1
DK,DISORIENTATION,1
DK,DYSPNOEA,1
DK,EMBOLISM,1
DK,FEBRILE NEUTROPENIA,1
DK,FOETAL EXPOSURE DURING PREGNANCY,1
DK,GASTROENTERITIS,1
DK,HEPATIC ENZYME INCREASED,1
DK,HERPES ZOSTER,1
DK,HYPERTENSION,1
DK,HYPOPHYSITIS,1
DK,HYPOPITUITARISM,1
DK,HYPOTHYROIDISM,1
DK,INFECTION,1
DK,INFUSION RELATED REACTION,1
DK,INTENTIONAL OVERDOSE,1
DK,LOSS OF CONSCIOUSNESS,1
DK,MENTAL IMPAIRMENT,1
DK,MENTAL STATUS CHANGES,1
DK,MUSCLE SPASMS,1
DK,MYALGIA,1
DK,MYOCARDITIS,1
DK,NASAL CONGESTION,1
DK,NEUTROPENIA,1
DK,OEDEMA PERIPHERAL,1
DK,OESOPHAGEAL OBSTRUCTION,1
DK,PLASMA CELL MYELOMA,1
DK,PLEURAL EFFUSION,1
DK,PNEUMONIA ASPIRATION,1
DK,PNEUMONIA VIRAL,1
DK,POOR PERIPHERAL CIRCULATION,1
DK,PYREXIA,1
DK,QUALITY OF LIFE DECREASED,1
DK,RENAL IMPAIRMENT,1
DK,RESPIRATORY DISORDER,1
DK,RHINITIS ALLERGIC,1
DK,SEPSIS,1
DK,THROMBOCYTOPENIA,1
DK,TOXICITY TO VARIOUS AGENTS,1
DK,TREMOR,1
DK,UPPER RESPIRATORY TRACT INFECTION,1
DK,VOMITING,1
DO,CHIKUNGUNYA VIRUS INFECTION,2
DO,ABDOMINAL PAIN UPPER,1
DO,ACUTE ABDOMEN,1
DO,ARTHRALGIA,1
DO,COLITIS ULCERATIVE,1
DO,DISCOMFORT,1
DO,DRUG INEFFECTIVE,1
DO,HAEMATURIA,1
DO,HEADACHE,1
DO,HEPATIC HAEMORRHAGE,1
DO,HEPATIC NECROSIS,1
DO,HEPATIC STEATOSIS,1
DO,HIP FRACTURE,1
DO,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
DO,NAUSEA,1
DO,PAIN,1
DO,PYREXIA,1
DO,RENAL CYST,1
DO,TUBERCULIN TEST POSITIVE,1
DO,VOMITING,1
EC,ACUTE MYOCARDIAL INFARCTION,2
EC,HEADACHE,2
EC,ANAPHYLACTIC SHOCK,1
EC,CHOLELITHIASIS,1
EC,DIZZINESS,1
EC,FLAVIVIRUS INFECTION,1
EC,GENERAL PHYSICAL HEALTH DETERIORATION,1
EC,HYPERSENSITIVITY,1
EC,HYPERTENSIVE CRISIS,1
EC,INFECTION,1
EC,INFUSION RELATED REACTION,1
EC,PARAESTHESIA,1
EC,PNEUMONIA,1
EC,PRODUCT PACKAGING ISSUE,1
EC,SEIZURE,1
EC,URTICARIA,1
EG,ABDOMINAL PAIN,1
EG,ALOPECIA,1
EG,ANAEMIA,1
EG,ERYTHEMA,1
EG,FATIGUE,1
EG,HAEMOGLOBIN DECREASED,1
EG,HAIR GROWTH ABNORMAL,1
EG,HYPERSENSITIVITY,1
EG,HYPERTHYROIDISM,1
EG,HYPOAESTHESIA,1
EG,JOINT ABSCESS,1
EG,LEUKOPENIA,1
EG,MUSCLE SPASMS,1
EG,MYASTHENIA GRAVIS,1
EG,NAIL GROWTH ABNORMAL,1
EG,PAIN,1
EG,PAIN IN EXTREMITY,1
EG,PANCYTOPENIA,1
EG,PLATELET COUNT DECREASED,1
EG,RED BLOOD CELL COUNT DECREASED,1
EG,WHITE BLOOD CELL COUNT DECREASED,1
FI,FATIGUE,19
FI,HEADACHE,16
FI,FALL,12
FI,NAUSEA,12
FI,C-REACTIVE PROTEIN INCREASED,11
FI,PYREXIA,11
FI,DYSPNOEA,10
FI,HYPOTENSION,9
FI,PAIN IN EXTREMITY,9
FI,CONFUSIONAL STATE,8
FI,GENERAL PHYSICAL HEALTH DETERIORATION,8
FI,HAEMOGLOBIN DECREASED,8
FI,ARRHYTHMIA,7
FI,DIZZINESS,7
FI,HYPERHIDROSIS,7
FI,HYPERTENSION,7
FI,AGGRESSION,6
FI,ALANINE AMINOTRANSFERASE INCREASED,6
FI,ARTHRALGIA,6
FI,ASTHENIA,6
FI,DIARRHOEA,6
FI,DYSPHAGIA,6
FI,ERYTHEMA,6
FI,GAIT DISTURBANCE,6
FI,MALAISE,6
FI,WEIGHT DECREASED,6
FI,ABDOMINAL PAIN,5
FI,ABDOMINAL PAIN UPPER,5
FI,DRUG INEFFECTIVE,5
FI,FEELING ABNORMAL,5
FI,MYALGIA,5
FI,PAIN,5
FI,URTICARIA,5
FI,VOMITING,5
FI,WOUND,5
FI,BACK PAIN,4
FI,CONDITION AGGRAVATED,4
FI,DECREASED APPETITE,4
FI,MUSCULOSKELETAL STIFFNESS,4
FI,OROPHARYNGEAL PAIN,4
FI,OXYGEN SATURATION DECREASED,4
FI,PRURITUS,4
FI,RESTLESSNESS,4
FI,STRESS FRACTURE,4
FI,THROMBOCYTOPENIA,4
FI,TREMOR,4
FI,UNINTENDED PREGNANCY,4
FI,URINARY TRACT INFECTION,4
FI,WEIGHT INCREASED,4
FI,WHITE BLOOD CELL COUNT DECREASED,4
FI,ABORTION SPONTANEOUS,3
FI,ALOPECIA,3
FI,ARTHROPATHY,3
FI,ASTHMA,3
FI,BLOOD CHOLESTEROL INCREASED,3
FI,CARDIAC DISORDER,3
FI,CHILLS,3
FI,CONSTIPATION,3
FI,COUGH,3
FI,DELUSION,3
FI,DEVICE OCCLUSION,3
FI,HEART RATE INCREASED,3
FI,HYPERSENSITIVITY,3
FI,HYPOAESTHESIA,3
FI,HYPOTHYROIDISM,3
FI,INFECTION,3
FI,LYMPHOPENIA,3
FI,MERALGIA PARAESTHETICA,3
FI,MIGRAINE,3
FI,OEDEMA PERIPHERAL,3
FI,PALLOR,3
FI,PNEUMONIA,3
FI,POSTERIOR TIBIAL NERVE INJURY,3
FI,PREGNANCY WITH IMPLANT CONTRACEPTIVE,3
FI,PULMONARY EMBOLISM,3
FI,RASH,3
FI,RETCHING,3
FI,SYNCOPE,3
FI,ABDOMINAL PAIN LOWER,2
FI,ALTERED STATE OF CONSCIOUSNESS,2
FI,ANAEMIA,2
FI,ANXIETY,2
FI,ASPARTATE AMINOTRANSFERASE INCREASED,2
FI,BLOOD ALKALINE PHOSPHATASE INCREASED,2
FI,BLOOD PRESSURE INCREASED,2
FI,BREAST CANCER METASTATIC,2
FI,CEREBRAL HAEMORRHAGE,2
FI,CEREBRAL INFARCTION,2
FI,CHEST PAIN,2
FI,DEATH,2
FI,DEVICE ISSUE,2
FI,DRUG DOSE OMISSION,2
FI,DRUG EFFECT INCOMPLETE,2
FI,DYSPHONIA,2
FI,ECZEMA,2
FI,EXTREMITY NECROSIS,2
FI,FAECES DISCOLOURED,2
FI,FUNCTIONAL GASTROINTESTINAL DISORDER,2
FI,GASTROINTESTINAL DISORDER,2
FI,GASTROINTESTINAL HAEMORRHAGE,2
FI,HAEMORRHAGE,2
FI,HEAD INJURY,2
FI,HEMIPLEGIA,2
FI,HYPONATRAEMIA,2
FI,IMMUNE THROMBOCYTOPENIC PURPURA,2
FI,INCORRECT DRUG ADMINISTRATION DURATION,2
FI,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
FI,INFREQUENT BOWEL MOVEMENTS,2
FI,INTESTINAL OBSTRUCTION,2
FI,LEUKOPENIA,2
FI,LIMB DISCOMFORT,2
FI,LOCALISED OEDEMA,2
FI,LOSS OF CONSCIOUSNESS,2
FI,LYMPHOCYTE COUNT DECREASED,2
FI,MEMORY IMPAIRMENT,2
FI,MENTAL DISORDER,2
FI,MOBILITY DECREASED,2
FI,MUSCULAR WEAKNESS,2
FI,NERVE INJURY,2
FI,NEUTROPHIL COUNT DECREASED,2
FI,PARKINSON^S DISEASE,2
FI,PHARYNGEAL OEDEMA,2
FI,PHOTOPHOBIA,2
FI,PLATELET COUNT DECREASED,2
FI,POISONING,2
FI,POOR QUALITY SLEEP,2
FI,PROCEDURAL PAIN,2
FI,PRODUCT QUALITY ISSUE,2
FI,PRODUCT USE IN UNAPPROVED INDICATION,2
FI,PYELONEPHRITIS,2
FI,ROAD TRAFFIC ACCIDENT,2
FI,SEIZURE,2
FI,SELF-INJURIOUS IDEATION,2
FI,SEPSIS,2
FI,SLEEP DISORDER,2
FI,SPEECH DISORDER,2
FI,TACHYCARDIA,2
FI,THROMBOSIS,2
FI,TOE AMPUTATION,2
FI,TOOTHACHE,2
FI,VISUAL IMPAIRMENT,2
FI,WHITE BLOOD CELL COUNT INCREASED,2
FI,WITHDRAWAL SYNDROME,2
FI,ABDOMINAL DISCOMFORT,1
FI,ABNORMAL BEHAVIOUR,1
FI,ABORTION INDUCED,1
FI,ABSCESS,1
FI,ABSCESS LIMB,1
FI,ABSCESS OF SALIVARY GLAND,1
FI,ACNE,1
FI,ADVERSE REACTION,1
FI,AFFECTIVE DISORDER,1
FI,AGITATION,1
FI,AMNESIA,1
FI,ANAL INCONTINENCE,1
FI,ANAPHYLACTIC REACTION,1
FI,ANAPHYLACTIC SHOCK,1
FI,ANGINA PECTORIS,1
FI,ANTI-THYROID ANTIBODY POSITIVE,1
FI,ANTICONVULSANT DRUG LEVEL DECREASED,1
FI,ANTICONVULSANT DRUG LEVEL INCREASED,1
FI,APHASIA,1
FI,APHONIA,1
FI,APLASTIC ANAEMIA,1
FI,ARTHRITIS REACTIVE,1
FI,ASCITES,1
FI,ASPHYXIA,1
FI,ATRIAL FIBRILLATION,1
FI,ATRIOVENTRICULAR BLOCK COMPLETE,1
FI,AUTOIMMUNE HEPATITIS,1
FI,BALANCE DISORDER,1
FI,BASAL GANGLIA HAEMORRHAGE,1
FI,BEDRIDDEN,1
FI,BEZOAR,1
FI,BLISTER,1
FI,BLISTER INFECTED,1
FI,BLOOD ALBUMIN DECREASED,1
FI,BLOOD BILIRUBIN INCREASED,1
FI,BLOOD BLISTER,1
FI,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
FI,BLOOD FOLATE INCREASED,1
FI,BLOOD GLUCOSE ABNORMAL,1
FI,BLOOD GLUCOSE INCREASED,1
FI,BLOOD MAGNESIUM DECREASED,1
FI,BLOOD PRESSURE ABNORMAL,1
FI,BLOOD SODIUM INCREASED,1
FI,BLOOD THYROID STIMULATING HORMONE DECREASED,1
FI,BLOOD THYROID STIMULATING HORMONE INCREASED,1
FI,BLOOD URIC ACID INCREASED,1
FI,BODY TEMPERATURE DECREASED,1
FI,BODY TEMPERATURE INCREASED,1
FI,BONE FISTULA,1
FI,BONE PAIN,1
FI,BRADYCARDIA,1
FI,BRAIN HYPOXIA,1
FI,BRONCHIAL HAEMORRHAGE,1
FI,CARDIAC ARREST,1
FI,CARDIOMYOPATHY,1
FI,CHOLECYSTITIS INFECTIVE,1
FI,CHOLELITHIASIS,1
FI,CHROMATURIA,1
FI,COLECTOMY,1
FI,COLON GANGRENE,1
FI,COMMUNICATION DISORDER,1
FI,COMPLICATION ASSOCIATED WITH DEVICE,1
FI,COMPLICATION OF DEVICE INSERTION,1
FI,CONTUSION,1
FI,CONVULSION,1
FI,CYSTITIS,1
FI,DEAFNESS UNILATERAL,1
FI,DECUBITUS ULCER,1
FI,DEEP VEIN THROMBOSIS,1
FI,DEHYDRATION,1
FI,DEPRESSED LEVEL OF CONSCIOUSNESS,1
FI,DEPRESSED MOOD,1
FI,DEPRESSION,1
FI,DERMATITIS,1
FI,DEVICE ALARM ISSUE,1
FI,DEVICE DISLOCATION,1
FI,DEVICE RELATED INFECTION,1
FI,DEVICE USE ISSUE,1
FI,DIABETES MELLITUS,1
FI,DILATATION VENTRICULAR,1
FI,DISEASE PROGRESSION,1
FI,DISORGANISED SPEECH,1
FI,DIVERTICULITIS,1
FI,DIVERTICULUM INTESTINAL,1
FI,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
FI,DRUG HYPERSENSITIVITY,1
FI,DRUG LEVEL INCREASED,1
FI,DRY EYE,1
FI,DRY SKIN,1
FI,DRY THROAT,1
FI,DUODENITIS,1
FI,DYSARTHRIA,1
FI,DYSGEUSIA,1
FI,DYSGRAPHIA,1
FI,DYSLIPIDAEMIA,1
FI,DYSPEPSIA,1
FI,DYSSTASIA,1
FI,ELECTROCARDIOGRAM QT PROLONGED,1
FI,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
FI,ELECTROCARDIOGRAM T WAVE INVERSION,1
FI,EMBOLISM ARTERIAL,1
FI,EMOTIONAL POVERTY,1
FI,ENDOCARDITIS,1
FI,ENDOMETRIAL DISORDER,1
FI,ENTHESOPATHY,1
FI,EOSINOPHILIA,1
FI,EPISTAXIS,1
FI,ERYSIPELAS,1
FI,ERYTHEMA MULTIFORME,1
FI,ESCHERICHIA BACTERAEMIA,1
FI,ESCHERICHIA TEST POSITIVE,1
FI,EXPIRED DRUG ADMINISTERED,1
FI,EYE IRRITATION,1
FI,FACIAL PARESIS,1
FI,FAECAL CALPROTECTIN INCREASED,1
FI,FAECES PALE,1
FI,FALLOPIAN TUBE CANCER,1
FI,FEELING COLD,1
FI,FEELING HOT,1
FI,FEMORAL NECK FRACTURE,1
FI,FEMUR FRACTURE,1
FI,FOOT OPERATION,1
FI,FRACTURE,1
FI,FREEZING PHENOMENON,1
FI,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
FI,GASTRIC ULCER,1
FI,GLOSSODYNIA,1
FI,GOUT,1
FI,HAEMATOCHEZIA,1
FI,HAEMATOCRIT DECREASED,1
FI,HAEMATOMA,1
FI,HAEMORRHAGE INTRACRANIAL,1
FI,HAEMORRHAGIC FEVER WITH RENAL SYNDROME,1
FI,HALLUCINATION_ VISUAL,1
FI,HEAD DISCOMFORT,1
FI,HEPATIC CYST,1
FI,HEPATIC ENZYME INCREASED,1
FI,HEPATIC FUNCTION ABNORMAL,1
FI,HEPATIC NECROSIS,1
FI,HEPATOMEGALY,1
FI,HIP FRACTURE,1
FI,HOT FLUSH,1
FI,HYDRONEPHROSIS,1
FI,HYPERSOMNIA,1
FI,HYPERTHYROIDISM,1
FI,HYPOGLYCAEMIA,1
FI,HYPOPHAGIA,1
FI,HYPOVOLAEMIA,1
FI,IMPAIRED DRIVING ABILITY,1
FI,IMPLANT SITE PAIN,1
FI,IMPLANT SITE PRURITUS,1
FI,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
FI,INCORRECT DOSE ADMINISTERED,1
FI,INFLAMMATORY MARKER INCREASED,1
FI,INFLUENZA,1
FI,INFUSION RELATED REACTION,1
FI,INJECTION SITE HAEMORRHAGE,1
FI,INJECTION SITE INFLAMMATION,1
FI,INJECTION SITE MASS,1
FI,INSOMNIA,1
FI,INTENTIONAL DEVICE MISUSE,1
FI,INTENTIONAL DRUG MISUSE,1
FI,INTENTIONAL OVERDOSE,1
FI,INTERNATIONAL NORMALISED RATIO DECREASED,1
FI,INTERVERTEBRAL DISC PROTRUSION,1
FI,INTESTINAL MUCOSAL HYPERTROPHY,1
FI,IRITIS,1
FI,IRRITABILITY,1
FI,JAUNDICE,1
FI,JOINT HYPEREXTENSION,1
FI,JOINT SWELLING,1
FI,JUVENILE IDIOPATHIC ARTHRITIS,1
FI,LABORATORY TEST ABNORMAL,1
FI,LARGE INTESTINE PERFORATION,1
FI,LEG AMPUTATION,1
FI,LEUKOCYTOSIS,1
FI,LIMB OPERATION,1
FI,LIVER DISORDER,1
FI,LIVER FUNCTION TEST INCREASED,1
FI,LIVER INJURY,1
FI,LIVING IN RESIDENTIAL INSTITUTION,1
FI,LOCAL SWELLING,1
FI,LOCALISED INTRAABDOMINAL FLUID COLLECTION,1
FI,LOWER LIMB FRACTURE,1
FI,LUNG CONSOLIDATION,1
FI,LUNG DISORDER,1
FI,LUNG INFECTION,1
FI,LUNG INFILTRATION,1
FI,LYMPHADENOPATHY,1
FI,MANIA,1
FI,MEDICATION ERROR,1
FI,MELAENA,1
FI,MENOPAUSE,1
FI,MENORRHAGIA,1
FI,METASTASES TO LIVER,1
FI,METATARSALGIA,1
FI,MONOCYTE COUNT INCREASED,1
FI,MONOCYTE PERCENTAGE INCREASED,1
FI,MOOD ALTERED,1
FI,MOOD SWINGS,1
FI,MOTOR DYSFUNCTION,1
FI,MOUTH SWELLING,1
FI,MOUTH ULCERATION,1
FI,MOVEMENT DISORDER,1
FI,MUSCLE SPASMS,1
FI,MUSCLE SPASTICITY,1
FI,MUSCULOSKELETAL CHEST PAIN,1
FI,MUSCULOSKELETAL DISORDER,1
FI,MYELITIS,1
FI,MYOCARDIAL INFARCTION,1
FI,MYOSITIS,1
FI,NECK PAIN,1
FI,NEUTROPENIA,1
FI,NYSTAGMUS,1
FI,OBESITY,1
FI,OCULAR ICTERUS,1
FI,OLIGOMENORRHOEA,1
FI,ORAL FUNGAL INFECTION,1
FI,ORAL PAIN,1
FI,ORGANISING PNEUMONIA,1
FI,OSTEOMYELITIS,1
FI,OSTEONECROSIS OF JAW,1
FI,OSTEOPOROSIS,1
FI,OSTEOPOROTIC FRACTURE,1
FI,OSTEOSCLEROSIS,1
FI,OTITIS MEDIA,1
FI,OVARIAN CANCER,1
FI,OVERDOSE,1
FI,PALPITATIONS,1
FI,PANCREATITIS,1
FI,PANCREATITIS ACUTE,1
FI,PARAESTHESIA,1
FI,PARANOIA,1
FI,PERIODONTITIS,1
FI,PERIPHERAL ARTERY THROMBOSIS,1
FI,PERIPHERAL ISCHAEMIA,1
FI,PERIPHERAL SWELLING,1
FI,PHOTOSENSITIVITY REACTION,1
FI,PLATELET COUNT ABNORMAL,1
FI,PLEURAL EFFUSION,1
FI,PNEUMONITIS,1
FI,POLYDIPSIA,1
FI,POLYMYOSITIS,1
FI,POST PROCEDURAL COMPLICATION,1
FI,POST PROCEDURAL DIARRHOEA,1
FI,POST PROCEDURAL HAEMORRHAGE,1
FI,POSTERIOR CAPSULE OPACIFICATION,1
FI,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
FI,PRECEREBRAL ARTERY THROMBOSIS,1
FI,PRODUCT LABEL ISSUE,1
FI,PRODUCTIVE COUGH,1
FI,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
FI,PRURITUS GENERALISED,1
FI,PSEUDOMONAS INFECTION,1
FI,PSYCHOTIC DISORDER,1
FI,PULMONARY FIBROSIS,1
FI,PURPURA,1
FI,PURULENT DISCHARGE,1
FI,QUALITY OF LIFE DECREASED,1
FI,RADIUS FRACTURE,1
FI,RASH PRURITIC,1
FI,RED BLOOD CELL COUNT DECREASED,1
FI,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
FI,RED CELL DISTRIBUTION WIDTH INCREASED,1
FI,RENAL CYST,1
FI,RESPIRATORY ARREST,1
FI,RESPIRATORY DEPRESSION,1
FI,RETINAL DETACHMENT,1
FI,RETINAL TEAR,1
FI,RHEUMATOID ARTHRITIS,1
FI,RHINITIS ALLERGIC,1
FI,RHINORRHOEA,1
FI,SCHIZOPHRENIA,1
FI,SEDATION,1
FI,SEPTIC SHOCK,1
FI,SERUM FERRITIN INCREASED,1
FI,SIALOADENITIS,1
FI,SKIN DISCOLOURATION,1
FI,SKIN EXFOLIATION,1
FI,SKIN NECROSIS,1
FI,SPINAL FRACTURE,1
FI,SPLENOMEGALY,1
FI,STAPHYLOCOCCAL INFECTION,1
FI,STAPHYLOCOCCAL SEPSIS,1
FI,STOMA SITE DISCHARGE,1
FI,STOMA SITE INFLAMMATION,1
FI,STRIDOR,1
FI,SUDDEN HEARING LOSS,1
FI,SUICIDE ATTEMPT,1
FI,SWELLING,1
FI,SWELLING FACE,1
FI,SWOLLEN TONGUE,1
FI,SYNOVITIS,1
FI,TACHYCARDIA PAROXYSMAL,1
FI,TENDERNESS,1
FI,THERAPY CESSATION,1
FI,THROAT IRRITATION,1
FI,THROAT TIGHTNESS,1
FI,THROMBOCYTOPENIC PURPURA,1
FI,THYROXINE FREE DECREASED,1
FI,THYROXINE FREE INCREASED,1
FI,TINNITUS,1
FI,TONGUE BLISTERING,1
FI,TONGUE OEDEMA,1
FI,TOOTH ABSCESS,1
FI,TOOTH FRACTURE,1
FI,TOOTH LOSS,1
FI,TRACHEAL HAEMORRHAGE,1
FI,TRANSFERRIN DECREASED,1
FI,TREATMENT NONCOMPLIANCE,1
FI,TRICHORRHEXIS,1
FI,ULNA FRACTURE,1
FI,UPPER RESPIRATORY TRACT INFLAMMATION,1
FI,URETERIC INJURY,1
FI,URINARY INCONTINENCE,1
FI,URINARY RETENTION,1
FI,URINARY TRACT INFECTION FUNGAL,1
FI,URINE FLOW DECREASED,1
FI,UTERINE NEOPLASM,1
FI,VENOUS THROMBOSIS LIMB,1
FI,VENTRICULAR FIBRILLATION,1
FI,VENTRICULAR HYPERTROPHY,1
FI,VULVOVAGINAL MYCOTIC INFECTION,1
FI,WHEEZING,1
FI,WOUND INFECTION,1
FI,WOUND NECROSIS,1
FI,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
FI,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
FI,YELLOW SKIN,1
FR,OVERDOSE,21
FR,HEPATOCELLULAR INJURY,19
FR,ACUTE KIDNEY INJURY,17
FR,HEPATITIS,17
FR,CHOLESTASIS,15
FR,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,15
FR,NEUTROPENIA,14
FR,PYREXIA,14
FR,TACHYCARDIA,14
FR,THROMBOCYTOPENIA,14
FR,HYPOTENSION,13
FR,LACTIC ACIDOSIS,11
FR,TOXICITY TO VARIOUS AGENTS,11
FR,VOMITING,11
FR,AGRANULOCYTOSIS,10
FR,EOSINOPHILIA,10
FR,RENAL FAILURE,10
FR,HYPOKALAEMIA,9
FR,LEUKOPENIA,9
FR,RESPIRATORY DISTRESS,9
FR,ABDOMINAL PAIN,8
FR,ASPARTATE AMINOTRANSFERASE INCREASED,8
FR,ERYTHEMA,8
FR,GENERAL PHYSICAL HEALTH DETERIORATION,8
FR,PANCREATITIS ACUTE,8
FR,PANCYTOPENIA,8
FR,RENAL FAILURE ACUTE,8
FR,RHABDOMYOLYSIS,8
FR,TOXIC EPIDERMAL NECROLYSIS,8
FR,URTICARIA,8
FR,CARDIAC FAILURE,7
FR,COMPLETED SUICIDE,7
FR,CONFUSIONAL STATE,7
FR,DEATH,7
FR,DIARRHOEA,7
FR,DRUG INEFFECTIVE,7
FR,DRUG LEVEL INCREASED,7
FR,DRUG-INDUCED LIVER INJURY,7
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,7
FR,HYPERTHERMIA,7
FR,ALANINE AMINOTRANSFERASE INCREASED,6
FR,ANGIOEDEMA,6
FR,ASTHENIA,6
FR,COMA,6
FR,FACE OEDEMA,6
FR,HEPATITIS FULMINANT,6
FR,INFLAMMATION,6
FR,LUNG DISORDER,6
FR,NAUSEA,6
FR,STEVENS-JOHNSON SYNDROME,6
FR,TOXIC SKIN ERUPTION,6
FR,ANAEMIA,5
FR,BRADYCARDIA,5
FR,CARDIO-RESPIRATORY ARREST,5
FR,DEEP VEIN THROMBOSIS,5
FR,HAEMATOMA,5
FR,HYPOGLYCAEMIA,5
FR,INTENTIONAL OVERDOSE,5
FR,ISCHAEMIC STROKE,5
FR,LYMPHOPENIA,5
FR,MALIGNANT NEOPLASM PROGRESSION,5
FR,MULTI-ORGAN FAILURE,5
FR,OEDEMA PERIPHERAL,5
FR,PNEUMONIA,5
FR,PULMONARY EMBOLISM,5
FR,RASH,5
FR,SEPSIS,5
FR,ACIDOSIS,4
FR,ADRENERGIC SYNDROME,4
FR,ASPHYXIA,4
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,4
FR,CARDIAC ARREST,4
FR,CELL DEATH,4
FR,CHILLS,4
FR,DEHYDRATION,4
FR,DERMATITIS EXFOLIATIVE,4
FR,DYSPHAGIA,4
FR,DYSPNOEA,4
FR,ENCEPHALOPATHY,4
FR,HALLUCINATION,4
FR,HEPATIC FAILURE,4
FR,HEPATITIS CHOLESTATIC,4
FR,HYPERBILIRUBINAEMIA,4
FR,HYPERKALAEMIA,4
FR,HYPERTENSION,4
FR,INTERNATIONAL NORMALISED RATIO INCREASED,4
FR,INTERSTITIAL LUNG DISEASE,4
FR,MALAISE,4
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
FR,PRESCRIBED OVERDOSE,4
FR,SEROTONIN SYNDROME,4
FR,SOMNOLENCE,4
FR,ACUTE HEPATIC FAILURE,3
FR,BACK PAIN,3
FR,CHEST PAIN,3
FR,CONDITION AGGRAVATED,3
FR,CONGESTIVE CARDIOMYOPATHY,3
FR,CONSTIPATION,3
FR,DEPRESSION,3
FR,DERMATITIS BULLOUS,3
FR,EPISTAXIS,3
FR,EXPOSURE DURING PREGNANCY,3
FR,FALL,3
FR,FOETAL EXPOSURE DURING PREGNANCY,3
FR,GENERALISED TONIC-CLONIC SEIZURE,3
FR,HAEMOLYTIC ANAEMIA,3
FR,HEADACHE,3
FR,HEPATIC FUNCTION ABNORMAL,3
FR,HEPATIC NECROSIS,3
FR,HEPATITIS ACUTE,3
FR,HEPATOCELLULAR CARCINOMA,3
FR,HYPERHIDROSIS,3
FR,IMMUNE THROMBOCYTOPENIC PURPURA,3
FR,IMMUNOSUPPRESSANT DRUG LEVEL INCREASED,3
FR,INFUSION RELATED REACTION,3
FR,INTRA-ABDOMINAL HAEMORRHAGE,3
FR,JAUNDICE,3
FR,LINEAR IGA DISEASE,3
FR,LIVER DISORDER,3
FR,MATERNAL EXPOSURE DURING PREGNANCY,3
FR,METABOLIC ACIDOSIS,3
FR,MUCOSAL INFLAMMATION,3
FR,OEDEMA,3
FR,OLIGURIA,3
FR,PAIN,3
FR,PANCREATIC CARCINOMA,3
FR,PERITONITIS,3
FR,PLEURAL EFFUSION,3
FR,PRODUCT USE ISSUE,3
FR,PROTHROMBIN TIME SHORTENED,3
FR,PRURITUS,3
FR,RASH ERYTHEMATOUS,3
FR,RASH MACULO-PAPULAR,3
FR,RESPIRATORY FAILURE,3
FR,SHOCK HAEMORRHAGIC,3
FR,TRANSAMINASES INCREASED,3
FR,WEIGHT DECREASED,3
FR,AGITATION,2
FR,ANALGESIC DRUG LEVEL INCREASED,2
FR,ANAPHYLACTIC SHOCK,2
FR,ANAPHYLACTOID SHOCK,2
FR,ASCITES,2
FR,ATRIAL FIBRILLATION,2
FR,ATRIOVENTRICULAR BLOCK,2
FR,BLOOD ALBUMIN DECREASED,2
FR,BLOOD BILIRUBIN INCREASED,2
FR,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
FR,BLOOD CREATININE ABNORMAL,2
FR,BLOOD PRESSURE DECREASED,2
FR,C-REACTIVE PROTEIN INCREASED,2
FR,CARDIOGENIC SHOCK,2
FR,CEREBELLAR SYNDROME,2
FR,CEREBRAL HAEMORRHAGE,2
FR,CEREBRAL ISCHAEMIA,2
FR,CEREBROVASCULAR ACCIDENT,2
FR,COLITIS,2
FR,COLITIS ISCHAEMIC,2
FR,CREATININE RENAL CLEARANCE DECREASED,2
FR,CYANOSIS,2
FR,DIABETES MELLITUS INADEQUATE CONTROL,2
FR,DISTURBANCE IN ATTENTION,2
FR,DRUG ADMINISTRATION ERROR,2
FR,DRUG WITHDRAWAL SYNDROME,2
FR,DYSPNOEA EXERTIONAL,2
FR,ECCHYMOSIS,2
FR,ELECTROLYTE IMBALANCE,2
FR,EPILEPSY,2
FR,ERYTHEMA MULTIFORME,2
FR,FATIGUE,2
FR,FEBRILE NEUTROPENIA,2
FR,GASTROINTESTINAL DISORDER,2
FR,GASTROINTESTINAL HAEMORRHAGE,2
FR,HAEMATOCHEZIA,2
FR,HAEMATURIA,2
FR,HAEMODYNAMIC INSTABILITY,2
FR,HAEMORRHAGE,2
FR,HEMIPLEGIA,2
FR,HEPATIC ENCEPHALOPATHY,2
FR,HEPATIC ENZYME INCREASED,2
FR,HEPATOTOXICITY,2
FR,HISTIOCYTOSIS HAEMATOPHAGIC,2
FR,HYPONATRAEMIA,2
FR,HYPOTHERMIA,2
FR,HYPOTHYROIDISM,2
FR,IMMUNOSUPPRESSANT DRUG LEVEL DECREASED,2
FR,INSOMNIA,2
FR,INTESTINAL ISCHAEMIA,2
FR,LARYNGEAL HAEMATOMA,2
FR,LOSS OF CONSCIOUSNESS,2
FR,MEDICATION ERROR,2
FR,METRORRHAGIA,2
FR,MIXED LIVER INJURY,2
FR,MUSCULAR WEAKNESS,2
FR,NEUROMUSCULAR BLOCK PROLONGED,2
FR,OXYGEN SATURATION DECREASED,2
FR,PERICARDIAL EFFUSION,2
FR,PERIPHERAL ISCHAEMIA,2
FR,PHOTOSENSITIVITY REACTION,2
FR,POISONING DELIBERATE,2
FR,PROSTATE CANCER,2
FR,RASH MORBILLIFORM,2
FR,RENAL IMPAIRMENT,2
FR,SEIZURE,2
FR,SINUS TACHYCARDIA,2
FR,SKIN REACTION,2
FR,STAPHYLOCOCCAL INFECTION,2
FR,SUICIDE ATTEMPT,2
FR,TYPE IV HYPERSENSITIVITY REACTION,2
FR,UMBILICAL CORD AROUND NECK,2
FR,UNRESPONSIVE TO STIMULI,2
FR,URINARY TRACT INFECTION,2
FR,VASCULAR PSEUDOANEURYSM,2
FR,VERTIGO,2
FR,VIITH NERVE PARALYSIS,2
FR,ABDOMINAL DISCOMFORT,1
FR,ABDOMINAL DISTENSION,1
FR,ABDOMINAL PAIN LOWER,1
FR,ABDOMINAL PAIN UPPER,1
FR,ABNORMAL FAECES,1
FR,ACCIDENTAL OVERDOSE,1
FR,ACUTE MOTOR-SENSORY AXONAL NEUROPATHY,1
FR,ACUTE MYELOID LEUKAEMIA,1
FR,ACUTE MYOCARDIAL INFARCTION,1
FR,ACUTE PULMONARY OEDEMA,1
FR,ACUTE RESPIRATORY DISTRESS SYNDROME,1
FR,ADMINISTRATION SITE NECROSIS,1
FR,ADRENAL HAEMATOMA,1
FR,ADRENAL INSUFFICIENCY,1
FR,ADVERSE EVENT,1
FR,ALTERED STATE OF CONSCIOUSNESS,1
FR,AMINOACIDURIA,1
FR,AMNESIA,1
FR,AMYOTROPHY,1
FR,ANAL ULCER,1
FR,ANAPHYLACTIC REACTION,1
FR,ANKLE FRACTURE,1
FR,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
FR,ANURIA,1
FR,AORTIC DISSECTION,1
FR,APLASIA,1
FR,APPLICATION SITE ERYTHEMA,1
FR,APPLICATION SITE VESICLES,1
FR,AREFLEXIA,1
FR,ASPERGILLUS INFECTION,1
FR,ASTERIXIS,1
FR,BACK DISORDER,1
FR,BEDRIDDEN,1
FR,BILIARY DILATATION,1
FR,BILIRUBIN CONJUGATED INCREASED,1
FR,BLOOD ALKALINE PHOSPHATASE ABNORMAL,1
FR,BLOOD CREATININE INCREASED,1
FR,BLOOD GLUCOSE INCREASED,1
FR,BLOOD MAGNESIUM DECREASED,1
FR,BLOOD PRESSURE FLUCTUATION,1
FR,BLOOD UREA INCREASED,1
FR,BLOOD URINE PRESENT,1
FR,BODY TEMPERATURE DECREASED,1
FR,BODY TEMPERATURE INCREASED,1
FR,BONE MARROW FAILURE,1
FR,BRAIN OEDEMA,1
FR,BRAIN SCAN ABNORMAL,1
FR,BRONCHIAL OBSTRUCTION,1
FR,BRONCHIOLITIS,1
FR,BRONCHITIS,1
FR,BRONCHOALVEOLAR LAVAGE ABNORMAL,1
FR,BRONCHOSPASM,1
FR,BURNING SENSATION,1
FR,CACHEXIA,1
FR,CAESAREAN SECTION,1
FR,CARDIAC DISORDER,1
FR,CAROTID ARTERY DISSECTION,1
FR,CELLULITIS,1
FR,CEREBRAL ARTERY THROMBOSIS,1
FR,CHOLECYSTITIS,1
FR,CHRONIC KIDNEY DISEASE,1
FR,CHRONIC LYMPHOCYTIC LEUKAEMIA,1
FR,CLOSTRIDIUM COLITIS,1
FR,CLOSTRIDIUM DIFFICILE INFECTION,1
FR,COARCTATION OF THE AORTA,1
FR,COGNITIVE DISORDER,1
FR,COLITIS ULCERATIVE,1
FR,COMPLICATION OF DEVICE INSERTION,1
FR,CONDUCTION DISORDER,1
FR,CONTRAINDICATION TO MEDICAL TREATMENT,1
FR,CONVULSION,1
FR,CORNEAL LIGHT REFLEX TEST ABNORMAL,1
FR,COUGH,1
FR,CREATININE RENAL CLEARANCE INCREASED,1
FR,CREATININE URINE INCREASED,1
FR,CRYPTOCOCCOSIS,1
FR,CUTANEOUS VASCULITIS,1
FR,CYTOMEGALOVIRUS INFECTION,1
FR,CYTOMEGALOVIRUS TEST POSITIVE,1
FR,DECREASED APPETITE,1
FR,DERMATITIS EXFOLIATIVE GENERALISED,1
FR,DERMO-HYPODERMITIS,1
FR,DEVICE OCCLUSION,1
FR,DIAPHRAGMATIC HERNIA,1
FR,DIPLOPIA,1
FR,DISEASE RECURRENCE,1
FR,DISORIENTATION,1
FR,DIVERTICULAR PERFORATION,1
FR,DIZZINESS,1
FR,DRUG ABUSE,1
FR,DRUG DISPENSING ERROR,1
FR,DRUG DIVERSION,1
FR,DRUG INTOLERANCE,1
FR,DRUG LEVEL BELOW THERAPEUTIC,1
FR,DRUG LEVEL DECREASED,1
FR,DYSLIPIDAEMIA,1
FR,DYSPHONIA,1
FR,DYSURIA,1
FR,ECZEMA,1
FR,ELECTROCARDIOGRAM QT PROLONGED,1
FR,ENCEPHALITIS,1
FR,EOSINOPHIL COUNT INCREASED,1
FR,EPSTEIN-BARR VIRUS INFECTION,1
FR,EYELID MYOCLONUS,1
FR,FACIAL NERVE DISORDER,1
FR,FAECAL VOMITING,1
FR,FAECES DISCOLOURED,1
FR,FEBRILE BONE MARROW APLASIA,1
FR,FEELING ABNORMAL,1
FR,FEMUR FRACTURE,1
FR,FIXED DRUG ERUPTION,1
FR,FOOT FRACTURE,1
FR,FORMICATION,1
FR,GASTRITIS,1
FR,GASTROENTERITIS CRYPTOSPORIDIAL,1
FR,GASTROINTESTINAL MOTILITY DISORDER,1
FR,GASTROOESOPHAGEAL REFLUX DISEASE,1
FR,GENERAL PHYSICAL CONDITION ABNORMAL,1
FR,GENERALISED ERYTHEMA,1
FR,GENERALISED OEDEMA,1
FR,GLIOBLASTOMA,1
FR,GLOSSITIS,1
FR,GLUCOCORTICOID DEFICIENCY,1
FR,GLUTATHIONE DECREASED,1
FR,GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT,1
FR,GRAFT VERSUS HOST DISEASE IN LIVER,1
FR,GRAFT VERSUS HOST DISEASE IN SKIN,1
FR,GRANULOMATOUS LIVER DISEASE,1
FR,HAEMATOTOXICITY,1
FR,HAEMORRHAGE NEONATAL,1
FR,HAEMORRHOIDS,1
FR,HAEMOTHORAX,1
FR,HALLUCINATION_ VISUAL,1
FR,HENOCH-SCHONLEIN PURPURA,1
FR,HEPATIC CIRRHOSIS,1
FR,HEPATIC STEATOSIS,1
FR,HEPATORENAL SYNDROME,1
FR,HERPES VIRUS INFECTION,1
FR,HERPES ZOSTER,1
FR,HOT FLUSH,1
FR,HUMAN HERPESVIRUS 7 INFECTION,1
FR,HYDROXYPROLINURIA,1
FR,HYPERAESTHESIA,1
FR,HYPERCALCAEMIA,1
FR,HYPERGLYCAEMIA,1
FR,HYPERLACTACIDAEMIA,1
FR,HYPERSENSITIVITY VASCULITIS,1
FR,HYPOAESTHESIA,1
FR,HYPOALBUMINAEMIA,1
FR,HYPOCAPNIA,1
FR,HYPOCHROMIC ANAEMIA,1
FR,HYPOPHOSPHATAEMIA,1
FR,HYPOVENTILATION,1
FR,HYPOVOLAEMIC SHOCK,1
FR,HYPOXIA,1
FR,ILEUS PARALYTIC,1
FR,IMMUNOSUPPRESSION,1
FR,IMPLANT SITE HAEMORRHAGE,1
FR,IMPLANT SITE PAIN,1
FR,IMPLANT SITE PRURITUS,1
FR,IN VITRO FERTILISATION,1
FR,INCORRECT DOSE ADMINISTERED,1
FR,INFECTION,1
FR,INFECTION REACTIVATION,1
FR,INFUSION SITE EXTRAVASATION,1
FR,INHIBITORY DRUG INTERACTION,1
FR,INTENTIONAL PRODUCT MISUSE,1
FR,INTERNATIONAL NORMALISED RATIO ABNORMAL,1
FR,INTERNATIONAL NORMALISED RATIO DECREASED,1
FR,INTERVERTEBRAL DISC OPERATION,1
FR,INTERVERTEBRAL DISCITIS,1
FR,INTUSSUSCEPTION,1
FR,JUGULAR VEIN THROMBOSIS,1
FR,LARGE INTESTINAL ULCER,1
FR,LARYNGEAL OEDEMA,1
FR,LEUKOCYTOSIS,1
FR,LEUKOSTASIS SYNDROME,1
FR,LIVE BIRTH,1
FR,LIVER FUNCTION TEST ABNORMAL,1
FR,LOCALISED OEDEMA,1
FR,LUNG INFECTION,1
FR,LYMPHADENOPATHY,1
FR,LYMPHOCYTE COUNT DECREASED,1
FR,LYMPHOCYTIC HYPOPHYSITIS,1
FR,LYMPHOCYTOSIS,1
FR,MALIGNANT MELANOMA,1
FR,MALNUTRITION,1
FR,MANIA,1
FR,MELAENA,1
FR,MENTAL IMPAIRMENT,1
FR,MESENTERIC ARTERY THROMBOSIS,1
FR,METABOLIC DISORDER,1
FR,METASTASES TO MUSCLE,1
FR,MIOSIS,1
FR,MOUTH HAEMORRHAGE,1
FR,MOUTH ULCERATION,1
FR,MUCOUS MEMBRANE DISORDER,1
FR,MUSCLE SPASMS,1
FR,MUSCULOSKELETAL CHEST PAIN,1
FR,MUSCULOSKELETAL STIFFNESS,1
FR,MYDRIASIS,1
FR,MYELODYSPLASTIC SYNDROME,1
FR,MYOCARDIAL INFARCTION,1
FR,MYOCARDITIS POST INFECTION,1
FR,NASOPHARYNGITIS,1
FR,NECK PAIN,1
FR,NECROSIS,1
FR,NEONATAL ASPHYXIA,1
FR,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
FR,NEOPLASM MALIGNANT,1
FR,NEOPLASM PROGRESSION,1
FR,NEPHROANGIOSCLEROSIS,1
FR,NEPHROPATHY,1
FR,NERVOUS SYSTEM DISORDER,1
FR,NEUROENDOCRINE CARCINOMA METASTATIC,1
FR,NEUROLEPTIC MALIGNANT SYNDROME,1
FR,NEUROLOGICAL DECOMPENSATION,1
FR,OESOPHAGEAL VARICEAL LIGATION,1
FR,OESOPHAGITIS,1
FR,ORAL DISORDER,1
FR,ORAL HERPES,1
FR,ORAL PAIN,1
FR,ORTHOSTATIC HYPOTENSION,1
FR,OSTEONECROSIS,1
FR,OUT OF SPECIFICATION TEST RESULTS,1
FR,OXYGEN SATURATION ABNORMAL,1
FR,PACKED RED BLOOD CELL TRANSFUSION,1
FR,PAIN IN JAW,1
FR,PAIN OF SKIN,1
FR,PALATAL OEDEMA,1
FR,PALPITATIONS,1
FR,PARAESTHESIA,1
FR,PELVIC PAIN,1
FR,PEMPHIGOID,1
FR,PERICARDIAL HAEMORRHAGE,1
FR,PERICARDITIS,1
FR,PERIPHERAL ARTERY THROMBOSIS,1
FR,PERITONEAL PERFORATION,1
FR,PHARYNGITIS,1
FR,PHOBIA,1
FR,PNEUMATOSIS,1
FR,PNEUMATOSIS INTESTINALIS,1
FR,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
FR,POISONING,1
FR,POLLAKIURIA,1
FR,POLYMYOSITIS,1
FR,POLYNEUROPATHY,1
FR,POLYURIA,1
FR,PORPHYRIA NON-ACUTE,1
FR,POTENTIATING DRUG INTERACTION,1
FR,PRECOCIOUS PUBERTY,1
FR,PREMATURE DELIVERY,1
FR,PRERENAL FAILURE,1
FR,PRESYNCOPE,1
FR,PRURIGO,1
FR,PRURITUS GENERALISED,1
FR,PSORIASIS,1
FR,PULMONARY FIBROSIS,1
FR,PULMONARY MASS,1
FR,PULMONARY TUBERCULOSIS,1
FR,PUPILS UNEQUAL,1
FR,PURPURA,1
FR,PYELONEPHRITIS ACUTE,1
FR,PYROGLUTAMATE INCREASED,1
FR,RADIOTHERAPY,1
FR,RASH MACULAR,1
FR,RASH PUSTULAR,1
FR,RECTAL HAEMORRHAGE,1
FR,RENAL ARTERY THROMBOSIS,1
FR,RENAL FAILURE CHRONIC,1
FR,RENAL ISCHAEMIA,1
FR,RENAL TUBULAR NECROSIS,1
FR,RETINAL ARTERY OCCLUSION,1
FR,RETROPERITONEAL HAEMATOMA,1
FR,SEDATION,1
FR,SEPTIC SHOCK,1
FR,SERUM FERRITIN INCREASED,1
FR,SINUSITIS,1
FR,SKIN PLAQUE,1
FR,SKIN WOUND,1
FR,SQUAMOUS CELL CARCINOMA,1
FR,SQUAMOUS CELL CARCINOMA OF THE TONGUE,1
FR,STAPHYLOCOCCAL BACTERAEMIA,1
FR,SUBDURAL HAEMATOMA,1
FR,SUFFOCATION FEELING,1
FR,SUICIDAL IDEATION,1
FR,SYNCOPE,1
FR,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
FR,TELANGIECTASIA,1
FR,THERAPEUTIC EMBOLISATION,1
FR,THERMAL BURN,1
FR,THROAT IRRITATION,1
FR,THROMBOPHLEBITIS SEPTIC,1
FR,THROMBOPHLEBITIS SUPERFICIAL,1
FR,THROMBOTIC MICROANGIOPATHY,1
FR,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
FR,TONIC CONVULSION,1
FR,TOOTH DISORDER,1
FR,TOOTHACHE,1
FR,TORSADE DE POINTES,1
FR,TRANSIENT ISCHAEMIC ATTACK,1
FR,TRAUMATIC DELIVERY,1
FR,TREATMENT NONCOMPLIANCE,1
FR,TUBULOINTERSTITIAL NEPHRITIS,1
FR,TWIN PREGNANCY,1
FR,ULCER HAEMORRHAGE,1
FR,UPPER AIRWAY OBSTRUCTION,1
FR,URINARY RETENTION,1
FR,UROSEPSIS,1
FR,VAGINAL HAEMORRHAGE,1
FR,VENOUS THROMBOSIS LIMB,1
FR,VENTRICULAR EXTRASYSTOLES,1
FR,VENTRICULAR SEPTAL DEFECT,1
FR,VIRAL INFECTION,1
FR,VULVOVAGINAL MYCOTIC INFECTION,1
FR,WEIGHT INCREASED,1
FR,WITHDRAWAL SYNDROME,1
GE,ANXIETY,1
GE,ASTHENIA,1
GE,BLOOD SODIUM DECREASED,1
GE,BLOOD URINE PRESENT,1
GE,DIZZINESS,1
GE,DRY SKIN,1
GE,DYSPNOEA,1
GE,HEAD DISCOMFORT,1
GE,MUSCLE SPASMS,1
GE,MUSCULAR WEAKNESS,1
GE,PETIT MAL EPILEPSY,1
GE,PRURITUS,1
GE,RENAL DISORDER,1
GE,THERAPY CESSATION,1
GE,THROAT TIGHTNESS,1
GE,TREMOR,1
GE,VISION BLURRED,1
GE,WEIGHT DECREASED,1
DE,ACUTE HEPATIC FAILURE,14
DE,DRUG-INDUCED LIVER INJURY,9
DE,ACCIDENTAL OVERDOSE,7
DE,HEPATIC ENCEPHALOPATHY,6
DE,NAUSEA,4
DE,SEPSIS,4
DE,VOMITING,4
DE,FATIGUE,3
DE,GENERAL PHYSICAL HEALTH DETERIORATION,3
DE,LEUKOPENIA,3
DE,OVERDOSE,3
DE,PANCYTOPENIA,3
DE,PRURITUS GENERALISED,3
DE,THROMBOCYTOPENIA,3
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,2
DE,COMA,2
DE,DEATH,2
DE,DIARRHOEA,2
DE,DRUG ADMINISTRATION ERROR,2
DE,DRUG INEFFECTIVE,2
DE,DYSPNOEA,2
DE,HEPATIC ENZYME INCREASED,2
DE,HEPATITIS VIRAL,2
DE,HERPES SIMPLEX,2
DE,HYPOTENSION,2
DE,LIVER INJURY,2
DE,MULTIPLE SCLEROSIS RELAPSE,2
DE,NEUTROPENIA,2
DE,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,2
DE,PRURITUS,2
DE,PYREXIA,2
DE,RASH,2
DE,RESTLESSNESS,2
DE,SEIZURE,2
DE,SYNCOPE,2
DE,TOXIC EPIDERMAL NECROLYSIS,2
DE,TOXICITY TO VARIOUS AGENTS,2
DE,WEIGHT DECREASED,2
DE,ABDOMINAL DISCOMFORT,1
DE,ABDOMINAL PAIN,1
DE,ABDOMINAL PAIN UPPER,1
DE,ABDOMINAL TENDERNESS,1
DE,ADENOCARCINOMA OF COLON,1
DE,ADVERSE EVENT,1
DE,AGRANULOCYTOSIS,1
DE,ALANINE AMINOTRANSFERASE INCREASED,1
DE,ANAEMIA,1
DE,ANAPHYLACTIC REACTION,1
DE,ANGINA PECTORIS,1
DE,ANXIETY,1
DE,APNOEA,1
DE,ARTHRALGIA,1
DE,ASPIRATION,1
DE,ATRIAL SEPTAL DEFECT,1
DE,BRAIN OEDEMA,1
DE,BRONCHIAL CARCINOMA,1
DE,C-REACTIVE PROTEIN INCREASED,1
DE,CARDIAC FAILURE,1
DE,CARDIAC FUNCTION TEST ABNORMAL,1
DE,CARDIOTOXICITY,1
DE,CARDIOVASCULAR DISORDER,1
DE,CEREBRAL HAEMORRHAGE,1
DE,CERVICAL INCOMPETENCE,1
DE,CHOLECYSTITIS,1
DE,CLOSTRIDIAL INFECTION,1
DE,COAGULATION FACTOR DECREASED,1
DE,COAGULOPATHY,1
DE,COLITIS,1
DE,COLITIS ULCERATIVE,1
DE,COMPLETED SUICIDE,1
DE,CONFUSIONAL STATE,1
DE,CORONARY ARTERY DISEASE,1
DE,CROHN^S DISEASE,1
DE,CRYPTORCHISM,1
DE,CYTOMEGALOVIRUS ENTERITIS,1
DE,CYTOMEGALOVIRUS INFECTION,1
DE,DECREASED APPETITE,1
DE,DELIRIUM,1
DE,DEPRESSION,1
DE,DEVICE RELATED INFECTION,1
DE,DIARRHOEA HAEMORRHAGIC,1
DE,DRUG ABUSE,1
DE,DRUG DOSE OMISSION,1
DE,DRUG EFFECT DECREASED,1
DE,DRUG EFFECT INCOMPLETE,1
DE,EJECTION FRACTION DECREASED,1
DE,ELECTROLYTE IMBALANCE,1
DE,EPILEPSY,1
DE,EXPOSURE DURING PREGNANCY,1
DE,EXTRASYSTOLES,1
DE,FACIAL PARESIS,1
DE,FEBRILE NEUTROPENIA,1
DE,FLUID RETENTION,1
DE,FOETAL DEATH,1
DE,FOETAL EXPOSURE DURING PREGNANCY,1
DE,GAIT DISTURBANCE,1
DE,GASTRITIS,1
DE,GASTROINTESTINAL NECROSIS,1
DE,GENERAL PHYSICAL CONDITION ABNORMAL,1
DE,HALLUCINATION,1
DE,HEADACHE,1
DE,HEMIPARESIS,1
DE,HEPATIC NECROSIS,1
DE,HEPATIC STEATOSIS,1
DE,HEPATITIS,1
DE,HEPATOCELLULAR INJURY,1
DE,HEPATOTOXICITY,1
DE,HERPES SIMPLEX HEPATITIS,1
DE,HERPES VIRUS INFECTION,1
DE,HYPERBILIRUBINAEMIA,1
DE,HYPERHIDROSIS,1
DE,HYPERTHYROIDISM,1
DE,HYPERTRIGLYCERIDAEMIA,1
DE,HYPERURICAEMIA,1
DE,INFECTION,1
DE,INFLUENZA,1
DE,INTENTIONAL OVERDOSE,1
DE,INTENTIONAL PRODUCT USE ISSUE,1
DE,INTERNATIONAL NORMALISED RATIO INCREASED,1
DE,LARGE FOR DATES BABY,1
DE,LEFT VENTRICULAR DYSFUNCTION,1
DE,LIVER FUNCTION TEST ABNORMAL,1
DE,LOCALISED INFECTION,1
DE,LOSS OF CONSCIOUSNESS,1
DE,LYMPHADENOPATHY,1
DE,LYMPHOPENIA,1
DE,MALAISE,1
DE,MATERNAL EXPOSURE BEFORE PREGNANCY,1
DE,MATERNAL EXPOSURE DURING PREGNANCY,1
DE,METAPNEUMOVIRUS INFECTION,1
DE,MORAXELLA INFECTION,1
DE,MUCOSAL INFLAMMATION,1
DE,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
DE,MUSCLE SPASMS,1
DE,MYALGIA,1
DE,NEPHROPATHY TOXIC,1
DE,NEUROBORRELIOSIS,1
DE,NOCARDIOSIS,1
DE,NON-HODGKIN^S LYMPHOMA,1
DE,OCULAR ICTERUS,1
DE,OESOPHAGEAL SPASM,1
DE,OSTEOPOROSIS,1
DE,PALLOR,1
DE,PANCREATIC CARCINOMA,1
DE,PANCREATITIS,1
DE,PANIC ATTACK,1
DE,PAPILLOMA VIRAL INFECTION,1
DE,PAPULOPUSTULAR ROSACEA,1
DE,PHOTOSENSITIVITY REACTION,1
DE,PNEUMONIA ASPIRATION,1
DE,PNEUMONIA CYTOMEGALOVIRAL,1
DE,PNEUMOPERITONEUM,1
DE,PREMATURE BABY,1
DE,PREMATURE DELIVERY,1
DE,PSORIASIS,1
DE,PULMONARY EMBOLISM,1
DE,PULMONARY TOXICITY,1
DE,RASH ERYTHEMATOUS,1
DE,RASH MACULAR,1
DE,RESPIRATORY DISORDER,1
DE,RESTLESS LEGS SYNDROME,1
DE,RHEUMATOID ARTHRITIS,1
DE,RHINOPHYMA,1
DE,RHINORRHOEA,1
DE,SENSITIVITY TO WEATHER CHANGE,1
DE,SINUSITIS,1
DE,SKIN TOXICITY,1
DE,SLEEP DISORDER,1
DE,SOMNOLENCE,1
DE,SQUAMOUS CELL CARCINOMA,1
DE,STASIS DERMATITIS,1
DE,STENT PLACEMENT,1
DE,STEVENS-JOHNSON SYNDROME,1
DE,SUICIDAL IDEATION,1
DE,SUICIDE ATTEMPT,1
DE,SUPRAVENTRICULAR TACHYCARDIA,1
DE,SYSTEMIC INFECTION,1
DE,TRANSAMINASES INCREASED,1
DE,TREMOR,1
DE,TUBERCULOSIS,1
DE,TYPE I HYPERSENSITIVITY,1
DE,URTICARIA,1
DE,VAGINAL HAEMORRHAGE,1
DE,VENTRICULAR SEPTAL DEFECT,1
DE,WEIGHT INCREASED,1
GR,SEPTIC SHOCK,3
GR,ANAEMIA,2
GR,DIARRHOEA,2
GR,LOWER RESPIRATORY TRACT INFECTION,2
GR,PRODUCT USE ISSUE,2
GR,PULMONARY EMBOLISM,2
GR,ABDOMINAL DISTENSION,1
GR,ABDOMINAL PAIN,1
GR,ALOPECIA,1
GR,ANXIETY,1
GR,ARRHYTHMIA,1
GR,ASTHENIA,1
GR,ATRIAL FIBRILLATION,1
GR,AUTOIMMUNE COLITIS,1
GR,BLOOD GLUCOSE INCREASED,1
GR,BLOOD PRESSURE DECREASED,1
GR,BLOOD PRESSURE INCREASED,1
GR,BRADYCARDIA,1
GR,BREATH SOUNDS ABNORMAL,1
GR,BRONCHOSPASM,1
GR,BURNING SENSATION,1
GR,CARDIAC ARREST,1
GR,CARDIOMYOPATHY,1
GR,CHEST PAIN,1
GR,CIRCULATORY COLLAPSE,1
GR,COLOSTOMY,1
GR,DEATH,1
GR,DEEP VEIN THROMBOSIS,1
GR,DISEASE PROGRESSION,1
GR,DIZZINESS,1
GR,DRUG INEFFECTIVE,1
GR,DRUG-INDUCED LIVER INJURY,1
GR,DYSPEPSIA,1
GR,ENTEROVESICAL FISTULA,1
GR,ERYTHEMA,1
GR,FOOD POISONING,1
GR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
GR,GASTROINTESTINAL DISORDER,1
GR,GINGIVITIS ULCERATIVE,1
GR,HAEMATOCRIT DECREASED,1
GR,HAEMORRHAGE,1
GR,HEADACHE,1
GR,HEPATITIS CHOLESTATIC,1
GR,HYPOTENSION,1
GR,HYPOXIA,1
GR,LEUKOPENIA,1
GR,LIP ULCERATION,1
GR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
GR,MUSCULAR WEAKNESS,1
GR,MUSCULOSKELETAL STIFFNESS,1
GR,NASOPHARYNGITIS,1
GR,NAUSEA,1
GR,ORAL CANDIDIASIS,1
GR,OSTEONECROSIS OF JAW,1
GR,PERICARDIAL EFFUSION,1
GR,PLEURAL EFFUSION,1
GR,PLEURITIC PAIN,1
GR,PNEUMONITIS,1
GR,POSTOPERATIVE RESPIRATORY DISTRESS,1
GR,PRODUCTIVE COUGH,1
GR,PULMONARY OEDEMA,1
GR,PYREXIA,1
GR,RASH ERYTHEMATOUS,1
GR,RECTAL PERFORATION,1
GR,RESPIRATORY DISTRESS,1
GR,RESPIRATORY FAILURE,1
GR,SCIATICA,1
GR,SEPSIS,1
GR,SURGERY,1
GR,THROMBOSIS,1
GR,URINARY TRACT INFECTION BACTERIAL,1
GR,WEIGHT INCREASED,1
GT,ABDOMINAL DISTENSION,1
GT,ABDOMINAL PAIN UPPER,1
GT,ABNORMAL BEHAVIOUR,1
GT,AGGRESSION,1
GT,ALANINE AMINOTRANSFERASE INCREASED,1
GT,ASPARTATE AMINOTRANSFERASE INCREASED,1
GT,BILIRUBIN CONJUGATED INCREASED,1
GT,DEATH,1
GT,DECREASED APPETITE,1
GT,DISORIENTATION,1
GT,DYSPNOEA,1
GT,FATIGUE,1
GT,FLUID RETENTION,1
GT,HEPATIC FAILURE,1
GT,HYPOKINESIA,1
GT,LIVER DISORDER,1
GT,MALAISE,1
GT,NAUSEA,1
GT,PERIPHERAL SWELLING,1
GT,RENAL DISORDER,1
GT,RESPIRATORY ARREST,1
GT,VOMITING,1
HN,ABASIA,1
HN,BONE PAIN,1
HN,LUNG INFECTION,1
HN,MALAISE,1
HN,PLEURAL EFFUSION,1
HN,PYREXIA,1
HN,URINARY TRACT INFECTION,1
HN,VOMITING,1
HK,ASCITES,4
HK,SEPSIS,3
HK,CEREBROVASCULAR DISORDER,2
HK,DISEASE PROGRESSION,2
HK,HEPATOTOXICITY,2
HK,METASTASES TO LUNG,2
HK,OEDEMA PERIPHERAL,2
HK,RESPIRATORY FAILURE,2
HK,TRANSIENT ISCHAEMIC ATTACK,2
HK,ACUTE CORONARY SYNDROME,1
HK,ACUTE KIDNEY INJURY,1
HK,AMMONIA INCREASED,1
HK,ANAEMIA,1
HK,ATRIAL FIBRILLATION,1
HK,BACK PAIN,1
HK,BLOOD CHLORIDE DECREASED,1
HK,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
HK,BLOOD CREATININE INCREASED,1
HK,CHEST PAIN,1
HK,COLONIC FISTULA,1
HK,CONDITION AGGRAVATED,1
HK,CONTUSION,1
HK,DEHYDRATION,1
HK,DIARRHOEA,1
HK,DISSEMINATED INTRAVASCULAR COAGULATION,1
HK,DISSEMINATED TUBERCULOSIS,1
HK,DIZZINESS,1
HK,DYSARTHRIA,1
HK,DYSPNOEA,1
HK,GASTROENTERITIS,1
HK,GASTROINTESTINAL HAEMORRHAGE,1
HK,GENERAL PHYSICAL HEALTH DETERIORATION,1
HK,HYPOGLYCAEMIA,1
HK,HYPOKALAEMIA,1
HK,HYPONATRAEMIA,1
HK,HYPOTENSION,1
HK,ILEUS PARALYTIC,1
HK,LEFT VENTRICULAR DYSFUNCTION,1
HK,LETHARGY,1
HK,LOCALISED OEDEMA,1
HK,LOWER GASTROINTESTINAL HAEMORRHAGE,1
HK,LOWER RESPIRATORY TRACT INFECTION,1
HK,MALAISE,1
HK,METABOLIC ACIDOSIS,1
HK,NON-SMALL CELL LUNG CANCER,1
HK,NON-SMALL CELL LUNG CANCER STAGE IV,1
HK,OVERDOSE,1
HK,PAIN,1
HK,PANCYTOPENIA,1
HK,PEPTIC ULCER,1
HK,PLEURAL EFFUSION,1
HK,PNEUMONIA,1
HK,PYREXIA,1
HK,RENAL DISORDER,1
HK,RENAL FAILURE,1
HK,RENAL IMPAIRMENT,1
HK,RESPIRATORY ACIDOSIS,1
HK,RHABDOMYOLYSIS,1
HK,SECONDARY ADRENOCORTICAL INSUFFICIENCY,1
HK,SHOCK,1
HK,SICK SINUS SYNDROME,1
HK,STAPHYLOCOCCAL BACTERAEMIA,1
HK,SYNCOPE,1
HK,URINARY TRACT INFECTION,1
HK,VISION BLURRED,1
HU,COMPLETED SUICIDE,2
HU,DEPRESSION,2
HU,FEBRILE NEUTROPENIA,2
HU,HYPOCHLORAEMIA,2
HU,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
HU,CHROMATURIA,1
HU,DISCOMFORT,1
HU,EPILEPTIC AURA,1
HU,FATIGUE,1
HU,GROIN INFECTION,1
HU,HEPATIC ENZYME INCREASED,1
HU,HEPATIC HYPERTROPHY,1
HU,HEPATOMEGALY,1
HU,HYPONATRAEMIA,1
HU,ISCHAEMIC STROKE,1
HU,JAUNDICE,1
HU,MUSCLE SPASMS,1
HU,NEOPLASM PROGRESSION,1
HU,NODULE,1
HU,PAIN,1
HU,PULMONARY FIBROSIS,1
HU,THERAPY NON-RESPONDER,1
HU,TONSILLITIS,1
HU,TOXIC SKIN ERUPTION,1
HU,TREMOR,1
IN,ANAESTHETIC COMPLICATION NEUROLOGICAL,8
IN,ACUTE HEPATIC FAILURE,5
IN,DRUG-INDUCED LIVER INJURY,4
IN,INTENTIONAL OVERDOSE,4
IN,DRUG ERUPTION,2
IN,DECREASED APPETITE,1
IN,DIABETES MELLITUS INADEQUATE CONTROL,1
IN,DRUG DISPENSING ERROR,1
IN,DYSPHAGIA,1
IN,ERYTHEMA,1
IN,EXPOSURE DURING PREGNANCY,1
IN,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,1
IN,HYPERKALAEMIA,1
IN,INCORRECT DOSE ADMINISTERED,1
IN,LIVER FUNCTION TEST ABNORMAL,1
IN,MATERNAL EXPOSURE DURING PREGNANCY,1
IN,MOUTH ULCERATION,1
IN,MUCORMYCOSIS,1
IN,NEPHROPATHY TOXIC,1
IN,OVERDOSE,1
IN,PAIN,1
IN,RASH PRURITIC,1
IN,RENAL CELL CARCINOMA,1
IN,SCAB,1
IN,SEROTONIN SYNDROME,1
IN,SKIN EROSION,1
IN,SKIN PLAQUE,1
IN,SOMNOLENCE,1
IN,TENDERNESS,1
IN,TOXIC EPIDERMAL NECROLYSIS,1
IN,ULCER,1
IN,URINARY INCONTINENCE,1
IN,URINARY TRACT INFECTION,1
IN,VOMITING,1
ID,LOSS OF CONSCIOUSNESS,3
ID,SUICIDE ATTEMPT,3
IR,OVERDOSE,3
IR,ACCIDENTAL OVERDOSE,1
IR,HAEMOLYTIC URAEMIC SYNDROME,1
IR,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
IR,TOXICITY TO VARIOUS AGENTS,1
IQ,ADENOIDAL HYPERTROPHY,1
IQ,FATIGUE,1
IQ,GASTROINTESTINAL PAIN,1
IQ,HOT FLUSH,1
IQ,LEUKOCYTOSIS,1
IE,ABDOMINAL PAIN,2
IE,CONFUSIONAL STATE,2
IE,DEATH,2
IE,DIARRHOEA,2
IE,ERYTHEMA,2
IE,FALL,2
IE,METABOLIC ACIDOSIS,2
IE,PAIN,2
IE,PRURITUS,2
IE,RASH,2
IE,ABDOMINAL DISCOMFORT,1
IE,ACUTE KIDNEY INJURY,1
IE,AGORAPHOBIA,1
IE,ANALGESIC DRUG LEVEL INCREASED,1
IE,ASCITES,1
IE,ASTHENIA,1
IE,ASTHMA,1
IE,BLISTER,1
IE,BLOOD BILIRUBIN INCREASED,1
IE,BLOOD GLUCOSE INCREASED,1
IE,CANCER PAIN,1
IE,CARDIAC FAILURE CONGESTIVE,1
IE,CEREBRAL HAEMORRHAGE,1
IE,CHEST DISCOMFORT,1
IE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IE,COLD SWEAT,1
IE,CONTUSION,1
IE,CONVULSION,1
IE,CYANOSIS,1
IE,DEMENTIA,1
IE,DIABETIC NEUROPATHY,1
IE,DISORIENTATION,1
IE,DIZZINESS,1
IE,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
IE,DYSPHAGIA,1
IE,DYSPNOEA,1
IE,ECZEMA,1
IE,ENCEPHALOPATHY,1
IE,EPISTAXIS,1
IE,EYE INFLAMMATION,1
IE,FEELING HOT,1
IE,FEMUR FRACTURE,1
IE,FLUSHING,1
IE,GASTRIC HAEMORRHAGE,1
IE,GENERAL PHYSICAL HEALTH DETERIORATION,1
IE,GLYCOSYLATED HAEMOGLOBIN,1
IE,HAEMORRHAGIC DIATHESIS,1
IE,HALLUCINATION_ AUDITORY,1
IE,HEPATIC CIRRHOSIS,1
IE,HEPATIC FAILURE,1
IE,HEPATOTOXICITY,1
IE,HERPES ZOSTER,1
IE,HOSPITALISATION,1
IE,HYPERSENSITIVITY,1
IE,HYPERTENSION,1
IE,HYPOGLYCAEMIA,1
IE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IE,INCORRECT DOSE ADMINISTERED,1
IE,JAUNDICE,1
IE,LACERATION,1
IE,LIVER FUNCTION TEST,1
IE,LIVER FUNCTION TEST ABNORMAL,1
IE,LIVER INJURY,1
IE,LOWER LIMB FRACTURE,1
IE,LOWER RESPIRATORY TRACT INFECTION,1
IE,MALAISE,1
IE,METASTASES TO LIVER,1
IE,METASTASES TO LUNG,1
IE,METASTASES TO SPINE,1
IE,OEDEMA,1
IE,OVERDOSE,1
IE,PANCREATITIS,1
IE,PHOTOSENSITIVITY REACTION,1
IE,PLASMA CELL MYELOMA,1
IE,PLEURAL EFFUSION,1
IE,PNEUMONIA,1
IE,PULMONARY MASS,1
IE,PULSE ABNORMAL,1
IE,PYREXIA,1
IE,RALES,1
IE,RENAL CELL CARCINOMA,1
IE,RESPIRATORY FAILURE,1
IE,SENSORY LOSS,1
IE,SKIN FISSURES,1
IE,SOMNOLENCE,1
IE,SPINAL FRACTURE,1
IE,TOXICITY TO VARIOUS AGENTS,1
IE,URINARY TRACT INFECTION,1
IE,WOUND SECRETION,1
IL,DISSEMINATED INTRAVASCULAR COAGULATION,3
IL,SEPTIC SHOCK,3
IL,TOXIC SHOCK SYNDROME,3
IL,ACUTE KIDNEY INJURY,1
IL,DYSPNOEA,1
IL,HAEMORRHAGE,1
IL,INTENTIONAL OVERDOSE,1
IL,STEVENS-JOHNSON SYNDROME,1
IL,TOXIC EPIDERMAL NECROLYSIS,1
IL,TRANSAMINASES INCREASED,1
IT,DISEASE PROGRESSION,14
IT,SEROTONIN SYNDROME,10
IT,RHABDOMYOLYSIS,9
IT,TOXICITY TO VARIOUS AGENTS,8
IT,ERYTHEMA,7
IT,ANAEMIA,6
IT,VOMITING,6
IT,COMA,5
IT,PYREXIA,5
IT,URTICARIA,5
IT,EPISTAXIS,4
IT,NAUSEA,4
IT,OVERDOSE,4
IT,PNEUMONIA,4
IT,PRURITUS,4
IT,RASH,4
IT,SEPSIS,4
IT,AGITATION,3
IT,ANAPHYLACTIC SHOCK,3
IT,ATAXIA,3
IT,BLOOD CREATININE INCREASED,3
IT,BRONCHOPULMONARY ASPERGILLOSIS,3
IT,CARDIOGENIC SHOCK,3
IT,DRUG ABUSE,3
IT,DRUG INEFFECTIVE,3
IT,DYSPNOEA,3
IT,HALLUCINATION_ VISUAL,3
IT,HYPOTENSION,3
IT,INTENTIONAL OVERDOSE,3
IT,NEUTROPENIA,3
IT,PAIN,3
IT,PANCYTOPENIA,3
IT,PRESCRIBED UNDERDOSE,3
IT,RESPIRATORY ARREST,3
IT,THROMBOCYTOPENIA,3
IT,TRANSAMINASES INCREASED,3
IT,VASOPLEGIA SYNDROME,3
IT,ABDOMINAL PAIN,2
IT,ABDOMINAL PAIN UPPER,2
IT,ACCIDENTAL OVERDOSE,2
IT,ACUTE HEPATIC FAILURE,2
IT,ACUTE KIDNEY INJURY,2
IT,ASPARTATE AMINOTRANSFERASE INCREASED,2
IT,CARDIOMYOPATHY,2
IT,DRUG ADMINISTRATION ERROR,2
IT,DRUG HYPERSENSITIVITY,2
IT,EYELID OEDEMA,2
IT,FEBRILE NEUTROPENIA,2
IT,FOETAL EXPOSURE DURING PREGNANCY,2
IT,GAIT DISTURBANCE,2
IT,GASTRIC CANCER,2
IT,HEADACHE,2
IT,HEPATITIS CHOLESTATIC,2
IT,HEPATOCELLULAR INJURY,2
IT,HEPATOTOXICITY,2
IT,HYPERBILIRUBINAEMIA,2
IT,HYPERPYREXIA,2
IT,HYPERTHERMIA,2
IT,INFUSION RELATED REACTION,2
IT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
IT,MYOCARDIAL ISCHAEMIA,2
IT,NEUROLOGICAL DECOMPENSATION,2
IT,PAIN IN EXTREMITY,2
IT,PRESYNCOPE,2
IT,PRODUCT USE IN UNAPPROVED INDICATION,2
IT,PULMONARY ARTERY STENOSIS,2
IT,PULMONARY EMBOLISM,2
IT,RESPIRATORY DEPRESSION,2
IT,SKIN TOXICITY,2
IT,SYNCOPE,2
IT,TACHYCARDIA,2
IT,TREATMENT FAILURE,2
IT,TREMOR,2
IT,WEIGHT DECREASED,2
IT,ACCIDENTAL POISONING,1
IT,ACIDOSIS,1
IT,ACQUIRED HAEMOPHILIA,1
IT,ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED,1
IT,ACUTE HAEMORRHAGIC OEDEMA OF INFANCY,1
IT,AGEUSIA,1
IT,AGRANULOCYTOSIS,1
IT,AIRWAY COMPLICATION OF ANAESTHESIA,1
IT,ALANINE AMINOTRANSFERASE INCREASED,1
IT,AMNESIA,1
IT,ANAPHYLACTIC REACTION,1
IT,ANGIOEDEMA,1
IT,APHASIA,1
IT,APRAXIA,1
IT,ASTHENIA,1
IT,ATROPHY OF GLOBE,1
IT,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
IT,AUTOIMMUNE NEUTROPENIA,1
IT,AZOTAEMIA,1
IT,BACK PAIN,1
IT,BALANCE DISORDER,1
IT,BASAL CELL CARCINOMA,1
IT,BLAST CELL COUNT INCREASED,1
IT,BLOOD ALKALINE PHOSPHATASE INCREASED,1
IT,BLOOD BICARBONATE INCREASED,1
IT,BLOOD BILIRUBIN INCREASED,1
IT,BLOOD CALCIUM DECREASED,1
IT,BLOOD CREATINE PHOSPHOKINASE DECREASED,1
IT,BLOOD GLUCOSE INCREASED,1
IT,BLOOD LACTATE DEHYDROGENASE INCREASED,1
IT,BLOOD POTASSIUM DECREASED,1
IT,BLOOD PRESSURE INCREASED,1
IT,BLOOD SODIUM DECREASED,1
IT,BLOOD SODIUM INCREASED,1
IT,BLOOD URIC ACID DECREASED,1
IT,BONE PAIN,1
IT,BRADYCARDIA,1
IT,C-REACTIVE PROTEIN INCREASED,1
IT,CARBON DIOXIDE INCREASED,1
IT,CARDIAC ARREST,1
IT,CARDIAC DISORDER,1
IT,CARDIAC MURMUR,1
IT,CARDIOTOXICITY,1
IT,CATARACT,1
IT,CHEST PAIN,1
IT,CHILLS,1
IT,CHOLANGITIS,1
IT,CHOLESTASIS,1
IT,CHRONIC KIDNEY DISEASE,1
IT,COLD SWEAT,1
IT,CONDITION AGGRAVATED,1
IT,CONFUSIONAL STATE,1
IT,CONVULSION,1
IT,CYTOKINE RELEASE SYNDROME,1
IT,CYTOLOGY ABNORMAL,1
IT,CYTOMEGALOVIRUS INFECTION,1
IT,DEPRESSED LEVEL OF CONSCIOUSNESS,1
IT,DERMATITIS ACNEIFORM,1
IT,DERMATITIS EXFOLIATIVE,1
IT,DIARRHOEA,1
IT,DISSEMINATED INTRAVASCULAR COAGULATION,1
IT,DIVERTICULITIS,1
IT,DRUG-INDUCED LIVER INJURY,1
IT,DRY MOUTH,1
IT,DUCTUS ARTERIOSUS PREMATURE CLOSURE,1
IT,DYSARTHRIA,1
IT,DYSGEUSIA,1
IT,DYSKINESIA,1
IT,ELECTROCARDIOGRAM ABNORMAL,1
IT,ENCEPHALOPATHY,1
IT,EPIDERMOLYSIS,1
IT,EPILEPSY,1
IT,EXCESSIVE CERUMEN PRODUCTION,1
IT,EXTRAPYRAMIDAL DISORDER,1
IT,FACE OEDEMA,1
IT,FACTOR VIII INHIBITION,1
IT,FATIGUE,1
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
IT,GASTROINTESTINAL HAEMORRHAGE,1
IT,GASTROINTESTINAL TOXICITY,1
IT,GENERAL PHYSICAL HEALTH DETERIORATION,1
IT,GENERALISED TONIC-CLONIC SEIZURE,1
IT,HAEMATOCRIT DECREASED,1
IT,HAEMOGLOBIN DECREASED,1
IT,HAEMOPTYSIS,1
IT,HEART RATE INCREASED,1
IT,HEPATIC FAILURE,1
IT,HEPATITIS,1
IT,HERPES ZOSTER,1
IT,HYPERHIDROSIS,1
IT,HYPERREFLEXIA,1
IT,HYPERSENSITIVITY,1
IT,HYPERTENSION,1
IT,HYPERTENSIVE CRISIS,1
IT,HYPERTHERMIA MALIGNANT,1
IT,HYPOKALAEMIA,1
IT,ILEUS PARALYTIC,1
IT,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IT,INFECTION,1
IT,INFLUENZA LIKE ILLNESS,1
IT,INHIBITORY DRUG INTERACTION,1
IT,INTENTIONAL SELF-INJURY,1
IT,INTERSTITIAL LUNG DISEASE,1
IT,JAUNDICE,1
IT,LABORATORY TEST ABNORMAL,1
IT,LARYNGEAL OEDEMA,1
IT,LIP OEDEMA,1
IT,LIPASE INCREASED,1
IT,LIVER DISORDER,1
IT,LIVER INJURY,1
IT,LOSS OF CONSCIOUSNESS,1
IT,LUNG INFECTION,1
IT,LYMPHADENOPATHY,1
IT,LYMPHOCYTE COUNT INCREASED,1
IT,LYMPHOCYTE PERCENTAGE DECREASED,1
IT,LYMPHOMA,1
IT,MALIGNANT NEOPLASM PROGRESSION,1
IT,MATERNAL DRUGS AFFECTING FOETUS,1
IT,MEAN CELL HAEMOGLOBIN INCREASED,1
IT,MECHANICAL URTICARIA,1
IT,MEDICATION ERROR,1
IT,MENINGISM,1
IT,METABOLIC ACIDOSIS,1
IT,METASTASES TO MENINGES,1
IT,MONOCYTE COUNT INCREASED,1
IT,MUCOSAL DRYNESS,1
IT,MYALGIA,1
IT,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
IT,NEOPLASM MALIGNANT,1
IT,NERVOUS SYSTEM DISORDER,1
IT,NERVOUSNESS,1
IT,NEUROLOGICAL SYMPTOM,1
IT,NEUROTOXICITY,1
IT,NEUTROPHIL PERCENTAGE DECREASED,1
IT,NYSTAGMUS,1
IT,OEDEMA,1
IT,OEDEMA PERIPHERAL,1
IT,OPTIC NERVE DISORDER,1
IT,PANCREATITIS ACUTE,1
IT,PEMPHIGOID,1
IT,PHOTOSENSITIVITY REACTION,1
IT,PLATELET COUNT DECREASED,1
IT,PO2 DECREASED,1
IT,POSTURE ABNORMAL,1
IT,PROSTATIC SPECIFIC ANTIGEN INCREASED,1
IT,PROTEIN TOTAL DECREASED,1
IT,PROTHROMBIN TIME PROLONGED,1
IT,PSYCHOMOTOR HYPERACTIVITY,1
IT,PSYCHOMOTOR SKILLS IMPAIRED,1
IT,PSYCHOTIC DISORDER,1
IT,PULMONARY OEDEMA,1
IT,PULSELESS ELECTRICAL ACTIVITY,1
IT,PURE WHITE CELL APLASIA,1
IT,RED BLOOD CELL COUNT DECREASED,1
IT,RED BLOOD CELL HYPOCHROMIC MORPHOLOGY PRESENT,1
IT,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
IT,RED CELL DISTRIBUTION WIDTH INCREASED,1
IT,RENAL FAILURE,1
IT,RESPIRATORY DISTRESS,1
IT,RESPIRATORY FAILURE,1
IT,RESPIRATORY TRACT INFECTION,1
IT,RETINAL DETACHMENT,1
IT,RIGHT VENTRICULAR DYSFUNCTION,1
IT,SCAB,1
IT,SINUS BRADYCARDIA,1
IT,SKIN EXFOLIATION,1
IT,SKIN FISSURES,1
IT,SKIN LESION,1
IT,SKIN WARM,1
IT,SLOW RESPONSE TO STIMULI,1
IT,SOMNOLENCE,1
IT,SOPOR,1
IT,SQUAMOUS CELL CARCINOMA,1
IT,SQUAMOUS CELL CARCINOMA OF SKIN,1
IT,SUICIDE ATTEMPT,1
IT,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
IT,SYSTEMIC MASTOCYTOSIS,1
IT,THERMAL BURN,1
IT,TOXIC SKIN ERUPTION,1
IT,TRANSFUSION,1
IT,TROPONIN INCREASED,1
IT,TUMOUR LYSIS SYNDROME,1
IT,URINARY RETENTION,1
IT,VISUAL IMPAIRMENT,1
IT,VITH NERVE PARALYSIS,1
IT,WHITE BLOOD CELL COUNT INCREASED,1
JP,PYREXIA,108
JP,PNEUMONIA,53
JP,HEPATIC FUNCTION ABNORMAL,50
JP,PLATELET COUNT DECREASED,43
JP,FEBRILE NEUTROPENIA,40
JP,NAUSEA,39
JP,RASH,38
JP,ANAEMIA,36
JP,DIARRHOEA,36
JP,NEUTROPHIL COUNT DECREASED,36
JP,VOMITING,35
JP,DECREASED APPETITE,32
JP,WHITE BLOOD CELL COUNT DECREASED,32
JP,LIVER DISORDER,28
JP,NEUTROPENIA,28
JP,ALANINE AMINOTRANSFERASE INCREASED,27
JP,INTERSTITIAL LUNG DISEASE,27
JP,MALIGNANT NEOPLASM PROGRESSION,24
JP,ASPARTATE AMINOTRANSFERASE INCREASED,23
JP,SEPSIS,22
JP,C-REACTIVE PROTEIN INCREASED,21
JP,DELIRIUM,21
JP,ALTERED STATE OF CONSCIOUSNESS,20
JP,DRUG-INDUCED LIVER INJURY,20
JP,RENAL IMPAIRMENT,20
JP,STEVENS-JOHNSON SYNDROME,20
JP,TOXIC EPIDERMAL NECROLYSIS,20
JP,HAEMOGLOBIN DECREASED,19
JP,CONSTIPATION,18
JP,ERYTHEMA,18
JP,BLOOD PRESSURE DECREASED,17
JP,CYTOMEGALOVIRUS INFECTION,17
JP,DYSPNOEA,17
JP,INFUSION RELATED REACTION,17
JP,URTICARIA,17
JP,DRUG ERUPTION,16
JP,HEADACHE,16
JP,HERPES ZOSTER,16
JP,HYPONATRAEMIA,16
JP,HYPOXIA,16
JP,PRURITUS,16
JP,CHILLS,15
JP,HYPOKALAEMIA,15
JP,INFLUENZA,15
JP,ABDOMINAL PAIN,14
JP,ANAPHYLACTIC REACTION,14
JP,INSOMNIA,14
JP,LYMPHOCYTE COUNT DECREASED,14
JP,MALAISE,14
JP,PLEURAL EFFUSION,14
JP,SOMNOLENCE,14
JP,TUBULOINTERSTITIAL NEPHRITIS,14
JP,CARDIAC FAILURE,13
JP,DEATH,13
JP,RESPIRATORY FAILURE,12
JP,RHABDOMYOLYSIS,12
JP,THROMBOCYTOPENIA,12
JP,ABNORMAL BEHAVIOUR,11
JP,ACUTE KIDNEY INJURY,11
JP,DEHYDRATION,11
JP,DISSEMINATED INTRAVASCULAR COAGULATION,11
JP,FALL,11
JP,LOSS OF CONSCIOUSNESS,11
JP,PANCYTOPENIA,11
JP,PERIPHERAL SENSORY NEUROPATHY,11
JP,STOMATITIS,11
JP,TUMOUR LYSIS SYNDROME,11
JP,AGRANULOCYTOSIS,10
JP,BLOOD ALKALINE PHOSPHATASE INCREASED,10
JP,BLOOD CREATININE INCREASED,10
JP,BLOOD LACTATE DEHYDROGENASE INCREASED,10
JP,CONDITION AGGRAVATED,10
JP,GAMMA-GLUTAMYLTRANSFERASE INCREASED,10
JP,NASOPHARYNGITIS,10
JP,OEDEMA PERIPHERAL,10
JP,PNEUMONIA ASPIRATION,10
JP,SKIN EROSION,10
JP,TOXICITY TO VARIOUS AGENTS,10
JP,URINARY TRACT INFECTION,10
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,9
JP,ENTEROCOLITIS,9
JP,GASTROENTERITIS,9
JP,HEPATIC ENZYME INCREASED,9
JP,INFECTION,9
JP,INTENTIONAL PRODUCT USE ISSUE,9
JP,OEDEMA,9
JP,PNEUMONIA BACTERIAL,9
JP,UPPER RESPIRATORY TRACT INFLAMMATION,9
JP,ASCITES,8
JP,BLOOD BILIRUBIN INCREASED,8
JP,GENERAL PHYSICAL HEALTH DETERIORATION,8
JP,NEUROPATHY PERIPHERAL,8
JP,PAIN,8
JP,PRESCRIBED UNDERDOSE,8
JP,PRODUCT USE ISSUE,8
JP,SEPTIC SHOCK,8
JP,SHOCK,8
JP,ARTHRALGIA,7
JP,ATRIAL FIBRILLATION,7
JP,BLOOD CREATINE PHOSPHOKINASE INCREASED,7
JP,BRONCHITIS,7
JP,CARDIAC ARREST,7
JP,COUGH,7
JP,CYTOMEGALOVIRUS VIRAEMIA,7
JP,DISEASE PROGRESSION,7
JP,EPSTEIN-BARR VIRUS INFECTION,7
JP,ERYTHEMA MULTIFORME,7
JP,FATIGUE,7
JP,HAEMORRHAGE,7
JP,HYPERTENSION,7
JP,LEUKOPENIA,7
JP,OVERDOSE,7
JP,OXYGEN SATURATION DECREASED,7
JP,PANCREATITIS ACUTE,7
JP,PLASMA CELL MYELOMA,7
JP,RENAL DISORDER,7
JP,RENAL FAILURE,7
JP,STAPHYLOCOCCAL SEPSIS,7
JP,ABDOMINAL DISTENSION,6
JP,ABDOMINAL TENDERNESS,6
JP,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,6
JP,BLOOD PRESSURE INCREASED,6
JP,BRADYCARDIA,6
JP,CEREBRAL INFARCTION,6
JP,CHOLECYSTITIS,6
JP,DEEP VEIN THROMBOSIS,6
JP,DYSARTHRIA,6
JP,HYPERGLYCAEMIA,6
JP,HYPOTENSION,6
JP,INFLAMMATION,6
JP,LUNG INFECTION,6
JP,MELAENA,6
JP,MYELODYSPLASTIC SYNDROME,6
JP,PERITONITIS,6
JP,PHARYNGITIS,6
JP,RENAL FAILURE ACUTE,6
JP,SEIZURE,6
JP,ACUTE MYELOID LEUKAEMIA,5
JP,ANAPHYLACTIC SHOCK,5
JP,ANGINA PECTORIS,5
JP,BACK PAIN,5
JP,BLISTER,5
JP,BLOOD ALBUMIN DECREASED,5
JP,BLOOD GLUCOSE INCREASED,5
JP,CATARACT,5
JP,CELLULITIS,5
JP,CEREBRAL HAEMORRHAGE,5
JP,CHOLANGITIS,5
JP,CHOLECYSTITIS ACUTE,5
JP,CHRONIC LYMPHOCYTIC LEUKAEMIA,5
JP,COLITIS,5
JP,CONCOMITANT DISEASE AGGRAVATED,5
JP,DECUBITUS ULCER,5
JP,DEVICE RELATED INFECTION,5
JP,DIZZINESS,5
JP,EYELID OEDEMA,5
JP,FEELING ABNORMAL,5
JP,HYPOALBUMINAEMIA,5
JP,HYPOGLYCAEMIA,5
JP,ILEUS,5
JP,NASAL CONGESTION,5
JP,ORAL HERPES,5
JP,OROPHARYNGEAL PAIN,5
JP,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,5
JP,PUSTULAR PSORIASIS,5
JP,RASH GENERALISED,5
JP,SUICIDE ATTEMPT,5
JP,WEIGHT DECREASED,5
JP,WHITE BLOOD CELL COUNT INCREASED,5
JP,ACUTE RESPIRATORY DISTRESS SYNDROME,4
JP,APNOEA,4
JP,ARRHYTHMIA,4
JP,BACTERAEMIA,4
JP,BONE MARROW FAILURE,4
JP,BREAST CANCER,4
JP,CHEST PAIN,4
JP,CONJUNCTIVITIS,4
JP,CYTOMEGALOVIRUS ENTEROCOLITIS,4
JP,DIABETES MELLITUS,4
JP,DRUG HYPERSENSITIVITY,4
JP,DRUG INEFFECTIVE,4
JP,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,4
JP,EPISTAXIS,4
JP,EXPOSURE DURING PREGNANCY,4
JP,FOETAL EXPOSURE DURING PREGNANCY,4
JP,GAIT DISTURBANCE,4
JP,GASTRIC ULCER,4
JP,GASTROINTESTINAL DISORDER,4
JP,GASTROINTESTINAL HAEMORRHAGE,4
JP,GASTROINTESTINAL MUCOSAL DISORDER,4
JP,GENERALISED ERYTHEMA,4
JP,GENERALISED OEDEMA,4
JP,HAEMOPTYSIS,4
JP,HAEMORRHAGE SUBCUTANEOUS,4
JP,HEPATIC FAILURE,4
JP,HEPATITIS B,4
JP,HERPES ZOSTER DISSEMINATED,4
JP,HOT FLUSH,4
JP,HYPERBILIRUBINAEMIA,4
JP,HYPERKALAEMIA,4
JP,INTENTIONAL OVERDOSE,4
JP,INTESTINAL OBSTRUCTION,4
JP,INTESTINAL PERFORATION,4
JP,JAUNDICE,4
JP,MALNUTRITION,4
JP,NEPHROTIC SYNDROME,4
JP,ORTHOSTATIC INTOLERANCE,4
JP,PLEURISY,4
JP,PNEUMONIA STAPHYLOCOCCAL,4
JP,PNEUMOTHORAX,4
JP,PULMONARY OEDEMA,4
JP,PYELONEPHRITIS,4
JP,RED BLOOD CELL COUNT DECREASED,4
JP,SERUM SICKNESS,4
JP,SHOCK HAEMORRHAGIC,4
JP,SKIN ABRASION,4
JP,STRESS CARDIOMYOPATHY,4
JP,UPPER RESPIRATORY TRACT INFECTION,4
JP,ACUTE HEPATIC FAILURE,3
JP,ACUTE RESPIRATORY FAILURE,3
JP,ADENOCARCINOMA OF COLON,3
JP,AMYLASE INCREASED,3
JP,ASTHENIA,3
JP,BACTERIAL INFECTION,3
JP,BENIGN PROSTATIC HYPERPLASIA,3
JP,BLADDER CANCER,3
JP,BLOOD UREA INCREASED,3
JP,BONE PAIN,3
JP,BRAIN OEDEMA,3
JP,CARDIAC FAILURE ACUTE,3
JP,CARDIAC FAILURE CHRONIC,3
JP,CARDIO-RESPIRATORY ARREST,3
JP,CHRONIC GRAFT VERSUS HOST DISEASE,3
JP,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
JP,CIRCULATORY COLLAPSE,3
JP,COLON CANCER,3
JP,COMPLETED SUICIDE,3
JP,CONJUNCTIVAL HYPERAEMIA,3
JP,CYSTITIS,3
JP,CYSTITIS HAEMORRHAGIC,3
JP,DEMENTIA,3
JP,DYSGEUSIA,3
JP,DYSPHONIA,3
JP,DYSURIA,3
JP,EOSINOPHIL COUNT INCREASED,3
JP,FLUSHING,3
JP,FUNGAL INFECTION,3
JP,GANGRENE,3
JP,GASTRIC CANCER,3
JP,GENERALISED TONIC-CLONIC SEIZURE,3
JP,GRAFT VERSUS HOST DISEASE,3
JP,HAEMATOCHEZIA,3
JP,HAEMATOCRIT DECREASED,3
JP,HAEMATURIA,3
JP,HEPATIC ENCEPHALOPATHY,3
JP,HISTIOCYTOSIS HAEMATOPHAGIC,3
JP,HYPERHIDROSIS,3
JP,HYPERSENSITIVITY,3
JP,HYPERTHERMIA,3
JP,HYPOAESTHESIA,3
JP,HYPOGAMMAGLOBULINAEMIA,3
JP,ILEUS PARALYTIC,3
JP,INADEQUATE ANALGESIA,3
JP,INCISION SITE PAIN,3
JP,LIVER FUNCTION TEST ABNORMAL,3
JP,LOWER GASTROINTESTINAL HAEMORRHAGE,3
JP,LYMPHOPENIA,3
JP,MATERNAL EXPOSURE DURING PREGNANCY,3
JP,METASTASES TO BONE,3
JP,METASTASES TO CENTRAL NERVOUS SYSTEM,3
JP,MUSCULAR WEAKNESS,3
JP,MYALGIA,3
JP,NEOPLASM MALIGNANT,3
JP,ORAL CANDIDIASIS,3
JP,OROPHARYNGEAL DISCOMFORT,3
JP,PERICHONDRITIS,3
JP,PHARYNGEAL ULCERATION,3
JP,PNEUMOCYSTIS JIROVECII PNEUMONIA,3
JP,PNEUMONIA INFLUENZAL,3
JP,PREMATURE BABY,3
JP,PURPURA,3
JP,RHEUMATOID ARTHRITIS,3
JP,RIGHT VENTRICULAR FAILURE,3
JP,SINUSITIS,3
JP,SKIN DISORDER,3
JP,SKIN EXFOLIATION,3
JP,SPINAL COMPRESSION FRACTURE,3
JP,STAPHYLOCOCCAL INFECTION,3
JP,SYNCOPE,3
JP,THERAPEUTIC RESPONSE DECREASED,3
JP,TUBERCULOUS PLEURISY,3
JP,TYPE 1 DIABETES MELLITUS,3
JP,URINE OUTPUT DECREASED,3
JP,VENOUS THROMBOSIS,3
JP,VERTIGO,3
JP,VISUAL IMPAIRMENT,3
JP,ABDOMINAL DISCOMFORT,2
JP,ABDOMINAL PAIN UPPER,2
JP,ABORTION,2
JP,ACUTE CORONARY SYNDROME,2
JP,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,2
JP,ACUTE GRAFT VERSUS HOST DISEASE,2
JP,ALOPECIA,2
JP,AMNESIA,2
JP,ANTITHROMBIN III DECREASED,2
JP,APLASIA PURE RED CELL,2
JP,ASPHYXIA,2
JP,ASPIRATION,2
JP,BLOOD CALCIUM DECREASED,2
JP,BLOOD CREATININE DECREASED,2
JP,BRONCHOPULMONARY ASPERGILLOSIS,2
JP,CAESAREAN SECTION,2
JP,CANCER PAIN,2
JP,CANDIDA INFECTION,2
JP,CATHETER SITE PAIN,2
JP,CHOLELITHIASIS,2
JP,COGNITIVE DISORDER,2
JP,COLD SWEAT,2
JP,COLITIS MICROSCOPIC,2
JP,COLORECTAL CANCER,2
JP,CONFUSIONAL STATE,2
JP,CYTOMEGALOVIRUS CHORIORETINITIS,2
JP,CYTOMEGALOVIRUS TEST POSITIVE,2
JP,DEAFNESS,2
JP,DENTAL CARIES,2
JP,DEPRESSION,2
JP,DERMATITIS PSORIASIFORM,2
JP,DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA,2
JP,DROWNING,2
JP,DRUG CROSS-REACTIVITY,2
JP,DRUG INTOLERANCE,2
JP,DRUG RESISTANCE,2
JP,DRY MOUTH,2
JP,DRY SKIN,2
JP,DUCTUS ARTERIOSUS STENOSIS FOETAL,2
JP,ECZEMA,2
JP,ENGRAFTMENT SYNDROME,2
JP,EOSINOPHILIC PNEUMONIA ACUTE,2
JP,EPIDERMAL NECROSIS,2
JP,ERYTHEMA NODOSUM,2
JP,EXCORIATION,2
JP,EYE DISCHARGE,2
JP,FACE OEDEMA,2
JP,FEMUR FRACTURE,2
JP,FOETAL DEATH,2
JP,GALLBLADDER ADENOCARCINOMA,2
JP,GALLBLADDER ENLARGEMENT,2
JP,GASTRIC HAEMORRHAGE,2
JP,GASTRITIS,2
JP,GASTROINTESTINAL INFLAMMATION,2
JP,GASTROOESOPHAGEAL REFLUX DISEASE,2
JP,GRANULOCYTOPENIA,2
JP,HAEMOCHROMATOSIS,2
JP,HAEMOLYTIC ANAEMIA,2
JP,HALLUCINATION,2
JP,HEPATIC CIRRHOSIS,2
JP,HEPATITIS FULMINANT,2
JP,HEPATOCELLULAR CARCINOMA,2
JP,HERPES ZOSTER MENINGITIS,2
JP,HISTIOCYTIC NECROTISING LYMPHADENITIS,2
JP,HODGKIN^S DISEASE,2
JP,HYPERAMMONAEMIA,2
JP,HYPERCAPNIA,2
JP,HYPERURICAEMIA,2
JP,HYPOAESTHESIA ORAL,2
JP,HYPOCALCAEMIA,2
JP,HYPOPHOSPHATAEMIA,2
JP,HYPOTHYROIDISM,2
JP,HYPOXIC-ISCHAEMIC ENCEPHALOPATHY,2
JP,ILEAL PERFORATION,2
JP,ILIUM FRACTURE,2
JP,IMMUNE THROMBOCYTOPENIC PURPURA,2
JP,IMPAIRED HEALING,2
JP,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
JP,INFLUENZA LIKE ILLNESS,2
JP,INJECTION SITE ERYTHEMA,2
JP,INTENTIONAL UNDERDOSE,2
JP,INTERNATIONAL NORMALISED RATIO INCREASED,2
JP,IRON DEFICIENCY ANAEMIA,2
JP,JAUNDICE CHOLESTATIC,2
JP,LARGE INTESTINE POLYP,2
JP,LARYNGEAL DISCOMFORT,2
JP,LIP SWELLING,2
JP,LOW BIRTH WEIGHT BABY,2
JP,LUNG ADENOCARCINOMA,2
JP,LUNG NEOPLASM MALIGNANT,2
JP,LYMPH NODE TUBERCULOSIS,2
JP,LYMPHADENOPATHY,2
JP,LYMPHOCYTE STIMULATION TEST POSITIVE,2
JP,MEMORY IMPAIRMENT,2
JP,MENINGITIS,2
JP,MENINGITIS ASEPTIC,2
JP,METABOLIC ACIDOSIS,2
JP,METASTASES TO LIVER,2
JP,MILLER FISHER SYNDROME,2
JP,MOUTH ULCERATION,2
JP,MUCOUS MEMBRANE DISORDER,2
JP,MUSCULOSKELETAL PAIN,2
JP,MYOCARDIAL INFARCTION,2
JP,MYOCARDITIS,2
JP,NECK PAIN,2
JP,NEPHRITIS,2
JP,OBSTRUCTIVE AIRWAYS DISORDER,2
JP,OCULAR HYPERAEMIA,2
JP,OCULOMUCOCUTANEOUS SYNDROME,2
JP,OESOPHAGEAL CARCINOMA,2
JP,ORAL INFECTION,2
JP,ORAL MUCOSA EROSION,2
JP,ORGANISING PNEUMONIA,2
JP,OTITIS MEDIA,2
JP,PAIN IN EXTREMITY,2
JP,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
JP,PANCREATITIS,2
JP,PERIORBITAL HAEMATOMA,2
JP,PHARYNGITIS BACTERIAL,2
JP,PNEUMONITIS,2
JP,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
JP,POSTRENAL FAILURE,2
JP,PREMATURE DELIVERY,2
JP,PRINZMETAL ANGINA,2
JP,PRODUCT USE IN UNAPPROVED INDICATION,2
JP,PRODUCTIVE COUGH,2
JP,PRURITUS GENERALISED,2
JP,PULMONARY CONGESTION,2
JP,PULMONARY EMBOLISM,2
JP,PULMONARY MASS,2
JP,RASH MACULO-PAPULAR,2
JP,RENAL FUNCTION TEST ABNORMAL,2
JP,RESPIRATORY ARREST,2
JP,RESPIRATORY DEPRESSION,2
JP,RESPIRATORY DISORDER,2
JP,RESTLESSNESS,2
JP,RETINOPATHY,2
JP,SCROTAL ULCER,2
JP,SERONEGATIVE ARTHRITIS,2
JP,SINUS TACHYCARDIA,2
JP,SINUSITIS FUNGAL,2
JP,SOMNAMBULISM,2
JP,STREPTOCOCCAL SEPSIS,2
JP,SUPRAVENTRICULAR TACHYCARDIA,2
JP,SYSTEMIC CANDIDA,2
JP,TONSILLITIS,2
JP,TOXIC SKIN ERUPTION,2
JP,TRANSFUSION,2
JP,TREMOR,2
JP,UPPER GASTROINTESTINAL HAEMORRHAGE,2
JP,URINARY RETENTION,2
JP,VANISHING BILE DUCT SYNDROME,2
JP,VARICELLA,2
JP,VENTRICULAR EXTRASYSTOLES,2
JP,VIRAL UPPER RESPIRATORY TRACT INFECTION,2
JP,VISUAL ACUITY REDUCED TRANSIENTLY,2
JP,VULVAR EROSION,2
JP,WEIGHT INCREASED,2
JP,WHEEZING,2
JP,XANTHOMA,2
JP,ABDOMINAL ABSCESS,1
JP,ABDOMINAL ADHESIONS,1
JP,ACCIDENTAL UNDERDOSE,1
JP,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,1
JP,ACUTE GRAFT VERSUS HOST DISEASE IN LIVER,1
JP,ACUTE LYMPHOCYTIC LEUKAEMIA,1
JP,ADENOVIRAL HAEMORRHAGIC CYSTITIS,1
JP,ADMINISTRATION SITE PRURITUS,1
JP,ADULT T-CELL LYMPHOMA/LEUKAEMIA,1
JP,AGITATION,1
JP,ALCOHOL INTERACTION,1
JP,ALLERGIC GRANULOMATOUS ANGIITIS,1
JP,ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
JP,AMOEBIC COLITIS,1
JP,ANAL FISTULA,1
JP,ANAL INCONTINENCE,1
JP,ANAPLASTIC LARGE-CELL LYMPHOMA,1
JP,ANASTOMOTIC COMPLICATION,1
JP,ANGER,1
JP,ANGIOEDEMA,1
JP,ANGIOGRAM PERIPHERAL ABNORMAL,1
JP,ANORECTAL DISORDER,1
JP,ANOSMIA,1
JP,ANTICONVULSANT DRUG LEVEL DECREASED,1
JP,ANTICONVULSANT DRUG LEVEL INCREASED,1
JP,ANURIA,1
JP,AORTIC RUPTURE,1
JP,APPENDICITIS,1
JP,APPLICATION SITE DERMATITIS,1
JP,AQUEOUS HUMOUR LEAKAGE,1
JP,ARRHYTHMIA SUPRAVENTRICULAR,1
JP,ARTERIOSCLEROSIS,1
JP,ASPERGILLUS INFECTION,1
JP,ASTERIXIS,1
JP,ASTHMA,1
JP,ATAXIA,1
JP,ATHEROEMBOLISM,1
JP,ATRIOVENTRICULAR BLOCK COMPLETE,1
JP,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
JP,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
JP,AUTOIMMUNE HEPATITIS,1
JP,AUTOIMMUNE NEUROPATHY,1
JP,AUTOIMMUNE PANCREATITIS,1
JP,AUTOIMMUNE PANCYTOPENIA,1
JP,B-CELL SMALL LYMPHOCYTIC LYMPHOMA,1
JP,BACILLUS TEST POSITIVE,1
JP,BACTERIAL SEPSIS,1
JP,BACTERIAL TEST POSITIVE,1
JP,BILE DUCT STONE,1
JP,BILIARY TRACT INFECTION,1
JP,BLADDER DISORDER,1
JP,BLAST CELL COUNT INCREASED,1
JP,BLISTER RUPTURE,1
JP,BLOOD ALKALINE PHOSPHATASE ABNORMAL,1
JP,BLOOD BETA-D-GLUCAN INCREASED,1
JP,BLOOD CORTICOTROPHIN DECREASED,1
JP,BLOOD DISORDER,1
JP,BLOOD ELECTROLYTES ABNORMAL,1
JP,BLOOD IMMUNOGLOBULIN A DECREASED,1
JP,BLOOD IMMUNOGLOBULIN G DECREASED,1
JP,BLOOD PHOSPHORUS DECREASED,1
JP,BLOOD PRESSURE DIASTOLIC INCREASED,1
JP,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
JP,BLOOD THYROID STIMULATING HORMONE INCREASED,1
JP,BLOOD URINE PRESENT,1
JP,BODY TEMPERATURE ABNORMAL,1
JP,BONE FISSURE,1
JP,BONE MARROW NECROSIS,1
JP,BRAIN DEATH,1
JP,BRAIN INJURY,1
JP,BREAST CANCER RECURRENT,1
JP,BREATH SOUNDS ABNORMAL,1
JP,BRONCHIAL FISTULA,1
JP,BRONCHITIS CHRONIC,1
JP,BRONCHOPNEUMONIA,1
JP,CACHEXIA,1
JP,CALCULUS URINARY,1
JP,CANDIDA SEPSIS,1
JP,CARCINOEMBRYONIC ANTIGEN INCREASED,1
JP,CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT,1
JP,CARDIAC FAILURE CONGESTIVE,1
JP,CARDIAC TAMPONADE,1
JP,CARDIAC VALVE RUPTURE,1
JP,CARDIOMEGALY,1
JP,CARDIOVASCULAR DISORDER,1
JP,CAROTID ARTERY CALCIFICATION,1
JP,CD4 LYMPHOCYTES DECREASED,1
JP,CELLULITIS STAPHYLOCOCCAL,1
JP,CENTRAL VENOUS CATHETERISATION,1
JP,CEREBRAL VENTRICULAR RUPTURE,1
JP,CEREBROVASCULAR DISORDER,1
JP,CERVICAL DYSPLASIA,1
JP,CHEILITIS,1
JP,CHOKING,1
JP,CHOLANGIOCARCINOMA,1
JP,CHOLANGITIS INFECTIVE,1
JP,CHOLANGITIS SCLEROSING,1
JP,CHOLESTASIS,1
JP,CHROMATURIA,1
JP,CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY,1
JP,CLOSTRIDIAL INFECTION,1
JP,COAGULOPATHY,1
JP,COLD AGGLUTININS POSITIVE,1
JP,COLITIS ISCHAEMIC,1
JP,COLITIS ULCERATIVE,1
JP,COLON CANCER STAGE 0,1
JP,COMA,1
JP,COMA HEPATIC,1
JP,COMMUNICATION DISORDER,1
JP,CONJUNCTIVAL DISORDER,1
JP,CONJUNCTIVAL EROSION,1
JP,CONJUNCTIVAL ULCER,1
JP,CONJUNCTIVITIS ALLERGIC,1
JP,CONTRAINDICATION TO MEDICAL TREATMENT,1
JP,COOMBS DIRECT TEST POSITIVE,1
JP,CORNEAL EPITHELIUM DEFECT,1
JP,CORNEAL PERFORATION,1
JP,CREATININE RENAL CLEARANCE DECREASED,1
JP,CSF CELL COUNT INCREASED,1
JP,CSF PROTEIN INCREASED,1
JP,CYANOSIS,1
JP,CYTOMEGALOVIRUS ENTERITIS,1
JP,CYTOMEGALOVIRUS GASTROENTERITIS,1
JP,CYTOPENIA,1
JP,DEPRESSED MOOD,1
JP,DERMATITIS,1
JP,DERMATITIS ACNEIFORM,1
JP,DERMATITIS ALLERGIC,1
JP,DIABETES MELLITUS INADEQUATE CONTROL,1
JP,DIABETIC GANGRENE,1
JP,DIABETIC NEUROPATHY,1
JP,DIPLEGIA,1
JP,DISSEMINATED TUBERCULOSIS,1
JP,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
JP,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
JP,DRUG DEPENDENCE,1
JP,DRUG LEVEL INCREASED,1
JP,DRUG PRESCRIBING ERROR,1
JP,DUODENAL POLYP,1
JP,DUODENAL ULCER PERFORATION,1
JP,DYSKINESIA,1
JP,DYSLALIA,1
JP,DYSMENORRHOEA,1
JP,DYSPHAGIA,1
JP,DYSPNOEA EXERTIONAL,1
JP,EAR DISCOMFORT,1
JP,EAR PAIN,1
JP,ELECTROCARDIOGRAM ABNORMAL,1
JP,ELECTROCARDIOGRAM QT PROLONGED,1
JP,ELECTROCARDIOGRAM QT SHORTENED,1
JP,ELECTROLYTE DEPLETION,1
JP,EMBOLISM VENOUS,1
JP,EMPHYSEMA,1
JP,ENCEPHALITIS,1
JP,ENCEPHALOPATHY,1
JP,ENDOCARDITIS,1
JP,ENDOMETRIAL CANCER,1
JP,ENDOMETRIOSIS,1
JP,ENDOMETRITIS,1
JP,ENDOPHTHALMITIS,1
JP,ENDOTOXAEMIA,1
JP,ENGRAFT FAILURE,1
JP,ENTERITIS,1
JP,ENTERITIS INFECTIOUS,1
JP,ENTEROBACTER SEPSIS,1
JP,ENTEROCOCCAL INFECTION,1
JP,ENTEROCOCCUS TEST POSITIVE,1
JP,ENTEROCOLITIS VIRAL,1
JP,EOSINOPHIL COUNT DECREASED,1
JP,EOSINOPHILIA,1
JP,EOSINOPHILIC MYOCARDITIS,1
JP,EOSINOPHILIC PNEUMONIA,1
JP,EPIDIDYMITIS,1
JP,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA,1
JP,EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER,1
JP,ERYSIPELAS,1
JP,ERYTHEMA OF EYELID,1
JP,ERYTHROPHAGOCYTOSIS,1
JP,ESCHERICHIA TEST POSITIVE,1
JP,EVANS SYNDROME,1
JP,EXPOSURE TO EXTREME TEMPERATURE,1
JP,EXTRAVASATION,1
JP,EXTREMITY NECROSIS,1
JP,EYELID EROSION,1
JP,EYELID PTOSIS,1
JP,FACIAL NERVE DISORDER,1
JP,FACTOR IX INHIBITION,1
JP,FAECES SOFT,1
JP,FEBRILE CONVULSION,1
JP,FEEDING DISORDER,1
JP,FEELING COLD,1
JP,FIBROMYALGIA,1
JP,FLUID RETENTION,1
JP,FOETAL EXPOSURE DURING DELIVERY,1
JP,FOLATE DEFICIENCY,1
JP,FRACTURE,1
JP,FULL BLOOD COUNT DECREASED,1
JP,FUNGAL PHARYNGITIS,1
JP,FUNGAL TEST POSITIVE,1
JP,FURUNCLE,1
JP,GALLBLADDER DISORDER,1
JP,GALLBLADDER PERFORATION,1
JP,GAMMA-GLUTAMYLTRANSFERASE,1
JP,GASTRIC MUCOSAL HYPERTROPHY,1
JP,GASTRIC NEOPLASM,1
JP,GASTRIC ULCER HAEMORRHAGE,1
JP,GASTRODUODENAL ULCER,1
JP,GASTROENTERITIS BACTERIAL,1
JP,GASTROENTERITIS EOSINOPHILIC,1
JP,GASTROENTERITIS NOROVIRUS,1
JP,GASTROINTESTINAL HYPOMOTILITY,1
JP,GASTROINTESTINAL OEDEMA,1
JP,GASTROINTESTINAL PERFORATION,1
JP,GASTROINTESTINAL WALL THICKENING,1
JP,GENITAL CANDIDIASIS,1
JP,GINGIVAL CANCER,1
JP,GINGIVAL ERYTHEMA,1
JP,GLAUCOMA,1
JP,GLOMERULONEPHRITIS MINIMAL LESION,1
JP,GLOMERULONEPHROPATHY,1
JP,GLUCOSE TOLERANCE IMPAIRED,1
JP,GOITRE,1
JP,GRAFT LOSS,1
JP,GRAFT VERSUS HOST DISEASE IN SKIN,1
JP,GRAND MAL CONVULSION,1
JP,HAEMATOTOXICITY,1
JP,HAEMODIALYSIS,1
JP,HAEMOGLOBIN INCREASED,1
JP,HAEMORRHAGIC DIATHESIS,1
JP,HAEMORRHOIDS,1
JP,HAEMOSIDEROSIS,1
JP,HAEMOTHORAX,1
JP,HAIR COLOUR CHANGES,1
JP,HAPTOGLOBIN DECREASED,1
JP,HEAD DISCOMFORT,1
JP,HEART INJURY,1
JP,HEPATIC ATROPHY,1
JP,HEPATIC ENZYME ABNORMAL,1
JP,HEPATIC NECROSIS,1
JP,HEPATIC STEATOSIS,1
JP,HEPATITIS ACUTE,1
JP,HEPATITIS INFECTIOUS MONONUCLEOSIS,1
JP,HEPATOSPLENOMEGALY,1
JP,HEPATOTOXICITY,1
JP,HERPES SIMPLEX ENCEPHALITIS,1
JP,HICCUPS,1
JP,HUMAN HERPESVIRUS 6 INFECTION,1
JP,HYDROCEPHALUS,1
JP,HYDRONEPHROSIS,1
JP,HYPERCALCAEMIA,1
JP,HYPERNATRAEMIA,1
JP,HYPERTHYROIDISM,1
JP,HYPERTONIA,1
JP,HYPERTONIC BLADDER,1
JP,HYPERTRIGLYCERIDAEMIA,1
JP,HYPOMAGNESAEMIA,1
JP,HYPOPHAGIA,1
JP,HYPOPITUITARISM,1
JP,HYPOPNOEA,1
JP,HYPORESPONSIVE TO STIMULI,1
JP,HYPOTHERMIA,1
JP,HYPOVENTILATION,1
JP,HYPOVOLAEMIC SHOCK,1
JP,IDIOPATHIC THROMBOCYTOPENIC PURPURA,1
JP,IMMUNODEFICIENCY,1
JP,IMMUNOGLOBULINS DECREASED,1
JP,IMPETIGO,1
JP,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
JP,INFANTILE SPASMS,1
JP,INFECTED CYST,1
JP,INFECTION PROPHYLAXIS,1
JP,INFECTIOUS MONONUCLEOSIS,1
JP,INFECTIVE THROMBOSIS,1
JP,INFUSION SITE EXTRAVASATION,1
JP,INGUINAL HERNIA,1
JP,INJECTION SITE PAIN,1
JP,INJECTION SITE REACTION,1
JP,INJURY,1
JP,INTENTIONAL DRUG MISUSE,1
JP,INTENTIONAL SELF-INJURY,1
JP,INTERCAPILLARY GLOMERULOSCLEROSIS,1
JP,INTERNAL HAEMORRHAGE,1
JP,INTESTINAL ANGIOEDEMA,1
JP,INTESTINAL DILATATION,1
JP,INTESTINAL STENOSIS,1
JP,INTRA-ABDOMINAL HAEMORRHAGE,1
JP,INTRACRANIAL HYPOTENSION,1
JP,INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM,1
JP,IRIS INCARCERATION,1
JP,IRON OVERLOAD,1
JP,IRRITABILITY,1
JP,IRRITABLE BOWEL SYNDROME,1
JP,JOINT RANGE OF MOTION DECREASED,1
JP,KIDNEY FIBROSIS,1
JP,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
JP,LABORATORY TEST ABNORMAL,1
JP,LACRIMAL DISORDER,1
JP,LACRIMATION INCREASED,1
JP,LARGE INTESTINAL ULCER,1
JP,LARGE INTESTINE PERFORATION,1
JP,LARYNGEAL ERYTHEMA,1
JP,LARYNGEAL ULCERATION,1
JP,LARYNGITIS,1
JP,LARYNX IRRITATION,1
JP,LETHARGY,1
JP,LEUKAEMIA MONOCYTIC,1
JP,LEUKOCYTOSIS,1
JP,LIMB INJURY,1
JP,LIP BLISTER,1
JP,LIP EROSION,1
JP,LIVE BIRTH,1
JP,LIVER FUNCTION TEST INCREASED,1
JP,LOW CARDIAC OUTPUT SYNDROME,1
JP,LUNG ABSCESS,1
JP,LUNG CYST,1
JP,LUNG DISORDER,1
JP,LUPUS-LIKE SYNDROME,1
JP,LYMPHANGIOSARCOMA,1
JP,LYMPHANGIOSIS CARCINOMATOSA,1
JP,LYMPHOCYTE PERCENTAGE DECREASED,1
JP,LYMPHOCYTE TRANSFORMATION TEST POSITIVE,1
JP,LYMPHOCYTIC INFILTRATION,1
JP,LYMPHOCYTOSIS,1
JP,LYMPHOPROLIFERATIVE DISORDER,1
JP,MALIGNANT ASCITES,1
JP,MALLORY-WEISS SYNDROME,1
JP,MARASMUS,1
JP,MATERNAL EXPOSURE DURING DELIVERY,1
JP,MECONIUM ABNORMAL,1
JP,MENORRHAGIA,1
JP,MESENTERIC ARTERY THROMBOSIS,1
JP,METASTASES TO KIDNEY,1
JP,METASTASES TO LUNG,1
JP,METASTASES TO MENINGES,1
JP,MILIARIA,1
JP,MITRAL VALVE DISEASE,1
JP,MONOPLEGIA,1
JP,MOUTH HAEMORRHAGE,1
JP,MUCORMYCOSIS,1
JP,MUCOSAL HAEMORRHAGE,1
JP,MUCOUS STOOLS,1
JP,MULTI-ORGAN FAILURE,1
JP,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
JP,MYASTHENIC SYNDROME,1
JP,MYCOPLASMA INFECTION,1
JP,MYCOPLASMA TEST POSITIVE,1
JP,MYCOTIC ENDOPHTHALMITIS,1
JP,MYELOFIBROSIS,1
JP,MYOCARDIAL ISCHAEMIA,1
JP,MYOCLONUS,1
JP,MYOMECTOMY,1
JP,MYOSITIS,1
JP,NECK INJURY,1
JP,NECROSIS,1
JP,NEOPLASM,1
JP,NEOPLASM PROGRESSION,1
JP,NEPHROPATHY,1
JP,NEPHROPATHY TOXIC,1
JP,NEURALGIA,1
JP,NEUROGENIC BLADDER,1
JP,NEUTROPHIL COUNT INCREASED,1
JP,NEUTROPHIL PERCENTAGE INCREASED,1
JP,NIGHTMARE,1
JP,NO ADVERSE EVENT,1
JP,NODAL MARGINAL ZONE B-CELL LYMPHOMA,1
JP,NODAL RHYTHM,1
JP,NON-CARDIAC CHEST PAIN,1
JP,NON-SMALL CELL LUNG CANCER STAGE IIIB,1
JP,NONSPECIFIC REACTION,1
JP,NUTRITIONAL CONDITION ABNORMAL,1
JP,OCCULT BLOOD,1
JP,OCCUPATIONAL EXPOSURE TO PRODUCT,1
JP,OESOPHAGEAL PERFORATION,1
JP,OESOPHAGITIS,1
JP,OLIGURIA,1
JP,OPTIC ATROPHY,1
JP,ORAL DISCOMFORT,1
JP,ORAL DISORDER,1
JP,OROPHARYNGEAL CANCER,1
JP,ORTHOSTATIC HYPOTENSION,1
JP,OSTEOMYELITIS,1
JP,OVARIAN HAEMORRHAGE,1
JP,PALLOR,1
JP,PALPITATIONS,1
JP,PANCREATIC CARCINOMA,1
JP,PANCREATIC DISORDER,1
JP,PAPULE,1
JP,PARAESTHESIA,1
JP,PARKINSON^S DISEASE,1
JP,PARONYCHIA,1
JP,PATELLA FRACTURE,1
JP,PATHOLOGICAL FRACTURE,1
JP,PCO2 INCREASED,1
JP,PEMPHIGOID,1
JP,PENILE ULCERATION,1
JP,PERIODONTITIS,1
JP,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
JP,PERIPHERAL ARTERY OCCLUSION,1
JP,PERIPHERAL ARTERY STENOSIS,1
JP,PERIPHERAL MOTOR NEUROPATHY,1
JP,PERIPHERAL SWELLING,1
JP,PERIPORTAL OEDEMA,1
JP,PERITONSILLAR ABSCESS,1
JP,PERONEAL MUSCULAR ATROPHY,1
JP,PHARYNGEAL ERYTHEMA,1
JP,PHARYNGEAL OEDEMA,1
JP,PHOTOSENSITIVITY REACTION,1
JP,PLACENTAL INSUFFICIENCY,1
JP,PLATELET COUNT INCREASED,1
JP,PLATELET DYSFUNCTION,1
JP,PNEUMONIA FUNGAL,1
JP,PNEUMONIA MYCOPLASMAL,1
JP,PNEUMONIA PNEUMOCOCCAL,1
JP,PNEUMONIA PSEUDOMONAL,1
JP,POLLAKIURIA,1
JP,POLYMYOSITIS,1
JP,POLYPECTOMY,1
JP,PORTAL VEIN THROMBOSIS,1
JP,POST STREPTOCOCCAL GLOMERULONEPHRITIS,1
JP,POSTOPERATIVE WOUND INFECTION,1
JP,PREMATURE LABOUR,1
JP,PRERENAL FAILURE,1
JP,PRESCRIBED OVERDOSE,1
JP,PRESYNCOPE,1
JP,PROCALCITONIN INCREASED,1
JP,PROCEDURAL HAEMORRHAGE,1
JP,PROCTALGIA,1
JP,PROTEIN TOTAL DECREASED,1
JP,PROTEIN URINE PRESENT,1
JP,PROTEINURIA,1
JP,PROTHROMBIN TIME PROLONGED,1
JP,PRURIGO,1
JP,PSEUDOMEMBRANOUS COLITIS,1
JP,PSORIASIS,1
JP,PSYCHOSOMATIC DISEASE,1
JP,PULMONARY ARTERIAL HYPERTENSION,1
JP,PULMONARY ARTERY THROMBOSIS,1
JP,PULMONARY FIBROSIS,1
JP,PULMONARY HYPERTENSION,1
JP,PULMONARY TUBERCULOSIS,1
JP,PULSE ABSENT,1
JP,PYELONEPHRITIS ACUTE,1
JP,PYURIA,1
JP,RADIATION SKIN INJURY,1
JP,RASH ERYTHEMATOUS,1
JP,RASH PAPULAR,1
JP,RECTAL HAEMORRHAGE,1
JP,RECTAL ULCER HAEMORRHAGE,1
JP,RENAL ABSCESS,1
JP,RENAL CELL CARCINOMA,1
JP,RENAL GRAFT LOSS,1
JP,RENAL INFARCT,1
JP,RENAL TUBULAR ACIDOSIS,1
JP,RESPIRATORY ALKALOSIS,1
JP,RETINAL DEGENERATION,1
JP,RETROGRADE AMNESIA,1
JP,RHINITIS,1
JP,RHINORRHOEA,1
JP,RIB FRACTURE,1
JP,ROAD TRAFFIC ACCIDENT,1
JP,SALMONELLA BACTERAEMIA,1
JP,SARCOIDOSIS,1
JP,SARCOMA UTERUS,1
JP,SCREAMING,1
JP,SCROTAL OEDEMA,1
JP,SEBORRHOEIC DERMATITIS,1
JP,SECOND PRIMARY MALIGNANCY,1
JP,SEIZURE CLUSTER,1
JP,SELF-MEDICATION,1
JP,SENSORY DISTURBANCE,1
JP,SENSORY LOSS,1
JP,SEPTIC EMBOLUS,1
JP,SERRATIA SEPSIS,1
JP,SERUM FERRITIN INCREASED,1
JP,SICK SINUS SYNDROME,1
JP,SKIN CANDIDA,1
JP,SKIN FISSURES,1
JP,SKIN INFECTION,1
JP,SKIN ODOUR ABNORMAL,1
JP,SKIN ULCER,1
JP,SKIN WOUND,1
JP,SLEEP APNOEA SYNDROME,1
JP,SLEEP DISORDER,1
JP,SPEECH DISORDER,1
JP,SPLENOMEGALY,1
JP,SPUTUM INCREASED,1
JP,SPUTUM RETENTION,1
JP,STAPHYLOCOCCAL SKIN INFECTION,1
JP,STAPHYLOCOCCUS TEST POSITIVE,1
JP,STATUS EPILEPTICUS,1
JP,STREPTOCOCCUS TEST POSITIVE,1
JP,SUBARACHNOID HAEMORRHAGE,1
JP,SUBDURAL HAEMATOMA,1
JP,SUDDEN HEARING LOSS,1
JP,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,1
JP,TACHYCARDIA,1
JP,TACHYCARDIA PAROXYSMAL,1
JP,TACHYPNOEA,1
JP,TAKAYASU^S ARTERITIS,1
JP,TEMPORAL ARTERITIS,1
JP,THERAPEUTIC PRODUCT CROSS-REACTIVITY,1
JP,THERAPEUTIC RESPONSE UNEXPECTED,1
JP,THERAPY NON-RESPONDER,1
JP,THIRST,1
JP,THREATENED LABOUR,1
JP,THROAT IRRITATION,1
JP,THROMBOPHLEBITIS SUPERFICIAL,1
JP,THROMBOSIS,1
JP,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
JP,THYROID ATROPHY,1
JP,THYROXINE FREE DECREASED,1
JP,TINEA PEDIS,1
JP,TOOTH DISORDER,1
JP,TORSADE DE POINTES,1
JP,TRACHEO-OESOPHAGEAL FISTULA,1
JP,TRAUMATIC HAEMATOMA,1
JP,TRAUMATIC HAEMORRHAGE,1
JP,TREATMENT NONCOMPLIANCE,1
JP,TUBERCULOSIS,1
JP,TUMOUR MARKER INCREASED,1
JP,ULCERATIVE KERATITIS,1
JP,UNEVALUABLE EVENT,1
JP,UPPER AIRWAY OBSTRUCTION,1
JP,UPPER GASTROINTESTINAL PERFORATION,1
JP,URINARY TRACT INFECTION FUNGAL,1
JP,URINARY TRACT INFECTION STAPHYLOCOCCAL,1
JP,UVEITIS,1
JP,VASCULITIS,1
JP,VENOOCCLUSIVE DISEASE,1
JP,VENTRICULAR ARRHYTHMIA,1
JP,VENTRICULAR FIBRILLATION,1
JP,VENTRICULAR TACHYCARDIA,1
JP,VISUAL ACUITY REDUCED,1
JP,VITAMIN B6 DEFICIENCY,1
JP,VOCAL CORD INFLAMMATION,1
JP,WITHDRAWAL SYNDROME,1
JP,WOUND COMPLICATION,1
JP,WOUND INFECTION,1
JP,WRIST FRACTURE,1
JP,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
JO,CARDIAC ARREST,2
JO,AGRANULOCYTOSIS,1
JO,ARTHRALGIA,1
JO,ASPERGILLUS TEST POSITIVE,1
JO,CANDIDA TEST POSITIVE,1
JO,CELLULITIS ORBITAL,1
JO,CHILLS,1
JO,CONVULSION,1
JO,ECZEMA,1
JO,ENTEROCOCCUS TEST POSITIVE,1
JO,FEBRILE NEUTROPENIA,1
JO,GENERAL PHYSICAL HEALTH DETERIORATION,1
JO,HAEMORRHAGE,1
JO,HYPOTENSION,1
JO,LOCALISED INFECTION,1
JO,MULTI-ORGAN FAILURE,1
JO,ORAL CANDIDIASIS,1
JO,PELVIC PAIN,1
JO,PHARYNGITIS,1
JO,PLATELET COUNT DECREASED,1
JO,PRURITUS,1
JO,PSORIASIS,1
JO,PYREXIA,1
JO,RASH,1
JO,SEPTIC SHOCK,1
JO,SKIN EXFOLIATION,1
KE,ANAEMIA,3
KE,DEATH,2
KE,EXTRAPULMONARY TUBERCULOSIS,2
KE,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS,2
KE,SEPSIS,2
KE,ACUTE KIDNEY INJURY,1
KE,LYMPHOPENIA,1
KE,PRODUCT USE ISSUE,1
KE,PULMONARY TUBERCULOSIS,1
KE,RENAL FAILURE ACUTE,1
KE,VOMITING,1
KP,ASTHENIA,1
KP,DECREASED APPETITE,1
KP,DRUG INEFFECTIVE,1
KP,DYSPHAGIA,1
KP,HYPERAESTHESIA,1
KP,NAUSEA,1
KP,NEUROLEPTIC MALIGNANT SYNDROME,1
KP,PANCYTOPENIA,1
KP,RASH,1
KP,TOXICITY TO VARIOUS AGENTS,1
KR,OVERDOSE,27
KR,PYREXIA,24
KR,PNEUMONIA,23
KR,DRUG DEPENDENCE,22
KR,HEPATIC ENZYME INCREASED,20
KR,DRUG INEFFECTIVE,17
KR,FEBRILE NEUTROPENIA,17
KR,NAUSEA,16
KR,NEUTROPENIA,16
KR,DIARRHOEA,13
KR,VOMITING,13
KR,RASH,12
KR,PRODUCT QUALITY ISSUE,11
KR,ABDOMINAL PAIN,10
KR,ASTHENIA,10
KR,CONSTIPATION,10
KR,DRUG ADMINISTRATION ERROR,10
KR,TOXIC EPIDERMAL NECROLYSIS,10
KR,TOXICITY TO VARIOUS AGENTS,10
KR,DECREASED APPETITE,8
KR,DIZZINESS,8
KR,URTICARIA,8
KR,PRURITUS,7
KR,ANAPHYLACTIC REACTION,6
KR,CONVULSION,6
KR,COUGH,6
KR,DYSPNOEA,6
KR,HEADACHE,6
KR,HYPOPHAGIA,6
KR,INSOMNIA,6
KR,ACUTE KIDNEY INJURY,5
KR,ANGIOEDEMA,5
KR,NEUTROPHIL COUNT DECREASED,5
KR,THROMBOCYTOPENIA,5
KR,UPPER RESPIRATORY TRACT INFECTION,5
KR,ABDOMINAL DISCOMFORT,4
KR,ASPARTATE AMINOTRANSFERASE INCREASED,4
KR,DELIRIUM,4
KR,GASTROOESOPHAGEAL REFLUX DISEASE,4
KR,HAEMATOCHEZIA,4
KR,HEPATIC FUNCTION ABNORMAL,4
KR,INFLUENZA,4
KR,LIVER INJURY,4
KR,MYALGIA,4
KR,PAIN,4
KR,PANCYTOPENIA,4
KR,SOMNOLENCE,4
KR,URINARY RETENTION,4
KR,ADVERSE EVENT,3
KR,ALANINE AMINOTRANSFERASE INCREASED,3
KR,ANAEMIA,3
KR,ARRHYTHMIA,3
KR,C-REACTIVE PROTEIN INCREASED,3
KR,CHEST DISCOMFORT,3
KR,DEEP VEIN THROMBOSIS,3
KR,DISEASE PROGRESSION,3
KR,DRUG-INDUCED LIVER INJURY,3
KR,DYSPEPSIA,3
KR,EXTRADURAL HAEMATOMA,3
KR,GASTRITIS,3
KR,HAEMOPTYSIS,3
KR,HEPATITIS,3
KR,HYPOTHERMIA,3
KR,OEDEMA,3
KR,OESOPHAGITIS,3
KR,OROPHARYNGEAL PAIN,3
KR,PALPITATIONS,3
KR,PANCREATITIS,3
KR,PARAESTHESIA,3
KR,PLEURAL EFFUSION,3
KR,PNEUMONITIS,3
KR,PRODUCT USE ISSUE,3
KR,SEIZURE,3
KR,SEPSIS,3
KR,STEVENS-JOHNSON SYNDROME,3
KR,SUICIDE ATTEMPT,3
KR,TREMOR,3
KR,ABDOMINAL DISTENSION,2
KR,ABDOMINAL PAIN LOWER,2
KR,ACCIDENTAL OVERDOSE,2
KR,ACUTE HEPATIC FAILURE,2
KR,ALOPECIA,2
KR,ANTICONVULSANT DRUG LEVEL DECREASED,2
KR,APPENDICITIS,2
KR,ASCITES,2
KR,ATRIAL FIBRILLATION,2
KR,BILIARY SEPSIS,2
KR,BLOOD PRESSURE INCREASED,2
KR,BODY TEMPERATURE INCREASED,2
KR,BURNING SENSATION,2
KR,CELLULITIS,2
KR,DEATH,2
KR,DERMATITIS CONTACT,2
KR,DRUG ABUSE,2
KR,DRUG EFFECT FASTER THAN EXPECTED,2
KR,DRUG ERUPTION,2
KR,DRY MOUTH,2
KR,EXPOSURE DURING PREGNANCY,2
KR,GASTRIC ULCER,2
KR,GASTROINTESTINAL DISORDER,2
KR,GASTROINTESTINAL HAEMORRHAGE,2
KR,GENERALISED OEDEMA,2
KR,HEPATITIS ACUTE,2
KR,HYPERSENSITIVITY,2
KR,HYPERTENSION,2
KR,HYPOGLYCAEMIA,2
KR,HYPOKALAEMIA,2
KR,HYPONATRAEMIA,2
KR,HYPOTENSION,2
KR,ILEUS,2
KR,INFUSION RELATED REACTION,2
KR,INTENTIONAL OVERDOSE,2
KR,LIVER DISORDER,2
KR,LIVER FUNCTION TEST ABNORMAL,2
KR,LOSS OF CONSCIOUSNESS,2
KR,LUNG INFECTION,2
KR,LUNG NEOPLASM MALIGNANT,2
KR,MENTAL IMPAIRMENT,2
KR,OTITIS MEDIA ACUTE,2
KR,PAIN IN EXTREMITY,2
KR,PERICARDIAL EFFUSION,2
KR,PERITONITIS,2
KR,PHARYNGITIS,2
KR,PLATELET COUNT DECREASED,2
KR,PRODUCTIVE COUGH,2
KR,PULMONARY EMBOLISM,2
KR,PULMONARY TUBERCULOSIS,2
KR,RHINORRHOEA,2
KR,SEDATION,2
KR,SEPTIC SHOCK,2
KR,SKIN DISCOLOURATION,2
KR,SKIN DISORDER,2
KR,WEIGHT DECREASED,2
KR,YELLOW SKIN,2
KR,ABDOMINAL PAIN UPPER,1
KR,ABNORMAL BEHAVIOUR,1
KR,ACUTE TONSILLITIS,1
KR,ADVERSE REACTION,1
KR,AMNESIA,1
KR,ANAL INFLAMMATION,1
KR,ANAPHYLACTIC SHOCK,1
KR,ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC,1
KR,ANXIETY,1
KR,APHASIA,1
KR,ARTHRALGIA,1
KR,ARTHRITIS BACTERIAL,1
KR,ASPIRATION,1
KR,ASTHMA,1
KR,AZOTAEMIA,1
KR,BENIGN GASTRIC NEOPLASM,1
KR,BK VIRUS INFECTION,1
KR,BLEPHARITIS,1
KR,BLINDNESS,1
KR,BLINDNESS UNILATERAL,1
KR,BRONCHIAL HYPERREACTIVITY,1
KR,CAESAREAN SECTION,1
KR,CARDIAC FAILURE,1
KR,CARDIAC FAILURE CONGESTIVE,1
KR,CATARACT,1
KR,CENTRAL NERVOUS SYSTEM STIMULATION,1
KR,CEREBROVASCULAR ACCIDENT,1
KR,CHEST PAIN,1
KR,CHILLS,1
KR,CHOLANGITIS,1
KR,CHOLECYSTITIS ACUTE,1
KR,CHRONIC KIDNEY DISEASE,1
KR,COGNITIVE DISORDER,1
KR,COLITIS,1
KR,COLITIS ISCHAEMIC,1
KR,COMA,1
KR,COMMUNICATION DISORDER,1
KR,CONDITION AGGRAVATED,1
KR,CONFUSIONAL STATE,1
KR,CONTUSION,1
KR,CORNEAL PERFORATION,1
KR,CORONARY ARTERY DISEASE,1
KR,CYTOMEGALOVIRUS HEPATITIS,1
KR,CYTOPENIA,1
KR,DECREASED IMMUNE RESPONSIVENESS,1
KR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
KR,DEPRESSION,1
KR,DERMATITIS,1
KR,DEVELOPMENTAL DELAY,1
KR,DEVICE RELATED INFECTION,1
KR,DROOLING,1
KR,DRUG EFFECT DECREASED,1
KR,DRUG HYPERSENSITIVITY,1
KR,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
KR,DRUG SCREEN POSITIVE,1
KR,DRY EYE,1
KR,DYSPHONIA,1
KR,ENCEPHALITIS,1
KR,EOSINOPHIL COUNT INCREASED,1
KR,EPISTAXIS,1
KR,EXANTHEMA SUBITUM,1
KR,EXPIRED PRODUCT ADMINISTERED,1
KR,EXTRA DOSE ADMINISTERED,1
KR,EXTRAPYRAMIDAL DISORDER,1
KR,EYE SWELLING,1
KR,FASCIITIS,1
KR,FATIGUE,1
KR,FLATULENCE,1
KR,FLUID RETENTION,1
KR,FOETAL EXPOSURE DURING PREGNANCY,1
KR,FOOD CRAVING,1
KR,GAIT DISTURBANCE,1
KR,GASTRIC PERFORATION,1
KR,GASTRIC ULCER HAEMORRHAGE,1
KR,GASTRITIS EROSIVE,1
KR,GASTROINTESTINAL ENDOSCOPIC THERAPY,1
KR,GRIMACING,1
KR,GROIN ABSCESS,1
KR,GROWTH RETARDATION,1
KR,HAEMORRHAGE INTRACRANIAL,1
KR,HAEMORRHOIDS,1
KR,HALLUCINATION_ AUDITORY,1
KR,HEAT CRAMPS,1
KR,HEPATIC CANCER,1
KR,HEPATIC FAILURE,1
KR,HEPATOTOXICITY,1
KR,HERPES VIRUS INFECTION,1
KR,HERPES ZOSTER,1
KR,HICCUPS,1
KR,HISTIOCYTOSIS HAEMATOPHAGIC,1
KR,HIV ANTIBODY POSITIVE,1
KR,HOSPITALISATION,1
KR,HYDRONEPHROSIS,1
KR,HYPERAESTHESIA,1
KR,HYPERBILIRUBINAEMIA,1
KR,HYPERKALAEMIA,1
KR,HYPERSOMNIA,1
KR,HYPERTHERMIA,1
KR,HYPERVENTILATION,1
KR,IDIOPATHIC THROMBOCYTOPENIC PURPURA,1
KR,INCORRECT DOSE ADMINISTERED,1
KR,INFECTION,1
KR,INFLUENZA LIKE ILLNESS,1
KR,INGUINAL HERNIA,1
KR,INTENTIONAL PRODUCT MISUSE,1
KR,IRRITABILITY,1
KR,JAUNDICE,1
KR,JAUNDICE CHOLESTATIC,1
KR,KAWASAKI^S DISEASE,1
KR,LETHARGY,1
KR,LEUKOCYTOSIS,1
KR,LEUKOPENIA,1
KR,LIVER FUNCTION TEST INCREASED,1
KR,LOCALISED OEDEMA,1
KR,LUMBAR SPINAL STENOSIS,1
KR,LUNG LOBECTOMY,1
KR,LYMPHADENITIS VIRAL,1
KR,MACULOPATHY,1
KR,MALIGNANT NEOPLASM PROGRESSION,1
KR,MELAENA,1
KR,MENINGITIS VIRAL,1
KR,MENTAL STATUS CHANGES,1
KR,METRORRHAGIA,1
KR,MIDDLE EAR EFFUSION,1
KR,MOOD SWINGS,1
KR,MUCOSAL INFLAMMATION,1
KR,MULTI-ORGAN FAILURE,1
KR,MUSCLE HAEMORRHAGE,1
KR,MYCOPLASMA INFECTION,1
KR,MYOCLONUS,1
KR,NAIL DISORDER,1
KR,NASAL OBSTRUCTION,1
KR,NASOPHARYNGITIS,1
KR,NEUROPATHY PERIPHERAL,1
KR,NEUTROPENIC COLITIS,1
KR,NO ADVERSE EVENT,1
KR,OCULAR ICTERUS,1
KR,ORAL MUCOSAL BLISTERING,1
KR,ORTHOSTATIC HYPOTENSION,1
KR,OSTEOARTHRITIS,1
KR,OSTEONECROSIS OF JAW,1
KR,OTORRHOEA,1
KR,PALLOR,1
KR,PANCREATITIS ACUTE,1
KR,PAPILLARY THYROID CANCER,1
KR,PARAINFLUENZAE VIRUS INFECTION,1
KR,PARKINSONISM,1
KR,PELVI-URETERIC OBSTRUCTION,1
KR,PERINEAL ERYTHEMA,1
KR,PERITONEAL HAEMORRHAGE,1
KR,PETIT MAL EPILEPSY,1
KR,PHARYNGEAL OEDEMA,1
KR,PLASMA CELL MYELOMA,1
KR,PNEUMONIA CYTOMEGALOVIRAL,1
KR,PNEUMONIA PNEUMOCOCCAL,1
KR,PNEUMOPERITONEUM,1
KR,POST HERPETIC NEURALGIA,1
KR,POST PROCEDURAL INFECTION,1
KR,PREMATURE LABOUR,1
KR,PRESYNCOPE,1
KR,PRETERM PREMATURE RUPTURE OF MEMBRANES,1
KR,PSYCHIATRIC SYMPTOM,1
KR,PULMONARY FIBROSIS,1
KR,PULMONARY INFARCTION,1
KR,PYELOCALIECTASIS,1
KR,PYELONEPHRITIS ACUTE,1
KR,RASH GENERALISED,1
KR,RENAL DYSPLASIA,1
KR,RENAL FAILURE,1
KR,RENAL IMPAIRMENT,1
KR,RENAL INFARCT,1
KR,RESPIRATION ABNORMAL,1
KR,SEBACEOUS GLAND DISORDER,1
KR,SEBACEOUS GLANDS OVERACTIVITY,1
KR,SENSORY DISTURBANCE,1
KR,SHOCK,1
KR,SKIN ABRASION,1
KR,SKIN EXFOLIATION,1
KR,SKIN PLAQUE,1
KR,SLEEP DISORDER,1
KR,SMALL INTESTINAL OBSTRUCTION,1
KR,SPINAL COMPRESSION FRACTURE,1
KR,STOMATITIS,1
KR,STUPOR,1
KR,SUBARACHNOID HAEMORRHAGE,1
KR,SUICIDAL IDEATION,1
KR,SURGERY,1
KR,SWELLING,1
KR,SYNCOPE,1
KR,SYSTEMIC MYCOSIS,1
KR,TENDON RUPTURE,1
KR,THECAL SAC COMPRESSION,1
KR,THORACIC VERTEBRAL FRACTURE,1
KR,THROMBOTIC THROMBOCYTOPENIC PURPURA,1
KR,THYROID CANCER,1
KR,TUBERCULOSIS,1
KR,ULCERATIVE KERATITIS,1
KR,URINARY TRACT INFECTION,1
KR,URTICARIAL VASCULITIS,1
KR,VAGINAL INFECTION,1
KR,VARICELLA,1
KR,VASCULAR DEMENTIA,1
KR,VISION BLURRED,1
KR,VITREOUS FLOATERS,1
KR,WEIGHT INCREASED,1
KR,WHEEZING,1
KR,WHITE BLOOD CELL COUNT DECREASED,1
LA,ACCIDENTAL OVERDOSE,1
LA,HEPATITIS,1
LA,JAUNDICE,1
LB,HYPERAMMONAEMIA,4
LB,COUGH,3
LB,CONFUSIONAL STATE,2
LB,DISORIENTATION,2
LB,DIZZINESS,2
LB,HAEMORRHOIDS,2
LB,HEADACHE,2
LB,HOT FLUSH,2
LB,LETHARGY,2
LB,NAUSEA,2
LB,PYREXIA,2
LB,RECTAL HAEMORRHAGE,2
LB,URINARY TRACT INFECTION,2
LB,VOMITING,2
LB,ABDOMINAL DISTENSION,1
LB,ABDOMINAL PAIN,1
LB,ABDOMINAL PAIN UPPER,1
LB,ACUTE KIDNEY INJURY,1
LB,ANAEMIA,1
LB,ANXIETY,1
LB,ASTHENIA,1
LB,BACK PAIN,1
LB,BENIGN NEOPLASM OF THYROID GLAND,1
LB,C-REACTIVE PROTEIN ABNORMAL,1
LB,CARDIOPULMONARY FAILURE,1
LB,CHILLS,1
LB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
LB,COLITIS ULCERATIVE,1
LB,DEATH,1
LB,DIARRHOEA,1
LB,DISCOMFORT,1
LB,DRUG ABUSE,1
LB,DRUG RESISTANCE,1
LB,DRUG WITHDRAWAL SYNDROME,1
LB,DRUG-INDUCED LIVER INJURY,1
LB,DYSPNOEA,1
LB,EAR INFECTION,1
LB,EAR PAIN,1
LB,EPHELIDES,1
LB,FATIGUE,1
LB,GASTROENTERITIS,1
LB,GASTROINTESTINAL HAEMORRHAGE,1
LB,GASTROOESOPHAGEAL REFLUX DISEASE,1
LB,HAEMATOCRIT ABNORMAL,1
LB,HEPATIC CIRRHOSIS,1
LB,HYPERSENSITIVITY,1
LB,HYPERTENSION,1
LB,HYPOGLYCAEMIA,1
LB,IMMUNOSUPPRESSION,1
LB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
LB,INFECTION,1
LB,INFLUENZA,1
LB,INSOMNIA,1
LB,INTENTIONAL PRODUCT MISUSE,1
LB,IRRITABLE BOWEL SYNDROME,1
LB,LIVER FUNCTION TEST ABNORMAL,1
LB,LOCALISED OEDEMA,1
LB,LUNG INFECTION,1
LB,MENSTRUAL DISORDER,1
LB,METASTATIC GASTRIC CANCER,1
LB,MYOPATHY,1
LB,NECK PAIN,1
LB,NEISSERIA INFECTION,1
LB,NOCTURIA,1
LB,OEDEMA,1
LB,ORGAN FAILURE,1
LB,OROPHARYNGEAL PAIN,1
LB,OVARIAN CYST,1
LB,OXYGEN SATURATION DECREASED,1
LB,PELVIC PAIN,1
LB,PERIPHERAL SWELLING,1
LB,PLATELET COUNT DECREASED,1
LB,PRESCRIBED UNDERDOSE,1
LB,PROGRESSIVE MULTIPLE SCLEROSIS,1
LB,RASH GENERALISED,1
LB,SECRETION DISCHARGE,1
LB,SEIZURE,1
LB,SKIN MASS,1
LB,SLEEP DISORDER,1
LB,STREPTOCOCCAL INFECTION,1
LB,STRESS,1
LB,SWELLING,1
LB,SWELLING FACE,1
LB,TENDONITIS,1
LB,THORACIC VERTEBRAL FRACTURE,1
LB,TREMOR,1
LB,UTERINE ENLARGEMENT,1
LB,VITAMIN B12 DECREASED,1
LB,WEIGHT DECREASED,1
LB,WEIGHT INCREASED,1
LT,PROCTITIS,1
LT,PROCTITIS INFECTIOUS,1
LU,TOXIC SKIN ERUPTION,1
MW,IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME,2
MW,LOWER RESPIRATORY TRACT INFECTION,2
MW,ASTHENIA,1
MW,CHILLS,1
MW,COUGH,1
MW,DRUG-INDUCED LIVER INJURY,1
MW,DYSPNOEA,1
MW,KAPOSI^S SARCOMA,1
MW,PNEUMONIA,1
MW,PYREXIA,1
MY,ACUTE HEPATIC FAILURE,2
MY,GASTROINTESTINAL HAEMORRHAGE,2
MY,JAUNDICE,2
MY,PYREXIA,2
MY,TOXICITY TO VARIOUS AGENTS,2
MY,ALANINE AMINOTRANSFERASE INCREASED,1
MY,ANAEMIA,1
MY,ANAPHYLACTIC SHOCK,1
MY,ARTHRALGIA,1
MY,ASCITES,1
MY,ASPARTATE AMINOTRANSFERASE INCREASED,1
MY,BLOOD ALKALINE PHOSPHATASE INCREASED,1
MY,COAGULOPATHY,1
MY,CONVULSION,1
MY,CREPITATIONS,1
MY,DEPRESSION,1
MY,ECZEMA,1
MY,END STAGE RENAL DISEASE,1
MY,FATIGUE,1
MY,FEMUR FRACTURE,1
MY,FLUID OVERLOAD,1
MY,GASTROENTERITIS,1
MY,GLOMERULAR FILTRATION RATE,1
MY,GOUT,1
MY,HAEMATEMESIS,1
MY,HAEMATOCRIT DECREASED,1
MY,HEPATIC ENCEPHALOPATHY,1
MY,HEPATITIS,1
MY,HEPATOMEGALY,1
MY,HYPERREFLEXIA,1
MY,HYPERTONIA,1
MY,HYPOGLYCAEMIA,1
MY,INTERNATIONAL NORMALISED RATIO INCREASED,1
MY,LIVER FUNCTION TEST ABNORMAL,1
MY,MEDICATION RESIDUE PRESENT,1
MY,MELAENA,1
MY,OEDEMA,1
MY,OEDEMA PERIPHERAL,1
MY,PALLOR,1
MY,PETECHIAE,1
MY,PRODUCT QUALITY ISSUE,1
MY,PROTHROMBIN TIME PROLONGED,1
MY,SOMNOLENCE,1
MY,SURGERY,1
MY,TINEA INFECTION,1
MT,ABDOMINAL DISTENSION,1
MT,ABDOMINAL PAIN UPPER,1
MT,HEPATOTOXICITY,1
MT,LIVER FUNCTION TEST ABNORMAL,1
MX,FATIGUE,14
MX,HEADACHE,14
MX,PAIN,12
MX,DIARRHOEA,10
MX,FALL,10
MX,GAIT DISTURBANCE,10
MX,VOMITING,10
MX,ASTHENIA,9
MX,DIZZINESS,9
MX,PAIN IN EXTREMITY,9
MX,WEIGHT DECREASED,9
MX,ANXIETY,8
MX,ARTHRALGIA,8
MX,INSOMNIA,8
MX,PYREXIA,8
MX,CONSTIPATION,7
MX,INFLAMMATION,7
MX,INFLUENZA,7
MX,PNEUMONIA,7
MX,WEIGHT INCREASED,7
MX,DEPRESSION,6
MX,DRUG INEFFECTIVE,6
MX,SOMNOLENCE,6
MX,COUGH,5
MX,DECREASED APPETITE,5
MX,DRY SKIN,5
MX,HYPERTENSION,5
MX,MALAISE,5
MX,MEMORY IMPAIRMENT,5
MX,MUSCLE SPASMS,5
MX,PERIPHERAL SWELLING,5
MX,RESPIRATORY DISTRESS,5
MX,ABDOMINAL PAIN UPPER,4
MX,ANAEMIA,4
MX,BACK PAIN,4
MX,BLOOD PRESSURE DECREASED,4
MX,BLOOD PRESSURE INCREASED,4
MX,DEPRESSED MOOD,4
MX,DYSPEPSIA,4
MX,DYSPHONIA,4
MX,DYSPNOEA,4
MX,EMOTIONAL DISORDER,4
MX,GASTROOESOPHAGEAL REFLUX DISEASE,4
MX,HYPOAESTHESIA,4
MX,LUNG INFILTRATION,4
MX,MOBILITY DECREASED,4
MX,PARAESTHESIA,4
MX,PRODUCT USE ISSUE,4
MX,RASH,4
MX,STRESS,4
MX,THROAT IRRITATION,4
MX,ABASIA,3
MX,ABDOMINAL PAIN,3
MX,ALOPECIA,3
MX,BURNING SENSATION,3
MX,CHEST PAIN,3
MX,DISORIENTATION,3
MX,DYSSTASIA,3
MX,GASTRITIS,3
MX,HEPATIC FUNCTION ABNORMAL,3
MX,HYPOTENSION,3
MX,LIGAMENT SPRAIN,3
MX,MUCOSAL INFLAMMATION,3
MX,MUSCULAR WEAKNESS,3
MX,MYALGIA,3
MX,NASOPHARYNGITIS,3
MX,NAUSEA,3
MX,ORAL CANDIDIASIS,3
MX,PRURITUS,3
MX,RESTLESSNESS,3
MX,STOMATITIS,3
MX,TENDON RUPTURE,3
MX,ABDOMINAL DISCOMFORT,2
MX,ABDOMINAL DISTENSION,2
MX,ABSCESS LIMB,2
MX,AMNESIA,2
MX,ANAPHYLACTIC REACTION,2
MX,ANGER,2
MX,ARTHRITIS,2
MX,BLOOD GLUCOSE INCREASED,2
MX,BREAST PAIN,2
MX,CARDIAC DISORDER,2
MX,CHILLS,2
MX,CHOLELITHIASIS,2
MX,DEHYDRATION,2
MX,DISEASE PROGRESSION,2
MX,DIVERTICULUM,2
MX,DRY THROAT,2
MX,EATING DISORDER,2
MX,EPISTAXIS,2
MX,FEAR,2
MX,FEELING ABNORMAL,2
MX,FEELING OF DESPAIR,2
MX,FLATULENCE,2
MX,FOOD CRAVING,2
MX,FOOT FRACTURE,2
MX,FRUSTRATION TOLERANCE DECREASED,2
MX,GASTRIC DISORDER,2
MX,GASTROENTERITIS,2
MX,GENERAL PHYSICAL HEALTH DETERIORATION,2
MX,HAEMORRHOIDS,2
MX,HIATUS HERNIA,2
MX,HYPERCHLORHYDRIA,2
MX,HYPERCHOLESTEROLAEMIA,2
MX,HYPERTENSIVE CRISIS,2
MX,INTERVERTEBRAL DISC PROTRUSION,2
MX,JOINT SWELLING,2
MX,LACTOSE INTOLERANCE,2
MX,LOCAL SWELLING,2
MX,LUNG DISORDER,2
MX,MALNUTRITION,2
MX,MEDICATION ERROR,2
MX,MENTAL DISORDER,2
MX,MIGRAINE,2
MX,MULTIPLE SCLEROSIS RELAPSE,2
MX,MUSCLE RIGIDITY,2
MX,MUSCULOSKELETAL DISORDER,2
MX,MUSCULOSKELETAL PAIN,2
MX,MUSCULOSKELETAL STIFFNESS,2
MX,MYOCARDIAL INFARCTION,2
MX,NECK PAIN,2
MX,NERVOUSNESS,2
MX,NODULE,2
MX,ORAL DISCOMFORT,2
MX,OROPHARYNGEAL PAIN,2
MX,PALLOR,2
MX,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2
MX,PHARYNGITIS,2
MX,PLEURAL EFFUSION,2
MX,POLLAKIURIA,2
MX,POSTOPERATIVE ABSCESS,2
MX,PROCEDURAL PAIN,2
MX,SKIN EXFOLIATION,2
MX,SPINAL PAIN,2
MX,SWELLING,2
MX,THROAT TIGHTNESS,2
MX,TRANSAMINASES INCREASED,2
MX,URINARY TRACT INFECTION,2
MX,VISUAL IMPAIRMENT,2
MX,VITAMIN B12 ABNORMAL,2
MX,WHEEZING,2
MX,WHITE BLOOD CELL COUNT DECREASED,2
MX,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
MX,ABDOMINAL SEPSIS,1
MX,ABSCESS,1
MX,ABSCESS DRAINAGE,1
MX,ACCIDENTAL OVERDOSE,1
MX,ACCIDENTAL POISONING,1
MX,AFFECT LABILITY,1
MX,AMOEBIASIS,1
MX,ANAPHYLACTIC SHOCK,1
MX,ANGINA UNSTABLE,1
MX,ANGIOEDEMA,1
MX,APHASIA,1
MX,APPLICATION SITE PAIN,1
MX,ARRHYTHMIA,1
MX,ARTHROPATHY,1
MX,ASPHYXIA,1
MX,ASTHENOPIA,1
MX,ASTHMA,1
MX,ATRIAL FIBRILLATION,1
MX,BACTERIAL INFECTION,1
MX,BARRETT^S OESOPHAGUS,1
MX,BLOOD CALCIUM DECREASED,1
MX,BLOOD CHOLESTEROL INCREASED,1
MX,BLOOD CREATININE INCREASED,1
MX,BLOOD GLUCOSE DECREASED,1
MX,BLOOD PRESSURE ABNORMAL,1
MX,BLOOD TEST ABNORMAL,1
MX,BLOOD URIC ACID INCREASED,1
MX,BONE PAIN,1
MX,BRADYCARDIA,1
MX,BRONCHIAL DISORDER,1
MX,BRONCHIAL HYPERREACTIVITY,1
MX,CANDIDA INFECTION,1
MX,CAPILLARY NAIL REFILL TEST ABNORMAL,1
MX,CARDIAC ARREST,1
MX,CARDIOMEGALY,1
MX,CATARACT,1
MX,CEREBROVASCULAR ACCIDENT,1
MX,CHIKUNGUNYA VIRUS INFECTION,1
MX,CHILLBLAINS,1
MX,COLITIS,1
MX,DEATH,1
MX,DIABETES MELLITUS,1
MX,DISCOMFORT,1
MX,DISSEMINATED INTRAVASCULAR COAGULATION,1
MX,DISSEMINATED TUBERCULOSIS,1
MX,DISTURBANCE IN ATTENTION,1
MX,DIVERTICULITIS,1
MX,DRUG DEPENDENCE,1
MX,DRUG PRESCRIBING ERROR,1
MX,DRUG-INDUCED LIVER INJURY,1
MX,DRY EYE,1
MX,DRY MOUTH,1
MX,DYSCHEZIA,1
MX,DYSPHEMIA,1
MX,EAR CONGESTION,1
MX,EAR PAIN,1
MX,ECZEMA,1
MX,EMOTIONAL DISTRESS,1
MX,ERYTHEMA OF EYELID,1
MX,EXCESSIVE EYE BLINKING,1
MX,EXOSTOSIS,1
MX,EYE INFLAMMATION,1
MX,EYE PAIN,1
MX,EYELID OEDEMA,1
MX,FACE INJURY,1
MX,FAECES DISCOLOURED,1
MX,FEBRILE NEUTROPENIA,1
MX,FEELING COLD,1
MX,FEELING HOT,1
MX,FEELING OF RELAXATION,1
MX,FLUID INTAKE REDUCED,1
MX,FRACTURE,1
MX,GASTROINTESTINAL BACTERIAL INFECTION,1
MX,GASTROINTESTINAL INFLAMMATION,1
MX,GASTROINTESTINAL SOUNDS ABNORMAL,1
MX,GENERALISED ERYTHEMA,1
MX,GLUTEN SENSITIVITY,1
MX,HAEMATOCHEZIA,1
MX,HAEMOGLOBIN DECREASED,1
MX,HAEMOLYTIC ANAEMIA,1
MX,HAEMOTHORAX,1
MX,HAIR COLOUR CHANGES,1
MX,HEAD DISCOMFORT,1
MX,HEART RATE INCREASED,1
MX,HELICOBACTER GASTRITIS,1
MX,HEMIPARESIS,1
MX,HEPATIC ENCEPHALOPATHY,1
MX,HEPATIC STEATOSIS,1
MX,HEPATITIS,1
MX,HEPATOCELLULAR CARCINOMA,1
MX,HEPATORENAL SYNDROME,1
MX,HERPES ZOSTER,1
MX,HIP FRACTURE,1
MX,HOSPITALISATION,1
MX,HYPERAESTHESIA,1
MX,HYPERGLYCAEMIA,1
MX,HYPERHIDROSIS,1
MX,HYPOTHYROIDISM,1
MX,IMMUNODEFICIENCY,1
MX,IMMUNOSUPPRESSION,1
MX,IMPAIRED DRIVING ABILITY,1
MX,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
MX,INCISION SITE ABSCESS,1
MX,INTENTIONAL PRODUCT MISUSE,1
MX,INTENTIONAL PRODUCT USE ISSUE,1
MX,IRRITABLE BOWEL SYNDROME,1
MX,JAUNDICE,1
MX,JOINT CONTRACTURE,1
MX,JOINT CREPITATION,1
MX,JOINT EFFUSION,1
MX,JOINT INJURY,1
MX,JOINT INSTABILITY,1
MX,JOINT STIFFNESS,1
MX,LETHARGY,1
MX,LEUKOPENIA,1
MX,LIMB DISCOMFORT,1
MX,LIP DISCOLOURATION,1
MX,LIVER DISORDER,1
MX,LUNG INFECTION,1
MX,LUNG NEOPLASM,1
MX,LYMPHOCYTE COUNT DECREASED,1
MX,LYMPHOMA,1
MX,MASS,1
MX,MENSTRUATION IRREGULAR,1
MX,METASTASES TO LUNG,1
MX,METHAEMOGLOBINAEMIA,1
MX,MICTURITION URGENCY,1
MX,MIDDLE INSOMNIA,1
MX,MONOPARESIS,1
MX,MOOD ALTERED,1
MX,MOUTH INJURY,1
MX,MOUTH ULCERATION,1
MX,MOVEMENT DISORDER,1
MX,MUCOSAL ATROPHY,1
MX,MUSCLE FATIGUE,1
MX,MUSCULOSKELETAL CHEST PAIN,1
MX,NAIL DISCOLOURATION,1
MX,NASAL CONGESTION,1
MX,NEPHROLITHIASIS,1
MX,NERVE COMPRESSION,1
MX,NERVE INJURY,1
MX,NERVOUS SYSTEM DISORDER,1
MX,NEURALGIA,1
MX,NEURITIS,1
MX,NUTRITIONAL CONDITION ABNORMAL,1
MX,OBSESSIVE THOUGHTS,1
MX,OBSTRUCTIVE AIRWAYS DISORDER,1
MX,OCULAR HYPERAEMIA,1
MX,OEDEMA PERIPHERAL,1
MX,OESOPHAGITIS,1
MX,ONYCHOCLASIS,1
MX,ONYCHOMADESIS,1
MX,OPTIC NERVE INJURY,1
MX,ORAL DISORDER,1
MX,OVERWEIGHT,1
MX,PALATAL DISORDER,1
MX,PALMOPLANTAR KERATODERMA,1
MX,PARAPLEGIA,1
MX,PAROSMIA,1
MX,PELVIC INFLAMMATORY DISEASE,1
MX,PEPTIC ULCER,1
MX,PERIPHERAL COLDNESS,1
MX,PETECHIAE,1
MX,PLATELET COUNT DECREASED,1
MX,PNEUMONIA FUNGAL,1
MX,PNEUMOTHORAX,1
MX,POST PROCEDURAL DISCHARGE,1
MX,POST PROCEDURAL HAEMATOMA,1
MX,PROSTATIC DISORDER,1
MX,PSORIASIS,1
MX,PULMONARY HYPERTENSION,1
MX,PULMONARY MASS,1
MX,RED BLOOD CELL ABNORMALITY,1
MX,REGURGITATION,1
MX,RENAL CYST,1
MX,RENAL DISORDER,1
MX,RENAL FAILURE,1
MX,RENAL NEOPLASM,1
MX,RENAL PAIN,1
MX,ROAD TRAFFIC ACCIDENT,1
MX,SCOLIOSIS,1
MX,SEROSITIS,1
MX,SILENT MYOCARDIAL INFARCTION,1
MX,SJOGREN^S SYNDROME,1
MX,SKIN BURNING SENSATION,1
MX,SKIN DISCOLOURATION,1
MX,SKIN FISSURES,1
MX,SKIN FRAGILITY,1
MX,SKIN IRRITATION,1
MX,SKIN LESION,1
MX,SKIN PAPILLOMA,1
MX,SLUGGISHNESS,1
MX,SNORING,1
MX,SOPOR,1
MX,STOMATITIS NECROTISING,1
MX,SUICIDAL BEHAVIOUR,1
MX,SUPERFICIAL VEIN PROMINENCE,1
MX,SUSPECTED COUNTERFEIT PRODUCT,1
MX,SWEAT GLAND DISORDER,1
MX,SYSTEMIC LUPUS ERYTHEMATOSUS,1
MX,TEARFULNESS,1
MX,TENSION,1
MX,THIRST,1
MX,THROAT LESION,1
MX,THROMBOCYTOPENIA,1
MX,THROMBOCYTOPENIC PURPURA,1
MX,TIC,1
MX,TONGUE DISORDER,1
MX,TONGUE OEDEMA,1
MX,TONSILLITIS,1
MX,TOXICITY TO VARIOUS AGENTS,1
MX,TRAUMATIC HAEMORRHAGE,1
MX,TREMOR,1
MX,TRIGEMINAL NEURALGIA,1
MX,TRISMUS,1
MX,TUBERCULOSIS,1
MX,TYPE I HYPERSENSITIVITY,1
MX,UMBILICAL HERNIA,1
MX,UNEVALUABLE EVENT,1
MX,URTICARIA,1
MX,VAGINAL HAEMORRHAGE,1
MX,VISION BLURRED,1
MX,WOUND COMPLICATION,1
MX,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
MA,ASTHENIA,1
MA,CHEILITIS,1
MA,CONJUNCTIVAL HYPERAEMIA,1
MA,EPIDERMAL NECROSIS,1
MA,GENITAL LABIAL ADHESIONS,1
MA,HYPOKALAEMIA,1
MA,HYPONATRAEMIA,1
MA,INFLUENZA LIKE ILLNESS,1
MA,OPTIC ISCHAEMIC NEUROPATHY,1
MA,PYREXIA,1
MA,RASH,1
MA,RASH MACULAR,1
MA,SKIN EXFOLIATION,1
MA,TOXIC EPIDERMAL NECROLYSIS,1
NP,CYSTITIS,3
NP,DRUG LEVEL INCREASED,2
NP,ACCIDENTAL OVERDOSE,1
NP,BURNING SENSATION,1
NP,CYSTITIS NONINFECTIVE,1
NP,DIZZINESS,1
NP,HYPOTENSION,1
NP,MYASTHENIA GRAVIS,1
NP,PAIN,1
NP,POLLAKIURIA,1
NP,PRESYNCOPE,1
NL,METABOLIC ACIDOSIS,16
NL,ACIDOSIS,15
NL,DEATH,6
NL,TOXICITY TO VARIOUS AGENTS,6
NL,VOMITING,6
NL,NAUSEA,5
NL,ACUTE KIDNEY INJURY,4
NL,DECREASED APPETITE,4
NL,DIARRHOEA,4
NL,FATIGUE,4
NL,HYPERNATRAEMIA,4
NL,RENAL FAILURE,4
NL,ABDOMINAL PAIN,3
NL,ABNORMAL FAECES,3
NL,CONSTIPATION,3
NL,DYSPNOEA,3
NL,EATING DISORDER,3
NL,INSOMNIA,3
NL,PYREXIA,3
NL,WEIGHT DECREASED,3
NL,ABDOMINAL DISCOMFORT,2
NL,ALANINE AMINOTRANSFERASE INCREASED,2
NL,BLOOD CREATININE INCREASED,2
NL,BOWEL MOVEMENT IRREGULARITY,2
NL,COMA,2
NL,DRUG INEFFECTIVE,2
NL,FALL,2
NL,GLOMERULAR FILTRATION RATE DECREASED,2
NL,HAEMORRHOIDS,2
NL,HEADACHE,2
NL,HEPATOTOXICITY,2
NL,HYPERCALCAEMIA,2
NL,INFECTION,2
NL,INTENTIONAL OVERDOSE,2
NL,LACTIC ACIDOSIS,2
NL,MALAISE,2
NL,MUSCLE SPASMS,2
NL,MUSCULOSKELETAL DISCOMFORT,2
NL,MUSCULOSKELETAL PAIN,2
NL,MYALGIA,2
NL,OSTEOARTHRITIS,2
NL,OVERWEIGHT,2
NL,PAIN,2
NL,PAIN IN EXTREMITY,2
NL,PANCREATITIS,2
NL,PNEUMONIA,2
NL,WEIGHT INCREASED,2
NL,ABDOMINAL PAIN LOWER,1
NL,ABDOMINAL PAIN UPPER,1
NL,ACCIDENTAL OVERDOSE,1
NL,ADRENAL INSUFFICIENCY,1
NL,AGITATION,1
NL,ALOPECIA,1
NL,ANAEMIA,1
NL,ANGIOPATHY,1
NL,ANTICHOLINERGIC SYNDROME,1
NL,ANXIETY,1
NL,APPENDICITIS,1
NL,ARTHRITIS REACTIVE,1
NL,ASTIGMATISM,1
NL,ATRIAL FIBRILLATION,1
NL,BACK PAIN,1
NL,BLINDNESS TRANSIENT,1
NL,BLOOD OSMOLARITY,1
NL,BLOOD PRESSURE INCREASED,1
NL,BODY TEMPERATURE INCREASED,1
NL,CARDIAC ARREST,1
NL,CARDIAC FAILURE,1
NL,CARDIOPULMONARY FAILURE,1
NL,CEREBRAL INFARCTION,1
NL,CHROMATURIA,1
NL,COLOUR BLINDNESS,1
NL,CONGENITAL ARTERIAL MALFORMATION,1
NL,CONGENITAL GREAT VESSEL ANOMALY,1
NL,CONVULSION,1
NL,DEMYELINATION,1
NL,DEPRESSED MOOD,1
NL,DEPRESSION,1
NL,DISEASE PROGRESSION,1
NL,DISTURBANCE IN ATTENTION,1
NL,DIZZINESS,1
NL,DRUG ADMINISTRATION ERROR,1
NL,DRUG EFFECT INCOMPLETE,1
NL,DRUG LEVEL ABOVE THERAPEUTIC,1
NL,DRUG-INDUCED LIVER INJURY,1
NL,DYSPHONIA,1
NL,EOSINOPHIL COUNT DECREASED,1
NL,EPIDERMOLYSIS,1
NL,EXPOSURE DURING PREGNANCY,1
NL,EXPOSURE VIA FATHER,1
NL,EYE DISORDER,1
NL,EYE IRRITATION,1
NL,FAECES SOFT,1
NL,FEMUR FRACTURE,1
NL,FLATULENCE,1
NL,FOETAL DEATH,1
NL,GASTROINTESTINAL HYPOMOTILITY,1
NL,GROIN PAIN,1
NL,HAEMATOCHEZIA,1
NL,HAEMORRHAGE,1
NL,HEART DISEASE CONGENITAL,1
NL,HEART RATE INCREASED,1
NL,HEPATIC FUNCTION ABNORMAL,1
NL,HERNIA,1
NL,HETEROTAXIA,1
NL,HIP FRACTURE,1
NL,HYDROCEPHALUS,1
NL,HYPERCHOLESTEROLAEMIA,1
NL,HYPOCALCAEMIA,1
NL,HYPOKALAEMIA,1
NL,HYPOMAGNESAEMIA,1
NL,HYPONATRAEMIA,1
NL,HYPOPLASTIC RIGHT HEART SYNDROME,1
NL,INCORRECT PRODUCT STORAGE,1
NL,INJECTION SITE ERYTHEMA,1
NL,INTERSTITIAL LUNG DISEASE,1
NL,LETHARGY,1
NL,LIVER DISORDER,1
NL,LIVER FUNCTION TEST ABNORMAL,1
NL,LOCALISED INFECTION,1
NL,MALIGNANT MELANOMA,1
NL,MALIGNANT NEOPLASM PROGRESSION,1
NL,MANIA,1
NL,METASTASES TO BONE,1
NL,METASTASES TO CENTRAL NERVOUS SYSTEM,1
NL,MIGRAINE,1
NL,MOBILITY DECREASED,1
NL,MONOCYTE COUNT INCREASED,1
NL,MOTOR DYSFUNCTION,1
NL,MYDRIASIS,1
NL,NAIL DYSTROPHY,1
NL,NASAL DISCOMFORT,1
NL,NERVOUS SYSTEM DISORDER,1
NL,NEUROPATHY PERIPHERAL,1
NL,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
NL,OEDEMA,1
NL,ORTHOPNOEA,1
NL,OVERDOSE,1
NL,PAINFUL RESPIRATION,1
NL,PARAESTHESIA,1
NL,PERIORBITAL OEDEMA,1
NL,POISONING,1
NL,POLYURIA,1
NL,POST PROCEDURAL HAEMORRHAGE,1
NL,PREMATURE BABY,1
NL,PRODUCT USE ISSUE,1
NL,PRODUCTIVE COUGH,1
NL,PROTHROMBIN TIME RATIO INCREASED,1
NL,PROTHROMBIN TIME SHORTENED,1
NL,PRURITUS,1
NL,PULMONARY HYPERTENSION,1
NL,PYROGLUTAMATE INCREASED,1
NL,RASH,1
NL,RED BLOOD CELL COUNT DECREASED,1
NL,RED CELL DISTRIBUTION WIDTH INCREASED,1
NL,RENAL FAILURE ACUTE,1
NL,RENAL IMPAIRMENT,1
NL,RENAL INJURY,1
NL,RESPIRATORY DEPRESSION,1
NL,RHABDOMYOLYSIS,1
NL,SECONDARY ADRENOCORTICAL INSUFFICIENCY,1
NL,SEIZURE,1
NL,SENSORY LOSS,1
NL,SEROTONIN SYNDROME,1
NL,SOMNOLENCE,1
NL,SPINAL COMPRESSION FRACTURE,1
NL,SUICIDAL IDEATION,1
NL,SUICIDE ATTEMPT,1
NL,SUPRAVENTRICULAR TACHYCARDIA,1
NL,SYNCOPE,1
NL,THROAT TIGHTNESS,1
NL,TUBULOINTERSTITIAL NEPHRITIS,1
NL,URINARY RETENTION,1
NL,URINARY TRACT INFECTION,1
NL,URINE ABNORMALITY,1
NL,UROSEPSIS,1
NL,VEIN DISORDER,1
NL,VISION BLURRED,1
NL,VISUAL IMPAIRMENT,1
NL,WOUND INFECTION,1
NZ,PYREXIA,5
NZ,ANAEMIA,3
NZ,FATIGUE,3
NZ,PNEUMONIA,3
NZ,ABDOMINAL PAIN,2
NZ,ACUTE RESPIRATORY DISTRESS SYNDROME,2
NZ,CHEST PAIN,2
NZ,CROHN^S DISEASE,2
NZ,DEATH,2
NZ,DYSPNOEA,2
NZ,GAIT DISTURBANCE,2
NZ,MALAISE,2
NZ,NAUSEA,2
NZ,NECROTISING FASCIITIS,2
NZ,ORAL PAIN,2
NZ,PAIN,2
NZ,PAIN IN EXTREMITY,2
NZ,RENAL IMPAIRMENT,2
NZ,TOOTH INFECTION,2
NZ,ACUTE MYOCARDIAL INFARCTION,1
NZ,ACUTE PULMONARY OEDEMA,1
NZ,ANAPHYLACTIC REACTION,1
NZ,ANXIETY,1
NZ,AORTIC DISSECTION,1
NZ,APPLICATION SITE ERYTHEMA,1
NZ,APPLICATION SITE PAIN,1
NZ,APPLICATION SITE PRURITUS,1
NZ,ASTHENIA,1
NZ,BACK PAIN,1
NZ,BALANCE DISORDER,1
NZ,BLOOD DISORDER,1
NZ,BLOOD PRESSURE INCREASED,1
NZ,BLOOD TEST ABNORMAL,1
NZ,BLOOD URINE PRESENT,1
NZ,BODY TEMPERATURE INCREASED,1
NZ,BONE PAIN,1
NZ,BURSITIS,1
NZ,CALCULUS URINARY,1
NZ,CARDIAC DISORDER,1
NZ,CARDIOGENIC SHOCK,1
NZ,CEREBROVASCULAR ACCIDENT,1
NZ,CHILLS,1
NZ,CIRCULATORY COLLAPSE,1
NZ,COLD SWEAT,1
NZ,CONSTIPATION,1
NZ,CONTUSION,1
NZ,DIARRHOEA,1
NZ,DIARRHOEA HAEMORRHAGIC,1
NZ,DISSEMINATED INTRAVASCULAR COAGULATION,1
NZ,DIZZINESS,1
NZ,DRUG EFFECT DECREASED,1
NZ,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
NZ,DRUG WITHDRAWAL SYNDROME,1
NZ,DYSACUSIS,1
NZ,DYSARTHRIA,1
NZ,DYSKINESIA,1
NZ,DYSPEPSIA,1
NZ,DYSPNOEA EXERTIONAL,1
NZ,DYSURIA,1
NZ,ERYTHEMA,1
NZ,ESSENTIAL HYPERTENSION,1
NZ,EYE PAIN,1
NZ,FACIAL PARALYSIS,1
NZ,FEELING ABNORMAL,1
NZ,FEELING HOT,1
NZ,GASTROINTESTINAL ANGIODYSPLASIA,1
NZ,GASTROOESOPHAGEAL REFLUX DISEASE,1
NZ,GENERAL PHYSICAL HEALTH DETERIORATION,1
NZ,HEADACHE,1
NZ,HEART RATE INCREASED,1
NZ,HEMIPLEGIA,1
NZ,HENOCH-SCHONLEIN PURPURA,1
NZ,HEPATIC ENZYME INCREASED,1
NZ,HYPERCALCAEMIA,1
NZ,HYPERHIDROSIS,1
NZ,HYPERKALAEMIA,1
NZ,HYPERSENSITIVITY,1
NZ,HYPERTENSION,1
NZ,HYPOACUSIS,1
NZ,HYPOAESTHESIA,1
NZ,HYPOKALAEMIA,1
NZ,HYPONATRAEMIA,1
NZ,HYPOTENSION,1
NZ,HYPOXIA,1
NZ,IGA NEPHROPATHY,1
NZ,INFUSION RELATED REACTION,1
NZ,INJECTION SITE PAIN,1
NZ,INTERVERTEBRAL DISC PROTRUSION,1
NZ,INTESTINAL RESECTION,1
NZ,JOINT SWELLING,1
NZ,LIMB DISCOMFORT,1
NZ,LOCALISED INFECTION,1
NZ,MALIGNANT MELANOMA,1
NZ,MELAENA,1
NZ,METASTASES TO CENTRAL NERVOUS SYSTEM,1
NZ,MIGRAINE,1
NZ,MOBILITY DECREASED,1
NZ,MUSCLE NECROSIS,1
NZ,MUSCLE STRAIN,1
NZ,MUSCLE TWITCHING,1
NZ,MUSCULOSKELETAL PAIN,1
NZ,MUSCULOSKELETAL STIFFNESS,1
NZ,MYOCARDITIS,1
NZ,NASOPHARYNGITIS,1
NZ,NEOPLASM MALIGNANT,1
NZ,NEPHRITIS,1
NZ,NEUTROPENIC SEPSIS,1
NZ,NON-CARDIAC CHEST PAIN,1
NZ,OESOPHAGITIS CHEMICAL,1
NZ,OESOPHAGITIS ULCERATIVE,1
NZ,OROPHARYNGEAL PAIN,1
NZ,ORTHOSTATIC HYPOTENSION,1
NZ,OVERDOSE,1
NZ,PELVIC PAIN,1
NZ,PHARYNGITIS STREPTOCOCCAL,1
NZ,PHOTOSENSITIVITY REACTION,1
NZ,PLASMA CELL MYELOMA,1
NZ,PRURITUS,1
NZ,PULSE ABNORMAL,1
NZ,RASH,1
NZ,RASH ERYTHEMATOUS,1
NZ,REFLUX GASTRITIS,1
NZ,RENAL FAILURE,1
NZ,RESPIRATORY DISTRESS,1
NZ,RETINAL VASCULITIS,1
NZ,RETROPERITONEAL HAEMATOMA,1
NZ,SCIATICA,1
NZ,SECONDARY ADRENOCORTICAL INSUFFICIENCY,1
NZ,SHOCK,1
NZ,SINUSITIS,1
NZ,SPINAL CORD DISORDER,1
NZ,STREPTOCOCCAL INFECTION,1
NZ,STRESS,1
NZ,SUICIDE ATTEMPT,1
NZ,SURGERY,1
NZ,SYNCOPE,1
NZ,TUMOUR FLARE,1
NZ,URINE ODOUR ABNORMAL,1
NZ,UVEITIS,1
NZ,VIRAL MYOCARDITIS,1
NZ,VOMITING,1
NG,PROCEDURAL HYPOTENSION,1
NG,THROMBOPHLEBITIS,1
NO,DEATH,9
NO,HAEMORRHAGE,3
NO,TRANSAMINASES INCREASED,3
NO,TOXICITY TO VARIOUS AGENTS,2
NO,ADDISON^S DISEASE,1
NO,ANXIETY,1
NO,ARTHRITIS BACTERIAL,1
NO,ASTHMA,1
NO,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
NO,C-REACTIVE PROTEIN ABNORMAL,1
NO,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
NO,CONFUSIONAL STATE,1
NO,DEPRESSION,1
NO,DYSPHAGIA,1
NO,DYSPNOEA,1
NO,FATIGUE,1
NO,FEMUR FRACTURE,1
NO,FIBRIN D DIMER INCREASED,1
NO,GENERALISED ANXIETY DISORDER,1
NO,HEPATIC ENZYME INCREASED,1
NO,HYPERHIDROSIS,1
NO,HYPERVENTILATION,1
NO,JC VIRUS TEST POSITIVE,1
NO,LEUKOCYTOSIS,1
NO,MALIGNANT NEOPLASM PROGRESSION,1
NO,MALNUTRITION,1
NO,MUSCLE RIGIDITY,1
NO,MUSCLE SPASMS,1
NO,MUSCULOSKELETAL STIFFNESS,1
NO,MYOPATHY,1
NO,NEUROLEPTIC MALIGNANT SYNDROME,1
NO,NEUTROPHILIA,1
NO,OVARIAN CYST,1
NO,PAIN,1
NO,PANIC DISORDER WITH AGORAPHOBIA,1
NO,PNEUMONIA,1
NO,PRODUCT USE IN UNAPPROVED INDICATION,1
NO,PYREXIA,1
NO,SKIN PAPILLOMA,1
NO,SPINAL CORD INFARCTION,1
NO,URINARY TRACT INFECTION BACTERIAL,1
PK,DRUG-INDUCED LIVER INJURY,1
PK,HEPATIC FAILURE,1
PK,STEVENS-JOHNSON SYNDROME,1
PK,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,1
PK,TOXIC EPIDERMAL NECROLYSIS,1
PS,AUTOIMMUNE HEPATITIS,1
PS,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
PS,INFECTIOUS MONONUCLEOSIS,1
PA,HYPOAESTHESIA,3
PA,MULTIPLE SCLEROSIS RELAPSE,3
PA,ABDOMINAL DISCOMFORT,2
PA,MEMORY IMPAIRMENT,2
PA,PAIN,2
PA,STRESS,2
PA,AMNESIA,1
PA,AMNIOTIC FLUID VOLUME DECREASED,1
PA,ASTIGMATISM,1
PA,BLADDER SPHINCTER ATONY,1
PA,BLOOD PRESSURE DECREASED,1
PA,BRADYARRHYTHMIA,1
PA,BRAIN OEDEMA,1
PA,CENTRAL NERVOUS SYSTEM LESION,1
PA,CHOLECYSTITIS ACUTE,1
PA,COORDINATION ABNORMAL,1
PA,DELIVERY,1
PA,DIPLEGIA,1
PA,DIZZINESS,1
PA,DYSKINESIA,1
PA,DYSSTASIA,1
PA,ERYTHEMA,1
PA,FALL,1
PA,GAIT DISTURBANCE,1
PA,GALLBLADDER DISORDER,1
PA,GASTRITIS,1
PA,HEMIPLEGIA,1
PA,HYPERHIDROSIS,1
PA,HYPERTENSION,1
PA,HYPERTENSIVE CRISIS,1
PA,HYPOTENSION,1
PA,INFLUENZA,1
PA,INTERVERTEBRAL DISC PROTRUSION,1
PA,LIMB DISCOMFORT,1
PA,LOSS OF CONSCIOUSNESS,1
PA,MALAISE,1
PA,MATERNAL EXPOSURE DURING PREGNANCY,1
PA,MELANOCYTIC NAEVUS,1
PA,MIGRAINE,1
PA,MOUTH HAEMORRHAGE,1
PA,MOVEMENT DISORDER,1
PA,MUSCLE CONTRACTIONS INVOLUNTARY,1
PA,MUSCLE RIGIDITY,1
PA,MYALGIA,1
PA,MYOPIA,1
PA,NEURALGIA,1
PA,NUCHAL RIGIDITY,1
PA,OEDEMA,1
PA,OPHTHALMOPLEGIA,1
PA,OPTIC NEURITIS,1
PA,PAIN IN EXTREMITY,1
PA,PALLOR,1
PA,PREMATURE DELIVERY,1
PA,PREMATURE LABOUR,1
PA,RASH,1
PA,RESPIRATORY DISTRESS,1
PA,RESPIRATORY FAILURE,1
PA,SEIZURE,1
PA,TACHYPNOEA,1
PA,URINARY INCONTINENCE,1
PA,VISUAL IMPAIRMENT,1
PE,HEADACHE,3
PE,PAIN,3
PE,PERIPHERAL SWELLING,3
PE,CONDITION AGGRAVATED,2
PE,MALAISE,2
PE,PAIN IN EXTREMITY,2
PE,PYREXIA,2
PE,ABDOMINAL PAIN UPPER,1
PE,ANAEMIA,1
PE,ASTHENIA,1
PE,BRONCHITIS,1
PE,CELLULITIS,1
PE,CEREBRAL INFARCTION,1
PE,CEREBROVASCULAR ACCIDENT,1
PE,CHILLS,1
PE,CHRONIC GASTRITIS,1
PE,CONSTIPATION,1
PE,CONVULSION,1
PE,COUGH,1
PE,CRYING,1
PE,DIARRHOEA,1
PE,DISEASE PROGRESSION,1
PE,DISORIENTATION,1
PE,DIZZINESS,1
PE,DYSPNOEA,1
PE,ERYTHEMA,1
PE,FALL,1
PE,FATIGUE,1
PE,FEMUR FRACTURE,1
PE,GAIT DISTURBANCE,1
PE,GASTRIC ULCER,1
PE,HAEMOGLOBIN DECREASED,1
PE,HEMIPARESIS,1
PE,HEPATIC CIRRHOSIS,1
PE,HEPATOMEGALY,1
PE,HIATUS HERNIA,1
PE,HYPERHIDROSIS,1
PE,HYPOTENSION,1
PE,IMMUNE SYSTEM DISORDER,1
PE,INFECTION,1
PE,INTERSTITIAL LUNG DISEASE,1
PE,IRON DEFICIENCY ANAEMIA,1
PE,LEUKOPENIA,1
PE,LOWER GASTROINTESTINAL HAEMORRHAGE,1
PE,MOBILITY DECREASED,1
PE,PALLOR,1
PE,PLATELET COUNT DECREASED,1
PE,PLEURAL EFFUSION,1
PE,PNEUMONIA,1
PE,PROCTALGIA,1
PE,PRODUCTIVE COUGH,1
PE,PRURITUS,1
PE,PYELONEPHRITIS ACUTE,1
PE,RASH ERYTHEMATOUS,1
PE,SKIN DISCOLOURATION,1
PE,SKIN DISORDER,1
PE,SUDDEN DEATH,1
PE,TREMOR,1
PE,URINARY TRACT INFECTION,1
PE,VIRAL INFECTION,1
PH,CONVULSION,1
PH,DEHYDRATION,1
PH,DIARRHOEA,1
PH,FEEDING DISORDER,1
PH,HYPOCALCAEMIA,1
PH,IMPAIRED HEALING,1
PH,INTESTINAL OBSTRUCTION,1
PH,METASTASES TO LIVER,1
PH,PEMPHIGOID,1
PH,PULMONARY TUBERCULOSIS,1
PH,SEPSIS,1
PL,TOXICITY TO VARIOUS AGENTS,8
PL,ANAEMIA,6
PL,OVERDOSE,5
PL,ABDOMINAL PAIN UPPER,3
PL,ACUTE HEPATIC FAILURE,3
PL,ASTHENIA,3
PL,CARDIOPULMONARY FAILURE,3
PL,DRUG-INDUCED LIVER INJURY,3
PL,HYPOTENSION,3
PL,LEUKOPENIA,3
PL,NEUTROPENIA,3
PL,SUICIDE ATTEMPT,3
PL,ALANINE AMINOTRANSFERASE INCREASED,2
PL,ASPARTATE AMINOTRANSFERASE INCREASED,2
PL,BLOOD BILIRUBIN INCREASED,2
PL,CATARACT,2
PL,DEATH,2
PL,DRUG INEFFECTIVE,2
PL,GENERAL PHYSICAL HEALTH DETERIORATION,2
PL,LARYNGEAL SQUAMOUS CELL CARCINOMA,2
PL,PYREXIA,2
PL,TRANSAMINASES INCREASED,2
PL,ACCIDENTAL OVERDOSE,1
PL,ACUTE MYELOID LEUKAEMIA,1
PL,ACUTE RESPIRATORY FAILURE,1
PL,ALCOHOL INTERACTION,1
PL,APLASIA,1
PL,BLADDER TAMPONADE,1
PL,BRAIN DEATH,1
PL,CARDIAC FAILURE,1
PL,CIRRHOSIS ALCOHOLIC,1
PL,COAGULOPATHY,1
PL,COMA HEPATIC,1
PL,CONFUSIONAL STATE,1
PL,DECREASED APPETITE,1
PL,DYSMENORRHOEA,1
PL,EPISTAXIS,1
PL,FALL,1
PL,FATIGUE,1
PL,FRACTURE,1
PL,GASTROINTESTINAL HAEMORRHAGE,1
PL,HAEMATURIA,1
PL,HAEMODIALYSIS,1
PL,HEPATIC ENCEPHALOPATHY,1
PL,HEPATIC FAILURE,1
PL,HYPERTENSIVE HEART DISEASE,1
PL,INFECTIOUS PLEURAL EFFUSION,1
PL,LARYNGEAL CANCER STAGE I,1
PL,LIVER FUNCTION TEST INCREASED,1
PL,LUNG ABSCESS,1
PL,LYMPHOPENIA,1
PL,MALIGNANT NEOPLASM PROGRESSION,1
PL,MENINGITIS,1
PL,MOUTH HAEMORRHAGE,1
PL,MYOCARDITIS,1
PL,NO THERAPEUTIC RESPONSE,1
PL,ORAL DISORDER,1
PL,PLEURAL EFFUSION,1
PL,PNEUMONIA NECROTISING,1
PL,POISONING,1
PL,PORPHYRIA ACUTE,1
PL,PULMONARY EMBOLISM,1
PL,PYELONEPHRITIS ACUTE,1
PL,RENAL FAILURE,1
PL,RENAL FAILURE ACUTE,1
PL,RENAL FAILURE CHRONIC,1
PL,RENAL IMPAIRMENT,1
PL,RESPIRATORY DISORDER,1
PL,SEPTIC SHOCK,1
PL,SERUM FERRITIN INCREASED,1
PL,SKIN DISORDER,1
PL,SKULL FRACTURE,1
PL,SOMNOLENCE,1
PL,STEVENS-JOHNSON SYNDROME,1
PL,THROAT LESION,1
PL,VENOOCCLUSIVE LIVER DISEASE,1
PT,HYPOTENSION,6
PT,PRURITUS,5
PT,URTICARIA,5
PT,ANAPHYLACTIC REACTION,3
PT,ANGIOEDEMA,3
PT,DRUG HYPERSENSITIVITY,3
PT,DYSPNOEA,3
PT,FATIGUE,3
PT,ANAEMIA,2
PT,BRADYCARDIA,2
PT,CHROMATURIA,2
PT,CIRCULATORY COLLAPSE,2
PT,DYSGEUSIA,2
PT,ERYTHEMA,2
PT,HEPATIC FUNCTION ABNORMAL,2
PT,HEPATITIS TOXIC,2
PT,MALAISE,2
PT,MUCOUS MEMBRANE DISORDER,2
PT,RASH GENERALISED,2
PT,TACHYCARDIA,2
PT,THROMBOCYTOPENIA,2
PT,TOXIC EPIDERMAL NECROLYSIS,2
PT,TOXICITY TO VARIOUS AGENTS,2
PT,WHITE BLOOD CELLS URINE POSITIVE,2
PT,ABDOMINAL PAIN,1
PT,ACUTE HEPATIC FAILURE,1
PT,AFFECT LABILITY,1
PT,ALLERGY TEST POSITIVE,1
PT,ALLERGY TO METALS,1
PT,ANAPHYLACTIC SHOCK,1
PT,ANOSMIA,1
PT,ARTHRITIS INFECTIVE,1
PT,AUTOIMMUNE HEPATITIS,1
PT,BACK PAIN,1
PT,BLISTER,1
PT,BLOOD ALKALINE PHOSPHATASE INCREASED,1
PT,BRONCHOSPASM,1
PT,CARDIAC ARREST,1
PT,CHOLURIA,1
PT,CONDITION AGGRAVATED,1
PT,DEPRESSION,1
PT,DERMATITIS,1
PT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
PT,DRUG-INDUCED LIVER INJURY,1
PT,EPILEPSY,1
PT,EXPOSURE DURING PREGNANCY,1
PT,EYELID MYOCLONUS,1
PT,EYELID OEDEMA,1
PT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
PT,GENERALISED TONIC-CLONIC SEIZURE,1
PT,HAEMORRHAGIC STROKE,1
PT,HYPERTENSION,1
PT,HYPOXIA,1
PT,INFECTIOUS PLEURAL EFFUSION,1
PT,INTENTIONAL OVERDOSE,1
PT,JAUNDICE,1
PT,LARYNGEAL OEDEMA,1
PT,LIBIDO DISORDER,1
PT,LICHENOID KERATOSIS,1
PT,LINEAR IGA DISEASE,1
PT,LIP OEDEMA,1
PT,MATERNAL EXPOSURE BEFORE PREGNANCY,1
PT,MATERNAL EXPOSURE DURING PREGNANCY,1
PT,METASTASES TO CENTRAL NERVOUS SYSTEM,1
PT,METHAEMOGLOBINAEMIA,1
PT,MUCOSAL DRYNESS,1
PT,NEUROLEPTIC MALIGNANT SYNDROME,1
PT,OEDEMA,1
PT,PACKED RED BLOOD CELL TRANSFUSION,1
PT,PLEURAL EFFUSION,1
PT,PNEUMONIA,1
PT,POISONING,1
PT,PRESCRIBED OVERDOSE,1
PT,PRODUCT USE IN UNAPPROVED INDICATION,1
PT,PRODUCT USE ISSUE,1
PT,RED BLOOD CELL SEDIMENTATION RATE INCREASED,1
PT,RENAL TUBULAR NECROSIS,1
PT,RESPIRATORY DISORDER,1
PT,RESPIRATORY DISTRESS,1
PT,SKIN LESION,1
PT,SKIN ULCER,1
PT,SKIN WOUND,1
PT,SPINAL CORD HAEMATOMA,1
PT,STAPHYLOCOCCAL INFECTION,1
PT,SURGERY,1
PT,SWELLING FACE,1
PT,THERAPEUTIC RESPONSE UNEXPECTED,1
PT,TONGUE OEDEMA,1
PT,TREMOR,1
PT,VENOUS THROMBOSIS,1
PT,VENTRICULAR FIBRILLATION,1
PT,VOMITING,1
PR,HEADACHE,10
PR,ASTHENIA,9
PR,DIZZINESS,9
PR,NASOPHARYNGITIS,9
PR,PAIN,9
PR,INJECTION SITE PAIN,8
PR,NAUSEA,7
PR,PAIN IN EXTREMITY,7
PR,PYREXIA,7
PR,MALAISE,6
PR,PRURITUS,6
PR,ARTHRALGIA,5
PR,DIARRHOEA,5
PR,FATIGUE,5
PR,ASTHMA,4
PR,BACK PAIN,4
PR,CHIKUNGUNYA VIRUS INFECTION,4
PR,DRUG INEFFECTIVE,4
PR,INFLAMMATION,4
PR,INJECTION SITE INFLAMMATION,4
PR,PERIPHERAL SWELLING,4
PR,VOMITING,4
PR,ARTHRITIS,3
PR,COUGH,3
PR,HAEMOGLOBIN DECREASED,3
PR,HYPERSENSITIVITY,3
PR,INFLUENZA,3
PR,INJECTION SITE ERYTHEMA,3
PR,INSOMNIA,3
PR,MUSCLE SPASMS,3
PR,PLATELET COUNT DECREASED,3
PR,PSORIASIS,3
PR,URINARY TRACT INFECTION,3
PR,WHITE BLOOD CELL COUNT DECREASED,3
PR,ACUTE HEPATIC FAILURE,2
PR,ALOPECIA,2
PR,BEDRIDDEN,2
PR,CELLULITIS,2
PR,CHEST PAIN,2
PR,CONSTIPATION,2
PR,DECREASED APPETITE,2
PR,DEPRESSED MOOD,2
PR,ERYTHEMA,2
PR,FALL,2
PR,GASTROINTESTINAL INFLAMMATION,2
PR,GLOSSODYNIA,2
PR,HYPERHIDROSIS,2
PR,HYPERTENSION,2
PR,INJECTION SITE HAEMATOMA,2
PR,INJECTION SITE PRURITUS,2
PR,INJECTION SITE SWELLING,2
PR,INJECTION SITE URTICARIA,2
PR,INJECTION SITE WARMTH,2
PR,MYALGIA,2
PR,OEDEMA PERIPHERAL,2
PR,PHARYNGITIS,2
PR,SKIN EXFOLIATION,2
PR,SOMNOLENCE,2
PR,THYROID CANCER,2
PR,UNEVALUABLE EVENT,2
PR,WEIGHT DECREASED,2
PR,ABDOMINAL DISCOMFORT,1
PR,ABDOMINAL PAIN,1
PR,ABDOMINAL PAIN UPPER,1
PR,AGEUSIA,1
PR,AGGRESSION,1
PR,ALANINE AMINOTRANSFERASE INCREASED,1
PR,ALLERGIC OEDEMA,1
PR,ASPARTATE AMINOTRANSFERASE INCREASED,1
PR,ATELECTASIS,1
PR,AXILLARY MASS,1
PR,BALANCE DISORDER,1
PR,BENIGN HEPATIC NEOPLASM,1
PR,BLISTER,1
PR,BLOOD GLUCOSE DECREASED,1
PR,BLOOD GLUCOSE INCREASED,1
PR,BLOOD PRESSURE INCREASED,1
PR,BLOOD TEST ABNORMAL,1
PR,BONE PAIN,1
PR,BURNING SENSATION,1
PR,CARDIAC FAILURE CONGESTIVE,1
PR,CARDIO-RESPIRATORY ARREST,1
PR,CERUMEN IMPACTION,1
PR,CHILLS,1
PR,CHOLECYSTITIS ACUTE,1
PR,CHOLELITHIASIS,1
PR,CHRONIC GASTRITIS,1
PR,CONDITION AGGRAVATED,1
PR,CONTUSION,1
PR,COXSACKIE VIRAL INFECTION,1
PR,CROHN^S DISEASE,1
PR,CYST,1
PR,DENGUE FEVER,1
PR,DERMATITIS ALLERGIC,1
PR,DIABETES MELLITUS,1
PR,DISORIENTATION,1
PR,DIZZINESS POSTURAL,1
PR,DRUG ADMINISTRATION ERROR,1
PR,DRUG DOSE OMISSION,1
PR,DRUG EFFECT INCOMPLETE,1
PR,DRUG HYPERSENSITIVITY,1
PR,DRUG PRESCRIBING ERROR,1
PR,DYSGEUSIA,1
PR,DYSPEPSIA,1
PR,DYSPNOEA,1
PR,EAR INFECTION,1
PR,EYE SWELLING,1
PR,FAECES SOFT,1
PR,FEELING ABNORMAL,1
PR,FEELING HOT,1
PR,FOOD INTOLERANCE,1
PR,GAIT DISTURBANCE,1
PR,GASTROINTESTINAL HAEMORRHAGE,1
PR,GASTROOESOPHAGEAL REFLUX DISEASE,1
PR,GLAUCOMA,1
PR,HAEMATOCRIT DECREASED,1
PR,HAEMATURIA,1
PR,HAEMODIALYSIS,1
PR,HAEMOPTYSIS,1
PR,HAEMORRHAGE,1
PR,HAIR COLOUR CHANGES,1
PR,HAIR DISORDER,1
PR,HAIR TEXTURE ABNORMAL,1
PR,HEAD INJURY,1
PR,HEPATIC ENZYME INCREASED,1
PR,HERNIA,1
PR,HYPOAESTHESIA,1
PR,IMMUNE SYSTEM DISORDER,1
PR,IMMUNODEFICIENCY,1
PR,INADEQUATE ANALGESIA,1
PR,INCORRECT DOSE ADMINISTERED,1
PR,INJECTION SITE BRUISING,1
PR,INJECTION SITE DISCOMFORT,1
PR,INJECTION SITE HAEMORRHAGE,1
PR,INJECTION SITE INDURATION,1
PR,INJECTION SITE PAPULE,1
PR,INJECTION SITE RASH,1
PR,INJECTION SITE VESICLES,1
PR,INJURY ASSOCIATED WITH DEVICE,1
PR,INTERVERTEBRAL DISC PROTRUSION,1
PR,JAUNDICE,1
PR,JOINT DISLOCATION,1
PR,KNEE ARTHROPLASTY,1
PR,LUNG DISORDER,1
PR,MADAROSIS,1
PR,METABOLIC ACIDOSIS,1
PR,MIGRAINE,1
PR,MUSCULOSKELETAL PAIN,1
PR,NECK PAIN,1
PR,NEOPLASM PROGRESSION,1
PR,NONINFECTIVE GINGIVITIS,1
PR,OPTIC NEURITIS,1
PR,ORAL DISCOMFORT,1
PR,ORAL FUNGAL INFECTION,1
PR,ORAL PAIN,1
PR,OROPHARYNGEAL PAIN,1
PR,OVERDOSE,1
PR,PALLOR,1
PR,PERIORBITAL OEDEMA,1
PR,PERIPHERAL VASCULAR DISORDER,1
PR,PHLEBITIS,1
PR,PROCTALGIA,1
PR,PRODUCT QUALITY ISSUE,1
PR,PRODUCT USE IN UNAPPROVED INDICATION,1
PR,PRODUCT USE ISSUE,1
PR,PRODUCTIVE COUGH,1
PR,PROTEINURIA,1
PR,PRURITUS GENERALISED,1
PR,PUSTULAR PSORIASIS,1
PR,RASH,1
PR,RASH ERYTHEMATOUS,1
PR,RECTAL HAEMORRHAGE,1
PR,RED BLOOD CELL COUNT DECREASED,1
PR,RENAL IMPAIRMENT,1
PR,RESPIRATORY ACIDOSIS,1
PR,RESPIRATORY DISTRESS,1
PR,RESPIRATORY TRACT CONGESTION,1
PR,ROAD TRAFFIC ACCIDENT,1
PR,SEPTIC SHOCK,1
PR,SINUSITIS,1
PR,SKIN DISCOLOURATION,1
PR,SKIN FISSURES,1
PR,SKIN ULCER,1
PR,SPINAL DISORDER,1
PR,STAPHYLOCOCCAL INFECTION,1
PR,STOMA SITE ABSCESS,1
PR,STOMA SITE CELLULITIS,1
PR,STOMA SITE INFLAMMATION,1
PR,SWELLING,1
PR,SWELLING FACE,1
PR,SYNCOPE,1
PR,TENDON PAIN,1
PR,THERMAL BURN,1
PR,THYROID DISORDER,1
PR,THYROID NEOPLASM,1
PR,TINNITUS,1
PR,TREMOR,1
PR,TYPE 2 DIABETES MELLITUS,1
PR,VISION BLURRED,1
PR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
PR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
RO,ACUTE HEPATIC FAILURE,1
RO,ALVEOLITIS,1
RO,BACTERIAL INFECTION,1
RO,CEREBELLAR ATROPHY,1
RO,CHOLECYSTITIS ACUTE,1
RO,CHOLESTASIS,1
RO,CLOSTRIDIUM DIFFICILE COLITIS,1
RO,ENZYME LEVEL DECREASED,1
RO,ESCHERICHIA URINARY TRACT INFECTION,1
RO,GASTRITIS,1
RO,HEPATOCELLULAR INJURY,1
RO,HYPERCORTICOIDISM,1
RO,INFECTION,1
RO,INTERSTITIAL LUNG DISEASE,1
RO,LABORATORY TEST ABNORMAL,1
RO,LIVER DISORDER,1
RO,LIVER TRANSPLANT REJECTION,1
RO,NEPHROPATHY,1
RO,ORAL HERPES,1
RO,POLYMYOSITIS,1
RO,POSTOPERATIVE DELIRIUM,1
RO,SEPSIS,1
RO,SINUS BRADYCARDIA,1
RO,STAPHYLOCOCCAL SEPSIS,1
RO,SUICIDE ATTEMPT,1
RO,THROMBOCYTOPENIA,1
RO,THROMBOSIS,1
RO,URINARY RETENTION,1
RO,WITHDRAWAL SYNDROME,1
RU,ALANINE AMINOTRANSFERASE INCREASED,2
RU,ASPARTATE AMINOTRANSFERASE INCREASED,2
RU,ATRIAL FIBRILLATION,1
RU,BRONCHITIS VIRAL,1
RU,DYSPNOEA,1
RU,DYSTONIA,1
RU,HAEMORRHAGE,1
RU,HEPATITIS,1
RU,HEPATOTOXICITY,1
RU,HYPERSENSITIVITY,1
RU,LIVER INJURY,1
RU,PNEUMONIA,1
RU,PULMONARY TUBERCULOSIS,1
RU,SCHIZOPHRENIA,1
RU,THROMBOCYTOPENIA,1
RU,TYPE 1 DIABETES MELLITUS,1
SA,ACUTE KIDNEY INJURY,2
SA,ANAPHYLACTIC REACTION,2
SA,DEATH,2
SA,DRUG INEFFECTIVE,2
SA,DYSPNOEA,2
SA,HEPATOTOXICITY,2
SA,HYPERGLYCAEMIA,2
SA,INTENTIONAL OVERDOSE,2
SA,RENAL IMPAIRMENT,2
SA,SUICIDE ATTEMPT,2
SA,VOMITING,2
SA,ABDOMINAL PAIN,1
SA,ADENOIDITIS,1
SA,ANASTOMOTIC STENOSIS,1
SA,BRONCHIAL HYPERREACTIVITY,1
SA,CARDIAC ARREST,1
SA,CEREBROVASCULAR ACCIDENT,1
SA,CYTOMEGALOVIRUS TEST POSITIVE,1
SA,DEHYDRATION,1
SA,DELUSION,1
SA,DIARRHOEA,1
SA,FATIGUE,1
SA,GASTRITIS,1
SA,GASTROINTESTINAL INFECTION,1
SA,GENERALISED TONIC-CLONIC SEIZURE,1
SA,HALLUCINATION,1
SA,HEPATIC ARTERY STENOSIS,1
SA,HEPATIC ENCEPHALOPATHY,1
SA,HEPATIC ENZYME INCREASED,1
SA,HERPES ZOSTER,1
SA,HYPERTENSION,1
SA,HYPOALBUMINAEMIA,1
SA,IMMUNODEFICIENCY,1
SA,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
SA,JUGULAR VEIN THROMBOSIS,1
SA,MALAISE,1
SA,MENTAL DISORDER,1
SA,NAUSEA,1
SA,NEUTROPENIA,1
SA,OVERDOSE,1
SA,POISONING,1
SA,RENAL FAILURE,1
SA,RESPIRATORY DISTRESS,1
SA,SEIZURE,1
SA,TOXICITY TO VARIOUS AGENTS,1
SA,TREATMENT NONCOMPLIANCE,1
SA,URINARY TRACT INFECTION,1
SA,WHITE BLOOD CELL COUNT DECREASED,1
RS,CARDIAC ARREST,1
RS,CARDIAC FAILURE CONGESTIVE,1
RS,HAEMATEMESIS,1
RS,MELAENA,1
RS,RENAL FAILURE,1
RS,SHOCK HAEMORRHAGIC,1
SG,DRUG-INDUCED LIVER INJURY,10
SG,INTENTIONAL OVERDOSE,10
SG,PERIORBITAL OEDEMA,4
SG,ACUTE HEPATIC FAILURE,2
SG,ANGIOEDEMA,2
SG,CHILLS,2
SG,CYTOKINE RELEASE SYNDROME,2
SG,HAEMOLYSIS,2
SG,HYPOTENSION,2
SG,METABOLIC ACIDOSIS,2
SG,OVERDOSE,2
SG,PNEUMONIA,2
SG,SOMNOLENCE,2
SG,TACHYCARDIA,2
SG,ABDOMINAL TENDERNESS,1
SG,ASPERGILLUS INFECTION,1
SG,BLOOD PRESSURE IMMEASURABLE,1
SG,BRADYCARDIA,1
SG,CARDIAC ARREST,1
SG,COLD SWEAT,1
SG,COMA,1
SG,CONFUSIONAL STATE,1
SG,CONVULSION,1
SG,DISEASE PROGRESSION,1
SG,DIZZINESS,1
SG,DYSKINESIA,1
SG,FEBRILE NEUTROPENIA,1
SG,GALLBLADDER PERFORATION,1
SG,GASTRITIS,1
SG,GASTROENTERITIS,1
SG,GASTROINTESTINAL HAEMORRHAGE,1
SG,GLUCOCORTICOID DEFICIENCY,1
SG,GLUCOCORTICOIDS INCREASED,1
SG,HEPATITIS ACUTE,1
SG,HEPATOCELLULAR INJURY,1
SG,HYPERHIDROSIS,1
SG,HYPOAESTHESIA,1
SG,HYPOGLYCAEMIA,1
SG,LACTIC ACIDOSIS,1
SG,LIVER FUNCTION TEST ABNORMAL,1
SG,MYELODYSPLASTIC SYNDROME,1
SG,NAUSEA,1
SG,NEUTROPENIA,1
SG,OXYGEN SATURATION DECREASED,1
SG,PLASMA CELL MYELOMA,1
SG,PRODUCT USE IN UNAPPROVED INDICATION,1
SG,PYREXIA,1
SG,RASH,1
SG,RESPIRATORY FAILURE,1
SG,SEPSIS,1
SG,SWELLING FACE,1
SG,T-CELL LYMPHOMA RECURRENT,1
SG,THINKING ABNORMAL,1
SG,TOXIC EPIDERMAL NECROLYSIS,1
SI,HEPATIC ENZYME ABNORMAL,1
SI,PNEUMONIA,1
ZA,ANAEMIA,2
ZA,DEATH,2
ZA,ABORTION INDUCED,1
ZA,ABORTION SPONTANEOUS,1
ZA,APHAGIA,1
ZA,ASTHENIA,1
ZA,CAESAREAN SECTION,1
ZA,CARDIOMYOPATHY,1
ZA,CONFUSIONAL STATE,1
ZA,CONVULSION,1
ZA,COUGH,1
ZA,DEEP VEIN THROMBOSIS,1
ZA,DELAYED RECOVERY FROM ANAESTHESIA,1
ZA,DIARRHOEA,1
ZA,DIZZINESS,1
ZA,DRUG LEVEL DECREASED,1
ZA,DYSPHAGIA,1
ZA,DYSPNOEA,1
ZA,EAR PAIN,1
ZA,EATING DISORDER,1
ZA,ECTOPIC PREGNANCY,1
ZA,FATIGUE,1
ZA,FOETAL EXPOSURE DURING PREGNANCY,1
ZA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
ZA,GASTRIC HAEMORRHAGE,1
ZA,HAEMODYNAMIC INSTABILITY,1
ZA,HEADACHE,1
ZA,HEPATOTOXICITY,1
ZA,HYPERHIDROSIS,1
ZA,HYPOKALAEMIA,1
ZA,INTENTIONAL OVERDOSE,1
ZA,JAUNDICE CHOLESTATIC,1
ZA,JOINT SWELLING,1
ZA,MATERNAL EXPOSURE DURING PREGNANCY,1
ZA,MUSCULAR WEAKNESS,1
ZA,NAUSEA,1
ZA,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
ZA,OEDEMA PERIPHERAL,1
ZA,PAIN IN EXTREMITY,1
ZA,PREGNANCY,1
ZA,PREGNANCY ON CONTRACEPTIVE,1
ZA,PREMATURE BABY,1
ZA,PREMATURE DELIVERY,1
ZA,PULMONARY EMBOLISM,1
ZA,PYREXIA,1
ZA,RENAL FAILURE,1
ZA,STATUS EPILEPTICUS,1
ZA,THROAT IRRITATION,1
ZA,VOMITING,1
ZA,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
ES,PYREXIA,16
ES,ACUTE HEPATIC FAILURE,11
ES,ASTHENIA,10
ES,NEUTROPENIA,10
ES,PSYCHOTIC DISORDER,10
ES,THROMBOCYTOPENIA,10
ES,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,9
ES,ANAEMIA,8
ES,PLEURAL EFFUSION,8
ES,HYPERTENSION,7
ES,METABOLIC ACIDOSIS,7
ES,RASH PRURITIC,7
ES,RESPIRATORY FAILURE,7
ES,DIZZINESS,6
ES,HEPATIC ENCEPHALOPATHY,6
ES,HYPOTENSION,6
ES,OVERDOSE,6
ES,PRURITUS,6
ES,RASH,6
ES,STEVENS-JOHNSON SYNDROME,6
ES,TOXIC EPIDERMAL NECROLYSIS,6
ES,TOXICITY TO VARIOUS AGENTS,6
ES,DRUG INEFFECTIVE,5
ES,HEADACHE,5
ES,RENAL FAILURE,5
ES,URTICARIA,5
ES,VOMITING,5
ES,ABDOMINAL PAIN,4
ES,ACUTE MYOCARDIAL INFARCTION,4
ES,ANGIOEDEMA,4
ES,ASTHMA,4
ES,CONDITION AGGRAVATED,4
ES,DEATH,4
ES,DELUSION,4
ES,FEBRILE NEUTROPENIA,4
ES,HALLUCINATION_ VISUAL,4
ES,HEPATOMEGALY,4
ES,HYPERSENSITIVITY,4
ES,HYPERTHYROIDISM,4
ES,PANCYTOPENIA,4
ES,PNEUMONIA,4
ES,PNEUMONITIS,4
ES,SEPSIS,4
ES,STRESS CARDIOMYOPATHY,4
ES,ABDOMINAL PAIN UPPER,3
ES,ACUTE KIDNEY INJURY,3
ES,ANAPHYLACTIC REACTION,3
ES,ANXIETY,3
ES,ARTHRALGIA,3
ES,BACK PAIN,3
ES,DEEP VEIN THROMBOSIS,3
ES,DEPRESSION,3
ES,DRUG INTOLERANCE,3
ES,DYSPNOEA,3
ES,EPILEPSY,3
ES,ERYTHEMA MULTIFORME,3
ES,FALL,3
ES,GASTROENTERITIS,3
ES,HEPATOTOXICITY,3
ES,INFECTION,3
ES,INSOMNIA,3
ES,INTENTIONAL OVERDOSE,3
ES,IRRITABILITY,3
ES,MALAISE,3
ES,MATERNAL DRUGS AFFECTING FOETUS,3
ES,NAUSEA,3
ES,NEUROPATHY PERIPHERAL,3
ES,PAIN IN EXTREMITY,3
ES,POISONING,3
ES,PSYCHOTIC DISORDER DUE TO A GENERAL MEDICAL CONDITION,3
ES,RENAL FAILURE ACUTE,3
ES,RESPIRATORY TRACT INFECTION,3
ES,SUICIDAL IDEATION,3
ES,TINNITUS,3
ES,URINARY TRACT INFECTION,3
ES,WEIGHT DECREASED,3
ES,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,2
ES,AGGRESSION,2
ES,AGRANULOCYTOSIS,2
ES,ARTHRITIS,2
ES,B-CELL LYMPHOMA RECURRENT,2
ES,BLOOD ALKALINE PHOSPHATASE INCREASED,2
ES,BLOOD CREATININE INCREASED,2
ES,BONE PAIN,2
ES,BRONCHOSPASM,2
ES,CARDIAC FAILURE,2
ES,COAGULOPATHY,2
ES,CRYPTORCHISM,2
ES,CYANOSIS,2
ES,DEAFNESS BILATERAL,2
ES,DECREASED APPETITE,2
ES,DELIRIUM,2
ES,DIARRHOEA,2
ES,DISEASE PROGRESSION,2
ES,DRUG HYPERSENSITIVITY,2
ES,EOSINOPHILIA,2
ES,FACE OEDEMA,2
ES,FATIGUE,2
ES,FOETAL EXPOSURE DURING PREGNANCY,2
ES,FOOD INTERACTION,2
ES,HAEMATOTOXICITY,2
ES,HEPATIC FAILURE,2
ES,HEPATITIS,2
ES,HYPOAESTHESIA,2
ES,HYPONATRAEMIA,2
ES,HYPOVENTILATION,2
ES,INFLAMMATION,2
ES,INFLAMMATORY CARCINOMA OF BREAST STAGE IV,2
ES,INFLUENZA,2
ES,INJECTION SITE ERYTHEMA,2
ES,INJECTION SITE PRURITUS,2
ES,LIVER TRANSPLANT,2
ES,LOSS OF CONSCIOUSNESS,2
ES,MOBILITY DECREASED,2
ES,MUSCULOSKELETAL DISCOMFORT,2
ES,NECK PAIN,2
ES,OEDEMA,2
ES,OESOPHAGITIS,2
ES,ORAL PRURITUS,2
ES,PAIN,2
ES,PULMONARY EMBOLISM,2
ES,RENAL IMPAIRMENT,2
ES,RHINITIS,2
ES,SOMNOLENCE,2
ES,SPINAL DISORDER,2
ES,SPINAL PAIN,2
ES,THROMBOPHLEBITIS,2
ES,TONGUE OEDEMA,2
ES,TOXIC NEUROPATHY,2
ES,ABASIA,1
ES,ABORTION SPONTANEOUS,1
ES,ACCIDENTAL OVERDOSE,1
ES,ACNE,1
ES,ACUTE CORONARY SYNDROME,1
ES,ACUTE PSYCHOSIS,1
ES,ACUTE RESPIRATORY DISTRESS SYNDROME,1
ES,ACUTE RESPIRATORY FAILURE,1
ES,ACUTE SINUSITIS,1
ES,AGEUSIA,1
ES,ALANINE AMINOTRANSFERASE INCREASED,1
ES,ALOPECIA,1
ES,ALTERED STATE OF CONSCIOUSNESS,1
ES,ANAEMIA MACROCYTIC,1
ES,APATHY,1
ES,APHASIA,1
ES,APPENDICECTOMY,1
ES,ASPARTATE AMINOTRANSFERASE INCREASED,1
ES,ASPIRIN-EXACERBATED RESPIRATORY DISEASE,1
ES,ATRIAL FIBRILLATION,1
ES,ATROPHIC GLOSSITIS,1
ES,ATYPICAL FEMUR FRACTURE,1
ES,BLADDER SPHINCTER ATONY,1
ES,BLINDNESS,1
ES,BLOOD BILIRUBIN INCREASED,1
ES,BLOOD CALCIUM DECREASED,1
ES,BLOOD CHOLESTEROL DECREASED,1
ES,BLOOD CHOLESTEROL INCREASED,1
ES,BLOOD LACTIC ACID INCREASED,1
ES,BLOOD POTASSIUM DECREASED,1
ES,BLOOD PRESSURE DECREASED,1
ES,BLOOD UREA INCREASED,1
ES,BONE DISORDER,1
ES,BONE MARROW FAILURE,1
ES,BRAIN INJURY,1
ES,CARBON MONOXIDE POISONING,1
ES,CARDIAC FAILURE CONGESTIVE,1
ES,CATARACT,1
ES,CHILLS,1
ES,CHOLANGITIS ACUTE,1
ES,CHOLESTASIS,1
ES,CHOLURIA,1
ES,CHROMATURIA,1
ES,CHRONIC GASTRITIS,1
ES,CHRONIC KIDNEY DISEASE,1
ES,CLAUSTROPHOBIA,1
ES,CLEAR CELL RENAL CELL CARCINOMA,1
ES,CLOSTRIDIUM DIFFICILE INFECTION,1
ES,COMA,1
ES,COMA SCALE ABNORMAL,1
ES,CONFUSIONAL STATE,1
ES,CONSTIPATION,1
ES,CONTUSION,1
ES,COUGH,1
ES,CUTANEOUS VASCULITIS,1
ES,CYST,1
ES,DEAFNESS,1
ES,DECREASED IMMUNE RESPONSIVENESS,1
ES,DEHYDRATION,1
ES,DEPRESSED LEVEL OF CONSCIOUSNESS,1
ES,DEPRESSED MOOD,1
ES,DERMATITIS ATOPIC,1
ES,DISABILITY,1
ES,DISORIENTATION,1
ES,DISTURBANCE IN ATTENTION,1
ES,DRUG ABUSE,1
ES,DRUG DISPENSED TO WRONG PATIENT,1
ES,DRUG EFFECT DECREASED,1
ES,DRUG-INDUCED LIVER INJURY,1
ES,DYSPEPSIA,1
ES,DYSPLASIA,1
ES,DYSPNOEA EXERTIONAL,1
ES,DYSURIA,1
ES,ENCEPHALOPATHY,1
ES,EPISTAXIS,1
ES,EROSIVE DUODENITIS,1
ES,ESCHERICHIA SEPSIS,1
ES,EXOSTOSIS OF JAW,1
ES,EXPOSED BONE IN JAW,1
ES,EXPOSURE DURING PREGNANCY,1
ES,EYE INFECTION,1
ES,EYELID DISORDER,1
ES,FEELING ABNORMAL,1
ES,FIBRINOLYSIS,1
ES,FIBROMYALGIA,1
ES,FLUID RETENTION,1
ES,GAIT DISTURBANCE,1
ES,GASTROINTESTINAL DISORDER,1
ES,GASTROINTESTINAL HAEMORRHAGE,1
ES,GASTROINTESTINAL NECROSIS,1
ES,GASTROINTESTINAL TRACT ADENOMA,1
ES,GENERAL PHYSICAL CONDITION ABNORMAL,1
ES,GENERALISED ERYTHEMA,1
ES,GLOMERULONEPHRITIS,1
ES,HAEMATOCHEZIA,1
ES,HAEMOGLOBIN DECREASED,1
ES,HEPATIC ENZYME INCREASED,1
ES,HEPATIC STEATOSIS,1
ES,HEPATITIS ACUTE,1
ES,HEPATITIS C RNA INCREASED,1
ES,HEPATITIS CHOLESTATIC,1
ES,HEPATITIS TOXIC,1
ES,HERPES ZOSTER,1
ES,HISTIOCYTOSIS HAEMATOPHAGIC,1
ES,HOMICIDAL IDEATION,1
ES,HYPERBILIRUBINAEMIA,1
ES,HYPERNATRAEMIA,1
ES,HYPERSENSITIVITY VASCULITIS,1
ES,HYPOCOAGULABLE STATE,1
ES,IDIOSYNCRATIC DRUG REACTION,1
ES,ILEUS PARALYTIC,1
ES,IMPAIRED HEALING,1
ES,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
ES,INCOHERENT,1
ES,INFLUENZA LIKE ILLNESS,1
ES,INJECTION SITE INFLAMMATION,1
ES,INJECTION SITE JOINT INFECTION,1
ES,INJECTION SITE MASS,1
ES,INJECTION SITE NECROSIS,1
ES,INJECTION SITE RASH,1
ES,INJECTION SITE REACTION,1
ES,INJECTION SITE SWELLING,1
ES,INJURY,1
ES,INTERVERTEBRAL DISC PROTRUSION,1
ES,INTESTINAL STENOSIS,1
ES,INTRA-ABDOMINAL HAEMORRHAGE,1
ES,IRIS ADHESIONS,1
ES,JAUNDICE,1
ES,JOINT EFFUSION,1
ES,KIDNEY INFECTION,1
ES,LACRIMATION INCREASED,1
ES,LACTIC ACIDOSIS,1
ES,LEUKOPENIA,1
ES,LIVER ABSCESS,1
ES,LIVER FUNCTION TEST ABNORMAL,1
ES,LIVER INJURY,1
ES,LYMPHOCYTIC HYPOPHYSITIS,1
ES,LYMPHOEDEMA,1
ES,MALIGNANT NEOPLASM PROGRESSION,1
ES,MANIA,1
ES,MARROW HYPERPLASIA,1
ES,MASTOCYTOSIS,1
ES,MENTAL DISORDER,1
ES,METASTATIC MALIGNANT MELANOMA,1
ES,MICROCYTIC ANAEMIA,1
ES,MUCOSAL INFLAMMATION,1
ES,MULTI-ORGAN FAILURE,1
ES,MULTIPLE DRUG THERAPY,1
ES,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
ES,MUSCLE INJURY,1
ES,MUSCLE RIGIDITY,1
ES,MUSCLE RUPTURE,1
ES,MUSCULOSKELETAL STIFFNESS,1
ES,MYALGIA,1
ES,MYOCARDIAL INFARCTION,1
ES,MYOCLONUS,1
ES,MYOPATHY,1
ES,NECROSIS,1
ES,NEPHROLITHIASIS,1
ES,NEPHROTIC SYNDROME,1
ES,NEUROTOXICITY,1
ES,NEUTROPHIL COUNT DECREASED,1
ES,NEUTROPHILIC DERMATOSIS,1
ES,NUCHAL RIGIDITY,1
ES,ODYNOPHAGIA,1
ES,OEDEMA PERIPHERAL,1
ES,ONYCHOCLASIS,1
ES,OPEN FRACTURE,1
ES,ORAL DISCOMFORT,1
ES,ORAL DISORDER,1
ES,ORAL INFECTION,1
ES,ORAL PAIN,1
ES,ORTHOSTATIC HYPOTENSION,1
ES,OSTEONECROSIS,1
ES,OSTEONECROSIS OF JAW,1
ES,OVARIAN CYST,1
ES,PANCREATITIS,1
ES,PARALYSIS,1
ES,PARANOIA,1
ES,PERICARDIAL EFFUSION,1
ES,PERIPROSTHETIC FRACTURE,1
ES,PERITONITIS,1
ES,PERITONITIS BACTERIAL,1
ES,PHLEBITIS,1
ES,PHOBIA,1
ES,PHOTOPHOBIA,1
ES,PLATELET COUNT DECREASED,1
ES,PNEUMONITIS CHEMICAL,1
ES,POLYP,1
ES,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
ES,PRESCRIBED OVERDOSE,1
ES,PRESCRIBED UNDERDOSE,1
ES,PRODUCT USE IN UNAPPROVED INDICATION,1
ES,PRODUCTIVE COUGH,1
ES,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
ES,PROTEINURIA,1
ES,PSEUDOMONAL BACTERAEMIA,1
ES,PSORIASIS,1
ES,PSYCHOMOTOR HYPERACTIVITY,1
ES,PULMONARY ALVEOLAR HAEMORRHAGE,1
ES,PULMONARY OEDEMA,1
ES,PULSE ABSENT,1
ES,PUNCTURE SITE REACTION,1
ES,RASH ERYTHEMATOUS,1
ES,RASH GENERALISED,1
ES,RASH MACULO-PAPULAR,1
ES,RECTAL HAEMORRHAGE,1
ES,RENAL COLIC,1
ES,RENAL CORTICAL NECROSIS,1
ES,RHABDOMYOLYSIS,1
ES,ROTAVIRUS TEST POSITIVE,1
ES,SALMONELLOSIS,1
ES,SCIATICA,1
ES,SEPTIC SHOCK,1
ES,SEROTONIN SYNDROME,1
ES,SKIN DISCOLOURATION,1
ES,SMALL CELL LUNG CANCER,1
ES,SQUAMOUS CELL CARCINOMA OF THE TONGUE,1
ES,STUPOR,1
ES,SUBDURAL HAEMATOMA,1
ES,SUDDEN HEARING LOSS,1
ES,SUICIDE ATTEMPT,1
ES,SYNCOPE,1
ES,SYSTEMIC LUPUS ERYTHEMATOSUS,1
ES,TENDON DISORDER,1
ES,THERAPEUTIC RESPONSE DELAYED,1
ES,THERAPY NON-RESPONDER,1
ES,THIRST,1
ES,THROMBOCYTOPENIC PURPURA,1
ES,THROMBOSIS,1
ES,TOOTH DISORDER,1
ES,TRANSAMINASES INCREASED,1
ES,TRANSFUSION,1
ES,TREATMENT NONCOMPLIANCE,1
ES,TREMOR,1
ES,TUBULOINTERSTITIAL NEPHRITIS,1
ES,UNDERDOSE,1
ES,UPPER GASTROINTESTINAL HAEMORRHAGE,1
ES,VENTRICULAR SEPTAL DEFECT,1
ES,VERTIGO,1
ES,VISUAL ACUITY REDUCED,1
ES,VISUAL IMPAIRMENT,1
ES,VULVAR EROSION,1
ES,WHITE BLOOD CELL COUNT DECREASED,1
ES,WITHDRAWAL SYNDROME,1
LK,HEPATITIS,1
SE,TOXICITY TO VARIOUS AGENTS,9
SE,ACCIDENTAL OVERDOSE,7
SE,OVERDOSE,5
SE,COMPLETED SUICIDE,2
SE,LIVER INJURY,2
SE,PULMONARY OEDEMA,2
SE,ACCIDENTAL DEATH,1
SE,ANXIETY,1
SE,BRAIN INJURY,1
SE,COLON CANCER,1
SE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
SE,DEPRESSED MOOD,1
SE,DRUG ABUSE,1
SE,DRUG INEFFECTIVE,1
SE,FEBRILE NEUTROPENIA,1
SE,FOETAL EXPOSURE DURING PREGNANCY,1
SE,HALLUCINATION_ VISUAL,1
SE,INJURY,1
SE,INTENTIONAL OVERDOSE,1
SE,INTERVERTEBRAL DISC COMPRESSION,1
SE,LACTIC ACIDOSIS,1
SE,LIP SQUAMOUS CELL CARCINOMA,1
SE,LOSS OF CONSCIOUSNESS,1
SE,MENTAL STATUS CHANGES,1
SE,MIGRAINE,1
SE,NAUSEA,1
SE,PNEUMONIA,1
SE,POISONING,1
SE,PULMONARY CONGESTION,1
SE,RECTAL ADENOCARCINOMA,1
SE,SEPSIS,1
SE,SUICIDAL IDEATION,1
SE,SUICIDE ATTEMPT,1
SE,VENTRICULAR SEPTAL DEFECT,1
CH,SUICIDE ATTEMPT,10
CH,DRUG-INDUCED LIVER INJURY,5
CH,INTENTIONAL OVERDOSE,5
CH,NAUSEA,5
CH,RASH,4
CH,TACHYCARDIA,4
CH,TOXICITY TO VARIOUS AGENTS,4
CH,AGITATION,3
CH,BLOOD CREATINE PHOSPHOKINASE INCREASED,3
CH,COMA,3
CH,DIABETIC KETOACIDOSIS,3
CH,EPISTAXIS,3
CH,EXPOSURE DURING PREGNANCY,3
CH,HYPOTENSION,3
CH,OVERDOSE,3
CH,SINUS BRADYCARDIA,3
CH,SOMNOLENCE,3
CH,BLOOD CREATININE INCREASED,2
CH,BONE PAIN,2
CH,CONFUSIONAL STATE,2
CH,DELIRIUM,2
CH,DIARRHOEA,2
CH,DIZZINESS,2
CH,ELECTROCARDIOGRAM QT PROLONGED,2
CH,EOSINOPHILIA,2
CH,FATIGUE,2
CH,HAEMATOCHEZIA,2
CH,HAEMORRHAGIC ANAEMIA,2
CH,HALLUCINATION,2
CH,HEPATOTOXICITY,2
CH,HYPERTHYROIDISM,2
CH,HYPOKALAEMIA,2
CH,INTERSTITIAL LUNG DISEASE,2
CH,LIVER INJURY,2
CH,MANIA,2
CH,POISONING,2
CH,RHABDOMYOLYSIS,2
CH,SEROTONIN SYNDROME,2
CH,SOPOR,2
CH,THERAPEUTIC RESPONSE INCREASED,2
CH,THYROIDITIS SUBACUTE,2
CH,TRANSAMINASES INCREASED,2
CH,UPPER GASTROINTESTINAL HAEMORRHAGE,2
CH,VOMITING,2
CH,ABDOMINAL PAIN LOWER,1
CH,ABNORMAL BEHAVIOUR,1
CH,ABNORMAL LOSS OF WEIGHT,1
CH,ABORTION INDUCED,1
CH,ACIDOSIS,1
CH,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
CH,ACUTE KIDNEY INJURY,1
CH,ACUTE MYELOID LEUKAEMIA,1
CH,ACUTE MYOCARDIAL INFARCTION,1
CH,AFFECT LABILITY,1
CH,AGGRESSION,1
CH,ALANINE AMINOTRANSFERASE INCREASED,1
CH,AMNIOTIC CAVITY INFECTION,1
CH,ANEURYSM RUPTURED,1
CH,ANOMALY OF EXTERNAL EAR CONGENITAL,1
CH,ARTHRALGIA,1
CH,ASPARTATE AMINOTRANSFERASE INCREASED,1
CH,BEZOAR,1
CH,BLOOD LACTATE DEHYDROGENASE INCREASED,1
CH,BLOOD PRESSURE DECREASED,1
CH,BREAST FEEDING,1
CH,CARDIAC FAILURE,1
CH,CEREBRAL HAEMORRHAGE,1
CH,CHITOTRIOSIDASE INCREASED,1
CH,CHOLELITHIASIS,1
CH,CHOLESTASIS,1
CH,COOMBS NEGATIVE HAEMOLYTIC ANAEMIA,1
CH,DEATH,1
CH,DISINHIBITION,1
CH,DISTURBANCE IN ATTENTION,1
CH,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
CH,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,1
CH,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
CH,DYSPNOEA,1
CH,EJECTION FRACTION DECREASED,1
CH,ELEVATED MOOD,1
CH,ENDOTRACHEAL INTUBATION,1
CH,ENERGY INCREASED,1
CH,EROSIVE OESOPHAGITIS,1
CH,EUPHORIC MOOD,1
CH,EXTRACORPOREAL MEMBRANE OXYGENATION,1
CH,FALL,1
CH,FEMUR FRACTURE,1
CH,FLIGHT OF IDEAS,1
CH,FOETAL EXPOSURE DURING PREGNANCY,1
CH,GASTRIC ULCER,1
CH,GASTROOESOPHAGEAL REFLUX DISEASE,1
CH,GINGIVAL DISORDER,1
CH,GOUTY ARTHRITIS,1
CH,GRANDIOSITY,1
CH,HAEMATEMESIS,1
CH,HAEMOGLOBIN DECREASED,1
CH,HAEMORRHAGE,1
CH,HAEMORRHAGE INTRACRANIAL,1
CH,HEPATIC NECROSIS,1
CH,HEPATITIS,1
CH,HEPATOCELLULAR INJURY,1
CH,HYPERPHOSPHATURIA,1
CH,HYPERSENSITIVITY VASCULITIS,1
CH,HYPERTENSION,1
CH,HYPOMAGNESAEMIA,1
CH,HYPOPHOSPHATAEMIA,1
CH,HYPOPHOSPHATASIA,1
CH,IMPULSIVE BEHAVIOUR,1
CH,INTERNATIONAL NORMALISED RATIO INCREASED,1
CH,IRRITABILITY,1
CH,JAUNDICE,1
CH,LOGORRHOEA,1
CH,LYMPHOPENIA,1
CH,MEDICATION ERROR,1
CH,METABOLIC ACIDOSIS,1
CH,MOBILITY DECREASED,1
CH,MYALGIA,1
CH,MYOCARDIAL INFARCTION,1
CH,MYOGLOBIN BLOOD INCREASED,1
CH,NEPHROLITHIASIS,1
CH,NEUROPATHY PERIPHERAL,1
CH,NEUTROPHILIA,1
CH,ORGANISING PNEUMONIA,1
CH,PANCREATITIS,1
CH,PARAESTHESIA,1
CH,PLATELET COUNT DECREASED,1
CH,PNEUMONIA ASPIRATION,1
CH,PNEUMONIA CYTOMEGALOVIRAL,1
CH,PREMATURE BABY,1
CH,PRESCRIBED OVERDOSE,1
CH,PRODUCT USE ISSUE,1
CH,PROTHROMBIN TIME PROLONGED,1
CH,PRURITUS,1
CH,PSYCHOMOTOR HYPERACTIVITY,1
CH,PULMONARY EMBOLISM,1
CH,PYREXIA,1
CH,RENAL FAILURE,1
CH,RENAL TUBULAR DISORDER,1
CH,RENAL TUBULAR NECROSIS,1
CH,SLEEP APNOEA SYNDROME,1
CH,SLEEP DISORDER,1
CH,TACHYPHRENIA,1
CH,TOOTH LOSS,1
CH,TORSADE DE POINTES,1
CH,TRACHEOSTOMY,1
CH,TRANSAMINASES ABNORMAL,1
CH,TREMOR,1
CH,UNEVALUABLE EVENT,1
CH,VASCULAR PSEUDOANEURYSM RUPTURED,1
CH,WEIGHT DECREASED,1
CH,WOUND HAEMORRHAGE,1
TW,PYREXIA,21
TW,PNEUMONIA,17
TW,PLATELET COUNT DECREASED,10
TW,RASH,9
TW,ABDOMINAL PAIN,8
TW,CELLULITIS,8
TW,DIARRHOEA,8
TW,HYPOKALAEMIA,8
TW,ALANINE AMINOTRANSFERASE INCREASED,7
TW,ALTERED STATE OF CONSCIOUSNESS,7
TW,ANAEMIA,7
TW,COUGH,7
TW,SEPSIS,7
TW,ABDOMINAL DISTENSION,5
TW,BLOOD GLUCOSE INCREASED,5
TW,DIZZINESS,5
TW,FEBRILE NEUTROPENIA,5
TW,HAEMOGLOBIN DECREASED,5
TW,INFLUENZA,5
TW,LARGE INTESTINE PERFORATION,5
TW,PRURITUS,5
TW,SEPTIC SHOCK,5
TW,UPPER RESPIRATORY TRACT INFECTION,5
TW,ACUTE RESPIRATORY FAILURE,4
TW,ASTHENIA,4
TW,BLOOD BILIRUBIN INCREASED,4
TW,COMA,4
TW,DEATH,4
TW,DECREASED APPETITE,4
TW,DYSPNOEA,4
TW,HAEMATOCRIT DECREASED,4
TW,HEPATIC FAILURE,4
TW,LEUKOCYTOSIS,4
TW,LYMPHOCYTE COUNT DECREASED,4
TW,METABOLIC ACIDOSIS,4
TW,OEDEMA PERIPHERAL,4
TW,PANCYTOPENIA,4
TW,PROMYELOCYTE COUNT INCREASED,4
TW,PULMONARY TUBERCULOSIS,4
TW,SHOCK,4
TW,THROMBOCYTOPENIA,4
TW,TOXICITY TO VARIOUS AGENTS,4
TW,WHITE BLOOD CELL COUNT DECREASED,4
TW,ABDOMINAL PAIN UPPER,3
TW,AORTIC CALCIFICATION,3
TW,ASPARTATE AMINOTRANSFERASE INCREASED,3
TW,BASOPHIL COUNT INCREASED,3
TW,C-REACTIVE PROTEIN INCREASED,3
TW,CARDIOMEGALY,3
TW,CHEST DISCOMFORT,3
TW,CHEST PAIN,3
TW,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
TW,CONSTIPATION,3
TW,EPISTAXIS,3
TW,GASTROENTERITIS,3
TW,HAEMATOCHEZIA,3
TW,HEPATOCELLULAR INJURY,3
TW,HYDROCEPHALUS,3
TW,HYPERLIPIDAEMIA,3
TW,INSOMNIA,3
TW,LYMPHOCYTE PERCENTAGE DECREASED,3
TW,MONOCYTE PERCENTAGE INCREASED,3
TW,MYELOCYTE COUNT INCREASED,3
TW,NEUTROPENIA,3
TW,PAIN,3
TW,PANCREATITIS ACUTE,3
TW,PERITONITIS,3
TW,PHARYNGITIS,3
TW,PLEURAL EFFUSION,3
TW,RED BLOOD CELL COUNT DECREASED,3
TW,RED CELL DISTRIBUTION WIDTH INCREASED,3
TW,RESPIRATORY FAILURE,3
TW,RHINORRHOEA,3
TW,SEIZURE,3
TW,SPLENOMEGALY,3
TW,UPPER GASTROINTESTINAL HAEMORRHAGE,3
TW,URINARY TRACT INFECTION,3
TW,VOMITING,3
TW,ABDOMINAL ABSCESS,2
TW,ABDOMINAL PAIN LOWER,2
TW,ACUTE KIDNEY INJURY,2
TW,ACUTE PRERENAL FAILURE,2
TW,AGGRESSION,2
TW,ARTERIOSCLEROSIS CORONARY ARTERY,2
TW,ARTHROPATHY,2
TW,ASCITES,2
TW,ASTHMA,2
TW,ATELECTASIS,2
TW,BACK PAIN,2
TW,BAND NEUTROPHIL COUNT INCREASED,2
TW,BLAST CELL COUNT INCREASED,2
TW,BLOOD ALKALINE PHOSPHATASE INCREASED,2
TW,BLOOD CREATININE INCREASED,2
TW,BLOOD PRESSURE SYSTOLIC INCREASED,2
TW,BRAIN ABSCESS,2
TW,CARBUNCLE,2
TW,CHILLS,2
TW,CLOSTRIDIUM DIFFICILE INFECTION,2
TW,DERMATITIS,2
TW,DIAPHRAGMATIC DISORDER,2
TW,DISSEMINATED INTRAVASCULAR COAGULATION,2
TW,DYSPHAGIA,2
TW,DYSURIA,2
TW,ENTEROCOLITIS INFECTIOUS,2
TW,ERYTHEMA,2
TW,GAIT DISTURBANCE,2
TW,GASTROINTESTINAL WALL THICKENING,2
TW,GASTROOESOPHAGEAL REFLUX DISEASE,2
TW,HAEMOCHROMATOSIS,2
TW,HEADACHE,2
TW,HEPATORENAL FAILURE,2
TW,HYPERGLYCAEMIA,2
TW,HYPERURICAEMIA,2
TW,HYPOTENSION,2
TW,HYPOTHERMIA,2
TW,HYPOTONIA,2
TW,ILEUS,2
TW,INFECTION,2
TW,LIPASE INCREASED,2
TW,LUNG CONSOLIDATION,2
TW,LUNG INFILTRATION,2
TW,LYMPHOCYTE COUNT INCREASED,2
TW,MENINGITIS CRYPTOCOCCAL,2
TW,METAMYELOCYTE COUNT INCREASED,2
TW,METAMYELOCYTE PERCENTAGE INCREASED,2
TW,MOUTH ULCERATION,2
TW,MULTI-ORGAN FAILURE,2
TW,MUSCULAR WEAKNESS,2
TW,MYALGIA,2
TW,MYELOCYTE PERCENTAGE INCREASED,2
TW,NASOPHARYNGITIS,2
TW,NAUSEA,2
TW,NECROTISING FASCIITIS,2
TW,NEUROTOXICITY,2
TW,NEUTROPHIL COUNT INCREASED,2
TW,OVERDOSE,2
TW,PALPITATIONS,2
TW,PANCREATITIS,2
TW,PEPTIC ULCER,2
TW,PERICARDIAL EFFUSION,2
TW,PNEUMONIA ASPIRATION,2
TW,PSEUDOMEMBRANOUS COLITIS,2
TW,PULMONARY FIBROSIS,2
TW,RED BLOOD CELL COUNT INCREASED,2
TW,RENAL FAILURE,2
TW,RHABDOMYOLYSIS,2
TW,SCOLIOSIS,2
TW,SPINAL OSTEOARTHRITIS,2
TW,STOMATITIS,2
TW,SUICIDE ATTEMPT,2
TW,SWELLING,2
TW,SWELLING FACE,2
TW,TOXIC EPIDERMAL NECROLYSIS,2
TW,URINARY RETENTION,2
TW,VERTIGO,2
TW,WHEEZING,2
TW,WOUND COMPLICATION,2
TW,ABDOMINAL ADHESIONS,1
TW,ABDOMINAL HERNIA,1
TW,ABDOMINAL REBOUND TENDERNESS,1
TW,ABDOMINAL RIGIDITY,1
TW,ABDOMINAL TENDERNESS,1
TW,ABDOMINAL WALL CYST,1
TW,ABSCESS,1
TW,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
TW,ACUTE ABDOMEN,1
TW,ACUTE MYELOID LEUKAEMIA,1
TW,ACUTE MYOCARDIAL INFARCTION,1
TW,ACUTE PULMONARY OEDEMA,1
TW,ACUTE RESPIRATORY DISTRESS SYNDROME,1
TW,AGRANULOCYTOSIS,1
TW,AMYLASE INCREASED,1
TW,ANAL ABSCESS,1
TW,ANAL EROSION,1
TW,ANAL FISSURE,1
TW,ANAL HAEMORRHAGE,1
TW,ANAL POLYP,1
TW,ANGIOEDEMA,1
TW,APHTHOUS STOMATITIS,1
TW,APPENDICITIS PERFORATED,1
TW,ARRHYTHMIA,1
TW,ARTHRALGIA,1
TW,ARTHRITIS BACTERIAL,1
TW,ASPIRATION JOINT,1
TW,ATAXIA,1
TW,ATRIAL FIBRILLATION,1
TW,ATRIOVENTRICULAR BLOCK,1
TW,AURA,1
TW,AZOTAEMIA,1
TW,BACTERAEMIA,1
TW,BACTERIAL INFECTION,1
TW,BAKER^S CYST EXCISION,1
TW,BASAL CELL CARCINOMA,1
TW,BASOPHIL PERCENTAGE INCREASED,1
TW,BENIGN PROSTATIC HYPERPLASIA,1
TW,BLADDER CANCER RECURRENT,1
TW,BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT,1
TW,BLISTER,1
TW,BLOOD ALBUMIN DECREASED,1
TW,BLOOD CALCIUM INCREASED,1
TW,BLOOD CHLORIDE INCREASED,1
TW,BLOOD CHOLESTEROL INCREASED,1
TW,BLOOD POTASSIUM DECREASED,1
TW,BLOOD PRESSURE DECREASED,1
TW,BLOOD PRESSURE DIASTOLIC DECREASED,1
TW,BLOOD URIC ACID INCREASED,1
TW,BONE DENSITY INCREASED,1
TW,BRADYCARDIA,1
TW,BRAIN OEDEMA,1
TW,BRONCHITIS,1
TW,BRONCHOPNEUMONIA,1
TW,BRONCHOSPASM,1
TW,CALCULUS BLADDER,1
TW,CANDIDA INFECTION,1
TW,CARDIAC ARREST,1
TW,CARDIAC FAILURE CONGESTIVE,1
TW,CARDIOGENIC SHOCK,1
TW,CAROTID ARTERIOSCLEROSIS,1
TW,CENTRAL NERVOUS SYSTEM LESION,1
TW,CEREBRAL ATROPHY,1
TW,CEREBRAL ISCHAEMIA,1
TW,CEREBROVASCULAR ACCIDENT,1
TW,CHOKING,1
TW,CHOLECYSTITIS,1
TW,CHOLECYSTITIS ACUTE,1
TW,CHOLELITHIASIS,1
TW,CHRONIC KIDNEY DISEASE,1
TW,COLD SWEAT,1
TW,COLITIS,1
TW,COLLATERAL CIRCULATION,1
TW,CONDITION AGGRAVATED,1
TW,CONJUNCTIVAL HAEMORRHAGE,1
TW,CONJUNCTIVITIS,1
TW,CONTUSION,1
TW,CROHN^S DISEASE,1
TW,CYST,1
TW,CYSTITIS,1
TW,CYTOMEGALOVIRUS INFECTION,1
TW,DEAFNESS BILATERAL,1
TW,DEHYDRATION,1
TW,DELIRIUM,1
TW,DEMYELINATION,1
TW,DEPRESSED LEVEL OF CONSCIOUSNESS,1
TW,DERMATITIS ATOPIC,1
TW,DERMATITIS DIAPER,1
TW,DERMATOPHYTOSIS OF NAIL,1
TW,DEVICE DISLOCATION,1
TW,DEVICE MALFUNCTION,1
TW,DEVICE RELATED INFECTION,1
TW,DEVICE RELATED THROMBOSIS,1
TW,DIASTOLIC DYSFUNCTION,1
TW,DISEASE PROGRESSION,1
TW,DISTRACTIBILITY,1
TW,DRUG ERUPTION,1
TW,DRUG INEFFECTIVE,1
TW,DRUG LEVEL INCREASED,1
TW,DRUG-INDUCED LIVER INJURY,1
TW,DUODENAL ULCER,1
TW,DYSARTHRIA,1
TW,DYSKINESIA,1
TW,DYSPEPSIA,1
TW,EAR NEOPLASM,1
TW,ECZEMA,1
TW,ELECTROCARDIOGRAM QT PROLONGED,1
TW,EMOTIONAL DISTRESS,1
TW,ENCEPHALOMALACIA,1
TW,ENCEPHALOPATHY,1
TW,ENDOTRACHEAL INTUBATION,1
TW,EOSINOPHIL COUNT INCREASED,1
TW,ESCHERICHIA INFECTION,1
TW,ESCHERICHIA SEPSIS,1
TW,EUPHORIC MOOD,1
TW,EYE PAIN,1
TW,EYE SWELLING,1
TW,FACIAL BONES FRACTURE,1
TW,FAECES DISCOLOURED,1
TW,FEELING COLD,1
TW,FEMORAL NECK FRACTURE,1
TW,FEMUR FRACTURE,1
TW,FRACTURE,1
TW,FUNGAEMIA,1
TW,FUNNEL CHEST ACQUIRED,1
TW,FURUNCLE,1
TW,GASTRIC DISORDER,1
TW,GASTRIC ULCER,1
TW,GASTRITIS,1
TW,GASTRITIS EROSIVE,1
TW,GASTROINTESTINAL HAEMORRHAGE,1
TW,GINGIVITIS,1
TW,GINGIVITIS ULCERATIVE,1
TW,GLIOSIS,1
TW,GRANULOCYTOPENIA,1
TW,HAEMANGIOMA OF LIVER,1
TW,HAEMATURIA,1
TW,HAEMORRHAGE INTRACRANIAL,1
TW,HAEMORRHOIDS,1
TW,HEPATIC ENZYME INCREASED,1
TW,HEPATITIS,1
TW,HEPATITIS ACUTE,1
TW,HEPATITIS CHOLESTATIC,1
TW,HEPATITIS TOXIC,1
TW,HEPATOCELLULAR CARCINOMA,1
TW,HEPATOTOXICITY,1
TW,HERPES VIRUS INFECTION,1
TW,HERPES ZOSTER,1
TW,HIATUS HERNIA,1
TW,HICCUPS,1
TW,HYPERCHOLESTEROLAEMIA,1
TW,HYPERKALAEMIA,1
TW,HYPERNATRAEMIA,1
TW,HYPOCALCAEMIA,1
TW,HYPOPHOSPHATAEMIA,1
TW,HYPOREFLEXIA,1
TW,HYPOVOLAEMIA,1
TW,HYPOVOLAEMIC SHOCK,1
TW,ILIAC VEIN OCCLUSION,1
TW,INCONTINENCE,1
TW,INFECTIOUS COLITIS,1
TW,INFERIOR VENA CAVAL OCCLUSION,1
TW,INGUINAL HERNIA_ OBSTRUCTIVE,1
TW,INTRACRANIAL ANEURYSM,1
TW,INTRACRANIAL PRESSURE INCREASED,1
TW,IRON DEFICIENCY ANAEMIA,1
TW,IRRITABILITY,1
TW,JAW FRACTURE,1
TW,JOINT EFFUSION,1
TW,LACERATION,1
TW,LARGE INTESTINAL ULCER,1
TW,LEFT VENTRICULAR DYSFUNCTION,1
TW,LEUKAEMIA,1
TW,LEUKOPENIA,1
TW,LIVER ABSCESS,1
TW,LIVER FUNCTION TEST ABNORMAL,1
TW,LOSS OF CONSCIOUSNESS,1
TW,LUNG INFECTION,1
TW,LYMPHADENOPATHY,1
TW,MAJOR DEPRESSION,1
TW,MANIA,1
TW,MASTOIDITIS,1
TW,MATERNAL EXPOSURE DURING PREGNANCY,1
TW,MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED,1
TW,MEAN CELL HAEMOGLOBIN DECREASED,1
TW,MEAN CELL VOLUME DECREASED,1
TW,MENINGITIS TUBERCULOUS,1
TW,MENORRHAGIA,1
TW,MENTAL STATUS CHANGES,1
TW,MONOCYTE COUNT INCREASED,1
TW,MUSCLE SPASMS,1
TW,MUSCULOSKELETAL PAIN,1
TW,MYOCARDIAL ISCHAEMIA,1
TW,MYOFASCIAL PAIN SYNDROME,1
TW,NEOPLASM PROGRESSION,1
TW,NEOPLASM PROSTATE,1
TW,NEPHROPATHY,1
TW,NUCHAL RIGIDITY,1
TW,OESOPHAGEAL CANDIDIASIS,1
TW,OESOPHAGITIS,1
TW,OROPHARYNGEAL PAIN,1
TW,OSTEOARTHRITIS,1
TW,OTITIS EXTERNA,1
TW,OTITIS MEDIA CHRONIC,1
TW,OTORRHOEA,1
TW,PAIN IN EXTREMITY,1
TW,PANIC ATTACK,1
TW,PARANASAL SINUS HAEMATOMA,1
TW,PELVIC FLUID COLLECTION,1
TW,PERIODONTITIS,1
TW,PERIPHERAL SWELLING,1
TW,PERSISTENT DEPRESSIVE DISORDER,1
TW,PLATELET COUNT INCREASED,1
TW,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
TW,PNEUMOMEDIASTINUM,1
TW,PNEUMONIA MYCOPLASMAL,1
TW,PNEUMONIA STREPTOCOCCAL,1
TW,PNEUMONITIS,1
TW,PNEUMOPERITONEUM,1
TW,POOR QUALITY SLEEP,1
TW,POST PROCEDURAL INFECTION,1
TW,PRE-ECLAMPSIA,1
TW,PREMATURE LABOUR,1
TW,PRETERM PREMATURE RUPTURE OF MEMBRANES,1
TW,PROCEDURAL ANXIETY,1
TW,PRODUCT USE ISSUE,1
TW,PRODUCTIVE COUGH,1
TW,PROTHROMBIN TIME PROLONGED,1
TW,PRURITUS GENERALISED,1
TW,PSORIASIS,1
TW,PSYCHOMOTOR HYPERACTIVITY,1
TW,PULMONARY EMBOLISM,1
TW,PULMONARY HYPERTENSION,1
TW,PULMONARY OEDEMA,1
TW,RALES,1
TW,RANULA,1
TW,RASH GENERALISED,1
TW,RASH PUSTULAR,1
TW,RECTAL ULCER,1
TW,RENAL CYST,1
TW,RENAL FAILURE ACUTE,1
TW,RENAL FAILURE CHRONIC,1
TW,RENAL TUBULAR INJURY,1
TW,RENAL VEIN THROMBOSIS,1
TW,RESTLESSNESS,1
TW,RHINITIS ALLERGIC,1
TW,RHONCHI,1
TW,ROAD TRAFFIC ACCIDENT,1
TW,SCHIZOPHRENIA,1
TW,SEROTONIN SYNDROME,1
TW,SERRATIA BACTERAEMIA,1
TW,SHUNT INFECTION,1
TW,SINUS BRADYCARDIA,1
TW,SKIN ABRASION,1
TW,SKIN BURNING SENSATION,1
TW,SKIN EXFOLIATION,1
TW,SKIN PAPILLOMA,1
TW,SKIN ULCER,1
TW,SLEEP DISORDER,1
TW,SOMNOLENCE,1
TW,SPUTUM INCREASED,1
TW,SQUAMOUS CELL CARCINOMA,1
TW,SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX,1
TW,STAPHYLOCOCCAL BACTERAEMIA,1
TW,STATUS EPILEPTICUS,1
TW,SUBARACHNOID HAEMORRHAGE,1
TW,SUBDURAL HAEMATOMA,1
TW,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,1
TW,SUPRAVENTRICULAR TACHYCARDIA,1
TW,SUSPECTED PRODUCT CONTAMINATION,1
TW,SYNCOPE,1
TW,SYSTEMIC LUPUS ERYTHEMATOSUS,1
TW,TACHYCARDIA,1
TW,TENDERNESS,1
TW,THERMAL BURN,1
TW,THORACIC VERTEBRAL FRACTURE,1
TW,TINEA PEDIS,1
TW,TINNITUS,1
TW,TOXIC ENCEPHALOPATHY,1
TW,TRACHEO-OESOPHAGEAL FISTULA,1
TW,TRAUMATIC FRACTURE,1
TW,TRICUSPID VALVE INCOMPETENCE,1
TW,TRIGGER FINGER,1
TW,URTICARIA,1
TW,VAGINAL HAEMORRHAGE,1
TW,VARICELLA,1
TW,VASCULITIS,1
TW,VENA CAVA THROMBOSIS,1
TW,VENTRICULAR FIBRILLATION,1
TW,VENTRICULAR TACHYCARDIA,1
TW,VERTEBROPLASTY,1
TW,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
TW,VISION BLURRED,1
TW,VISUAL IMPAIRMENT,1
TW,VITAMIN D DECREASED,1
TW,WHITE BLOOD CELL COUNT INCREASED,1
TW,WOUND SECRETION,1
TH,OVERDOSE,5
TH,HEPATOTOXICITY,4
TH,ABORTION THREATENED,2
TH,CAESAREAN SECTION,2
TH,LIVE BIRTH,2
TH,MATERNAL EXPOSURE DURING PREGNANCY,2
TH,PREGNANCY ON CONTRACEPTIVE,2
TH,PREMATURE DELIVERY,2
TH,PREMATURE RUPTURE OF MEMBRANES,2
TH,ABDOMINAL PAIN,1
TH,ANAPHYLACTIC REACTION,1
TH,ANGIOEDEMA,1
TH,ARTHRALGIA,1
TH,BACK PAIN,1
TH,BLOOD PRESSURE DECREASED,1
TH,BRONCHIECTASIS,1
TH,CARDIAC FAILURE,1
TH,DRUG HYPERSENSITIVITY,1
TH,DRUG-INDUCED LIVER INJURY,1
TH,FEMORAL NECK FRACTURE,1
TH,FOETAL EXPOSURE DURING PREGNANCY,1
TH,GASTROINTESTINAL DISORDER,1
TH,GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY,1
TH,HEPATIC ENZYME INCREASED,1
TH,HEPATIC FUNCTION ABNORMAL,1
TH,HIP FRACTURE,1
TH,JAUNDICE NEONATAL,1
TH,JOINT RANGE OF MOTION DECREASED,1
TH,KIDNEY TRANSPLANT REJECTION,1
TH,LIVER INJURY,1
TH,LOSS OF CONSCIOUSNESS,1
TH,METHAEMOGLOBINAEMIA,1
TH,NAUSEA,1
TH,PAIN IN EXTREMITY,1
TH,PREGNANCY,1
TH,PREMATURE BABY,1
TH,PRODUCT USE IN UNAPPROVED INDICATION,1
TH,PULMONARY HYPERTENSION,1
TH,SOMNOLENCE,1
TH,STILLBIRTH,1
TH,SUPERINFECTION,1
TH,TRANSAMINASES INCREASED,1
TH,URTICARIA,1
TH,VOMITING,1
TT,ABDOMINAL PAIN,1
TT,ABDOMINAL PAIN UPPER,1
TT,APPARENT DEATH,1
TT,BURNING SENSATION,1
TT,EXPIRED DRUG ADMINISTERED,1
TT,NAUSEA,1
TT,PALPITATIONS,1
TT,PARAESTHESIA,1
TT,URETHRAL SPASM,1
TT,VULVOVAGINAL BURNING SENSATION,1
TT,VULVOVAGINAL PAIN,1
TN,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,6
TN,DRUG WITHDRAWAL SYNDROME,3
TN,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,3
TN,ABDOMINAL DISTENSION,1
TN,DELUSION,1
TN,DIARRHOEA,1
TN,GRANDIOSITY,1
TN,HALLUCINATION_ AUDITORY,1
TN,HALLUCINATION_ SYNAESTHETIC,1
TN,HEPATOCELLULAR INJURY,1
TN,HYPOXIA,1
TN,INFLAMMATORY BOWEL DISEASE,1
TN,INSOMNIA,1
TN,REBOUND PSYCHOSIS,1
TN,RESTLESSNESS,1
TN,SHOCK,1
TR,ANGIOEDEMA,3
TR,TOXICITY TO VARIOUS AGENTS,3
TR,ANAPHYLACTIC REACTION,2
TR,DIARRHOEA,2
TR,DRUG HYPERSENSITIVITY,2
TR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
TR,ACUTE HEPATIC FAILURE,1
TR,ALANINE AMINOTRANSFERASE INCREASED,1
TR,APHASIA,1
TR,ARTHRALGIA,1
TR,ASPARTATE AMINOTRANSFERASE INCREASED,1
TR,ASTHENIA,1
TR,AUTOIMMUNE HAEMOLYTIC ANAEMIA,1
TR,BLOOD LACTIC ACID INCREASED,1
TR,BRONCHITIS,1
TR,CATARACT OPERATION,1
TR,CYSTOCELE,1
TR,DECREASED APPETITE,1
TR,DELIRIUM,1
TR,DIALYSIS,1
TR,DRUG ADMINISTRATION ERROR,1
TR,DRUG INEFFECTIVE,1
TR,EATING DISORDER,1
TR,ERYSIPELAS,1
TR,EYELID IRRITATION,1
TR,FIXED DRUG ERUPTION,1
TR,GASTRIC ULCER,1
TR,GENITAL ULCERATION,1
TR,HAEMATEMESIS,1
TR,HEPATIC ENCEPHALOPATHY,1
TR,HEPATIC FAILURE,1
TR,HEPATITIS B,1
TR,HEPATITIS TOXIC,1
TR,HEPATOTOXICITY,1
TR,HYPERSOMNIA,1
TR,HYPOAESTHESIA,1
TR,HYPOGLYCAEMIA,1
TR,INFLUENZA,1
TR,JOINT SWELLING,1
TR,LABORATORY TEST ABNORMAL,1
TR,LACRIMATION INCREASED,1
TR,LIVER INJURY,1
TR,LOCAL SWELLING,1
TR,MAJOR DEPRESSION,1
TR,METABOLIC ACIDOSIS,1
TR,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
TR,PAIN,1
TR,PAIN IN EXTREMITY,1
TR,PARAESTHESIA,1
TR,PYREXIA,1
TR,RENAL FAILURE,1
TR,RETICULOCYTOSIS,1
TR,SEIZURE,1
TR,SKIN HYPERPIGMENTATION,1
TR,STRESS,1
TR,SWELLING FACE,1
TR,TUMOUR LYSIS SYNDROME,1
TR,URINARY TRACT INFECTION,1
TR,URTICARIA,1
TR,UTERINE PROLAPSE,1
TR,WEIGHT DECREASED,1
UG,BRONCHOPNEUMONIA,2
UG,DEATH,2
UG,MALNUTRITION,2
UG,ANAEMIA,1
UG,BRONCHOPULMONARY ASPERGILLOSIS,1
UG,DEHYDRATION,1
UG,LEUKOPENIA,1
UG,PNEUMONIA,1
UG,RENAL FAILURE ACUTE,1
UG,SEPSIS,1
UG,SHOCK,1
UG,THROMBOCYTOPENIA,1
UA,ALANINE AMINOTRANSFERASE INCREASED,1
UA,IMMUNODEFICIENCY,1
UA,MALIGNANT NEOPLASM PROGRESSION,1
UA,OSTEOSCLEROSIS,1
UA,PNEUMONITIS,1
UA,RESPIRATORY TRACT OEDEMA,1
UA,VASCULITIS,1
AE,PANCREATIC NEOPLASM,1
GB,OVERDOSE,76
GB,ACUTE HEPATIC FAILURE,58
GB,FATIGUE,30
GB,HEADACHE,25
GB,TOXICITY TO VARIOUS AGENTS,24
GB,MALAISE,23
GB,HYPOTENSION,20
GB,NAUSEA,20
GB,PAIN IN EXTREMITY,20
GB,CONFUSIONAL STATE,19
GB,PNEUMONIA,19
GB,LOWER RESPIRATORY TRACT INFECTION,18
GB,VOMITING,18
GB,CONSTIPATION,17
GB,PYREXIA,17
GB,ACUTE KIDNEY INJURY,16
GB,DRUG-INDUCED LIVER INJURY,14
GB,LIVER FUNCTION TEST ABNORMAL,14
GB,PAIN,14
GB,URINARY TRACT INFECTION,14
GB,ANAEMIA,13
GB,COUGH,13
GB,DYSPNOEA,13
GB,DIARRHOEA,12
GB,LIVER INJURY,12
GB,ABDOMINAL PAIN,11
GB,ANXIETY,11
GB,ARTHRALGIA,11
GB,DIZZINESS,11
GB,FALL,11
GB,METABOLIC ACIDOSIS,11
GB,RASH,11
GB,RENAL IMPAIRMENT,11
GB,SUICIDE ATTEMPT,11
GB,ASTHENIA,10
GB,ATRIAL FIBRILLATION,10
GB,BUNDLE BRANCH BLOCK LEFT,10
GB,HEPATIC ENCEPHALOPATHY,10
GB,LEFT VENTRICULAR HYPERTROPHY,10
GB,MUSCULAR WEAKNESS,10
GB,MYALGIA,10
GB,SEPSIS,10
GB,SINUS BRADYCARDIA,10
GB,CHRONIC KIDNEY DISEASE,9
GB,CONDITION AGGRAVATED,9
GB,INSOMNIA,9
GB,MEMORY IMPAIRMENT,9
GB,BACK PAIN,8
GB,DEPRESSION,8
GB,FEBRILE NEUTROPENIA,8
GB,HEPATOTOXICITY,8
GB,HYPONATRAEMIA,8
GB,PARAESTHESIA,8
GB,PRURITUS,8
GB,RENAL FAILURE ACUTE,8
GB,TREMOR,8
GB,BRAIN OEDEMA,7
GB,CONTUSION,7
GB,DRUG ERUPTION,7
GB,DYSPHAGIA,7
GB,ELECTROCARDIOGRAM T WAVE INVERSION,7
GB,EOSINOPHILIC PNEUMONIA,7
GB,INTENTIONAL OVERDOSE,7
GB,NEUTROPENIA,7
GB,NEUTROPENIC SEPSIS,7
GB,POLLAKIURIA,7
GB,ABDOMINAL PAIN UPPER,6
GB,AGITATION,6
GB,ALANINE AMINOTRANSFERASE INCREASED,6
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,6
GB,BLOOD URINE PRESENT,6
GB,DEATH,6
GB,DECREASED APPETITE,6
GB,DYSKINESIA,6
GB,FLUSHING,6
GB,GASTROINTESTINAL HAEMORRHAGE,6
GB,HAEMATEMESIS,6
GB,HAEMOGLOBIN DECREASED,6
GB,HALLUCINATION,6
GB,HEPATIC FAILURE,6
GB,HYPOAESTHESIA,6
GB,INCORRECT DRUG ADMINISTRATION DURATION,6
GB,INFECTION,6
GB,MALIGNANT NEOPLASM PROGRESSION,6
GB,MUSCLE SPASMS,6
GB,PULMONARY EMBOLISM,6
GB,RASH PRURITIC,6
GB,RHABDOMYOLYSIS,6
GB,SEROTONIN SYNDROME,6
GB,SINUS ARRHYTHMIA,6
GB,SYNCOPE,6
GB,TACHYCARDIA,6
GB,VERTIGO,6
GB,VISUAL IMPAIRMENT,6
GB,ABORTION SPONTANEOUS,5
GB,BLOOD CREATININE INCREASED,5
GB,CHEST PAIN,5
GB,COAGULOPATHY,5
GB,CONVULSION,5
GB,DYSPEPSIA,5
GB,EXPOSURE DURING PREGNANCY,5
GB,FEMUR FRACTURE,5
GB,HYPERSENSITIVITY,5
GB,LETHARGY,5
GB,LOBAR PNEUMONIA,5
GB,OEDEMA PERIPHERAL,5
GB,PALPITATIONS,5
GB,PRODUCT USE ISSUE,5
GB,PROTEIN URINE,5
GB,RASH GENERALISED,5
GB,REPETITIVE SPEECH,5
GB,SOMNOLENCE,5
GB,SWELLING,5
GB,TRANSIENT GLOBAL AMNESIA,5
GB,URINE OUTPUT INCREASED,5
GB,VISION BLURRED,5
GB,WEIGHT DECREASED,5
GB,ANGER,4
GB,ASCITES,4
GB,BLISTER,4
GB,BLOOD BILIRUBIN INCREASED,4
GB,CHILLS,4
GB,COMPLETED SUICIDE,4
GB,DISEASE PROGRESSION,4
GB,DRY SKIN,4
GB,ERYTHEMA,4
GB,FEELING ABNORMAL,4
GB,GAIT DISTURBANCE,4
GB,HYPERGLYCAEMIA,4
GB,HYPERHIDROSIS,4
GB,HYPERTENSION,4
GB,LIVER FUNCTION TEST INCREASED,4
GB,LOSS OF CONSCIOUSNESS,4
GB,MIGRAINE,4
GB,MOBILITY DECREASED,4
GB,MULTI-ORGAN FAILURE,4
GB,MYOCARDIAL INFARCTION,4
GB,NASOPHARYNGITIS,4
GB,OESOPHAGITIS,4
GB,ORAL CANDIDIASIS,4
GB,PANCREATITIS ACUTE,4
GB,PRESYNCOPE,4
GB,PSYCHOTIC DISORDER,4
GB,PULMONARY OEDEMA,4
GB,RESTLESSNESS,4
GB,RIB FRACTURE,4
GB,SLEEP DISORDER,4
GB,STEVENS-JOHNSON SYNDROME,4
GB,SUICIDAL IDEATION,4
GB,SWOLLEN TONGUE,4
GB,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,4
GB,THROMBOCYTOPENIA,4
GB,UNRESPONSIVE TO STIMULI,4
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,4
GB,ABDOMINAL DISCOMFORT,3
GB,ABDOMINAL DISTENSION,3
GB,ABNORMAL WEIGHT GAIN,3
GB,ACUTE CORONARY SYNDROME,3
GB,AMNESIA,3
GB,ANAPHYLACTIC REACTION,3
GB,BLOOD PRESSURE DECREASED,3
GB,BLOOD TEST ABNORMAL,3
GB,CELLULITIS,3
GB,CEREBROVASCULAR ACCIDENT,3
GB,CIRCULATORY COLLAPSE,3
GB,COLITIS,3
GB,CORONARY ARTERY OCCLUSION,3
GB,DEHYDRATION,3
GB,DEPRESSED MOOD,3
GB,DIPLOPIA,3
GB,DISTURBANCE IN ATTENTION,3
GB,DRUG WITHDRAWAL SYNDROME,3
GB,DYSARTHRIA,3
GB,ECZEMA,3
GB,EPILEPSY,3
GB,ERECTILE DYSFUNCTION,3
GB,GASTROINTESTINAL DISORDER,3
GB,GASTROOESOPHAGEAL REFLUX DISEASE,3
GB,HALLUCINATION_ VISUAL,3
GB,HEPATIC PAIN,3
GB,HYPERKALAEMIA,3
GB,HYPOAESTHESIA ORAL,3
GB,HYPOKINESIA,3
GB,IMMUNE THROMBOCYTOPENIC PURPURA,3
GB,INFLUENZA,3
GB,INFLUENZA LIKE ILLNESS,3
GB,ISCHAEMIC STROKE,3
GB,JAUNDICE,3
GB,LIVER DISORDER,3
GB,LIVER TRANSPLANT,3
GB,MANIA,3
GB,MUCOSAL INFLAMMATION,3
GB,NIGHTMARE,3
GB,ORAL HERPES,3
GB,ORGAN FAILURE,3
GB,OROPHARYNGEAL PAIN,3
GB,PALLOR,3
GB,PANCYTOPENIA,3
GB,PERIPHERAL SWELLING,3
GB,PETECHIAE,3
GB,PLATELET COUNT DECREASED,3
GB,PNEUMONITIS,3
GB,POOR QUALITY SLEEP,3
GB,RASH MACULO-PAPULAR,3
GB,RENAL FAILURE,3
GB,SCAB,3
GB,SCAR,3
GB,SEIZURE,3
GB,SELF INJURIOUS BEHAVIOUR,3
GB,SKIN ULCER,3
GB,SPEECH DISORDER,3
GB,STOMATITIS,3
GB,STRESS FRACTURE,3
GB,TRANSAMINASES INCREASED,3
GB,UROSEPSIS,3
GB,WHEEZING,3
GB,ABDOMINAL PAIN LOWER,2
GB,ABNORMAL BEHAVIOUR,2
GB,ACNE,2
GB,ACUTE MYOCARDIAL INFARCTION,2
GB,AGGRESSION,2
GB,ANAPHYLACTOID REACTION,2
GB,APHASIA,2
GB,ARRHYTHMIA,2
GB,ARTERIOSCLEROSIS,2
GB,BALANCE DISORDER,2
GB,BASAL CELL CARCINOMA,2
GB,BLINDNESS,2
GB,BLOOD CREATINE INCREASED,2
GB,BLOOD PRESSURE DIASTOLIC DECREASED,2
GB,BLOOD PRESSURE INCREASED,2
GB,BRADYCARDIA,2
GB,BURNING SENSATION,2
GB,C-REACTIVE PROTEIN DECREASED,2
GB,CARDIAC FAILURE,2
GB,CATATONIA,2
GB,CHEST DISCOMFORT,2
GB,CHROMATURIA,2
GB,COGNITIVE DISORDER,2
GB,COLD SWEAT,2
GB,CYSTITIS,2
GB,DELIRIUM,2
GB,DEMENTIA,2
GB,DEPRESSION SUICIDAL,2
GB,DIABETES MELLITUS,2
GB,DILATATION INTRAHEPATIC DUCT ACQUIRED,2
GB,DISCOMFORT,2
GB,DISORIENTATION,2
GB,DRUG ADMINISTRATION ERROR,2
GB,DRUG INEFFECTIVE,2
GB,DRUG INTOLERANCE,2
GB,DRY MOUTH,2
GB,ELECTROCARDIOGRAM QT PROLONGED,2
GB,ENCEPHALOPATHY,2
GB,EOSINOPHILIA,2
GB,EXFOLIATIVE RASH,2
GB,EYE PAIN,2
GB,FAECES DISCOLOURED,2
GB,FEELING DRUNK,2
GB,FEELING HOT,2
GB,FEELING OF BODY TEMPERATURE CHANGE,2
GB,FLUID OVERLOAD,2
GB,GASTRIC ULCER,2
GB,GASTRITIS,2
GB,GASTROENTERITIS,2
GB,GASTROINTESTINAL ULCER,2
GB,GLOMERULAR FILTRATION RATE DECREASED,2
GB,HAEMATOCHEZIA,2
GB,HAEMORRHAGE,2
GB,HEMIPLEGIA,2
GB,HEPATIC FUNCTION ABNORMAL,2
GB,HEPATIC STEATOSIS,2
GB,HOT FLUSH,2
GB,HYPOACUSIS,2
GB,HYPOPHAGIA,2
GB,HYPOTHYROIDISM,2
GB,INTERNATIONAL NORMALISED RATIO DECREASED,2
GB,INTERNATIONAL NORMALISED RATIO INCREASED,2
GB,IRON DEFICIENCY ANAEMIA,2
GB,IRRITABILITY,2
GB,ISCHAEMIA,2
GB,LACTIC ACIDOSIS,2
GB,LEFT VENTRICULAR FAILURE,2
GB,LIMB DISCOMFORT,2
GB,LIP SWELLING,2
GB,LIVE BIRTH,2
GB,LOCAL SWELLING,2
GB,LUNG INFILTRATION,2
GB,LUNG NEOPLASM MALIGNANT,2
GB,LYMPHADENOPATHY,2
GB,MASS,2
GB,MELAENA,2
GB,MENTAL DISORDER,2
GB,MOOD ALTERED,2
GB,MUSCULOSKELETAL CHEST PAIN,2
GB,MUSCULOSKELETAL STIFFNESS,2
GB,MYELODYSPLASTIC SYNDROME,2
GB,NECK PAIN,2
GB,NEUTROPHIL COUNT INCREASED,2
GB,NIGHT SWEATS,2
GB,NON-SMALL CELL LUNG CANCER,2
GB,ORAL PAIN,2
GB,OSTEONECROSIS,2
GB,OTORRHOEA,2
GB,PANIC ATTACK,2
GB,PAPILLOEDEMA,2
GB,PLEURAL EFFUSION,2
GB,PNEUMONIA ASPIRATION,2
GB,POLYMYALGIA RHEUMATICA,2
GB,PROCEDURAL HAEMORRHAGE,2
GB,PRODUCT USE IN UNAPPROVED INDICATION,2
GB,PRURITUS GENERALISED,2
GB,PURULENT DISCHARGE,2
GB,RASH ERYTHEMATOUS,2
GB,RASH MACULAR,2
GB,RENAL DISORDER,2
GB,RESPIRATORY TRACT INFECTION,2
GB,SELF-INJURIOUS IDEATION,2
GB,SKIN BURNING SENSATION,2
GB,SKIN DEPIGMENTATION,2
GB,SKIN EXFOLIATION,2
GB,SUDDEN DEATH,2
GB,SURGERY,2
GB,SWELLING FACE,2
GB,THERMAL BURN,2
GB,THINKING ABNORMAL,2
GB,TOXIC EPIDERMAL NECROLYSIS,2
GB,TYMPANIC MEMBRANE PERFORATION,2
GB,TYPE 2 DIABETES MELLITUS,2
GB,URINARY RETENTION,2
GB,URTICARIA,2
GB,VENOOCCLUSIVE LIVER DISEASE,2
GB,WOUND INFECTION,2
GB,WRONG TECHNIQUE IN DRUG USAGE PROCESS,2
GB,YELLOW SKIN,2
GB,ABDOMINAL SEPSIS,1
GB,ABDOMINAL TENDERNESS,1
GB,ACCIDENTAL EXPOSURE TO PRODUCT,1
GB,ACCIDENTAL OVERDOSE,1
GB,ACQUIRED EPIDERMOLYSIS BULLOSA,1
GB,ACROMEGALY,1
GB,ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED,1
GB,ACUTE PSYCHOSIS,1
GB,ACUTE RESPIRATORY FAILURE,1
GB,ADENOVIRUS INFECTION,1
GB,ADRENAL HAEMORRHAGE,1
GB,ADRENAL INSUFFICIENCY,1
GB,ADVERSE EVENT,1
GB,ALCOHOL POISONING,1
GB,ALTERED VISUAL DEPTH PERCEPTION,1
GB,AMMONIA INCREASED,1
GB,AMNIOTIC CAVITY INFECTION,1
GB,AMYLASE INCREASED,1
GB,ANGIOEDEMA,1
GB,APPENDICITIS,1
GB,APPENDICITIS PERFORATED,1
GB,AREFLEXIA,1
GB,ARTERIAL THROMBOSIS,1
GB,ARTERIOSCLEROSIS CORONARY ARTERY,1
GB,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
GB,ASPARTATE AMINOTRANSFERASE INCREASED,1
GB,ASPERGILLOSIS,1
GB,ATELECTASIS,1
GB,ATRIOVENTRICULAR BLOCK COMPLETE,1
GB,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
GB,ATYPICAL FEMUR FRACTURE,1
GB,AUTOIMMUNE HEPATITIS,1
GB,AXONAL NEUROPATHY,1
GB,BACK DISORDER,1
GB,BACTERAEMIA,1
GB,BACTERIAL VAGINOSIS,1
GB,BARRETT^S OESOPHAGUS,1
GB,BILIARY SEPSIS,1
GB,BLEEDING TIME PROLONGED,1
GB,BLINDNESS TRANSIENT,1
GB,BLOOD CHOLESTEROL INCREASED,1
GB,BLOOD ETHANOL INCREASED,1
GB,BLOOD GLUCOSE FLUCTUATION,1
GB,BLOOD GLUCOSE INCREASED,1
GB,BLOOD LACTIC ACID INCREASED,1
GB,BLOOD PHOSPHORUS DECREASED,1
GB,BLOOD POTASSIUM DECREASED,1
GB,BLOOD POTASSIUM INCREASED,1
GB,BLOOD TESTOSTERONE DECREASED,1
GB,BODY TEMPERATURE INCREASED,1
GB,BONE DISORDER,1
GB,BRAIN INJURY,1
GB,BREAST CANCER,1
GB,BREAST CYST,1
GB,BREAST PAIN,1
GB,BREAST SWELLING,1
GB,BREAST TENDERNESS,1
GB,BRONCHOPNEUMONIA,1
GB,BRONCHOPULMONARY ASPERGILLOSIS,1
GB,BRONCHOSPASM,1
GB,BURSITIS,1
GB,CANDIDA INFECTION,1
GB,CARDIAC ARREST,1
GB,CARDIAC DISORDER,1
GB,CARDIAC FAILURE ACUTE,1
GB,CARDIAC FAILURE CONGESTIVE,1
GB,CARDIAC MURMUR,1
GB,CARDIOMEGALY,1
GB,CARDIOMYOPATHY,1
GB,CEREBRAL ASPERGILLOSIS,1
GB,CEREBRAL HAEMORRHAGE,1
GB,CEREBRAL INFARCTION,1
GB,CERVICAL SPINAL STENOSIS,1
GB,CHANGE OF BOWEL HABIT,1
GB,CHOKING,1
GB,CHOLANGITIS,1
GB,CHOLECYSTECTOMY,1
GB,CHOLECYSTITIS,1
GB,CHOLELITHIASIS,1
GB,CHOLESTASIS,1
GB,CLAUDICATION OF JAW MUSCLES,1
GB,CLOSTRIDIUM DIFFICILE INFECTION,1
GB,COLITIS ULCERATIVE,1
GB,COMA,1
GB,COMPLICATIONS OF TRANSPLANTED LIVER,1
GB,CONCUSSION,1
GB,CONJUNCTIVAL HAEMORRHAGE,1
GB,CONJUNCTIVAL HYPERAEMIA,1
GB,COORDINATION ABNORMAL,1
GB,CORNEAL REFLEX DECREASED,1
GB,CORONARY ARTERY DISEASE,1
GB,CORONARY ARTERY STENOSIS,1
GB,CYTOMEGALOVIRUS INFECTION,1
GB,DARK CIRCLES UNDER EYES,1
GB,DEFAECATION URGENCY,1
GB,DELUSION,1
GB,DEMENTIA ALZHEIMER^S TYPE,1
GB,DEPRESSED LEVEL OF CONSCIOUSNESS,1
GB,DEPRESSIVE SYMPTOM,1
GB,DERMATITIS EXFOLIATIVE,1
GB,DESMOPLASTIC SMALL ROUND CELL TUMOUR,1
GB,DEVICE BREAKAGE,1
GB,DEVICE DEPLOYMENT ISSUE,1
GB,DISEASE COMPLICATION,1
GB,DISSEMINATED INTRAVASCULAR COAGULATION,1
GB,DIVERTICULITIS,1
GB,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
GB,DIZZINESS POSTURAL,1
GB,DRUG ABUSE,1
GB,DRUG DEPENDENCE,1
GB,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
GB,DRUG LEVEL INCREASED,1
GB,DRY EYE,1
GB,DUODENAL ULCER HAEMORRHAGE,1
GB,DYSPHONIA,1
GB,DYSPNOEA EXERTIONAL,1
GB,DYSURIA,1
GB,EAR DISCOMFORT,1
GB,EATING DISORDER,1
GB,ELECTROCARDIOGRAM ST SEGMENT ELEVATION,1
GB,EMOTIONAL DISORDER,1
GB,EMOTIONAL DISTRESS,1
GB,ENCEPHALITIS,1
GB,ENDOCARDITIS,1
GB,ENERGY INCREASED,1
GB,EPILEPTIC AURA,1
GB,EPISTAXIS,1
GB,ESCHERICHIA INFECTION,1
GB,ESCHERICHIA SEPSIS,1
GB,EXTERNAL EAR CELLULITIS,1
GB,EXTRAPYRAMIDAL DISORDER,1
GB,EYE COLOUR CHANGE,1
GB,EYE INFECTION,1
GB,EYE IRRITATION,1
GB,EYE PRURITUS,1
GB,FACIAL PARALYSIS,1
GB,FAECAL INCONTINENCE,1
GB,FAECALOMA,1
GB,FEAR OF DEATH,1
GB,FEELING JITTERY,1
GB,FEMORAL NECK FRACTURE,1
GB,FOETAL DEATH,1
GB,FOETAL EXPOSURE DURING PREGNANCY,1
GB,FOOT FRACTURE,1
GB,FORCED VITAL CAPACITY DECREASED,1
GB,FURUNCLE,1
GB,GALLBLADDER CANCER,1
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
GB,GASTRIC DISORDER,1
GB,GASTRIC ULCER HAEMORRHAGE,1
GB,GASTRIC ULCER PERFORATION,1
GB,GASTRITIS EROSIVE,1
GB,GASTROINTESTINAL TUBE INSERTION,1
GB,GASTROSTOMY,1
GB,GENERAL PHYSICAL CONDITION ABNORMAL,1
GB,GENERALISED TONIC-CLONIC SEIZURE,1
GB,GENITAL DISCOMFORT,1
GB,GLOSSITIS,1
GB,GLOSSODYNIA,1
GB,GOUT,1
GB,GROIN PAIN,1
GB,GUILLAIN-BARRE SYNDROME,1
GB,H1N1 INFLUENZA,1
GB,HAEMATOMA,1
GB,HAEMORRHAGE IN PREGNANCY,1
GB,HAEMORRHAGE INTRACRANIAL,1
GB,HAEMORRHAGIC ANAEMIA,1
GB,HAEMORRHOIDS,1
GB,HAEMOTHORAX,1
GB,HALLUCINATIONS_ MIXED,1
GB,HEART RATE INCREASED,1
GB,HEPATIC ISCHAEMIA,1
GB,HEPATIC VEIN THROMBOSIS,1
GB,HEPATITIS,1
GB,HEPATOMEGALY,1
GB,HERPES ZOSTER,1
GB,HYPERACUSIS,1
GB,HYPERAESTHESIA,1
GB,HYPERCHLORHYDRIA,1
GB,HYPERCHOLESTEROLAEMIA,1
GB,HYPOCALCAEMIA,1
GB,HYPOGLYCAEMIA,1
GB,HYPOKALAEMIA,1
GB,HYPOTONIA,1
GB,IMPLANT SITE DEHISCENCE,1
GB,IMPLANT SITE EXTRAVASATION,1
GB,IMPLANT SITE INFECTION,1
GB,IMPLANT SITE PAIN,1
GB,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
GB,INCORRECT DOSE ADMINISTERED,1
GB,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
GB,INCREASED APPETITE,1
GB,INCREASED UPPER AIRWAY SECRETION,1
GB,INFECTED SKIN ULCER,1
GB,INFECTIVE EXACERBATION OF BRONCHIECTASIS,1
GB,INFLAMMATORY MARKER INCREASED,1
GB,INFLUENZA A VIRUS TEST,1
GB,INFUSION RELATED REACTION,1
GB,INFUSION SITE PAIN,1
GB,INJECTION SITE ERYTHEMA,1
GB,INTENTIONAL PRODUCT MISUSE,1
GB,INTERLEUKIN LEVEL INCREASED,1
GB,INTERVERTEBRAL DISC DEGENERATION,1
GB,INTESTINAL PERFORATION,1
GB,IRRITABLE BOWEL SYNDROME,1
GB,JAUNDICE CHOLESTATIC,1
GB,JOINT STIFFNESS,1
GB,JOINT SWELLING,1
GB,KETOACIDOSIS,1
GB,KIDNEY INFECTION,1
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
GB,LARGE INTESTINE PERFORATION,1
GB,LEARNING DISORDER,1
GB,LEUKOPENIA,1
GB,LIBIDO DECREASED,1
GB,LIGAMENT PAIN,1
GB,LIP BLISTER,1
GB,LOOSE TOOTH,1
GB,LUNG INFECTION,1
GB,LYMPHOEDEMA,1
GB,LYMPHOMA,1
GB,MACROPHAGES INCREASED,1
GB,MALE SEXUAL DYSFUNCTION,1
GB,MATERNAL EXPOSURE DURING PREGNANCY,1
GB,MEDICAL DEVICE COMPLICATION,1
GB,MENINGITIS STREPTOCOCCAL,1
GB,MENORRHAGIA,1
GB,MENSTRUATION DELAYED,1
GB,METABOLIC ALKALOSIS,1
GB,METAPNEUMOVIRUS INFECTION,1
GB,METRORRHAGIA,1
GB,MONOCYTE COUNT,1
GB,MOOD SWINGS,1
GB,MUCOUS STOOLS,1
GB,MULTIPLE ORGAN DYSFUNCTION SYNDROME,1
GB,MUSCLE CONTRACTURE,1
GB,MUSCLE RIGIDITY,1
GB,MUSCLE TIGHTNESS,1
GB,MUSCLE TWITCHING,1
GB,MUSCULOSKELETAL PAIN,1
GB,MYELOPATHY,1
GB,MYOCLONUS,1
GB,MYOPATHY,1
GB,MYOSITIS,1
GB,NEPHROLITHIASIS,1
GB,NEPHROPATHY TOXIC,1
GB,NEURALGIA,1
GB,NEUROENDOCRINE TUMOUR,1
GB,NEUROPATHY PERIPHERAL,1
GB,NEUROPATHY_ ATAXIA_ RETINITIS PIGMENTOSA SYNDROME,1
GB,NEUROPSYCHIATRIC SYMPTOMS,1
GB,NEUTROPHIL CHEMOTAXIS ABNORMAL,1
GB,NEUTROPHIL FUNCTION DISORDER,1
GB,NIPPLE DISORDER,1
GB,NOSOCOMIAL INFECTION,1
GB,OBSESSIVE-COMPULSIVE DISORDER,1
GB,OCULAR DISCOMFORT,1
GB,OEDEMA,1
GB,OEDEMA MOUTH,1
GB,OESOPHAGEAL HAEMORRHAGE,1
GB,OESOPHAGEAL RUPTURE,1
GB,OESOPHAGEAL ULCER,1
GB,OESOPHAGITIS HAEMORRHAGIC,1
GB,ONYCHOMYCOSIS,1
GB,ORAL DISCOMFORT,1
GB,ORAL DISORDER,1
GB,ORAL MUCOSAL BLISTERING,1
GB,ORGANIC ERECTILE DYSFUNCTION,1
GB,ORGANISING PNEUMONIA,1
GB,OROANTRAL FISTULA,1
GB,ORTHOSTATIC HYPOTENSION,1
GB,OSTEONECROSIS OF JAW,1
GB,OTITIS MEDIA,1
GB,OXYGEN SATURATION DECREASED,1
GB,PAIN IN JAW,1
GB,PAINFUL DEFAECATION,1
GB,PANCREATIC CARCINOMA,1
GB,PANCREATIC CYST,1
GB,PARANOIA,1
GB,PARKINSON^S DISEASE,1
GB,PELVIC CYST,1
GB,PEPTIC ULCER,1
GB,PERIORBITAL OEDEMA,1
GB,PERIPHERAL ENDARTERECTOMY,1
GB,PERIPHERAL ISCHAEMIA,1
GB,PERIPHERAL SENSORIMOTOR NEUROPATHY,1
GB,PERIPROSTHETIC FRACTURE,1
GB,PERSONALITY CHANGE,1
GB,PERSONALITY DISORDER,1
GB,PHARYNGEAL OEDEMA,1
GB,PHARYNGITIS,1
GB,PIGMENTATION DISORDER,1
GB,PITUITARY TUMOUR BENIGN,1
GB,PLATELET COUNT INCREASED,1
GB,PLEURISY,1
GB,POISONING,1
GB,POISONING DELIBERATE,1
GB,POLIOMYELITIS,1
GB,POOR VENOUS ACCESS,1
GB,POST PROCEDURAL INFECTION,1
GB,PROCEDURAL COMPLICATION,1
GB,PROCEDURAL INTESTINAL PERFORATION,1
GB,PROCTALGIA,1
GB,PRODUCT QUALITY ISSUE,1
GB,PROSTATE CANCER,1
GB,PROTHROMBIN TIME PROLONGED,1
GB,PSEUDOMONAS INFECTION,1
GB,PSYCHOMOTOR HYPERACTIVITY,1
GB,PULMONARY CONGESTION,1
GB,PULMONARY FIBROSIS,1
GB,PULMONARY INFARCTION,1
GB,PULSE ABSENT,1
GB,PYELONEPHRITIS,1
GB,QUALITY OF LIFE DECREASED,1
GB,RALES,1
GB,RECTAL HAEMORRHAGE,1
GB,RECTAL TENESMUS,1
GB,RENAL COLIC,1
GB,RENAL CYST,1
GB,RENAL INJURY,1
GB,RENAL PAIN,1
GB,RENAL REPLACEMENT THERAPY,1
GB,RESPIRATORY ALKALOSIS,1
GB,RESPIRATORY ARREST,1
GB,RESPIRATORY DISORDER,1
GB,RESPIRATORY DISTRESS,1
GB,RESTLESS LEGS SYNDROME,1
GB,RETCHING,1
GB,SCRATCH,1
GB,SEDATION,1
GB,SINUS CONGESTION,1
GB,SINUSITIS,1
GB,SKIN DISCOLOURATION,1
GB,SKIN DISORDER,1
GB,SKIN HYPOPIGMENTATION,1
GB,SKIN INFECTION,1
GB,SMALL CELL CARCINOMA,1
GB,SNEEZING,1
GB,SOCIAL AVOIDANT BEHAVIOUR,1
GB,SOMNAMBULISM,1
GB,SPINAL CORD COMPRESSION,1
GB,SQUAMOUS CELL CARCINOMA OF THE TONGUE,1
GB,STERNAL FRACTURE,1
GB,STRESS,1
GB,SUBDURAL HAEMATOMA,1
GB,SUBSTANCE-INDUCED PSYCHOTIC DISORDER,1
GB,SUSPECTED COUNTERFEIT PRODUCT,1
GB,TEMPORAL ARTERITIS,1
GB,TENSION HEADACHE,1
GB,TESTICULAR PAIN,1
GB,THERAPEUTIC RESPONSE UNEXPECTED,1
GB,THROAT IRRITATION,1
GB,THROMBOPHLEBITIS,1
GB,THROMBOSIS,1
GB,TOOTH DISCOLOURATION,1
GB,TOOTH EROSION,1
GB,TOOTH LOSS,1
GB,TOXIC SHOCK SYNDROME STREPTOCOCCAL,1
GB,TRACHEO-OESOPHAGEAL FISTULA,1
GB,TRANSIENT ISCHAEMIC ATTACK,1
GB,TRAUMATIC LUNG INJURY,1
GB,TROPONIN I INCREASED,1
GB,TUBULOINTERSTITIAL NEPHRITIS,1
GB,UNINTENDED PREGNANCY,1
GB,UPPER-AIRWAY COUGH SYNDROME,1
GB,VAGINAL DISCHARGE,1
GB,VAGINAL HAEMORRHAGE,1
GB,VAGINAL INFECTION,1
GB,VARICES OESOPHAGEAL,1
GB,VASODILATATION,1
GB,VENOUS THROMBOSIS,1
GB,VENTRICULAR ASYSTOLE,1
GB,VENTRICULAR DYSKINESIA,1
GB,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
GB,VULVAL ULCERATION,1
GB,VULVOVAGINAL CANDIDIASIS,1
GB,VULVOVAGINAL DISCOMFORT,1
GB,VULVOVAGINAL MYCOTIC INFECTION,1
GB,WEIGHT BEARING DIFFICULTY,1
GB,WHEELCHAIR USER,1
GB,WHITE BLOOD CELL COUNT INCREASED,1
GB,WITHDRAWAL SYNDROME,1
GB,WOUND COMPLICATION,1
GB,WOUND DEHISCENCE,1
GB,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
GB,X-RAY OF PELVIS AND HIP ABNORMAL,1
US,FATIGUE,4301
US,DRUG INEFFECTIVE,4185
US,NAUSEA,4008
US,HEADACHE,3669
US,DIARRHOEA,3203
US,PAIN,2951
US,DEATH,2903
US,DYSPNOEA,2782
US,TOXICITY TO VARIOUS AGENTS,2592
US,INCORRECT DOSE ADMINISTERED,2541
US,VOMITING,2504
US,DIZZINESS,2267
US,ASTHENIA,2099
US,PYREXIA,1940
US,PRODUCT USE ISSUE,1882
US,ARTHRALGIA,1877
US,FALL,1850
US,MALAISE,1849
US,COMPLETED SUICIDE,1813
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1737
US,RASH,1716
US,PAIN IN EXTREMITY,1692
US,BACK PAIN,1635
US,PNEUMONIA,1626
US,COUGH,1413
US,WEIGHT DECREASED,1413
US,CONSTIPATION,1406
US,PRURITUS,1403
US,INSOMNIA,1359
US,ANXIETY,1348
US,DECREASED APPETITE,1289
US,ABDOMINAL PAIN,1259
US,ANAEMIA,1238
US,SINUSITIS,1172
US,OVERDOSE,1168
US,FEELING ABNORMAL,1167
US,URINARY TRACT INFECTION,1128
US,CHEST PAIN,1118
US,DEPRESSION,1101
US,SOMNOLENCE,1093
US,DRUG DOSE OMISSION,1073
US,HYPERTENSION,1031
US,ABDOMINAL PAIN UPPER,1030
US,GAIT DISTURBANCE,995
US,DRUG HYPERSENSITIVITY,987
US,MUSCLE SPASMS,985
US,ABDOMINAL DISCOMFORT,963
US,HYPOTENSION,956
US,DRUG ADMINISTRATION ERROR,934
US,CHILLS,913
US,DEHYDRATION,912
US,GASTROINTESTINAL HAEMORRHAGE,903
US,PERIPHERAL SWELLING,882
US,NASOPHARYNGITIS,865
US,HYPOAESTHESIA,838
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,793
US,WEIGHT INCREASED,780
US,CONDITION AGGRAVATED,773
US,MYALGIA,773
US,PRODUCT USE IN UNAPPROVED INDICATION,761
US,CONFUSIONAL STATE,760
US,TREMOR,758
US,URTICARIA,758
US,BLOOD PRESSURE INCREASED,752
US,PARAESTHESIA,720
US,ERYTHEMA,710
US,ACUTE KIDNEY INJURY,700
US,OEDEMA PERIPHERAL,698
US,THERAPEUTIC RESPONSE UNEXPECTED,695
US,INTENTIONAL PRODUCT MISUSE,682
US,HYPERSENSITIVITY,675
US,INFUSION RELATED REACTION,671
US,INTENTIONAL OVERDOSE,669
US,BRONCHITIS,666
US,INJECTION SITE PAIN,665
US,CONTUSION,658
US,SEPSIS,656
US,ALOPECIA,641
US,MUSCULAR WEAKNESS,625
US,HYPERHIDROSIS,616
US,PULMONARY EMBOLISM,616
US,NEUROPATHY PERIPHERAL,606
US,DRUG EFFECT INCOMPLETE,594
US,VISION BLURRED,593
US,ATRIAL FIBRILLATION,589
US,EPISTAXIS,574
US,MEMORY IMPAIRMENT,571
US,OROPHARYNGEAL PAIN,565
US,INFLUENZA LIKE ILLNESS,562
US,DEEP VEIN THROMBOSIS,560
US,DYSPEPSIA,560
US,GASTROOESOPHAGEAL REFLUX DISEASE,557
US,FLUSHING,551
US,MIGRAINE,542
US,DYSPHAGIA,539
US,DISEASE PROGRESSION,534
US,CHEST DISCOMFORT,526
US,THROMBOCYTOPENIA,526
US,HAEMOGLOBIN DECREASED,518
US,UNDERDOSE,514
US,MUSCULOSKELETAL PAIN,507
US,UPPER RESPIRATORY TRACT INFECTION,507
US,ABDOMINAL DISTENSION,505
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,504
US,CEREBROVASCULAR ACCIDENT,500
US,BALANCE DISORDER,499
US,PLATELET COUNT DECREASED,496
US,ARTHRITIS,495
US,WHITE BLOOD CELL COUNT DECREASED,494
US,PRODUCT QUALITY ISSUE,491
US,INFLUENZA,484
US,SEIZURE,468
US,INJURY,462
US,INFECTION,461
US,DRUG ABUSE,453
US,JOINT SWELLING,453
US,CARDIAC FAILURE CONGESTIVE,452
US,ACUTE HEPATIC FAILURE,451
US,INCORRECT DRUG ADMINISTRATION DURATION,451
US,RENAL FAILURE,449
US,EXTRA DOSE ADMINISTERED,442
US,PALPITATIONS,440
US,SWELLING,440
US,HEART RATE INCREASED,436
US,EXPIRED PRODUCT ADMINISTERED,429
US,DYSGEUSIA,428
US,LOSS OF CONSCIOUSNESS,425
US,PLEURAL EFFUSION,425
US,TACHYCARDIA,425
US,DRY MOUTH,424
US,RESPIRATORY FAILURE,419
US,BLOOD GLUCOSE INCREASED,415
US,NECK PAIN,407
US,SYNCOPE,403
US,MUSCULOSKELETAL STIFFNESS,395
US,HAEMORRHAGE,390
US,CARDIAC ARREST,387
US,INTENTIONAL PRODUCT USE ISSUE,382
US,CELLULITIS,381
US,DRY SKIN,375
US,BONE PAIN,374
US,LETHARGY,373
US,FEBRILE NEUTROPENIA,370
US,OSTEOARTHRITIS,369
US,VISUAL IMPAIRMENT,369
US,MYOCARDIAL INFARCTION,365
US,NEUTROPENIA,364
US,INJECTION SITE ERYTHEMA,362
US,SUICIDE ATTEMPT,362
US,RHINORRHOEA,359
US,STOMATITIS,357
US,CARDIO-RESPIRATORY ARREST,356
US,THROMBOSIS,350
US,UNEVALUABLE EVENT,347
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,342
US,CROHN^S DISEASE,337
US,PRODUCT PACKAGING ISSUE,336
US,HOT FLUSH,330
US,ASTHMA,329
US,MALIGNANT NEOPLASM PROGRESSION,329
US,HALLUCINATION,326
US,FLATULENCE,322
US,RECTAL HAEMORRHAGE,320
US,RHEUMATOID ARTHRITIS,316
US,BURNING SENSATION,314
US,OEDEMA,314
US,NASAL CONGESTION,310
US,DRUG INTOLERANCE,309
US,EXPOSURE DURING PREGNANCY,308
US,HEPATIC ENZYME INCREASED,307
US,DYSPHONIA,303
US,COAGULOPATHY,300
US,PLASMA CELL MYELOMA,297
US,HYPOXIA,295
US,MENTAL STATUS CHANGES,295
US,ADVERSE EVENT,294
US,ALANINE AMINOTRANSFERASE INCREASED,292
US,DRUG EFFECT DECREASED,288
US,HYPOKALAEMIA,287
US,MULTIPLE SCLEROSIS RELAPSE,287
US,SWELLING FACE,287
US,CATARACT,284
US,STRESS,284
US,AMNESIA,282
US,BLOOD CREATININE INCREASED,282
US,ASPARTATE AMINOTRANSFERASE INCREASED,279
US,BLISTER,279
US,EMOTIONAL DISTRESS,279
US,RASH PRURITIC,278
US,FEELING HOT,276
US,PANCYTOPENIA,276
US,FLUID RETENTION,275
US,PRODUCTIVE COUGH,269
US,WHEEZING,269
US,ARTHROPATHY,260
US,CARDIAC DISORDER,259
US,HERPES ZOSTER,259
US,RENAL FAILURE ACUTE,257
US,INJECTION SITE BRUISING,255
US,FOETAL EXPOSURE DURING PREGNANCY,253
US,METABOLIC ACIDOSIS,253
US,OSTEOPOROSIS,251
US,ADVERSE DRUG REACTION,250
US,HYPONATRAEMIA,250
US,AGITATION,249
US,GENERAL PHYSICAL HEALTH DETERIORATION,249
US,HAEMATOCHEZIA,248
US,ORAL PAIN,248
US,ACCIDENTAL OVERDOSE,245
US,TRANSAMINASES INCREASED,243
US,EAR INFECTION,240
US,DYSPNOEA EXERTIONAL,237
US,PULMONARY OEDEMA,237
US,PSORIASIS,236
US,MOBILITY DECREASED,233
US,HEPATIC FAILURE,232
US,NIGHT SWEATS,232
US,LIVER FUNCTION TEST ABNORMAL,231
US,THROAT IRRITATION,231
US,SLEEP DISORDER,230
US,BLOOD PRESSURE DECREASED,229
US,GASTROINTESTINAL DISORDER,228
US,HAEMATURIA,225
US,LYMPHADENOPATHY,225
US,SKIN DISCOLOURATION,225
US,VERTIGO,225
US,ACCIDENTAL EXPOSURE TO PRODUCT,224
US,HOSPITALISATION,222
US,POLLAKIURIA,221
US,DYSURIA,220
US,CYSTITIS,219
US,SUICIDAL IDEATION,219
US,COMA,216
US,IRRITABILITY,215
US,RESPIRATORY ARREST,213
US,DIABETES MELLITUS,212
US,RED BLOOD CELL COUNT DECREASED,212
US,ACUTE RESPIRATORY FAILURE,211
US,NERVOUSNESS,211
US,HEAD INJURY,209
US,THERAPEUTIC RESPONSE DECREASED,209
US,DISCOMFORT,208
US,NEPHROLITHIASIS,207
US,PAIN IN JAW,207
US,BLOOD POTASSIUM DECREASED,206
US,LIVER DISORDER,205
US,SKIN EXFOLIATION,205
US,MEDICATION ERROR,202
US,WHITE BLOOD CELL COUNT INCREASED,201
US,LIVER INJURY,200
US,LEUKOCYTOSIS,199
US,STAPHYLOCOCCAL INFECTION,198
US,GASTRIC DISORDER,197
US,INTERNATIONAL NORMALISED RATIO INCREASED,197
US,RENAL IMPAIRMENT,197
US,HIP FRACTURE,195
US,URINARY INCONTINENCE,194
US,PRODUCT LABEL ISSUE,193
US,TINNITUS,192
US,SPEECH DISORDER,191
US,VIRAL INFECTION,191
US,TRANSIENT ISCHAEMIC ATTACK,190
US,ATELECTASIS,189
US,DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE,189
US,INTERVERTEBRAL DISC PROTRUSION,189
US,SLEEP APNOEA SYNDROME,189
US,CLOSTRIDIUM DIFFICILE INFECTION,188
US,HEPATOTOXICITY,188
US,RASH ERYTHEMATOUS,187
US,ANAPHYLACTIC REACTION,186
US,COLITIS,186
US,LOCAL SWELLING,186
US,OXYGEN SATURATION DECREASED,186
US,ABASIA,185
US,HYPERSOMNIA,185
US,OSTEONECROSIS OF JAW,185
US,CRYING,183
US,SEPTIC SHOCK,181
US,IMPAIRED HEALING,180
US,RENAL DISORDER,180
US,PANCREATITIS,179
US,CHOLELITHIASIS,178
US,LACERATION,178
US,HYPOPHAGIA,176
US,SPINAL OSTEOARTHRITIS,176
US,BLOOD CHOLESTEROL INCREASED,174
US,INJECTION SITE PRURITUS,174
US,BONE DISORDER,173
US,BRADYCARDIA,173
US,HAEMORRHOIDS,172
US,OSTEOPENIA,172
US,ROAD TRAFFIC ACCIDENT,172
US,DISTURBANCE IN ATTENTION,169
US,DRY EYE,169
US,HYPERGLYCAEMIA,169
US,FUNGAL INFECTION,168
US,HAEMOPTYSIS,168
US,RETCHING,168
US,UPPER GASTROINTESTINAL HAEMORRHAGE,168
US,FULL BLOOD COUNT DECREASED,167
US,DEPRESSED MOOD,166
US,MATERNAL EXPOSURE DURING PREGNANCY,166
US,EYE PAIN,165
US,INJECTION SITE SWELLING,165
US,LUNG INFECTION,165
US,NEURALGIA,164
US,RASH GENERALISED,164
US,OSTEOMYELITIS,163
US,PRE-EXISTING CONDITION IMPROVED,163
US,ACTIVITIES OF DAILY LIVING IMPAIRED,162
US,NO ADVERSE EVENT,162
US,DISORIENTATION,161
US,FEELING COLD,160
US,ENCEPHALOPATHY,159
US,GASTRITIS,159
US,SINUS DISORDER,159
US,TYPE 2 DIABETES MELLITUS,159
US,COLITIS ULCERATIVE,158
US,DEVICE ISSUE,158
US,HAEMATOCRIT DECREASED,158
US,DIVERTICULITIS,157
US,INJECTION SITE HAEMORRHAGE,157
US,URINARY RETENTION,157
US,DYSARTHRIA,156
US,HYPERKALAEMIA,156
US,COGNITIVE DISORDER,155
US,GASTROENTERITIS VIRAL,155
US,INTESTINAL OBSTRUCTION,153
US,PERICARDIAL EFFUSION,153
US,RASH MACULAR,152
US,UNRESPONSIVE TO STIMULI,152
US,INTENTIONAL UNDERDOSE,151
US,PNEUMONIA ASPIRATION,151
US,INTERVERTEBRAL DISC DEGENERATION,150
US,TOOTHACHE,150
US,IRRITABLE BOWEL SYNDROME,149
US,CEREBRAL HAEMORRHAGE,148
US,DRUG-INDUCED LIVER INJURY,148
US,LIMB DISCOMFORT,148
US,CORONARY ARTERY DISEASE,147
US,DEPRESSED LEVEL OF CONSCIOUSNESS,147
US,HAEMORRHAGIC ANAEMIA,146
US,HYPOGLYCAEMIA,146
US,HYPOTHYROIDISM,146
US,LACRIMATION INCREASED,146
US,THROAT TIGHTNESS,146
US,DRUG PRESCRIBING ERROR,145
US,VAGINAL HAEMORRHAGE,145
US,HIATUS HERNIA,144
US,RESPIRATORY DISTRESS,144
US,RIB FRACTURE,144
US,LUNG DISORDER,143
US,BLOOD BILIRUBIN INCREASED,142
US,PANIC ATTACK,142
US,JOINT STIFFNESS,140
US,FIBROMYALGIA,139
US,INFUSION SITE PAIN,139
US,MUSCULOSKELETAL CHEST PAIN,139
US,THERAPY CESSATION,139
US,TOOTH DISORDER,139
US,EYE IRRITATION,138
US,EYE SWELLING,138
US,HYPOACUSIS,138
US,HAEMATOMA,137
US,LIP SWELLING,137
US,MULTIPLE SCLEROSIS,137
US,PRURITUS GENERALISED,137
US,ASCITES,136
US,ABNORMAL BEHAVIOUR,135
US,LEUKOPENIA,135
US,PULMONARY MASS,135
US,DYSSTASIA,134
US,PNEUMONITIS,134
US,SURGERY,134
US,ACNE,133
US,CONVULSION,133
US,HYPERLIPIDAEMIA,133
US,CARDIAC FAILURE,132
US,GOUT,132
US,INTENTIONAL DRUG MISUSE,132
US,OCULAR HYPERAEMIA,132
US,PULMONARY HYPERTENSION,132
US,ACUTE MYOCARDIAL INFARCTION,131
US,ATRIAL SEPTAL DEFECT,131
US,CARDIOMEGALY,131
US,INJECTION SITE REACTION,131
US,METASTASES TO BONE,131
US,SWOLLEN TONGUE,130
US,EAR PAIN,128
US,FAECES DISCOLOURED,128
US,WOUND,128
US,BLOOD URINE PRESENT,127
US,HEART RATE DECREASED,127
US,BODY HEIGHT DECREASED,126
US,RESPIRATORY TRACT INFECTION,126
US,SMALL INTESTINAL OBSTRUCTION,126
US,ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD,125
US,BREAST CANCER,125
US,PRODUCT PHYSICAL ISSUE,125
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,125
US,INFLAMMATION,124
US,LIMB INJURY,124
US,SKIN DISORDER,124
US,VISUAL ACUITY REDUCED,124
US,FEELING JITTERY,123
US,FLUID OVERLOAD,123
US,PRESYNCOPE,123
US,CHRONIC KIDNEY DISEASE,122
US,ARRHYTHMIA,121
US,LOWER GASTROINTESTINAL HAEMORRHAGE,121
US,NIGHTMARE,121
US,POOR QUALITY SLEEP,120
US,ANGER,119
US,INFUSION SITE ERYTHEMA,119
US,MUCOSAL INFLAMMATION,119
US,RESTLESSNESS,119
US,TREATMENT NONCOMPLIANCE,119
US,CLOSTRIDIUM DIFFICILE COLITIS,118
US,FOOT FRACTURE,118
US,MUSCULOSKELETAL DISCOMFORT,118
US,SUBDURAL HAEMATOMA,118
US,KIDNEY INFECTION,117
US,PREMATURE BABY,117
US,SKIN ULCER,117
US,TENDERNESS,117
US,BODY TEMPERATURE INCREASED,116
US,CANDIDA INFECTION,116
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,116
US,INFUSION SITE SWELLING,116
US,APHASIA,115
US,MENTAL DISORDER,115
US,DEAFNESS,114
US,DRUG WITHDRAWAL SYNDROME,114
US,INTERNAL HAEMORRHAGE,114
US,LABORATORY TEST ABNORMAL,114
US,NEUTROPHIL COUNT DECREASED,114
US,RESTLESS LEGS SYNDROME,114
US,MOVEMENT DISORDER,113
US,NEOPLASM PROGRESSION,113
US,PROTHROMBIN TIME PROLONGED,112
US,SKIN LESION,112
US,DYSKINESIA,111
US,TRICUSPID VALVE INCOMPETENCE,111
US,HEPATIC ENCEPHALOPATHY,110
US,AGGRESSION,109
US,FOREIGN BODY,109
US,PRODUCT CONTAINER ISSUE,109
US,BLOOD COUNT ABNORMAL,108
US,HEPATIC STEATOSIS,108
US,MITRAL VALVE INCOMPETENCE,107
US,JOINT INJURY,106
US,PRODUCT DIFFICULT TO SWALLOW,106
US,SINUS CONGESTION,106
US,GLOSSODYNIA,105
US,PRODUCT CLOSURE REMOVAL DIFFICULT,105
US,DELIRIUM,104
US,DEVICE RELATED INFECTION,104
US,EATING DISORDER,104
US,SPINAL COLUMN STENOSIS,104
US,HEART RATE IRREGULAR,103
US,LOCALISED INFECTION,103
US,PHARYNGEAL OEDEMA,103
US,DIVERTICULUM,102
US,FEAR,102
US,FREQUENT BOWEL MOVEMENTS,102
US,MOOD SWINGS,101
US,BLOOD ALKALINE PHOSPHATASE INCREASED,100
US,BLOOD GLUCOSE DECREASED,100
US,CONGENITAL ANOMALY,100
US,DEVICE MALFUNCTION,100
US,EMOTIONAL DISORDER,100
US,SNEEZING,100
US,FEMUR FRACTURE,99
US,MATERNAL EXPOSURE TIMING UNSPECIFIED,99
US,PHOTOPHOBIA,99
US,ROTATOR CUFF SYNDROME,99
US,BLOOD PRESSURE ABNORMAL,98
US,DIPLOPIA,98
US,GINGIVAL BLEEDING,98
US,MUSCLE TWITCHING,98
US,SEASONAL ALLERGY,98
US,BACK DISORDER,97
US,PRODUCT SUBSTITUTION ISSUE,97
US,SINUS TACHYCARDIA,97
US,ANHEDONIA,96
US,HAEMORRHAGE INTRACRANIAL,96
US,SPLENOMEGALY,96
US,TOOTH ABSCESS,96
US,EXOSTOSIS,95
US,EYE DISORDER,95
US,JAUNDICE,95
US,SCIATICA,95
US,ABDOMINAL PAIN LOWER,94
US,COLD SWEAT,94
US,DENTAL CARIES,94
US,HYPERCALCAEMIA,94
US,INCORRECT PRODUCT STORAGE,94
US,PRODUCT PACKAGE ASSOCIATED INJURY,94
US,VITAMIN D DEFICIENCY,94
US,HEMIPARESIS,93
US,SCAR,93
US,BLOOD UREA INCREASED,92
US,CHROMATURIA,92
US,GASTRIC ULCER,92
US,MALNUTRITION,92
US,FAILURE TO THRIVE,91
US,LIGAMENT SPRAIN,91
US,LUNG INFILTRATION,91
US,MUSCLE TIGHTNESS,91
US,RESPIRATORY DISORDER,91
US,RHABDOMYOLYSIS,91
US,BLOOD SODIUM DECREASED,90
US,CARDIOMYOPATHY,90
US,DEMENTIA,90
US,HEAD DISCOMFORT,90
US,ILL-DEFINED DISORDER,90
US,INFUSION SITE EXTRAVASATION,90
US,MICTURITION URGENCY,90
US,SPINAL FRACTURE,90
US,TOOTH INFECTION,90
US,EYE PRURITUS,89
US,LUNG NEOPLASM MALIGNANT,89
US,MENTAL IMPAIRMENT,89
US,SPINAL COMPRESSION FRACTURE,89
US,CHOKING,88
US,HAEMATEMESIS,88
US,INJECTION SITE MASS,88
US,MASS,88
US,MOOD ALTERED,88
US,NEOPLASM MALIGNANT,88
US,UPPER LIMB FRACTURE,88
US,AGEUSIA,87
US,BLINDNESS,87
US,GLAUCOMA,87
US,LYMPHOCYTE COUNT DECREASED,87
US,MUSCLE SPASTICITY,87
US,PNEUMOTHORAX,87
US,GALLBLADDER DISORDER,86
US,INCREASED TENDENCY TO BRUISE,86
US,ORAL CANDIDIASIS,86
US,RESPIRATORY TRACT CONGESTION,86
US,WITHDRAWAL SYNDROME,86
US,ABNORMAL DREAMS,85
US,LIVER FUNCTION TEST INCREASED,85
US,MENORRHAGIA,85
US,PRODUCT SIZE ISSUE,85
US,THINKING ABNORMAL,85
US,BURSITIS,84
US,DECUBITUS ULCER,84
US,PALLOR,84
US,PATENT DUCTUS ARTERIOSUS,84
US,ANGINA PECTORIS,83
US,BASAL CELL CARCINOMA,83
US,FEEDING DISORDER,83
US,ORTHOSTATIC HYPOTENSION,83
US,PELVIC PAIN,83
US,SCOLIOSIS,83
US,SEDATION,83
US,BACTERAEMIA,82
US,METASTASES TO LIVER,82
US,RENAL CYST,82
US,STEVENS-JOHNSON SYNDROME,82
US,WRONG DRUG ADMINISTERED,82
US,ECCHYMOSIS,81
US,IRON DEFICIENCY ANAEMIA,81
US,RASH PAPULAR,81
US,ONYCHOCLASIS,80
US,PSORIATIC ARTHROPATHY,80
US,CARPAL TUNNEL SYNDROME,79
US,CHOKING SENSATION,79
US,ELECTROCARDIOGRAM QT PROLONGED,79
US,ELECTROLYTE IMBALANCE,78
US,ORAL DISCOMFORT,78
US,PULMONARY CONGESTION,78
US,SHOCK,78
US,ERUCTATION,77
US,SKIN BURNING SENSATION,77
US,VENTRICULAR SEPTAL DEFECT,77
US,ANKLE FRACTURE,76
US,CENTRAL NERVOUS SYSTEM LESION,76
US,CYST,76
US,IMPAIRED WORK ABILITY,76
US,LARGE INTESTINE POLYP,76
US,LOWER LIMB FRACTURE,76
US,RENAL FAILURE CHRONIC,76
US,EYE INFECTION,75
US,INFLAMMATORY BOWEL DISEASE,75
US,INFUSION SITE PRURITUS,75
US,OESOPHAGITIS,75
US,RESPIRATORY DEPRESSION,75
US,THIRST,75
US,HYPOAESTHESIA ORAL,74
US,MYELODYSPLASTIC SYNDROME,74
US,PHARYNGITIS STREPTOCOCCAL,74
US,PULMONARY ARTERIAL HYPERTENSION,74
US,BONE LESION,73
US,BRAIN OEDEMA,73
US,DECREASED INTEREST,73
US,INJECTION SITE RASH,73
US,INTERSTITIAL LUNG DISEASE,73
US,MUSCULOSKELETAL DISORDER,73
US,PAIN OF SKIN,73
US,PROCEDURAL PAIN,73
US,TENDONITIS,73
US,HYPOCALCAEMIA,72
US,KNEE ARTHROPLASTY,72
US,NERVOUS SYSTEM DISORDER,72
US,NOCTURIA,72
US,ORAL HERPES,72
US,ARTERIOSCLEROSIS,71
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,71
US,BLOOD MAGNESIUM DECREASED,71
US,FLANK PAIN,71
US,NODULE,71
US,OSTEOSCLEROSIS,71
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,71
US,SYSTEMIC LUPUS ERYTHEMATOSUS,71
US,TOOTH FRACTURE,71
US,TRANSFUSION,71
US,CONJUNCTIVITIS,70
US,HEPATIC CIRRHOSIS,70
US,HERNIA,70
US,OBESITY,70
US,TACHYPNOEA,70
US,VENTRICULAR TACHYCARDIA,70
US,WEIGHT FLUCTUATION,70
US,BACTERIAL INFECTION,69
US,HYPOMAGNESAEMIA,69
US,LYMPHOEDEMA,69
US,METASTASES TO LUNG,69
US,TOOTH LOSS,69
US,ABSCESS,68
US,ECZEMA,68
US,MOUTH ULCERATION,68
US,PREGNANCY,68
US,PSYCHOTIC DISORDER,68
US,PULMONARY FIBROSIS,68
US,ULCER,68
US,BLOOD POTASSIUM INCREASED,67
US,CARDIAC MURMUR,67
US,CONTRAINDICATED PRODUCT ADMINISTERED,67
US,INCONTINENCE,67
US,PLATELET COUNT INCREASED,67
US,TREATMENT FAILURE,67
US,WRIST FRACTURE,67
US,BLOOD PRESSURE FLUCTUATION,66
US,DRUG DEPENDENCE,66
US,FISTULA,66
US,GASTROENTERITIS,66
US,INCREASED APPETITE,66
US,INTENTIONAL SELF-INJURY,66
US,MELAENA,66
US,MIDDLE INSOMNIA,66
US,PRESCRIBED UNDERDOSE,66
US,CHOLECYSTITIS,65
US,GENERALISED TONIC-CLONIC SEIZURE,65
US,LARYNGITIS,65
US,DEFORMITY,64
US,FOOT DEFORMITY,64
US,PANCREATITIS ACUTE,64
US,SPINAL PAIN,64
US,UPPER-AIRWAY COUGH SYNDROME,64
US,HAIR COLOUR CHANGES,63
US,MALIGNANT MELANOMA,63
US,MULTI-ORGAN FAILURE,63
US,PARAESTHESIA ORAL,63
US,PARKINSON^S DISEASE,63
US,PRODUCT TASTE ABNORMAL,63
US,ANGIOEDEMA,62
US,HAEMORRHAGIC STROKE,62
US,MULTIPLE FRACTURES,62
US,PHARYNGITIS,62
US,PRODUCT LOT NUMBER ISSUE,62
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,62
US,PSYCHOMOTOR HYPERACTIVITY,62
US,TEMPERATURE INTOLERANCE,62
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,62
US,VITAMIN D DECREASED,62
US,ATRIAL FLUTTER,61
US,BLOOD IRON DECREASED,61
US,DIABETIC KETOACIDOSIS,61
US,DISABILITY,61
US,EXPOSED BONE IN JAW,61
US,EXPOSURE VIA INGESTION,61
US,HEPATOMEGALY,61
US,HYPOKINESIA,61
US,LACTIC ACIDOSIS,61
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,61
US,OSTEOLYSIS,61
US,SKIN CANCER,61
US,UROSEPSIS,61
US,ACUTE MYELOID LEUKAEMIA,60
US,ACUTE RESPIRATORY DISTRESS SYNDROME,60
US,APPETITE DISORDER,60
US,BLOOD LACTATE DEHYDROGENASE INCREASED,60
US,COORDINATION ABNORMAL,60
US,EYELID OEDEMA,60
US,GINGIVAL PAIN,60
US,MUSCLE STRAIN,60
US,NERVE INJURY,60
US,PROTEINURIA,60
US,DRUG DISPENSING ERROR,59
US,EMPHYSEMA,59
US,HAIR TEXTURE ABNORMAL,59
US,PARANOIA,59
US,POST PROCEDURAL HAEMORRHAGE,59
US,PRESCRIBED OVERDOSE,59
US,RHINITIS ALLERGIC,59
US,SENSORY DISTURBANCE,59
US,SKIN INFECTION,59
US,ACIDOSIS,58
US,BLADDER DISORDER,58
US,BLOOD TRIGLYCERIDES INCREASED,58
US,CONTRAINDICATED DRUG ADMINISTERED,58
US,DERMATITIS,58
US,DISSEMINATED INTRAVASCULAR COAGULATION,58
US,EJECTION FRACTION DECREASED,58
US,HEPATITIS,58
US,HUNGER,58
US,HYDRONEPHROSIS,58
US,INJECTION SITE URTICARIA,58
US,LOWER RESPIRATORY TRACT INFECTION,58
US,PATHOLOGICAL FRACTURE,58
US,FACIAL PAIN,57
US,GASTROINTESTINAL PAIN,57
US,HEPATIC NECROSIS,57
US,MENINGITIS ASEPTIC,57
US,SINUS HEADACHE,57
US,THROMBOPHLEBITIS SUPERFICIAL,57
US,THYROID DISORDER,57
US,BACK INJURY,56
US,BLOOD CALCIUM DECREASED,56
US,BRONCHOSPASM,56
US,CONCUSSION,56
US,EAR DISCOMFORT,56
US,HALLUCINATION_ VISUAL,56
US,HYPOVOLAEMIA,56
US,IMMUNE SYSTEM DISORDER,56
US,ISCHAEMIC STROKE,56
US,MALABSORPTION,56
US,POOR QUALITY DRUG ADMINISTERED,56
US,SEROTONIN SYNDROME,56
US,TOXIC EPIDERMAL NECROLYSIS,56
US,CYTOPENIA,55
US,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,55
US,ADRENAL INSUFFICIENCY,54
US,APPLICATION SITE ERYTHEMA,54
US,CEREBRAL INFARCTION,54
US,ESSENTIAL HYPERTENSION,54
US,GROIN PAIN,54
US,HAEMOLYTIC ANAEMIA,54
US,HAEMORRHOIDAL HAEMORRHAGE,54
US,HEPATIC FUNCTION ABNORMAL,54
US,JOINT DISLOCATION,54
US,MUSCLE ATROPHY,54
US,POST PROCEDURAL COMPLICATION,54
US,SPINAL DISORDER,54
US,SUPRAVENTRICULAR TACHYCARDIA,54
US,ABORTION SPONTANEOUS,53
US,ARTERIOSCLEROSIS CORONARY ARTERY,53
US,CHOLECYSTECTOMY,53
US,COMPRESSION FRACTURE,53
US,LYMPHOMA,53
US,METASTASES TO CENTRAL NERVOUS SYSTEM,53
US,MULTIPLE ALLERGIES,53
US,NERVE COMPRESSION,53
US,PRODUCT ADHESION ISSUE,53
US,PULMONARY THROMBOSIS,53
US,BREAST PAIN,52
US,ILEUS,52
US,IMPAIRED GASTRIC EMPTYING,52
US,JOINT EFFUSION,52
US,LUMBAR SPINAL STENOSIS,52
US,MYDRIASIS,52
US,PROCTALGIA,52
US,SECOND PRIMARY MALIGNANCY,52
US,SUBARACHNOID HAEMORRHAGE,52
US,VENTRICULAR EXTRASYSTOLES,52
US,ADVERSE REACTION,51
US,BLOOD TEST ABNORMAL,51
US,DECREASED ACTIVITY,51
US,DELUSION,51
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,51
US,DRUG EFFECT DELAYED,51
US,DRY THROAT,51
US,HYPERCHOLESTEROLAEMIA,51
US,JOINT RANGE OF MOTION DECREASED,51
US,NO THERAPEUTIC RESPONSE,51
US,SKIN IRRITATION,51
US,ATAXIA,50
US,CORONARY ARTERY OCCLUSION,50
US,GENERALISED OEDEMA,50
US,HYPERKERATOSIS,50
US,MACULAR DEGENERATION,50
US,RENAL TUBULAR NECROSIS,50
US,SINUS BRADYCARDIA,50
US,SPUTUM DISCOLOURED,50
US,WOUND INFECTION,50
US,GAIT INABILITY,49
US,INJECTION SITE EXTRAVASATION,49
US,MULTIPLE ORGAN DYSFUNCTION SYNDROME,49
US,PRODUCT USE COMPLAINT,49
US,SKIN WARM,49
US,SQUAMOUS CELL CARCINOMA,49
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,48
US,HEARING IMPAIRED,48
US,LEFT VENTRICULAR HYPERTROPHY,48
US,MOUTH HAEMORRHAGE,48
US,PHOTOSENSITIVITY REACTION,48
US,RASH MACULO-PAPULAR,48
US,SKIN FISSURES,48
US,SKIN HAEMORRHAGE,48
US,ADMINISTRATION SITE SWELLING,47
US,BIPOLAR DISORDER,47
US,BONE MARROW FAILURE,47
US,HAEMOLYSIS,47
US,HEREDITARY ANGIOEDEMA,47
US,METASTASES TO SPINE,47
US,ORAL DISORDER,47
US,PETECHIAE,47
US,PROSTATE CANCER,47
US,SCAB,47
US,VITREOUS FLOATERS,47
US,APHONIA,46
US,EYE DISCHARGE,46
US,FACE OEDEMA,46
US,HYPOPHOSPHATAEMIA,46
US,PELVIC FRACTURE,46
US,PERONEAL NERVE PALSY,46
US,URINE OUTPUT DECREASED,46
US,VERTEBRAL FORAMINAL STENOSIS,46
US,AORTIC ARTERIOSCLEROSIS,45
US,AORTIC VALVE INCOMPETENCE,45
US,BEDRIDDEN,45
US,BONE LOSS,45
US,FEELING DRUNK,45
US,HYPERBILIRUBINAEMIA,45
US,INITIAL INSOMNIA,45
US,MYOCLONUS,45
US,ORAL MUCOSAL BLISTERING,45
US,PRODUCT FORMULATION ISSUE,45
US,PYELONEPHRITIS,45
US,SENSORY LOSS,45
US,SQUAMOUS CELL CARCINOMA OF SKIN,45
US,TENDON RUPTURE,45
US,BRAIN INJURY,44
US,CARDIOGENIC SHOCK,44
US,CHOLECYSTITIS CHRONIC,44
US,CYANOSIS,44
US,DERMATITIS CONTACT,44
US,DEVELOPMENTAL DELAY,44
US,DISEASE RECURRENCE,44
US,EXPOSURE DURING BREAST FEEDING,44
US,GASTRIC HAEMORRHAGE,44
US,HYPERAESTHESIA,44
US,IMMUNODEFICIENCY,44
US,INJECTION SITE WARMTH,44
US,KYPHOSIS,44
US,NASAL DRYNESS,44
US,PARALYSIS,44
US,PERIPHERAL COLDNESS,44
US,PREMATURE DELIVERY,44
US,SKIN REACTION,44
US,ASPIRATION,43
US,BLINDNESS UNILATERAL,43
US,END STAGE RENAL DISEASE,43
US,IMPAIRED DRIVING ABILITY,43
US,METASTASES TO LYMPH NODES,43
US,OVARIAN CYST,43
US,POISONING,43
US,PRODUCT STORAGE ERROR,43
US,TUMOUR LYSIS SYNDROME,43
US,ANION GAP,42
US,APNOEA,42
US,APPLICATION SITE PRURITUS,42
US,BREATH SOUNDS ABNORMAL,42
US,EYE HAEMORRHAGE,42
US,GLOMERULAR FILTRATION RATE DECREASED,42
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,42
US,INFUSION SITE NODULE,42
US,MENISCUS INJURY,42
US,NAIL DISORDER,42
US,PERITONITIS,42
US,PRIMARY SEQUESTRUM,42
US,RENAL PAIN,42
US,RIGHT VENTRICULAR FAILURE,42
US,TROPONIN INCREASED,42
US,ULCER HAEMORRHAGE,42
US,ABDOMINAL TENDERNESS,41
US,ABNORMAL LOSS OF WEIGHT,41
US,ADMINISTRATION SITE PAIN,41
US,APPLICATION SITE PAIN,41
US,ATTENTION DEFICIT/HYPERACTIVITY DISORDER,41
US,DEVICE DISLOCATION,41
US,ERECTILE DYSFUNCTION,41
US,FURUNCLE,41
US,HALLUCINATION_ AUDITORY,41
US,METABOLIC ENCEPHALOPATHY,41
US,OSTEONECROSIS,41
US,POLYP,41
US,RENAL INJURY,41
US,SPINAL OPERATION,41
US,AORTIC ANEURYSM,40
US,DIABETIC NEUROPATHY,40
US,DRUG SCREEN POSITIVE,40
US,HEPATIC LESION,40
US,HOSPICE CARE,40
US,INTERVERTEBRAL DISC DISORDER,40
US,LEFT VENTRICULAR DYSFUNCTION,40
US,LOOSE TOOTH,40
US,MAJOR DEPRESSION,40
US,PERIPHERAL VASCULAR DISORDER,40
US,PULMONARY HAEMORRHAGE,40
US,BENIGN PROSTATIC HYPERPLASIA,39
US,BLOOD ALBUMIN DECREASED,39
US,BREAST CANCER METASTATIC,39
US,CEREBRAL ATROPHY,39
US,DIVERTICULUM INTESTINAL,39
US,FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT,39
US,GASTROINTESTINAL INFECTION,39
US,GINGIVITIS,39
US,HEART DISEASE CONGENITAL,39
US,HEPATIC CYST,39
US,HIP ARTHROPLASTY,39
US,SENSATION OF FOREIGN BODY,39
US,SNORING,39
US,THERAPY NON-RESPONDER,39
US,WALKING AID USER,39
US,AORTIC CALCIFICATION,38
US,BARRETT^S OESOPHAGUS,38
US,BLOOD CALCIUM INCREASED,38
US,BLOOD GLUCOSE ABNORMAL,38
US,CARDIOVASCULAR DISORDER,38
US,DIALYSIS,38
US,DIARRHOEA HAEMORRHAGIC,38
US,ELECTROCARDIOGRAM ABNORMAL,38
US,FRACTURE,38
US,HYPERTHYROIDISM,38
US,NEUTROPHIL COUNT INCREASED,38
US,NON-CARDIAC CHEST PAIN,38
US,ONYCHOMYCOSIS,38
US,OTITIS MEDIA,38
US,POST-TRAUMATIC STRESS DISORDER,38
US,PRODUCT COMMINGLING,38
US,PROSTATOMEGALY,38
US,SECRETION DISCHARGE,38
US,SLUGGISHNESS,38
US,SPINAL CORD COMPRESSION,38
US,TONGUE DISORDER,38
US,UTERINE LEIOMYOMA,38
US,UTERINE PERFORATION,38
US,ANORECTAL DISCOMFORT,37
US,CATAPLEXY,37
US,COLON CANCER,37
US,FOOD ALLERGY,37
US,HAEMORRHAGIC DIATHESIS,37
US,HANGOVER,37
US,HICCUPS,37
US,PRODUCT EXPIRATION DATE ISSUE,37
US,SKIN HYPERPIGMENTATION,37
US,SOMNAMBULISM,37
US,BOWEL MOVEMENT IRREGULARITY,36
US,CLAVICLE FRACTURE,36
US,ESCHERICHIA URINARY TRACT INFECTION,36
US,HAND FRACTURE,36
US,INFUSION SITE BRUISING,36
US,INTESTINAL ISCHAEMIA,36
US,PERSONALITY CHANGE,36
US,PURULENT DISCHARGE,36
US,RHINITIS,36
US,SKIN ABRASION,36
US,BONE DENSITY DECREASED,35
US,C-REACTIVE PROTEIN INCREASED,35
US,CHRONIC SINUSITIS,35
US,DEMENTIA ALZHEIMER^S TYPE,35
US,DYSLIPIDAEMIA,35
US,ENERGY INCREASED,35
US,INCREASED UPPER AIRWAY SECRETION,35
US,INTERVERTEBRAL DISC SPACE NARROWING,35
US,NEUROGENIC BLADDER,35
US,ODYNOPHAGIA,35
US,PARANASAL SINUS HYPERSECRETION,35
US,PHARYNGEAL DISORDER,35
US,RALES,35
US,SPONDYLOLISTHESIS,35
US,SYNOVIAL CYST,35
US,VISUAL FIELD DEFECT,35
US,ANAPHYLACTIC SHOCK,34
US,ARTHRITIS INFECTIVE,34
US,CHOLECYSTITIS ACUTE,34
US,HEPATITIS ACUTE,34
US,HYPERNATRAEMIA,34
US,HYPOALBUMINAEMIA,34
US,INJECTION SITE NODULE,34
US,METASTATIC RENAL CELL CARCINOMA,34
US,NEPHROPATHY,34
US,OCULAR DISCOMFORT,34
US,ORTHOPNOEA,34
VE,DRUG-INDUCED LIVER INJURY,2
VE,DEATH,1
VE,DECREASED APPETITE,1
VE,DIARRHOEA,1
VE,DIZZINESS,1
VE,DRUG INEFFECTIVE,1
VE,FLATULENCE,1
VE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
VE,GENERAL PHYSICAL HEALTH DETERIORATION,1
VE,HAEMORRHAGE,1
VE,HEPATOCELLULAR INJURY,1
VE,INFARCTION,1
VE,IRRITABLE BOWEL SYNDROME,1
VE,MELANOSIS COLI,1
VE,MOBILITY DECREASED,1
VE,OBSTRUCTIVE UROPATHY,1
VE,PETECHIAE,1
VE,PYREXIA,1
VE,SPLEEN DISORDER,1
VE,ULTRASOUND SCAN ABNORMAL,1
VE,WEIGHT DECREASED,1
VN,FATIGUE,2
VN,PYREXIA,2
VN,TACHYCARDIA,2
VN,ANAEMIA,1
VN,CHILLS,1
VN,DECREASED APPETITE,1
VN,DYSPNOEA,1
VN,HEART RATE INCREASED,1
VN,HYPERHIDROSIS,1
VN,HYPERTHYROIDISM,1
VN,HYPOTENSION,1
VN,MUCOSAL DISCOLOURATION,1
VN,NEUTROPENIA,1
VN,PALLOR,1
VN,PANIC REACTION,1
VN,SERUM FERRITIN INCREASED,1
VN,THROMBOCYTOPENIA,1
VN,TRANSAMINASES INCREASED,1
VN,URTICARIA,1
YE,HALLUCINATION_ VISUAL,1
ZM,AMPUTATION,1
ZM,PERIPHERAL VASCULAR DISORDER,1
ZM,VASOCONSTRICTION,1
ZW,CONFUSIONAL STATE,1
ZW,DECREASED APPETITE,1
ZW,DIARRHOEA,1
ZW,INSOMNIA,1
ZW,LOCAL SWELLING,1
